WO2020217710A1 - Compound, liquid crystal composition, and liquid crystal display element - Google Patents

Compound, liquid crystal composition, and liquid crystal display element Download PDF

Info

Publication number
WO2020217710A1
WO2020217710A1 PCT/JP2020/008675 JP2020008675W WO2020217710A1 WO 2020217710 A1 WO2020217710 A1 WO 2020217710A1 JP 2020008675 W JP2020008675 W JP 2020008675W WO 2020217710 A1 WO2020217710 A1 WO 2020217710A1
Authority
WO
WIPO (PCT)
Prior art keywords
replaced
diyl
hydrogen
fluorine
carbon atoms
Prior art date
Application number
PCT/JP2020/008675
Other languages
French (fr)
Japanese (ja)
Inventor
智広 矢野
和寛 荻田
Original Assignee
Jnc株式会社
Jnc石油化学株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jnc株式会社, Jnc石油化学株式会社 filed Critical Jnc株式会社
Priority to JP2021515844A priority Critical patent/JPWO2020217710A1/ja
Priority to CN202080029849.5A priority patent/CN113710652A/en
Publication of WO2020217710A1 publication Critical patent/WO2020217710A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00Thiocarboxylic acids
    • C07C327/20Esters of monothiocarboxylic acids
    • C07C327/28Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/10Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings
    • C09K19/12Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings at least two benzene rings directly linked, e.g. biphenyls
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/10Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings
    • C09K19/14Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a carbon chain
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/10Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings
    • C09K19/14Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a carbon chain
    • C09K19/16Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a carbon chain the chain containing carbon-to-carbon double bonds, e.g. stilbenes
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/10Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings
    • C09K19/14Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a carbon chain
    • C09K19/18Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a carbon chain the chain containing carbon-to-carbon triple bonds, e.g. tolans
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/10Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings
    • C09K19/20Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a chain containing carbon and oxygen atoms as chain links, e.g. esters or ethers
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/30Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/32Non-steroidal liquid crystal compounds containing condensed ring systems, i.e. fused, bridged or spiro ring systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/38Polymers
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/52Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K19/54Additives having no specific mesophase characterised by their chemical composition
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/52Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K19/54Additives having no specific mesophase characterised by their chemical composition
    • C09K19/56Aligning agents
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells

Definitions

  • the present invention relates to a liquid crystal composition having positive or negative anisotropy, and a liquid crystal display element containing this composition.
  • the classification based on the operation mode of the liquid crystal molecule is PC (phase change), TN (twisted nematic), STN (super twisted nematic), ECB (electrically controlled birefringence), OCB (optically compensated bend), IPS. (In-plane switching), VA (vertical alignment), FFS (fringe field switching), FPA (field-induced photo-reactive alignment) and other modes.
  • the classifications based on the drive method of the element are PM (passive matrix) and AM (active matrix). PM is classified into static, multiplex and the like, and AM is classified into TFT (thin film transistor), MIM (metal insulator metal) and the like.
  • TFT is amorphous silicon (amorphous silicon) and polycrystalline silicon (polycrystal silicon). The latter is classified into a high temperature type and a low temperature type according to the manufacturing process.
  • the classification based on the light source is a reflective type that uses natural light, a transmissive type that uses a backlight, and a transflective type that uses both natural light and a backlight.
  • the liquid crystal display element contains a liquid crystal composition having a nematic phase.
  • This composition has suitable properties. By improving the characteristics of this composition, an AM element having good characteristics can be obtained.
  • the relationship between the two characteristics is summarized in Table 1 below.
  • the properties of the composition will be further described based on commercially available AM devices.
  • the temperature range of the nematic phase is related to the temperature range in which the device can be used.
  • the preferred upper limit temperature of the nematic phase is about 70 ° C. or higher, and the preferred lower limit temperature of the nematic phase is about ⁇ 10 ° C. or lower.
  • the viscosity of the composition is related to the response time of the device. A short response time is preferred for displaying moving images on the device. A shorter response time of even 1 millisecond is desirable. Therefore, a small viscosity in the composition is preferred. Small viscosities at low temperatures are more preferred.
  • the optical anisotropy of the composition is related to the contrast ratio of the device. Depending on the mode of the device, a large optical anisotropy or a small optical anisotropy, that is, an appropriate optical anisotropy is required.
  • the product ( ⁇ n ⁇ d) of the optical anisotropy ( ⁇ n) of the composition and the cell gap (d) of the device is designed to maximize the contrast ratio.
  • the appropriate product value depends on the type of operating mode. This value is about 0.45 ⁇ m for devices in modes such as TN. This value ranges from about 0.30 ⁇ m to about 0.40 ⁇ m for VA mode devices and from about 0.20 ⁇ m to about 0.30 ⁇ m for IPS or FFS mode devices.
  • a composition having a large optical anisotropy is preferable for a device having a small cell gap.
  • the large permittivity anisotropy in the composition contributes to the low threshold voltage, low power consumption and large contrast ratio in the device. Therefore, a large positive or negative dielectric anisotropy is preferable.
  • a large resistivity in the composition contributes to a large voltage retention and a large contrast ratio in the device. Therefore, a composition having a large resistivity at an initial stage not only at room temperature but also at a temperature close to the upper limit temperature of the nematic phase is preferable.
  • a composition having a large specific resistance not only at room temperature but also at a temperature close to the upper limit temperature of the nematic phase is preferable.
  • the stability of the composition against UV and heat is related to the life of the device. When this stability is high, the life of the device is long. Such characteristics are preferable for AM elements used in liquid crystal projectors, liquid crystal televisions, and the like.
  • a composition having a positive dielectric anisotropy is used in the AM device having the TN mode.
  • a composition having a negative dielectric anisotropy is used in an AM device having an IPS mode or an FFS mode.
  • a composition having positive or negative dielectric anisotropy is used in an AM device having an IPS mode or an FFS mode.
  • a composition having positive or negative dielectric anisotropy is used in an AM device having an IPS mode or an FFS mode.
  • a composition having positive or negative dielectric anisotropy is used in a polymer sustained alignment (PSA) type AM device.
  • a composition having positive or negative dielectric anisotropy is used in a polymer sustained alignment (PSA) type liquid crystal display element. First, the composition to which a small amount of the polymerizable compound is added is injected into the device.
  • the composition is irradiated with ultraviolet rays while applying a voltage between the substrates of this device.
  • the polymerizable compound polymerizes to form a network structure of the polymer in the composition.
  • the response time of the device is shortened and the burn-in of the image is improved.
  • Such effects of the polymer can be expected for devices having modes such as TN, ECB, OCB, IPS, VA, FFS, FPA.
  • Patent Documents 1, 2 or 3 a method of controlling the orientation of a liquid crystal by using a low molecular weight compound having a cinnamate group, polyvinyl synnamate, a low molecular weight compound having a chalcone structure, a low molecular weight compound having an azobenzene structure, or a dendrimer is used. It has been reported (Patent Documents 1, 2 or 3). In the method of Patent Documents 1, 2 or 3, first, the low molecular weight compound or polymer is dissolved in the liquid crystal composition as an additive. Next, the additive is phase-separated to form a thin film composed of the low molecular weight compound or polymer on the substrate.
  • the substrate is irradiated with linearly polarized light at a temperature higher than the upper limit temperature of the liquid crystal composition.
  • this linearly polarized light dimerizes or isomerizes a low molecular weight compound or polymer
  • the molecules are arranged in a certain direction.
  • an element in a horizontal orientation mode such as IPS or FFS and an element in a vertical orientation mode such as VA can be manufactured.
  • it is important that the low molecular weight compound or polymer is easily dissolved at a temperature higher than the upper limit temperature of the liquid crystal composition, and when the temperature is returned to room temperature, the compound is easily phase-separated from the liquid crystal composition.
  • Patent Document 2 contains a compound (S-1) (paragraph 0034 of the specification, [Chemical Formula 2]), and a patent.
  • Document 3 describes compound (S-2) (compound of P176 in the specification [14]) and the like.
  • S-1 pargraph 0034 of the specification, [Chemical Formula 2]
  • S-2 compound of P176 in the specification [14]
  • these compounds require high-energy light irradiation in order to horizontally orient the liquid crystal molecules with sufficient orientation, and there is a concern that the production time will increase due to long-term light irradiation and that the liquid crystal will be damaged. Yes, improvement is desired.
  • the first object of the present invention is at least one of high chemical stability, high ability to horizontally orient liquid crystal molecules, high orientation over a wide range of additive concentrations, appropriate reactivity, and high solubility in liquid crystal compositions. It is to provide a compound which has two characteristics and is expected to have a large voltage retention when used in a liquid crystal display element.
  • the second challenge is to include this compound and have a high upper limit temperature of the nematic phase, a lower lower limit temperature of the nematic phase, a small viscosity, proper optical anisotropy, a large positive or negative dielectric anisotropy, a large specific resistance.
  • the third problem is that when this composition is contained and the polar compound forms a film in the device by irradiating the composition with ultraviolet rays, the film has appropriate hardness, low permeability of the components to be contacted, and high weather resistance. At least one characteristic of property, at least one characteristic of appropriate volume resistance, wide temperature range in which the device can be used, short response time, high voltage retention, low threshold voltage, large contrast ratio, long life. It is to provide the liquid crystal display element which has.
  • the first advantages of the present invention are at least chemically high stability, high ability to orient liquid crystal molecules horizontally, high orientation over a wide range of addition concentrations, suitable reactivity, and high solubility in liquid crystal compositions. It is to provide a compound which has one and is expected to have a large voltage retention when used in a liquid crystal display element.
  • the second advantage is that it contains this compound and has a high upper limit temperature of the nematic phase, a lower lower limit temperature of the nematic phase, a small viscosity, suitable optical anisotropy, a large positive or negative dielectric anisotropy, a large specific resistance.
  • the third advantage is that the composition contains this composition, and when the polar compound forms a film in the device by irradiating the composition with ultraviolet rays, the film has appropriate hardness, low permeability of the components to be contacted, and high weather resistance. At least one characteristic of property, at least one characteristic of appropriate volume resistance, wide temperature range in which the device can be used, short response time, high voltage retention, low threshold voltage, large contrast ratio, long life. It is to provide the liquid crystal display element which has. By using the liquid crystal composition containing the compound of the present invention, the step of forming the alignment film becomes unnecessary, so that a liquid crystal display element having a reduced manufacturing cost can be obtained.
  • liquid crystal composition and “liquid crystal display element” may be abbreviated as “composition” and “element”, respectively.
  • “Liquid crystal display element” is a general term for a liquid crystal display panel and a liquid crystal display module.
  • the “liquid crystal compound” is a compound having a liquid crystal phase such as a nematic phase or a smectic phase, and a compound having no liquid crystal phase, but is composed for the purpose of adjusting characteristics such as temperature range, viscosity, and dielectric anisotropy of the nematic phase. It is a general term for compounds mixed in a product.
  • This compound has a six-membered ring such as 1,4-cyclohexylene and 1,4-phenylene, and its molecular structure is rod-like.
  • the "polymerizable compound” is a compound added for the purpose of forming a polymer in the composition.
  • a "polar compound” helps liquid crystal molecules to align by interacting with polar groups on the substrate surface.
  • the liquid crystal composition is prepared by mixing a plurality of liquid crystal compounds.
  • the proportion (content) of the liquid crystal compound is expressed as a weight percentage (% by weight) based on the weight of the liquid crystal composition.
  • Additives such as optically active compounds, antioxidants, ultraviolet absorbers, dyes, defoamers, polymerizable compounds, polymerization initiators, polymerization inhibitors, and polar compounds are added to the liquid crystal composition as needed.
  • the ratio of the additive is expressed as a weight percentage (% by weight) based on the weight of the liquid crystal composition, similarly to the ratio of the liquid crystal compound. Parts per million (ppm) by weight may also be used.
  • the ratio of the polymerization initiator and the polymerization inhibitor is exceptionally expressed based on the weight of the polymerizable compound.
  • the compound represented by the formula (1) may be abbreviated as "compound (1)".
  • Compound (1) means one compound represented by the formula (1), a mixture of two compounds, or a mixture of three or more compounds. This rule also applies to at least one compound selected from the group of compounds represented by the formula (2).
  • Symbols such as B 1 , C 1 , and F enclosed in a hexagon correspond to ring B 1 , ring C 1 , and ring F, respectively.
  • the hexagon represents a six-membered ring such as a cyclohexane ring or a benzene ring or a fused ring such as a naphthalene ring.
  • the diagonal lines across this hexagon indicate that any hydrogen on the ring may be replaced by a group such as -Sp 1- P 1 .
  • Subscripts such as e indicate the number of replaced groups. When the subscript is 0, there is no such replacement.
  • the symbol of the terminal groups R 11 was used in a plurality of component compounds.
  • two groups represented by any two R 11 may be the same or different.
  • R 11 of compound (2) is ethyl and R 11 of compound (3) is ethyl.
  • R 11 of compound (2) is ethyl and R 11 of compound (3) is propyl.
  • This rule also applies to symbols such as other end groups, rings, and binding groups.
  • i when i is 2, two rings D 1 are present.
  • two groups two rings D 1 represents may be the same or different.
  • i applies to any two rings D 1 of the case 2 larger.
  • This rule also applies to symbols such as other rings and binding groups.
  • the expression "at least one'A'” means that the number of'A's is arbitrary.
  • the expression “at least one'A'may be replaced by'B'” is that when the number of'A's is 1, the position of the'A'is arbitrary and the number of'A's is 2. When there is more than one, their positions can be selected without limitation. This rule also applies to the expression “at least one'A' has been replaced by a'B'".
  • the expression “at least one A may be replaced by B, C, or D” is expressed when at least one A is replaced by B, at least one A is replaced by C, and at least. When one A is replaced by D, it means that a plurality of A's are replaced by at least two of B, C and D.
  • alkyl, alkoxyalkenyl, alkenyloxyalkyl It is not preferable that two consecutive -CH 2- are replaced with -O- to become -O-O-.
  • Alkyl such as in, -CH 2 methyl moiety (-CH 2 -H) - by is replaced by -O- is not preferred also be the -O-H.
  • Halogen means fluorine, chlorine, bromine, or iodine. Preferred halogens are fluorine or chlorine. A more preferred halogen is fluorine.
  • Alkyl is linear or branched and does not contain cyclic alkyl. Linear alkyl is generally preferred over branched alkyl. The same applies to terminal groups such as alkoxy and alkenyl.
  • the configuration for 1,4-cyclohexylene is preferably trans over cis in order to raise the upper temperature limit of the nematic phase.
  • 2-Fluoro-1,4-phenylene means the following two divalent groups.
  • fluorine may be left-facing (L) or right-facing (R). This rule also applies to asymmetric divalent groups generated by removing two hydrogens from the ring, such as tetrahydropyran-2,5-diyl.
  • the present invention includes the following items and the like.
  • a compound represented by the formula (1) is independently 0, 1 or 2, 0 ⁇ a + b ⁇ 3, and so on.
  • Ring A 1 , Ring A 2 , Ring A 3 and Ring A 4 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, naphthalene-2,6-diyl, Decahydronaphthrene-2,6-diyl, 1,2,3,4-tetrahydronaphthalene-2,6-diyl, tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyrimidine- 2,5-diyl, pyridine-2,5-diyl, fluorene-2,7-diyl, phenanthrene-2,7-diyl, anthracene-2,6-diyl, perhydrocyclopenta [a
  • -COS- and -OCO- or -SCO- and -COO- are never simultaneously present in the 4, when a is 2, two Z 1 may be different when b is 2, the two Z 5 may be different;
  • Sp 1 and Sp 2 are independently single-bonded or alkylene with 1 to 10 carbon atoms, in which at least one -CH 2- is -O-, -CO-, -COO-, -OCO.
  • One hydrogen may be replaced with fluorine or chlorine, If multiple Sp 1 or Sp 2 are present, it may be different from each;
  • P 1 and P 2 are independent groups represented by any of the formulas (1b) to (1h), and when a plurality of P 1 or P 2 are present, they may be different from each other;
  • M 1 , M 2 , M 3 and M 4 are independently hydrogen, fluorine, chlorine, alkyl with 1 to 5 carbon atoms, or alkyl with 1 to 5 carbon atoms in which at least one hydrogen is replaced with fluorine or chlorine.
  • X 1 is O or S
  • R 2 is hydrogen, fluorine, chlorine, or an alkyl having 1 to 5 carbon atoms, in which at least one hydrogen may be replaced by fluorine or chlorine, and at least one -CH 2- is -O-. May be replaced with;
  • a and b are independently 0, 1 or 2, and 0 ⁇ a + b ⁇ 2.
  • Ring A 1 , Ring A 2 , Ring A 3 and Ring A 4 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, naphthalene-2,6-diyl, Decahydronaphthrene-2,6-diyl, 1,2,3,4-tetrahydronaphthalene-2,6-diyl, tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyrimidine- 2,5-diyl, pyridine-2,5-diyl, fluorene-2,7-diyl, phenanthrene-2,7-diyl, anthracene-2,6-diyl, perhydrocyclopenta [a] phenanthrene-3,17 -
  • a 2
  • two Z 1 may be different, the two Z 5 may be different;
  • Sp 1 and Sp 2 are independently a single bond or alkylene having 1 to 10 carbon atoms, in the alkylene, at least one of -CH 2 -, -O -, - COO-, or substituted with -OCO-
  • P 1 and P 2 are independent groups represented by any of the formulas (1b) to (1h), and when a plurality of P 1 or P 2 are present, they may be different from each other;
  • M 1 , M 2 , M 3 and M 4 are independently hydrogen, fluorine, chlorine, alkyl with 1 to 5 carbon atoms, or alkyl with 1 to 5 carbon atoms in which at least one hydrogen is replaced with fluorine or chlorine.
  • X 1 is O or S
  • R 2 is hydrogen, fluorine, chlorine, or an alkyl having 1 to 5 carbon atoms, in which at least one hydrogen may be replaced by fluorine or chlorine, and at least one -CH 2- is -O-. May be replaced with;
  • Ring A 1 , Ring A 2 , Ring A 3 and Ring A 4 are independent, 1,4-cyclohexylene, 1,4-phenylene, naphthalene-2,6-diyl, pyrimidine-2,5-diyl, Pyridine-2,5-diyl, fluorene-2,7-diyl, phenanthrene-2,7-diyl, or anthracene-2,6-diyl, in which at least one hydrogen is fluorine, chlorine, Replaced by alkyl with 1 to 12 carbons, alkenyl with 2 to 12 carbons, alkoxy with 1 to 11 carbons, alkenyloxy with 2 to 11 carbons, -Sp 1- P 1 or -Sp 2- P 2.
  • X 1 is O or S
  • R 2 is hydrogen, fluorine, chlorine, or an alkyl having 1 to 5 carbon atoms, in which at least one hydrogen may be replaced by fluorine or chlorine, and at least one -CH 2- is -O-. May be replaced with;
  • Sp 1 and Sp 2 are independently single-bonded or alkylene with 1 to 10 carbon atoms, in which at least one -CH 2- is -O-, -COO-, -OCOO-, or-.
  • M 1 , M 2 , M 3 and M 4 are independently hydrogen, fluorine, chlorine, alkyl with 1 to 5 carbon atoms, or alkyl with 1 to 5 carbon atoms in which at least one hydrogen is replaced with fluorine or chlorine.
  • X 1 is O or S
  • R 2 is hydrogen, fluorine, chlorine, or an alkyl having 1 to 5 carbon atoms, in which at least one hydrogen may be replaced by fluorine or chlorine, and at least one -CH 2- is -O-. May be replaced with;
  • Ring A 1 , Ring A 2 , Ring A 3 and Ring A 4 are independent, 1,4-cyclohexylene, 1,4-phenylene, naphthalene-2,6-diyl, fluorene-2,7-diyl, Alternatively, it may be phenanthrene-2,7-diyl, in which at least one hydrogen may be replaced with fluorine, chlorine, methyl, or ethyl;
  • Sp 1 and Sp 2 are independently single-bonded or alkylene with 1 to 10 carbon atoms, in which at least one -CH 2- is -O-, -COO-, -OCOO-, or-.
  • any one of Z 2 , Z 3 , or Z 4 is -COS- or -SCO-, [ 3] The compound according to.
  • P 1 and P 2 are each independently formula (1b-1), (1b -2), (1b-3), (1b-4), formula (1b-5), (1c -1), (1d -1), a group represented by (1d-2) or (1e-1), where X 2 , X 3 , X 4 , X 5 and X 6 are independently O or S; Sp 1 and Sp 2 are independently single bonds or alkylenes having 1 to 10 carbon atoms, in which at least one -CH 2- is -O-, -COO-, -OCOO-, or-.
  • At least one hydrogen may be replaced with fluorine, chlorine, methyl, or ethyl.
  • Sp 1 and Sp 2 are independently alkylenes having 1 to 10 carbon atoms, and in this alkylene, at least one -CH 2- is -O-, -COO-,.
  • the compound according to [7], which may be replaced by -OCOO-, or -OCO-, and at least one- (CH 2 ) 2 -may be replaced by -CH CH-.
  • R 11 and R 12 are independently alkyl with 1 to 10 carbon atoms or alkenyl with 2 to 10 carbon atoms, even if at least one -CH 2- is replaced with -O- in the alkyl and alkenyl.
  • at least one hydrogen may be replaced by fluorine;
  • Ring B 1 , Ring B 2 , Ring B 3 , and Ring B 4 are independent, 1,4-cyclohexylene, 1,4-phenylene, 2-fluoro-1,4-phenylene, 2,5-difluoro-.
  • R 13 is an alkyl having 1 to 10 carbon atoms or an alkenyl having 2 to 10 carbon atoms, in which at least one -CH 2- may be replaced with -O-, and at least one hydrogen is.
  • Ring C 1 , Ring C 2 , and Ring C 3 are independently 1,4-cyclohexylene, 1,4-phenylene, where at least one hydrogen may be replaced by fluorine, tetrahydropyran-2,5-diyl.
  • liquid crystal composition according to any one of [9] to [11], which further contains at least one compound selected from the group of compounds represented by the formula (8).
  • R 14 is an alkyl having 1 to 10 carbon atoms or an alkenyl having 2 to 10 carbon atoms, in which at least one -CH 2- may be replaced with -O-, and at least one hydrogen is.
  • X 12 is -C ⁇ N or -C ⁇ C-C ⁇ N
  • Ring D 1 is independently 1,4-cyclohexylene, 1,4-phenylene in which at least one hydrogen may be replaced by fluorine, tetrahydropyran-2,5-diyl, 1,3-dioxane-2, 5-dioxane, or pyrimidine-2,5-dioxane
  • Z 17 is independently a single bond, - (CH 2) 2 - , - C ⁇ C -, - COO -, - CF 2 O -, - OCF 2 -, or -CH 2 O-
  • L 13 and L 14 are independently hydrogen or fluorine
  • i is 1, 2, 3, or 4.
  • At least one hydrogen may be replaced by fluorine; Ring E 1 , Ring E 2 , Ring E 3 , and Ring E 4 may independently replace 1,4-cyclohexylene, 1,4-cyclohexenylene, and at least one hydrogen with fluorine 1, 4-Phenylene, tetrahydropyran-2,5-diyl, or decahydronaphthalene-2,6-diyl; Rings E 5 and E 6 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, tetrahydropyran-2,5-diyl, or decahydronaphthalene-2,6.
  • Z 18, Z 19, Z 20 , and Z 21 are independently a single bond, - (CH 2) 2 - , - COO -, - CH 2 O -, - OCF 2 -, or -OCF 2 CH 2 CH 2- is; L 15 and L 16 are independently fluorine or chlorine; S 11 is hydrogen or methyl; X is -CHF- or -CF 2- ; j, k, m, n, p, q, r, and s are independently 0 or 1, and the sum of k, m, n, and p is 1 or 2, q, r, and The sum of s is 0, 1, 2, or 3, and t is 1, 2, or 3.
  • Ring G is 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, naphthalene-1,2-diyl, naphthalene-1,3-diyl, naphthalene-1,4-diyl, Naphthalene-1,5-diyl, naphthalene-1,6-diyl, naphthalene-1,7-diyl, naphthalene-1,8-diyl, naphthalene-2,3-diyl, naphthalene-2,6-diyl, naphthalene- 2,7-Diyl, tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyrimidine-2,5-diyl, or pyridine-2,5-diyl, in these rings.
  • At least one hydrogen is replaced with fluorine, chlorine, alkyl with 1 to 12 carbon atoms, alkoxy with 1 to 12 carbon atoms, or alkyl with 1 to 12 carbon atoms in which at least one hydrogen is replaced with fluorine or chlorine.
  • (CH 3 ) C (CH 3 )-and at least one hydrogen in these groups may be replaced by fluorine or chlorine;
  • P 11, P 12, and P 13 are independently a polymerizable group selected from the group of radicals represented by the formula (P-1) by the formula (P-5);
  • M 11 , M 12 , and M 13 are independently hydrogen, fluorine, alkyl having 1 to 5 carbon atoms, or alkyl having 1 to 5 carbon atoms in which at least one hydrogen is replaced with fluorine or chlorine;
  • Sp 11 , Sp 12 , and Sp 13 are independently single bonds or alkylenes with 1 to 10 carbon atoms, in which at least one -CH 2- is -O-, -COO-, -OCO.
  • One hydrogen may be replaced with fluorine or chlorine; u is 0, 1, or 2; f, g, and h are independently 0, 1, 2, 3, or 4, and the sum of f, g, and h is greater than or equal to 2.
  • M 12 are independently hydrogen, fluorine, alkyl of C 1 -C 5 alkyl or at least one hydrogen is from 1 carbon atoms is replaced by fluorine or chlorine, 5;
  • Sp 11 , Sp 12 , and Sp 13 are independently single bonds or alkylenes with 1 to 10 carbon atoms, in which at least one -CH 2- is -O-, -COO-, -OCO.
  • One hydrogen may be replaced with fluorine or chlorine.
  • the present invention also includes the following sections.
  • A Further contains at least two additives such as a polymerizable compound, a polymerization initiator, a polymerization inhibitor, an optically active compound, an antioxidant, an ultraviolet absorber, a light stabilizer, a heat stabilizer, and an antifoaming agent.
  • the above liquid crystal composition (B) A polymerizable composition prepared by adding a polymerizable compound different from the compound (1) or the compound (16) to the above liquid crystal composition. (C) A polymerizable composition prepared by adding compound (1) and compound (16) to the above liquid crystal composition. (D) A liquid crystal composite prepared by polymerizing a polymerizable composition. (E) A polymer-supported orientation type device containing this liquid crystal composite.
  • a polymerizable composition prepared by adding a compound (1), a compound (16), and a polymerizable compound different from the compound (1) or the compound (16) to the above liquid crystal composition is used.
  • a polymer-supported orientation type element created by this. Aspects of compound (1), synthesis of compound (1), a liquid crystal composition, and a liquid crystal display element will be described in order.
  • compound (1) is an additive for a liquid crystal composition used in a liquid crystal display element.
  • Compound (1) is added for the purpose of horizontally controlling the orientation of liquid crystal molecules.
  • Such additives are preferably chemically stable under the condition of being sealed in the device, have high solubility in the liquid crystal composition, and have a high voltage retention when used in the liquid crystal display device. .. Compound (1) satisfies such properties to a large extent.
  • a preferred example of compound (1) will be described.
  • Preferred examples of compounds of (1) R 1, Z 1 ⁇ Z 5, A 1 ⁇ A 4, Sp 1, Sp 2, P 1, P 2, a and b are applied to the sub-formulas of compound (1) Will be done.
  • the properties can be arbitrarily adjusted by appropriately combining the types of these groups.
  • Compound (1) may contain more isotopes such as 2 H (deuterium) and 13 C than the natural abundance ratio, as there are no significant differences in the properties of the compounds.
  • Ring A 1 , Ring A 2 , Ring A 3 and Ring A 4 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, naphthalene-2,6-diyl, Decahydronaphthrene-2,6-diyl, 1,2,3,4-tetrahydronaphthalene-2,6-diyl, tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyrimidine- 2,5-diyl, pyridine-2,5-diyl, fluorene-2,7-diyl, phenanthrene-2,7-diyl, anthracene-2,6-diyl, perhydrocyclopenta [a] phenanthrene-3,17 -Diyl, 2,3,4,7,8,9,10,11,12,13,14,15,16,17-
  • Preferred rings A 1 , A 2 , A 3 and A 4 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, naphthalene-2,6-diyl, decahydro.
  • At least one hydrogen is fluorine or It may be replaced with chlorine. More preferably, 1,4-cyclohexylene, 1,4-phenylene, perhydrocyclopenta [a] phenanthrene-3,17-diyl, or 2,3,4,7,8,9,10,11, 12,13,14,15,16,17-tetradecahydrocyclopenta [a] phenanthrene-3,17-diyl, in these rings at least one hydrogen is fluorine or alkyl with 1 to 5 carbon atoms.
  • One hydrogen may be replaced with fluorine or chlorine.
  • Preferred Sp 1 and Sp 2 are independently single bonds, alkylenes with 1 to 6 carbon atoms, alkylene with 1 to 6 carbon atoms in which one -CH 2- has been replaced with -O-, or -OCOO-. .. More preferably, it is an alkylene having 1 to 6 carbon atoms or -OCOO-.
  • P 1 and P 2 are independent groups represented by any of the formulas (1b) to (1h).
  • Preferred P 1 and P 2 are independently represented by any of (1b), (1c), (1d), and (1e).
  • Preferred M 1 , M 2 , M 3 and M 4 are independently hydrogen, fluorine, methyl, ethyl, or trifluoromethyl. More preferably, it is hydrogen.
  • R 2 is hydrogen, fluorine, chlorine, or an alkyl having 1 to 5 carbon atoms, in which at least one hydrogen may be replaced by fluorine or chlorine, and at least one -CH 2- is -O-. May be replaced with.
  • Preferred R 2 is hydrogen, fluorine, methyl, ethyl, methoxymethyl, or trifluoromethyl. More preferably, it is hydrogen.
  • R 3 , R 4 , R 5 , R 6 and R 7 are independently hydrogen, linear alkyl with 1-10 carbon atoms, linear alkoxy with 2-10 carbon atoms, 1-10 carbon atoms. Linear alkoxy, or cyclic alkyl having 3 to 6 carbon atoms. More preferably, it is hydrogen, a linear alkyl having 2 to 6 carbon atoms, a linear alkenyl having 2 to 6 carbon atoms, a linear alkoxy having 1 to 5 carbon atoms, or a cyclic alkyl having 4 to 6 carbon atoms. ..
  • X 1 is O or S.
  • M 1 and M 2 independently have hydrogen, fluorine, chlorine, an alkyl having 1 to 5 carbon atoms, or at least one hydrogen having a carbon number replaced by fluorine or chlorine. It is an alkyl of 1 to 5, and X 2 , X 3 , X 4 , X 5 and X 6 are independently O or S.
  • a and b are independently 0, 1 or 2, preferably 0 ⁇ a + b ⁇ 2.
  • Preferred examples of the compound (1) are formulas (1-1) to (1-3).
  • Ring A 1 , Ring A 2 , Ring A 3 and Ring A 4 are independent, 1,4-cyclohexylene, 1,4-phenylene, naphthalene-2,6-diyl, pyrimidine-2,5-diyl, Pyridine-2,5-diyl, fluorene-2,7-diyl, phenanthrene-2,7-diyl, anthracene-2,6-diyl, and at least one hydrogen in these rings is fluorine, chlorine, carbon.
  • At least one hydrogen may be replaced by fluorine or chlorine, when a is 2, two rings a 1 may be different when b is 2, the two ring A 4 may be different; In these rings, at least one hydrogen is fluorine, chlorine, alkyl with 1 to 12 carbons, alkenyl with 2 to 12 carbons, alkoxy with 1 to 11 carbons, alkenyloxy with 2 to 11 carbons, -Sp.
  • P 1 and P 2 are independent groups represented by any of the formulas (1b) to (1h), and when a plurality of P 1 or P 2 are present in the structure, they are different from each other.
  • M 1 , M 2 , M 3 and M 4 are independently hydrogen, fluorine, chlorine, alkyl having 1 to 5 carbon atoms, or at least one hydrogen is fluorine or chlorine.
  • R 2 is hydrogen, fluorine, chlorine, or an alkyl having 1 to 5 carbon atoms, in which at least one hydrogen may be replaced by fluorine or chlorine, and at least one -CH 2- is -O-.
  • the compound (1) is preferably a compound represented by the following formula.
  • P 1 and P 2 are each independently formula (1b-1), (1b -2), (1b-3), (1b-4), formula (1b-5), (1c -1), (1d -1), a group represented by (1d-2) or (1e-1), where X 2 , X 3 , X 4 , X 5 and X 6 are independently O or S; Sp 1 and Sp 2 are independently single bonds or alkylenes having 1 to 10 carbon atoms, in which at least one -CH 2- is -O-, -COO-, -OCOO-, or-.
  • At least one hydrogen may be replaced with fluorine, chlorine, methyl, or ethyl.
  • Formulas (2) to (15) represent the component compounds of the liquid crystal composition.
  • Compounds (2) to (4) have small dielectric anisotropy.
  • Compounds (5) to (7) have a very large dielectric anisotropy. Since compound (8) has a cyano group, it has a larger positive dielectric anisotropy.
  • Compounds (9) to (16) have a large negative dielectric anisotropy. Specific examples of these compounds will be described later.
  • P 11 , P 12 , and P 13 are independently polymerizable groups.
  • Preferred P 11 , P 12 and P 13 are polymerizable groups selected from the group of groups represented by formulas (P-1) to (P-5). More preferred P 11 , P 12 , and P 13 are groups (P-1), groups (P-2), or groups (P-3).
  • the wavy line from the group (P-1) to the group (P-5) indicates the site to be bonded.
  • M 11 , M 12 , and M 13 are independently hydrogen, fluorine, alkyl with 1 to 5 carbon atoms, or at least one hydrogen is fluorine or chlorine. It is an alkyl having 1 to 5 carbon atoms replaced with.
  • Preferred M 11 , M 12 , and M 13 are hydrogen or methyl to increase reactivity. The more preferred M 11 is methyl and the more preferred M 12 and M 13 are hydrogen.
  • One hydrogen may be replaced with fluorine or chlorine.
  • Preferred Sp 11 , Sp 12 , and Sp 13 are single bonds.
  • Rings F and I are independently cyclohexyl, cyclohexenyl, phenyl, 1-naphthyl, 2-naphthyl, tetrahydropyran-2-yl, 1,3-dioxane-2-yl, pyrimidin-2-yl, or pyridine.
  • -2-yl, in these rings at least one hydrogen is fluorine, chlorine, alkyl with 1 to 12 carbons, alkoxy with 1 to 12 carbons, or at least one hydrogen is replaced with fluorine or chlorine. It may be replaced with an alkyl having 1 to 12 carbon atoms.
  • Ring G is 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, naphthalene-1,2-diyl, naphthalene-1,3-diyl, naphthalene-1,4-diyl, Naphthalene-1,5-diyl, naphthalene-1,6-diyl, naphthalene-1,7-diyl, naphthalene-1,8-diyl, naphthalene-2,3-diyl, naphthalene-2,6-diyl, naphthalene- 2,7-Diyl, tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyrimidine-2,5-diyl, or pyridine-2,5-diyl, in these rings.
  • At least one hydrogen is replaced with fluorine, chlorine, alkyl with 1 to 12 carbon atoms, alkoxy with 1 to 12 carbon atoms, or alkyl with 1 to 12 carbon atoms in which at least one hydrogen is replaced with fluorine or chlorine.
  • a particularly preferred ring G is 1,4-phenylene or 2-fluoro-1,4-phenylene.
  • Preferred Z 22 and Z 23 are single bonds,-(CH 2 ) 2- , -CH 2 O-, -OCH 2- , -COO-, or -OCO-. More preferred Z 22 and Z 23 are single bonds.
  • U is 0, 1, or 2.
  • the preferred u is 0 or 1.
  • f, g, and h are independently 0, 1, 2, 3, or 4, and the sum of f, g, and h is greater than or equal to 1.
  • the preferred f, g, or h is 1 or 2.
  • MSG 1 is a monovalent organic group having at least one ring.
  • the monovalent organic groups represented by a plurality of MSG 1 (or MSG 2) may be the same or different.
  • Compounds (1A) to (1L) correspond to compound (1) or an intermediate of compound (1).
  • rings A 1 , A 2 , A 3 and A 4 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, 2-fluoro-1,4-phenylene, 2-methyl-1 , 4-Phenanthrene, 2-Ethyl-1,4-Phenanthrene, Naphthalene-2,6-Diyl, Decahydronaphthalene-2,6-Diyl, 1,2,3,4-Tetrahydropyranphthalene-2,6-Diyl, Tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyrimidine-2,5-diyl, pyridine-2,5-diyl, perhydrocyclopenta [a] phenanthrene-3,17- For rings such as dioxane, 2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradeca
  • Preferred examples of the polymerizable group P 1 or P 2 are acrylic ester (1b), maleimide (1c), itaconic acid ester (1d). , Vinyl ester (1e), oxylanyl (1g), or vinyloxy (1h).
  • MSG 1 is a monovalent organic group having at least one ring.
  • Compounds (1S) to (1X) correspond to compound (1).
  • the polymerizable group is an acrylate derivative, it is synthesized by esterification of the corresponding acrylic acid and HO-MSG 1 .
  • Vinyloxy is synthesized by etherification of HO-MSG 1 and vinyl bromide.
  • Oxylanyl is synthesized by oxidation of the terminal double bond.
  • the maleimide group is synthesized by the reaction of an amino group with maleic anhydride.
  • Itaconic acid esters are synthesized by esterification of the corresponding itaconic acid with HO-MSG 1 .
  • Vinyl ester is synthesized by transesterification reaction of vinyl acetate and HOOC-MSG 1 .
  • MES is a mesogen group with at least one ring.
  • P 1 , M 1 , M 2 , Sp 1 , and Sp 2 are the same as above.
  • Compound (51A) and compound (51B) can be synthesized according to a general organic synthesis method using commercially available or mesogen (MES) having an appropriate ring structure as a starting material.
  • MES commercially available or mesogen
  • the compound (51A) is used as a starting material, and the compound is etherified with a base such as compound (52) and potassium hydroxide.
  • (53A) can be obtained.
  • a cross-coupling reaction is carried out using compound (52), a metal catalyst such as palladium, and a base starting from compound (51B).
  • the compound (53B) can be obtained by carrying out the above.
  • Compound (53A) or (53B) may, if necessary, induce compound (54A) or (54B) on which a protecting group such as TMS or THP is acted.
  • the compound (53A), (53B), (54A) or compound (54B) is then etherified again in the presence of a base such as compound (55) and potassium hydroxide to give compound (57A) or (54B).
  • 57B) can be obtained.
  • the protecting group is allowed to act in the previous step, the protecting group is removed by a deprotection reaction.
  • Compound (1) of which P 2 is a group represented by the formula (1b-3), can be synthesized from compound (57) by the following method.
  • Compound (57) can be derived to compound (1Y) by performing an esterification reaction in the presence of compound (58), DCC and DMAP.
  • the liquid crystal composition according to the embodiment of the present invention contains compound (1) as a component A.
  • the compound (1) can contribute to the control of the orientation of the liquid crystal molecules by the non-covalent interaction with the substrate of the device.
  • This composition preferably contains compound (1) as component A and further contains a liquid crystal compound selected from the components B, C, D, and E shown below.
  • Component B is compounds (2) to (4).
  • Component C is compounds (5) to (7).
  • Component D is compound (8).
  • Component E is compounds (9) to (16).
  • This composition may contain other liquid crystal compounds different from the compounds (2) to (16).
  • a composition with properly selected components has a high upper limit temperature, a lower lower limit temperature, a small viscosity, a suitable optical anisotropy (ie, a large optical anisotropy or a small optical anisotropy), and a large positive or negative modulus. It has anisotropy, high specific resistance, stability against heat or ultraviolet rays, and a suitable elastic constant (ie, a large elastic constant or a small elastic constant).
  • the preferred proportion of compound (1) is typically about 0.01% by weight or more, based on the weight of the liquid crystal composition to maintain high stability to UV light, to dissolve in the liquid crystal composition. Usually, it is about 10% by weight or less. A more preferred proportion is in the range of about 0.1% to about 5% by weight, based on the weight of the liquid crystal composition. The most preferred proportion is in the range of about 0.5% by weight to about 3% by weight, based on the weight of the liquid crystal composition.
  • Component B is a compound having two terminal groups such as alkyl.
  • Preferred examples of the component B include compounds (2-1) to (2-11), compounds (3-1) to (3-19), and compounds (4-1) to (4-7). it can.
  • R 11 and R 12 are independently an alkyl having 1 to 10 carbon atoms or an alkenyl having 2 to 10 carbon atoms, and in this alkyl or alkenyl, at least one -CH 2- is -O. It may be replaced with ⁇ , and at least one hydrogen may be replaced with fluorine.
  • Component B is a compound that is close to neutral because the absolute value of dielectric anisotropy is small.
  • Compound (2) is mainly effective in reducing viscosity or adjusting optical anisotropy.
  • the compounds (3) and (4) are effective in widening the temperature range of the nematic phase by increasing the upper limit temperature, or in adjusting the optical anisotropy.
  • the content of component B is preferably 30% by weight or more, more preferably 40% by weight or more, based on the weight of the liquid crystal composition.
  • Component C is a compound (5) to (7) having fluorine, chlorine or a fluorine-containing group at the right end.
  • Preferred examples of the component C include compounds (5-1) to (5-16), compounds (6-1) to (6-120), and compounds (7-1) to (7-62). ..
  • R 13 is an alkyl having 1 to 10 carbon atoms or an alkenyl having 2 to 10 carbon atoms, in which at least one -CH 2- may be replaced with -O-.
  • At least one hydrogen may be replaced with fluorine;
  • X 11 is fluorine, chlorine, -OCF 3 , -OCHF 2 , -CF 3 , -CHF 2 , -CH 2 F, -OCF 2 CHF 2 , or. -OCF 2 CHFCF 3 .
  • Component C has a positive dielectric anisotropy and is extremely stable against heat, light, etc., and is therefore used when preparing a composition for modes such as IPS, FFS, and OCB.
  • the content of component C is preferably in the range of 1% by weight to 99% by weight, preferably in the range of 10% by weight to 97% by weight, more preferably 40% by weight to 95% by weight, based on the weight of the liquid crystal composition. It is in the range of%.
  • the component C is added to a composition having a negative dielectric anisotropy, the content of the component C is preferably 30% by weight or less based on the weight of the liquid crystal composition.
  • Component D is compound (8) whose right terminal group is -C ⁇ N or -C ⁇ C-C ⁇ N.
  • Preferred examples of the component D include compounds (8-1) to (8-64).
  • R 14 is an alkyl having 1 to 10 carbon atoms or an alkenyl having 2 to 10 carbon atoms, in which at least one -CH 2- may be replaced with -O-. , At least one hydrogen may be replaced by fluorine;
  • X 12 is -C ⁇ N or -C ⁇ C-C ⁇ N.
  • Component D has a positive dielectric anisotropy and a large value, so it is mainly used when preparing a composition for a mode such as TN. By adding this component D, the dielectric anisotropy of the composition can be increased.
  • the component D has the effect of widening the temperature range of the liquid crystal phase, adjusting the viscosity, or adjusting the optical anisotropy.
  • Component D is also useful for adjusting the voltage-transmittance curve of the device.
  • the content of component D is preferably in the range of 1% by weight to 99% by weight, preferably from 10% by weight, based on the weight of the liquid crystal composition. It is in the range of 97% by weight, more preferably 40% by weight to 95% by weight.
  • the content of the component D is preferably 30% by weight or less based on the weight of the liquid crystal composition.
  • Component E is compounds (9) to (16). These compounds have phenylene in which the lateral position is substituted with two fluorines or chlorine, such as 2,3-difluoro-1,4-phenylene.
  • component E is compounds (9-1) to (9-8), compounds (10-1) to (10-17), compounds (11-1), compounds (12-1) to (12-). 3), compound (13-1) to (13-11), compound (14-1) to (14-3), compound (15-1) to (15-3) and compound (16-1) to (16-1). 16-3) can be mentioned.
  • R 15 and R 16 are independently alkyl with 1 to 10 carbon atoms or alkenyl with 2 to 10 carbon atoms, in which at least one -CH 2- is -O.
  • R 17 is hydrogen, fluorine, alkenyl alkyl of from 10 1 carbon atoms, or from 2 to 10 carbon atoms, the alkyl And in alkenyl, at least one -CH 2- may be replaced with -O- and at least one hydrogen may be replaced with fluorine.
  • Component E has a large negative dielectric anisotropy.
  • Component E is used when preparing a composition for modes such as IPS, VA, PSA and the like. As the content of the component E is increased, the dielectric anisotropy of the composition becomes negatively large, but the viscosity becomes large. Therefore, as long as the required value of the threshold voltage of the element is satisfied, the content is preferably small. Considering that the dielectric anisotropy is about ⁇ 5, the content of the component E is preferably 40% by weight or more based on the weight of the liquid crystal composition in order to drive the liquid crystal sufficiently.
  • the compound (9) is a bicyclic compound, and is therefore mainly effective in reducing the viscosity, adjusting the optical anisotropy, or increasing the dielectric anisotropy.
  • the compounds (10) and (11) are tricyclic compounds, they have the effects of increasing the upper limit temperature, increasing the optical anisotropy, or increasing the dielectric anisotropy.
  • the compounds (12) to (16) have the effect of increasing the dielectric anisotropy.
  • the content of component E is preferably 40% by weight or more, more preferably 50% by weight, based on the weight of the liquid crystal composition. In the range of 95% by weight.
  • the content of the component E is preferably 30% by weight or less based on the weight of the liquid crystal composition.
  • liquid crystal composition By properly combining the components B, C, D, and E described above, a high upper limit temperature, a lower lower limit temperature, a small viscosity, an appropriate optical anisotropy, a large positive or negative dielectric anisotropy, and a large A liquid crystal composition can be prepared that satisfies at least one of the properties such as specific resistance, high stability against ultraviolet rays, high stability against heat, and a large elastic constant. If necessary, liquid crystal compounds different from the components B, C, D, and E may be added.
  • the liquid crystal composition is prepared by a known method.
  • the constituent compounds are mixed and dissolved by heating.
  • Additives may be added to this composition depending on the application.
  • additives include polymerizable compounds other than the formulas (1) and (16), polymerization initiators, polymerization inhibitors, optically active compounds, antioxidants, ultraviolet absorbers, light stabilizers, heat stabilizers, and defoamers.
  • foaming agent Such additives are well known to those of skill in the art and are described in the literature.
  • the polymerizable compound is added for the purpose of forming a polymer in the liquid crystal composition.
  • a polymer is produced in the liquid crystal composition by irradiating ultraviolet rays with a voltage applied between the electrodes to copolymerize the polymerizable compound and the compound (1).
  • the compound (1) is immobilized in a state in which the polar group interacts with the surface of the glass (or metal oxide) substrate in a non-covalent bond.
  • the ability to control the orientation of the liquid crystal molecules is further improved, and at the same time, the compound (1) does not leak into the liquid crystal composition.
  • an appropriate pretilt can be obtained even on the substrate surface of glass (or metal oxide), a liquid crystal display element having a short response time and a large voltage holding ratio can be obtained.
  • Preferred examples of the polymerizable compound are acrylate, methacrylate, vinyl compound, vinyloxy compound, propenyl ether, epoxy compound (oxylane, oxetane), and vinyl ketone. More preferred examples are compounds having at least one acryloyloxy and compounds having at least one methacryloyloxy. More preferred examples also include compounds having both acryloyloxy and methacryloyloxy.
  • More preferred examples of the polymerizable compounds are compounds (M-1) to (M-17).
  • R 25 to R 31 are independently hydrogen or methyl; s, v, and x are independently 0 or 1; t and u.
  • s, v, and x are independently 0 or 1; t and u.
  • L 21 to L 26 are independently hydrogen or fluorine, and L 27 and L 28 are independently hydrogen, fluorine, or methyl.
  • the polymerizable compound can be rapidly polymerized by adding a polymerization initiator. By optimizing the reaction temperature, the amount of residual polymerizable compound can be reduced.
  • photoradical polymerization initiators are TPO, 1173, and 4265 from BASF's DaroCure series and 184,369,500,651,784,819,907,1300,1700,1800,1850 from the Irgacure series. , And 2959.
  • photoradical polymerization initiators include 4-methoxyphenyl-2,4-bis (trichloromethyl) triazine, 2- (4-butoxystyryl) -5-trichloromethyl-1,3,4-oxadiazole, 9-Phenylaclysine, 9,10-benzphenazine, benzophenone / Michler's ketone mixture, hexaarylbiimidazole / mercaptobenzimidazole mixture, 1- (4-isopropylphenyl) -2-hydroxy-2-methylpropan-1-one, benzyl Dimethylketal, 2-methyl-1- [4- (methylthio) phenyl] -2-morpholinopropane-1-one, 2,4-diethylxanthone / p-dimethylaminomethyl benzoate mixture, benzophenone / methyltriethanolamine mixture Is.
  • polymerization After adding a photoradical polymerization initiator to the liquid crystal composition, polymerization can be carried out by irradiating ultraviolet rays with an electric field applied. However, unreacted polymerization initiators or degradation products of the polymerization initiators may cause display defects such as image burn-in on the device. In order to prevent this, photopolymerization may be carried out without adding a polymerization initiator.
  • the preferred wavelength of the emitted light is in the range of 150 nm to 500 nm. More preferred wavelengths are in the range of 250 nm to 450 nm, and most preferred wavelengths are in the range of 300 nm to 400 nm.
  • the main effects of (1) on the properties of the composition are as follows. This compound (1) is arranged in a certain direction at the molecular level when the Fries rearrangement or photodimerization is caused by polarized light. Therefore, the thin film prepared from the polar compound orients the liquid crystal molecules in the same manner as the alignment film such as polyimide.
  • the aromatic thioester site is photodecomposed by irradiation with ultraviolet light to form radicals, which causes photofries rearrangement. ..
  • photodecomposition of the aromatic thioester moiety occurs when the polarization direction of the polarized ultraviolet light and the long axis direction of the aromatic thioester moiety are the same direction. After photolysis, it recombines and tautomerization produces thiol groups in the molecule. It is considered that this thiol group causes an interaction between the substrate interfaces and makes it easier for polar compounds to be adsorbed on the substrate interface side with anisotropy.
  • the compound (1) that has reacted along the direction of polarized light by polymerization is immobilized without losing its directionality.
  • a thin film capable of orienting liquid crystal molecules can be prepared by utilizing this property.
  • linearly polarized light is suitable for the ultraviolet rays to be irradiated.
  • the compound (1) which is a polar compound, is added to the liquid crystal composition in the range of 0.1% by weight to 10% by weight, and the composition is heated to dissolve the polar compound. This composition is injected into a device that does not have an alignment film.
  • the polar compound is subjected to photofries rearrangement and polymerized by irradiating the element with linearly polarized light while heating it.
  • the polar compounds rearranged with optical fries are arranged in a certain direction, and the thin film formed after polymerization has a function as a liquid crystal alignment film.
  • a polymerization inhibitor When storing the polymerizable compound, a polymerization inhibitor may be added to prevent polymerization.
  • the polymerizable compound is usually added to the composition without removing the polymerization inhibitor.
  • polymerization inhibitors are hydroquinone, hydroquinone derivatives such as methylhydroquinone, 4-t-butylcatechol, 4-methoxyphenol, phenothiazine and the like.
  • the optically active compound has the effect of preventing reverse twisting by inducing a helical structure in the liquid crystal molecule to give the required twist angle.
  • the spiral pitch can be adjusted by adding an optically active compound.
  • Two or more optically active compounds may be added for the purpose of adjusting the temperature dependence of the spiral pitch.
  • Preferred examples of the optically active compound include the following compounds (Op-1) to (Op-18).
  • ring J is 1,4-cyclohexylene or 1,4-phenylene
  • R 28 is an alkyl having 1 to 10 carbon atoms.
  • Antioxidants are effective in maintaining a large voltage retention rate.
  • Preferred examples of the antioxidants include the following compounds (AO-1) and (AO-2); IRGANOX 415, IRGANOX 565, IRGANOX 1010, IRGANOX 1035, IRGANOX 3114, and IRGANOX 1098 (trade name: BASF). be able to.
  • the ultraviolet absorber is effective for preventing a decrease in the upper limit temperature.
  • Preferred examples of the UV absorber are benzophenone derivatives, benzoate derivatives, triazole derivatives and the like.
  • AO-3 and (AO-4) Specific examples include the following compounds (AO-3) and (AO-4); TINUVIN 329, TINUVIN P, TINUVIN 326, TINUVIN 234, TINUVIN 213, TINUVIN 400, TINUVIN 328, and TINUVIN 99-2 (trade name: BASF). ); And 1,4-diazabicyclo [2.2.2] octane (DABCO) can be mentioned.
  • a light stabilizer such as amine with steric hindrance is preferable in order to maintain a large voltage holding ratio.
  • Preferred examples of the light stabilizer include the following compounds (AO-5) and (AO-6); TINUVIN 144, TINUVIN 765, and TINUVIN 770DF (trade name: BASF).
  • a heat stabilizer is also effective for maintaining a large voltage holding ratio, and a preferable example thereof is IRGAFOS 168 (trade name: BASF).
  • Defoamers are effective in preventing foaming.
  • Preferred examples of the defoaming agent are dimethyl silicone oil, methyl phenyl silicone oil and the like.
  • R 40 is an alkyl having 1 to 20 carbon atoms, an alkoxy having 1 to 20 carbon atoms, -COOR 41 , or -CH 2 CH 2 COOR 41 , where R 41 has 1 carbon atom.
  • R 42 is an alkyl having 1 to 20 carbon atoms.
  • R 43 is hydrogen, methyl, or O ⁇ (oxygen radical)
  • ring G is 1,4-cyclohexylene or 1,4-phenylene
  • z is 1, 2, Or 3.
  • the liquid crystal composition has an operation mode such as PC, TN, STN, OCB, PSA, and can be used for a liquid crystal display element driven by an active matrix method.
  • This composition has an operation mode such as PC, TN, STN, OCB, VA, and IPS, and can also be used for a liquid crystal display element driven by a passive matrix method.
  • These elements can be applied to any type of reflective type, transmissive type, and semitransparent type.
  • This composition consists of an NCAP (nematic curvilinear aligned phase) element produced by microencapsulating a nematic liquid crystal, a polymer dispersed liquid crystal display element (PDLCD) produced by forming a three-dimensional network polymer in the liquid crystal, and a polymer. It can also be used for network liquid crystal display elements (PNLCD).
  • NCAP network curvilinear aligned phase
  • PLCD polymer dispersed liquid crystal display element
  • PLCD network liquid crystal display elements
  • a more preferred proportion is in the range of about 0.2% by weight to about 1.0% by weight, based on the weight of the liquid crystal composition.
  • the PSA mode element can be driven by a drive system such as an active matrix or a passive matrix. Such an element can be applied to any type of reflective type, transmissive type, and semitransparent type. By increasing the amount of the polymerizable compound added, a device in the polymer dispersed mode can also be manufactured.
  • the polymer contained in the composition orients the liquid crystal molecules.
  • Compound (1) which is a polar compound, assists in arranging liquid crystal molecules. That is, compound (1) can be used instead of the alignment film.
  • An example of a method for manufacturing such an element is as follows. An element having two substrates called an array substrate and a color filter substrate is prepared. This substrate has no alignment film. At least one of the substrates has an electrode layer. Liquid crystal compounds are mixed to prepare a liquid crystal composition. A polymerizable compound and a compound (1) which is a polar compound are added to this composition. Additional additives may be added as needed. This composition is injected into the device. Light is applied to this element. Ultraviolet rays are preferred. The polymerizable compound is polymerized by light irradiation. By this polymerization, a composition containing a polymer is produced, and an element having a PSA mode is produced.
  • the method of manufacturing the element will be explained.
  • the first is a step of adding the compound (1), which is a polar compound, to the liquid crystal composition, and heating and dissolving the composition at a temperature higher than the upper limit temperature.
  • the second is a step of injecting this composition into the liquid crystal display element.
  • the third is a step of irradiating polarized ultraviolet rays while the liquid crystal composition is heated to a temperature higher than the upper limit temperature.
  • Compound (1) which is a polar compound, undergoes photo-Fries rearrangement or photodimerization by linearly polarized light, and at the same time, polymerization also proceeds.
  • the polymer of compound (1) is formed and immobilized on the substrate as a thin film. Since this polymer is arranged in a certain direction at the molecular level, the thin film has a function as a liquid crystal alignment film. By this method, a liquid crystal display element having no alignment film such as polyimide can be manufactured.
  • the polar compound (1) is unevenly distributed on the substrate because the polar groups interact with the surface of the substrate.
  • the compound (1) orients the liquid crystal molecules by irradiation with polarized ultraviolet rays, and at the same time, the polymerizable compound is polymerized by the ultraviolet rays, so that a polymer maintaining this orientation is produced.
  • the effect of this polymer further stabilizes the orientation of the liquid crystal molecules, thus shortening the response time of the device. Since the burn-in of the image is a malfunction of the liquid crystal molecules, the burn-in is also improved at the same time by the effect of this polymer.
  • the compound (1) according to the embodiment of the present invention is a polymerizable polar compound
  • the liquid crystal molecules are oriented and copolymerized with other polymerizable compounds.
  • the polar compound does not leak into the liquid crystal composition, so that a liquid crystal display element having a large voltage holding ratio can be obtained.
  • the present invention will be described in more detail with reference to Examples (including synthesis examples and device usage examples). The present invention is not limited by these examples.
  • the present invention includes a mixture of the composition of Example 1 and the composition of Example 2.
  • the present invention also includes a mixture prepared by mixing at least two of the compositions of Examples. 1. 1.
  • Example of compound (1) (1)
  • Compound (1) was synthesized by the procedure shown in Example 1 and the like. Unless otherwise stated, the reaction was carried out in a nitrogen atmosphere. The synthesized compound was identified by a method such as NMR analysis. The characteristics of the compound (1), the liquid crystal compound, the composition, and the device were measured by the following methods.
  • NMR analysis A DRX-500 manufactured by Bruker Biospin was used for the measurement. 1 In the 1 H-NMR measurement, the sample was dissolved in a deuterated solvent such as CDCl 3, and the measurement was carried out at room temperature under the conditions of 500 MHz and 16 times of integration. Tetramethylsilane was used as an internal standard. 19 In the F-NMR measurement, CFCl 3 was used as an internal standard, and the number of integrations was 24. In the description of the nuclear magnetic resonance spectrum, s is singlet, d is doublet, t is triplet, q is quartet, quin is quintet, sex is sextet, m is multiplet, and br is broad.
  • a GC-2010 type gas chromatograph manufactured by Shimadzu Corporation was used for the measurement.
  • a capillary column DB-1 (length 60 m, inner diameter 0.25 mm, film thickness 0.25 ⁇ m) manufactured by Agilent Technologies Inc. was used.
  • Helium (1 ml / min) was used as the carrier gas.
  • the temperature of the sample vaporization chamber was set to 300 ° C., and the temperature of the detector (FID) portion was set to 300 ° C.
  • the sample was dissolved in acetone to prepare a 1% by weight solution, and 1 ⁇ l of the obtained solution was injected into the sample vaporization chamber.
  • a GC Solution system manufactured by Shimadzu Corporation was used as the recorder.
  • HPLC analysis Prominence (LC-20AD; SPD-20A) manufactured by Shimadzu Corporation was used for the measurement.
  • YMC-Pack ODS-A length 150 mm, inner diameter 4.6 mm, particle diameter 5 ⁇ m
  • the eluate used was an appropriate mixture of acetonitrile and water.
  • the detector a UV detector, an RI detector, a CORONA detector and the like were appropriately used. When a UV detector was used, the detection wavelength was 254 nm.
  • the sample was prepared to dissolve in acetonitrile to form a 0.1% by weight solution, and 1 ⁇ L of this solution was introduced into the sample chamber.
  • C-R7Aplus manufactured by Shimadzu Corporation was used.
  • Ultraviolet-visible spectroscopic analysis For the measurement, PharmaSpec UV-1700 manufactured by Shimadzu Corporation was used. The detection wavelength was 190 nm to 700 nm. The sample was prepared by dissolving it in acetonitrile to form a solution of 0.01 mmol / L, and placed in a quartz cell (optical path length 1 cm) for measurement.
  • Measurement sample When measuring the phase structure and transition temperature (transparency point, melting point, polymerization initiation temperature, etc.), the compound itself was used as a sample.
  • Measurement method The characteristics were measured by the following method. Most of these are methods described in the JEITA standard (JEITA ED-2521B), which is deliberated and enacted by the Japan Electronics and Information Technology Industries Association (JEITA), or a modified method. there were. A thin film transistor (TFT) was not attached to the TN element used for the measurement.
  • JEITA Japan Electronics and Information Technology Industries Association
  • Phase structure A sample was placed on a hot plate (FP-52 type hot stage manufactured by Mettler) of a melting point measuring device equipped with a polarizing microscope. The phase state and its change were observed with a polarizing microscope while heating this sample at a rate of 3 ° C./min to identify the type of phase.
  • Transition temperature (° C)
  • a scanning calorimeter manufactured by PerkinElmer, a Diamond DSC system, or a high-sensitivity differential scanning calorimeter manufactured by SSI Nanotechnology, X-DSC7000 was used.
  • the temperature of the sample was raised and lowered at a rate of 3 ° C./min, and the start point of the endothermic peak or the exothermic peak accompanying the phase change of the sample was determined by extrapolation to determine the transition temperature.
  • the melting point and polymerization initiation temperature of the compound were also measured using this device.
  • the temperature at which a compound transitions from a solid to a liquid crystal phase such as a smectic phase or a nematic phase may be abbreviated as "lower limit temperature of the liquid crystal phase”.
  • the temperature at which a compound transitions from the liquid crystal phase to a liquid may be abbreviated as "transparency point”.
  • the crystal was represented as C. When the types of crystals can be distinguished, they are represented as C 1 and C 2 , respectively.
  • the smectic phase was represented as S and the nematic phase was represented as N.
  • a smectic A phase, a smectic B phase if can be distinguished in the smectic C phase, or a smectic F phase, respectively S A, S B, expressed as S C or S F,.
  • the liquid (isotropic) was represented as I.
  • the transition temperature is expressed as, for example, "C 50.0 N 100.0 I". This indicates that the transition temperature from the crystal to the nematic phase is 50.0 ° C. and the transition temperature from the nematic phase to the liquid is 100.0 ° C.
  • T C Minimum Temperature of a Nematic Phase
  • a sample having a nematic phase was stored in a freezer at 0 ° C., ⁇ 10 ° C., ⁇ 20 ° C., ⁇ 30 ° C., and ⁇ 40 ° C. for 10 days, and then the liquid crystal phase was observed.
  • TC was described as ⁇ -20 ° C when the sample remained in the nematic phase at ⁇ 20 ° C. and changed to a crystalline or smectic phase at ⁇ 30 ° C.
  • the lower limit temperature of the nematic phase may be abbreviated as "lower limit temperature”.
  • Viscosity Bulk viscosity; ⁇ ; measured at 20 ° C; mPa ⁇ s
  • An E-type rotational viscometer manufactured by Tokyo Keiki Co., Ltd. was used for the measurement.
  • the method of measuring the characteristics may differ between a sample with a positive dielectric anisotropy and a sample with a negative dielectric anisotropy.
  • the measuring method when the dielectric anisotropy is positive is described in Items (8a) to (12a).
  • the dielectric anisotropy is negative, it is described in the items (8b) to (12b).
  • Viscosity Rotational viscosity; ⁇ 1; measured at 25 ° C.; mPa ⁇ s) Positive Permittivity Anisotropy: Measurements were made according to the method described in M. Imai et al., Molecular Crystals and Liquid Crystals, Vol. 259, 37 (1995). The sample was placed in a TN device having a twist angle of 0 degrees and a distance (cell gap) between the two glass substrates of 5 ⁇ m. A stepwise application was applied to this device in 0.5 V increments in the range of 16 V to 19.5 V. After no application for 0.2 seconds, application was repeated under the conditions of only one square wave (square pulse; 0.2 seconds) and no application (2 seconds).
  • Viscosity Rotational viscosity; ⁇ 1; measured at 25 ° C.; mPa ⁇ s) Negative Permittivity Anisotropy: Measurements were made according to the method described in M. Imai et al., Molecular Crystals and Liquid Crystals, Vol. 259, 37 (1995). The sample was placed in a VA element having a distance (cell gap) of 20 ⁇ m between the two glass substrates. A stepwise application was applied to this device in the range of 39 to 50 volts in 1 volt increments. After no application for 0.2 seconds, application was repeated under the conditions of only one square wave (square pulse; 0.2 seconds) and no application (2 seconds).
  • a sample was placed in a VA element in which the distance (cell gap) between the two glass substrates was 4 ⁇ m, and this element was sealed with an adhesive that cures with ultraviolet rays.
  • a sine wave (0.5 V, 1 kHz) was applied to this device, and after 2 seconds, the permittivity ( ⁇ ) of the liquid crystal molecule in the long axis direction was measured.
  • the sample was placed in a TN element in which the distance (cell gap) between the two glass substrates was 9 ⁇ m and the twist angle was 80 degrees.
  • a sine wave (0.5 V, 1 kHz) was applied to this device, and after 2 seconds, the permittivity ( ⁇ ) of the liquid crystal molecule in the minor axis direction was measured.
  • K 11 and K 33 were obtained from the equation (2.99).
  • K 22 was calculated using the values of K 11 and K 33 obtained earlier in the formula (3.18) on page 171.
  • the elastic constant K is represented by the average value of K 11 , K 22, and K 33 thus obtained.
  • Threshold voltage (Vth; measured at 25 ° C; V) Positive permittivity anisotropy An LCD5100 type luminance meter manufactured by Otsuka Electronics Co., Ltd. was used for the measurement.
  • the light source was a halogen lamp.
  • the sample was placed in a normally white mode TN element in which the distance (cell gap) between the two glass substrates was 0.45 / ⁇ n ( ⁇ m) and the twist angle was 80 degrees.
  • the voltage (32 Hz, square wave) applied to this device was gradually increased by 0.02 V from 0 V to 10 V.
  • the element was irradiated with light from the vertical direction, and the amount of light transmitted through the element was measured.
  • a voltage-transmittance curve was created in which the transmittance was 100% when the amount of light was maximum and the transmittance was 0% when the amount of light was minimum.
  • the threshold voltage is expressed as the voltage when the transmittance reaches 90%.
  • the element was irradiated with light from the vertical direction, and the amount of light transmitted through the element was measured.
  • a voltage-transmittance curve was created in which the transmittance was 100% when the amount of light was maximum and the transmittance was 0% when the amount of light was minimum.
  • the threshold voltage is expressed as the voltage when the transmittance reaches 10%.
  • the rise time ( ⁇ r: rise time; millisecond) is the time required for the transmittance to change from 90% to 10%.
  • the fall time ( ⁇ f: fall time; millisecond) is the time required for the transmittance to change from 10% to 90%.
  • the response time was expressed as the sum of the rise time and the fall time obtained in this way.
  • a square wave (60 Hz, 10 V, 0.5 seconds) was applied to this device.
  • the element was irradiated with light from the vertical direction, and the amount of light transmitted through the element was measured. It was considered that the transmittance was 100% when the amount of light was maximum, and the transmittance was 0% when the amount of light was minimum.
  • the response time was expressed as the time required for the transmittance to change from 90% to 10% (fall time; fall time; millisecond).
  • Raw material Solmix (registered trademark) A-11 is a mixture of ethanol (85.5%), methanol (13.4%) and isopropanol (1.1%), and was obtained from Japan Alcohol Trading Co., Ltd.
  • Step 3 Compound (T-9) (12.6 g), methacrylic acid (3.0 g), DMAP (0.99 g), and dichloromethane (250 ml) were placed in a reactor and cooled to 0 ° C. DCC (7.19 g) was added thereto, and the mixture was stirred for 12 hours while returning to room temperature. After filtering the insoluble material, the reaction mixture was poured into water and the aqueous layer was extracted with dichloromethane. The organic layer was washed with water and dried over anhydrous magnesium sulfate. The solution was concentrated under reduced pressure and the residue was purified by silica gel chromatography (toluene) to give compound (T-10) (10.64 g; 71%).
  • Step 4 Compound (T-10) (10.1 g), Compound (T-11) (3.2 g), Copper iodide (0.35 g), Pd (PPh 3 ) 4 (1.08 g), THF ( 100 ml) and triethylamine (50 ml) were taken in a container and stirred overnight in a nitrogen atmosphere. The reaction mixture was poured into water, extracted with toluene, washed with water, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure to give a light brown solid.
  • compound (1) As a specific example of compound (1), the following compound can be synthesized in addition to the compound shown in the synthesis example according to the synthesis method described in the synthesis example.
  • Example of device use The compounds in the example of use are represented by symbols based on the definitions in Table 2 below.
  • Table 2 the configuration for 1,4-cyclohexylene is trans.
  • the number in parentheses after the symbol corresponds to the compound number.
  • the symbol (-) means other liquid crystal compounds.
  • the proportion (percentage) of the liquid crystal compound is a weight percentage (% by weight) based on the weight of the liquid crystal composition.
  • the composition to which the polar compound was added was injected into the device having no raw material alignment film. After irradiating with linearly polarized light, the orientation of the liquid crystal molecules in this device was confirmed. First, the raw materials will be described. The raw material was appropriately selected from the composition (M1) to the composition (M41) and the compound (No. 1) to the compound (No. 618) such as the compound (1).
  • the composition is as follows.
  • V-HB (2F, 3F) -O2 (9-1) 10% V2-HB (2F, 3F) -O2 (9-1) 10% 2-H1OB (2F, 3F) -O2 (9-5) 3% 3-H1OB (2F, 3F) -O2 (9-5) 3% 2O-BB (2F, 3F) -O2 (9-3) 3% V2-BB (2F, 3F) -O2 (9-3) 8% V2-HHB (2F, 3F) -O2 (10-1) 5% 2-HBB (2F, 3F) -O2 (10-7) 3% 3-HBB (2F, 3F) -O2 (10-7) 3% V-HBB (2F, 3F) -O2 (10-7) 6% V-HBB (2F, 3F) -O4 (10-7) 8% V-HHB (2F, 3Cl) -O2 (10-12) 7% 3-HH-4 (2-1) 14% V-HHB-1 (3-1) 10% 3-HBB-2 (3-4)
  • Usage example 8 to usage example 28 Using a composition (M1), as an antioxidant, it was added compound R 40 is n- heptyl and (AO-1) in a proportion of 150 ppm, was mixed in the ratio shown compound (1) in Table 3 below. Others were operated in the same manner as in Usage Example 1. The irradiation time was measured by the same method as in Example 1. The results are summarized in Table 3 below. The mixture of Examples 8 to 28 also showed an isotropic phase at 90 ° C.
  • composition (M1) to the composition (M41) and the compound (No. 1) to the compound (No. 618) were appropriately selected from the composition (1), and the same operation was performed. In each case, the irradiation time was within 10 minutes.
  • Comparative Examples 1 to 21 Compound (A-1-1-1), compound (S-1) described in Patent Document 3 and compound (S-2) described in Patent Document 2 are designated as compound (1) at the ratios shown in Table 4 below. It was mixed with the composition (M1), and the irradiation time was evaluated by the same operation as in the example of use. The mixture of Comparative Examples 1 to 21 also showed an isotropic phase at 90 ° C. As a result, as compared with the compound according to the embodiment of the present invention, in any of the compounds, good orientation was not obtained at the longest irradiation time of 10 minutes in the use example, and good orientation was confirmed. The time was more than 30 minutes. Moreover, when the same evaluation was performed using the compositions (M2) to (M41), the tendency was the same as that when the composition (M1) was used.
  • the composition and the type and amount of the compound (1), which is a polar compound were changed, but there was no undissolved residue or precipitation, and no light leakage of the device was observed within 10 minutes of irradiation.
  • This result indicates that the orientation is good even if the device does not have an alignment film such as polyimide, and all the liquid crystal molecules are arranged in a certain direction.
  • the comparative example light leakage of the element was observed in the irradiation within 30 minutes, and the orientation was not good.
  • the compound (1) according to the embodiment of the present invention can be used in light irradiation for a short time or with low energy, thereby shortening the tact time and reducing the damage caused by the light irradiation of the mother liquid crystal. can do.
  • the liquid crystal composition according to the embodiment of the present invention at least one characteristic of a wide temperature range in which the device can be used, a short response time, a high voltage retention rate, a low threshold voltage, a large contrast ratio, and a long life can be obtained.
  • the liquid crystal display element to have is obtained.
  • liquid crystal display element having a liquid crystal composition satisfying at least one of the above characteristics can be obtained.
  • the liquid crystal composition according to the embodiment of the present invention can be used for a liquid crystal monitor, a liquid crystal television, or the like.

Abstract

Provided is a compound having at least one characteristic proprety selected from high chemical stability, high ability to horizontally align liquid crystal molecules, high alignability over a broad range of addition concentrations, proper reactivity, high solubility in liquid crystal compositions, and so forth. Provided is a compound represented by formula (1). In formula (1), a and b independently represent 0, 1 or 2 and satisfy the requirement represented by the formula: 0 ≦ a+b ≦ 3, ring A1, ring A2, ring A3 and ring A4 independently represent, for example, a 1,4-cyclohexylene group, Z1, Z2, Z3, Z4 and Z5 independently represent a single bond, an alkylene group having 1 to 10 carbon atoms or the like, Sp1 and Sp2 independently represent a single bond, an alkylene group having 1 to 10 carbon atoms or the like, and P1 and P2 independently represent a specific polymerizable group.

Description

化合物、液晶組成物および液晶表示素子Compounds, liquid crystal compositions and liquid crystal display devices
 本発明は、化合物、液晶組成物および液晶表示素子に関する。さらに詳しくは、分子内にチオエステル(-COS-、-SCO-)またはチオ桂皮酸エステル(-CH=CHCOS-、-SCOCH=CH-)を有する重合性の極性化合物、この化合物を含み、誘電率異方性が正または負の液晶組成物、およびこの組成物を含む液晶表示素子に関する。 The present invention relates to compounds, liquid crystal compositions and liquid crystal display devices. More specifically, a polymerizable polar compound having a thioester (-COS-, -SCO-) or a thiosilicate ester (-CH = CHCOS-, -SCOCH = CH-) in the molecule, which comprises this compound and has a dielectric constant. The present invention relates to a liquid crystal composition having positive or negative anisotropy, and a liquid crystal display element containing this composition.
 液晶表示素子において、液晶分子の動作モードに基づいた分類は、PC(phase change)、TN(twisted nematic)、STN(super twisted nematic)、ECB(electrically controlled birefringence)、OCB(optically compensated bend)、IPS(in-plane switching)、VA(vertical alignment)、FFS(fringe field switching)、FPA(field-induced photo-reactive alignment)などのモードである。素子の駆動方式に基づいた分類は、PM(passive matrix)とAM(active matrix)である。PMは、スタティック(static)、マルチプレックス(multiplex)などに分類され、AMは、TFT(thin film transistor)、MIM(metal insulator metal)などに分類される。TFTの分類は非晶質シリコン(amorphous silicon)および多結晶シリコン(polycrystal silicon)である。後者は製造工程によって高温型と低温型とに分類される。光源に基づいた分類は、自然光を利用する反射型、バックライトを利用する透過型、そして自然光とバックライトの両方を利用する半透過型である。 In the liquid crystal display element, the classification based on the operation mode of the liquid crystal molecule is PC (phase change), TN (twisted nematic), STN (super twisted nematic), ECB (electrically controlled birefringence), OCB (optically compensated bend), IPS. (In-plane switching), VA (vertical alignment), FFS (fringe field switching), FPA (field-induced photo-reactive alignment) and other modes. The classifications based on the drive method of the element are PM (passive matrix) and AM (active matrix). PM is classified into static, multiplex and the like, and AM is classified into TFT (thin film transistor), MIM (metal insulator metal) and the like. The classification of TFT is amorphous silicon (amorphous silicon) and polycrystalline silicon (polycrystal silicon). The latter is classified into a high temperature type and a low temperature type according to the manufacturing process. The classification based on the light source is a reflective type that uses natural light, a transmissive type that uses a backlight, and a transflective type that uses both natural light and a backlight.
 液晶表示素子はネマチック相を有する液晶組成物を含有する。この組成物は適切な特性を有する。この組成物の特性を向上させることによって、良好な特性を有するAM素子を得ることができる。2つの特性における関連を下記の表1にまとめる。組成物の特性を市販されているAM素子に基づいてさらに説明する。ネマチック相の温度範囲は、素子の使用できる温度範囲に関連する。ネマチック相の好ましい上限温度は約70℃以上であり、そしてネマチック相の好ましい下限温度は約-10℃以下である。組成物の粘度は素子の応答時間に関連する。素子で動画を表示するためには短い応答時間が好ましい。1ミリ秒でもより短い応答時間が望ましい。したがって、組成物における小さな粘度が好ましい。低い温度における小さな粘度はより好ましい。 The liquid crystal display element contains a liquid crystal composition having a nematic phase. This composition has suitable properties. By improving the characteristics of this composition, an AM element having good characteristics can be obtained. The relationship between the two characteristics is summarized in Table 1 below. The properties of the composition will be further described based on commercially available AM devices. The temperature range of the nematic phase is related to the temperature range in which the device can be used. The preferred upper limit temperature of the nematic phase is about 70 ° C. or higher, and the preferred lower limit temperature of the nematic phase is about −10 ° C. or lower. The viscosity of the composition is related to the response time of the device. A short response time is preferred for displaying moving images on the device. A shorter response time of even 1 millisecond is desirable. Therefore, a small viscosity in the composition is preferred. Small viscosities at low temperatures are more preferred.

Figure JPOXMLDOC01-appb-I000022

Figure JPOXMLDOC01-appb-I000022
 組成物の光学異方性は、素子のコントラスト比に関連する。素子のモードに応じて、大きな光学異方性または小さな光学異方性、すなわち適切な光学異方性が必要である。組成物の光学異方性(Δn)と素子のセルギャップ(d)との積(Δn×d)は、コントラスト比を最大にするように設計される。適切な積の値は動作モードの種類に依存する。この値は、TNのようなモードの素子では約0.45μmである。この値は、VAモードの素子では約0.30μmから約0.40μmの範囲であり、IPSモードまたはFFSモードの素子では約0.20μmから約0.30μmの範囲である。これらの場合、小さなセルギャップの素子には大きな光学異方性を有する組成物が好ましい。組成物における大きな誘電率異方性は、素子における低いしきい値電圧、小さな消費電力と大きなコントラスト比に寄与する。したがって、正または負に大きな誘電率異方性が好ましい。組成物における大きな比抵抗は、素子における大きな電圧保持率と大きなコントラスト比とに寄与する。したがって、初期段階において室温だけでなくネマチック相の上限温度に近い温度でも大きな比抵抗を有する組成物が好ましい。長時間使用したあと、室温だけでなくネマチック相の上限温度に近い温度でも大きな比抵抗を有する組成物が好ましい。紫外線および熱に対する組成物の安定性は、素子の寿命に関連する。この安定性が高いとき、素子の寿命は長い。このような特性は、液晶プロジェクター、液晶テレビなどに用いるAM素子に好ましい。 The optical anisotropy of the composition is related to the contrast ratio of the device. Depending on the mode of the device, a large optical anisotropy or a small optical anisotropy, that is, an appropriate optical anisotropy is required. The product (Δn × d) of the optical anisotropy (Δn) of the composition and the cell gap (d) of the device is designed to maximize the contrast ratio. The appropriate product value depends on the type of operating mode. This value is about 0.45 μm for devices in modes such as TN. This value ranges from about 0.30 μm to about 0.40 μm for VA mode devices and from about 0.20 μm to about 0.30 μm for IPS or FFS mode devices. In these cases, a composition having a large optical anisotropy is preferable for a device having a small cell gap. The large permittivity anisotropy in the composition contributes to the low threshold voltage, low power consumption and large contrast ratio in the device. Therefore, a large positive or negative dielectric anisotropy is preferable. A large resistivity in the composition contributes to a large voltage retention and a large contrast ratio in the device. Therefore, a composition having a large resistivity at an initial stage not only at room temperature but also at a temperature close to the upper limit temperature of the nematic phase is preferable. After long-term use, a composition having a large specific resistance not only at room temperature but also at a temperature close to the upper limit temperature of the nematic phase is preferable. The stability of the composition against UV and heat is related to the life of the device. When this stability is high, the life of the device is long. Such characteristics are preferable for AM elements used in liquid crystal projectors, liquid crystal televisions, and the like.
 TNモードを有するAM素子においては正の誘電率異方性を有する組成物が用いられる。VAモードを有するAM素子においては負の誘電率異方性を有する組成物が用いられる。IPSモードまたはFFSモードを有するAM素子においては正または負の誘電率異方性を有する組成物が用いられる。
 高分子支持配向(PSA;polymer sustained alignment)型のAM素子においては正または負の誘電率異方性を有する組成物が用いられる。高分子支持配向(PSA;polymer sustained alignment)型の液晶表示素子では、重合体を含有する液晶組成物が用いられる。まず、少量の重合性化合物を添加した組成物を素子に注入する。次に、この素子の基板のあいだに電圧を印加しながら、組成物に紫外線を照射する。重合性化合物は重合して、組成物中に重合体の網目構造を生成する。この組成物では、重合体によって液晶分子の配向を制御することが可能になるので、素子の応答時間が短縮され、画像の焼き付きが改善される。重合体のこのような効果は、TN、ECB、OCB、IPS、VA、FFS、FPAのようなモードを有する素子に期待できる。
In the AM device having the TN mode, a composition having a positive dielectric anisotropy is used. In the AM device having the VA mode, a composition having a negative dielectric anisotropy is used. In an AM device having an IPS mode or an FFS mode, a composition having positive or negative dielectric anisotropy is used.
In a polymer sustained alignment (PSA) type AM device, a composition having positive or negative dielectric anisotropy is used. In a polymer sustained alignment (PSA) type liquid crystal display element, a liquid crystal composition containing a polymer is used. First, the composition to which a small amount of the polymerizable compound is added is injected into the device. Next, the composition is irradiated with ultraviolet rays while applying a voltage between the substrates of this device. The polymerizable compound polymerizes to form a network structure of the polymer in the composition. In this composition, since the orientation of the liquid crystal molecules can be controlled by the polymer, the response time of the device is shortened and the burn-in of the image is improved. Such effects of the polymer can be expected for devices having modes such as TN, ECB, OCB, IPS, VA, FFS, FPA.
 ポリイミドのような配向膜の代わりに、シンナメート基を有する低分子化合物やポリビニルシンナメート、カルコン構造を有する低分子化合物、アゾベンゼン構造を有する低分子化合物やデンドリマーを用いて液晶の配向を制御する方法が報告されている(特許文献1、2または3)。特許文献1、2または3の方法では、まず、この低分子化合物やポリマーを添加物として液晶組成物に溶解させる。次に、この添加物を相分離させることによってこの低分子化合物やポリマーからなる薄膜を基板上に生成させる。最後に、液晶組成物の上限温度より高い温度で基板に直線偏光を照射する。この直線偏光によって低分子化合物やポリマー二量化または異性化するとき、その分子が一定方向に配列される。この方法では、低分子化合物やポリマーの種類を選択することにより、IPSやFFSのような水平配向モードの素子とVAのような垂直配向モードの素子とを製造することができる。この方法においては、低分子化合物やポリマーが液晶組成物の上限温度より高い温度で容易に溶解し、室温に戻したとき、この化合物が液晶組成物から容易に相分離することが重要である。ただし、低分子化合物やポリマーと液晶組成物との相溶性を確保するのが困難であった。 Instead of an alignment film such as polyimide, a method of controlling the orientation of a liquid crystal by using a low molecular weight compound having a cinnamate group, polyvinyl synnamate, a low molecular weight compound having a chalcone structure, a low molecular weight compound having an azobenzene structure, or a dendrimer is used. It has been reported (Patent Documents 1, 2 or 3). In the method of Patent Documents 1, 2 or 3, first, the low molecular weight compound or polymer is dissolved in the liquid crystal composition as an additive. Next, the additive is phase-separated to form a thin film composed of the low molecular weight compound or polymer on the substrate. Finally, the substrate is irradiated with linearly polarized light at a temperature higher than the upper limit temperature of the liquid crystal composition. When this linearly polarized light dimerizes or isomerizes a low molecular weight compound or polymer, the molecules are arranged in a certain direction. In this method, by selecting the type of low molecular weight compound or polymer, an element in a horizontal orientation mode such as IPS or FFS and an element in a vertical orientation mode such as VA can be manufactured. In this method, it is important that the low molecular weight compound or polymer is easily dissolved at a temperature higher than the upper limit temperature of the liquid crystal composition, and when the temperature is returned to room temperature, the compound is easily phase-separated from the liquid crystal composition. However, it has been difficult to ensure compatibility between the low molecular weight compound or polymer and the liquid crystal composition.
 これまでに、配向膜を有しない液晶表示素子において、液晶分子を水平配向させることの出来る化合物として、特許文献2に化合物(S-1)(明細書の段落0034の [化2])、特許文献3には化合物(S-2)(明細書中のP176の化合物[14])等が記載されている。しかし、これらの化合物は液晶分子を充分な配向性で水平配向させるには、高エネルギーの光照射が必要であり、長時間の光照射による製造時間の増加やそれによる液晶へのダメージの懸念があり改善が望まれる。 So far, as a compound capable of horizontally aligning a liquid crystal molecule in a liquid crystal display element having no alignment film, Patent Document 2 contains a compound (S-1) (paragraph 0034 of the specification, [Chemical Formula 2]), and a patent. Document 3 describes compound (S-2) (compound of P176 in the specification [14]) and the like. However, these compounds require high-energy light irradiation in order to horizontally orient the liquid crystal molecules with sufficient orientation, and there is a concern that the production time will increase due to long-term light irradiation and that the liquid crystal will be damaged. Yes, improvement is desired.

Figure JPOXMLDOC01-appb-I000023

Figure JPOXMLDOC01-appb-I000023
国際公開第2015/146369号International Publication No. 2015/146369 国際公開第2017/057162号International Publication No. 2017/051762 国際公開第2017/102068号International Publication No. 2017/102068
 本発明の第一の課題は、化学的に高い安定性、液晶分子を水平配向させる高い能力、広い添加濃度範囲における高い配向性、適切な反応性、および液晶組成物への高い溶解度の少なくとも1つの特性を有し、そして液晶表示素子に用いた場合に電圧保持率が大きいことが期待される化合物を提供することである。第二の課題は、この化合物を含み、そしてネマチック相の高い上限温度、ネマチック相の低い下限温度、小さな粘度、適切な光学異方性、正または負に大きな誘電率異方性、大きな比抵抗、紫外線に対する高い安定性、熱に対する高い安定性、大きな弾性定数などの特性の少なくとも1つを充足する液晶組成物を提供することである。第三の課題は、この組成物を含み、この組成物に紫外線照射することにより極性化合物が素子内で膜を形成した際、その膜が適切な硬度、接触する成分の低い浸透性、高い耐候性、適切な体積抵抗値の少なくとも1つの特性を有し、素子を使用できる広い温度範囲、短い応答時間、高い電圧保持率、低いしきい値電圧、大きなコントラスト比、長い寿命の少なくとも1つの特性を有する液晶表示素子を提供することである。 The first object of the present invention is at least one of high chemical stability, high ability to horizontally orient liquid crystal molecules, high orientation over a wide range of additive concentrations, appropriate reactivity, and high solubility in liquid crystal compositions. It is to provide a compound which has two characteristics and is expected to have a large voltage retention when used in a liquid crystal display element. The second challenge is to include this compound and have a high upper limit temperature of the nematic phase, a lower lower limit temperature of the nematic phase, a small viscosity, proper optical anisotropy, a large positive or negative dielectric anisotropy, a large specific resistance. It is an object of the present invention to provide a liquid crystal composition satisfying at least one of properties such as high stability against ultraviolet rays, high stability against heat, and a large elastic constant. The third problem is that when this composition is contained and the polar compound forms a film in the device by irradiating the composition with ultraviolet rays, the film has appropriate hardness, low permeability of the components to be contacted, and high weather resistance. At least one characteristic of property, at least one characteristic of appropriate volume resistance, wide temperature range in which the device can be used, short response time, high voltage retention, low threshold voltage, large contrast ratio, long life. It is to provide the liquid crystal display element which has.
 本発明者らは、以下の式(1)で表される化合物が、上記の課題を解決できることを見出し、発明を完成させた。

Figure JPOXMLDOC01-appb-I000024

(式中の記号の説明は後述する)
The present inventors have found that the compound represented by the following formula (1) can solve the above-mentioned problems, and have completed the invention.

Figure JPOXMLDOC01-appb-I000024

(The explanation of the symbols in the formula will be described later)
 本発明の第一の長所は、化学的に高い安定性、液晶分子を水平に配向させる高い能力、広い添加濃度範囲における高い配向性、適切な反応性、および液晶組成物への高い溶解度の少なくとも1つを有し、そして液晶表示素子に用いた場合に電圧保持率が大きいことが期待される化合物を提供することである。第二の長所は、この化合物を含み、そしてネマチック相の高い上限温度、ネマチック相の低い下限温度、小さな粘度、適切な光学異方性、正または負に大きな誘電率異方性、大きな比抵抗、紫外線に対する高い安定性、熱に対する高い安定性、大きな弾性定数などの特性の少なくとも1つを充足する液晶組成物を提供することである。第三の長所は、この組成物を含み、この組成物に紫外線照射することにより極性化合物が素子内で膜を形成した際、その膜が適切な硬度、接触する成分の低い浸透性、高い耐候性、適切な体積抵抗値の少なくとも1つの特性を有し、素子を使用できる広い温度範囲、短い応答時間、高い電圧保持率、低いしきい値電圧、大きなコントラスト比、長い寿命の少なくとも1つの特性を有する液晶表示素子を提供することである。本発明の化合物を含む液晶組成物を利用することによって、配向膜の形成工程が不要になるので、製造コストを低減させた液晶表示素子を得ることができる。 The first advantages of the present invention are at least chemically high stability, high ability to orient liquid crystal molecules horizontally, high orientation over a wide range of addition concentrations, suitable reactivity, and high solubility in liquid crystal compositions. It is to provide a compound which has one and is expected to have a large voltage retention when used in a liquid crystal display element. The second advantage is that it contains this compound and has a high upper limit temperature of the nematic phase, a lower lower limit temperature of the nematic phase, a small viscosity, suitable optical anisotropy, a large positive or negative dielectric anisotropy, a large specific resistance. It is an object of the present invention to provide a liquid crystal composition satisfying at least one of properties such as high stability against ultraviolet rays, high stability against heat, and a large elastic constant. The third advantage is that the composition contains this composition, and when the polar compound forms a film in the device by irradiating the composition with ultraviolet rays, the film has appropriate hardness, low permeability of the components to be contacted, and high weather resistance. At least one characteristic of property, at least one characteristic of appropriate volume resistance, wide temperature range in which the device can be used, short response time, high voltage retention, low threshold voltage, large contrast ratio, long life. It is to provide the liquid crystal display element which has. By using the liquid crystal composition containing the compound of the present invention, the step of forming the alignment film becomes unnecessary, so that a liquid crystal display element having a reduced manufacturing cost can be obtained.
 この明細書における用語の使い方は次のとおりである。「液晶組成物」および「液晶表示素子」の用語をそれぞれ「組成物」および「素子」と略すことがある。「液晶表示素子」は液晶表示パネルおよび液晶表示モジュールの総称である。「液晶性化合物」は、ネマチック相、スメクチック相などの液晶相を有する化合物および液晶相を有しないが、ネマチック相の温度範囲、粘度、誘電率異方性のような特性を調節する目的で組成物に混合される化合物の総称である。この化合物は、例えば1,4-シクロヘキシレンや1,4-フェニレンのような六員環を有し、その分子構造は棒状(rod like)である。「重合性化合物」は、組成物中に重合体を生成させる目的で添加する化合物である。「極性化合物」は、極性基が基板表面と相互作用することによって液晶分子が配列するのを援助する。 The usage of terms in this specification is as follows. The terms "liquid crystal composition" and "liquid crystal display element" may be abbreviated as "composition" and "element", respectively. "Liquid crystal display element" is a general term for a liquid crystal display panel and a liquid crystal display module. The "liquid crystal compound" is a compound having a liquid crystal phase such as a nematic phase or a smectic phase, and a compound having no liquid crystal phase, but is composed for the purpose of adjusting characteristics such as temperature range, viscosity, and dielectric anisotropy of the nematic phase. It is a general term for compounds mixed in a product. This compound has a six-membered ring such as 1,4-cyclohexylene and 1,4-phenylene, and its molecular structure is rod-like. The "polymerizable compound" is a compound added for the purpose of forming a polymer in the composition. A "polar compound" helps liquid crystal molecules to align by interacting with polar groups on the substrate surface.
 液晶組成物は、複数の液晶性化合物を混合することによって調製される。液晶性化合物の割合(含有量)は、この液晶組成物の重量に基づいた重量百分率(重量%)で表される。この液晶組成物に、光学活性化合物、酸化防止剤、紫外線吸収剤、色素、消泡剤、重合性化合物、重合開始剤、重合禁止剤、極性化合物のような添加物が必要に応じて添加される。添加物の割合(添加量)は、液晶性化合物の割合と同様に、液晶組成物の重量に基づいた重量百分率(重量%)で表される。重量百万分率(ppm)が用いられることもある。重合開始剤および重合禁止剤の割合は、例外的に重合性化合物の重量に基づいて表される。 The liquid crystal composition is prepared by mixing a plurality of liquid crystal compounds. The proportion (content) of the liquid crystal compound is expressed as a weight percentage (% by weight) based on the weight of the liquid crystal composition. Additives such as optically active compounds, antioxidants, ultraviolet absorbers, dyes, defoamers, polymerizable compounds, polymerization initiators, polymerization inhibitors, and polar compounds are added to the liquid crystal composition as needed. To. The ratio of the additive (addition amount) is expressed as a weight percentage (% by weight) based on the weight of the liquid crystal composition, similarly to the ratio of the liquid crystal compound. Parts per million (ppm) by weight may also be used. The ratio of the polymerization initiator and the polymerization inhibitor is exceptionally expressed based on the weight of the polymerizable compound.
 式(1)で表される化合物を「化合物(1)」と略すことがある。化合物(1)は、式(1)で表される1つの化合物、2つの化合物の混合物、または3つ以上の化合物の混合物を意味する。このルールは、式(2)で表される化合物の群から選択される少なくとも1つの化合物などにも適用される。六角形で囲んだB、C、Fなどの記号はそれぞれ環B、環C、環Fなどに対応する。六角形は、シクロヘキサン環やベンゼン環のような六員環またはナフタレン環のような縮合環を表す。この六角形を横切る斜線は、環上の任意の水素が-Sp-Pなどの基で置き換えられてもよいことを表す。eなどの添え字は、置き換えられた基の数を示す。添え字が0のとき、そのような置き換えはない。 The compound represented by the formula (1) may be abbreviated as "compound (1)". Compound (1) means one compound represented by the formula (1), a mixture of two compounds, or a mixture of three or more compounds. This rule also applies to at least one compound selected from the group of compounds represented by the formula (2). Symbols such as B 1 , C 1 , and F enclosed in a hexagon correspond to ring B 1 , ring C 1 , and ring F, respectively. The hexagon represents a six-membered ring such as a cyclohexane ring or a benzene ring or a fused ring such as a naphthalene ring. The diagonal lines across this hexagon indicate that any hydrogen on the ring may be replaced by a group such as -Sp 1- P 1 . Subscripts such as e indicate the number of replaced groups. When the subscript is 0, there is no such replacement.
 末端基R11の記号を複数の成分化合物に用いた。これらの化合物において、任意の2つのR11が表す2つの基は、同一であってもよいし、または異なってもよい。例えば、化合物(2)のR11がエチルであり、化合物(3)のR11がエチルであるケースがある。化合物(2)のR11がエチルであり、化合物(3)のR11がプロピルであるケースもある。このルールは、他の末端基、環、結合基などの記号にも適用される。式(8)において、iが2のとき、2つの環Dが存在する。この化合物において、2つの環Dが表す2つの基は、同一であってもよいし、または異なってもよい。このルールは、iが2より大きいときの任意の2つの環Dにも適用される。このルールは、他の環、結合基などの記号にも適用される。 The symbol of the terminal groups R 11 was used in a plurality of component compounds. In these compounds, two groups represented by any two R 11 may be the same or different. For example, there are cases where R 11 of compound (2) is ethyl and R 11 of compound (3) is ethyl. In some cases, R 11 of compound (2) is ethyl and R 11 of compound (3) is propyl. This rule also applies to symbols such as other end groups, rings, and binding groups. In the formula (8), when i is 2, two rings D 1 are present. In this compound, two groups two rings D 1 represents may be the same or different. This rule, i applies to any two rings D 1 of the case 2 larger. This rule also applies to symbols such as other rings and binding groups.
 「少なくとも1つの‘A’」の表現は、‘A’の数は任意であることを意味する。「少なくとも1つの‘A’は、‘B’で置き換えられてもよい」の表現は、‘A’の数が1つのとき、‘A’の位置は任意であり、‘A’の数が2つ以上のときも、それらの位置は制限なく選択できる。このルールは、「少なくとも1つの‘A’が、‘B’で置き換えられた」の表現にも適用される。「少なくとも1つのAが、B、C、またはDで置き換えられてもよい」という表現は、少なくとも1つのAがBで置き換えられた場合、少なくとも1つのAがCで置き換えられた場合、および少なくとも1つのAがDで置き換えられた場合、さらに複数のAがB、C、Dの少なくとも2つで置き換えられた場合を含むことを意味する。例えば、少なくとも1つの-CH-(または、-(CH-)が-O-(または、-CH=CH-)で置き換えられてもよいアルキルには、アルキル、アルケニル、アルコキシ、アルコキシアルキル、アルコキシアルケニル、アルケニルオキシアルキルが含まれる。なお、連続する2つの-CH-が-O-で置き換えられて、-O-O-のようになることは好ましくない。アルキルなどにおいて、メチル部分(-CH-H)の-CH-が-O-で置き換えられて-O-Hになることも好ましくない。 The expression "at least one'A'" means that the number of'A's is arbitrary. The expression "at least one'A'may be replaced by'B'" is that when the number of'A's is 1, the position of the'A'is arbitrary and the number of'A's is 2. When there is more than one, their positions can be selected without limitation. This rule also applies to the expression "at least one'A' has been replaced by a'B'". The expression "at least one A may be replaced by B, C, or D" is expressed when at least one A is replaced by B, at least one A is replaced by C, and at least. When one A is replaced by D, it means that a plurality of A's are replaced by at least two of B, C and D. For example, alkyl, alkenyl, alkoxy, alkoxy, which may replace at least one -CH 2- (or-(CH 2 ) 2- ) with -O- (or -CH = CH-). Includes alkyl, alkoxyalkenyl, alkenyloxyalkyl. It is not preferable that two consecutive -CH 2- are replaced with -O- to become -O-O-. Alkyl such as in, -CH 2 methyl moiety (-CH 2 -H) - by is replaced by -O- is not preferred also be the -O-H.
 ハロゲンはフッ素、塩素、臭素、またはヨウ素を意味する。好ましいハロゲンは、フッ素または塩素である。さらに好ましいハロゲンはフッ素である。アルキルは、直鎖状または分岐状であり、環状アルキルを含まない。直鎖状アルキルは、一般的に分岐状アルキルよりも好ましい。これらのことは、アルコキシ、アルケニルなどの末端基についても同様である。1,4-シクロヘキシレンに関する立体配置は、ネマチック相の上限温度を上げるためにシスよりもトランスが好ましい。2-フルオロ-1,4-フェニレンは、下記の2つの二価基を意味する。化学式において、フッ素は左向き(L)であってもよいし、右向き(R)であってもよい。このルールは、テトラヒドロピラン-2,5-ジイルのような、環から水素を2つ除くことによって生成した非対称な二価基にも適用される。

Figure JPOXMLDOC01-appb-I000025
Halogen means fluorine, chlorine, bromine, or iodine. Preferred halogens are fluorine or chlorine. A more preferred halogen is fluorine. Alkyl is linear or branched and does not contain cyclic alkyl. Linear alkyl is generally preferred over branched alkyl. The same applies to terminal groups such as alkoxy and alkenyl. The configuration for 1,4-cyclohexylene is preferably trans over cis in order to raise the upper temperature limit of the nematic phase. 2-Fluoro-1,4-phenylene means the following two divalent groups. In the chemical formula, fluorine may be left-facing (L) or right-facing (R). This rule also applies to asymmetric divalent groups generated by removing two hydrogens from the ring, such as tetrahydropyran-2,5-diyl.

Figure JPOXMLDOC01-appb-I000025
 本発明は、下記の項などを包含する。 The present invention includes the following items and the like.
[1]式(1)で表される化合物。

Figure JPOXMLDOC01-appb-I000026

 式(1)において、
 aおよびbは独立して、0、1または2であり、0≦a+b≦3であり、
 環A、環A、環Aおよび環Aは独立して、1,4-シクロへキシレン、1,4-シクロヘキセニレン、1,4-フェニレン、ナフタレン-2,6-ジイル、デカヒドロナフタレン-2,6-ジイル、1,2,3,4-テトラヒドロナフタレン-2,6-ジイル、テトラヒドロピラン-2,5-ジイル、1,3-ジオキサン-2,5-ジイル、ピリミジン-2,5-ジイル、ピリジン-2,5-ジイル、フルオレン-2,7-ジイル、フェナントレン-2,7-ジイル、アントラセン-2,6-ジイル、ペルヒドロシクロペンタ[a]フェナントレン-3,17-ジイル、または2,3,4,7,8,9,10,11,12,13,14,15,16,17-テトラデカヒドロシクロペンタ[a]フェナントレン-3,17-ジイルであり、これらの環において、少なくとも1つの水素は、フッ素、塩素、炭素数1から12のアルキル、炭素数2から12のアルケニル、炭素数1から11のアルコキシ、炭素数2から11のアルケニルオキシ、-Sp-P、であり
-Pで置き換えられてもよく、これらの基において、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよく、
aが2のとき、2つの環Aは異なっていてもよく、bが2のとき、2つの環Aは異なっていてもよく;
 Z、Z、Z、ZおよびZは独立して、単結合または炭素数1から10のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-、-S-、-CO-、-COO-、-OCO-、または-OCOO-で置き換えられてもよく、少なくとも1つの-(CH-は、-CH=CH-または-C≡C-で置き換えられてもよく、これらの基において、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよい。ただし、Z、Z、またはZの中で少なくとも1つは、-COS-、-SCO-、-CH=CHCOS-、または-SCOCH=CH-であり、Z、Z、またはZにおいて-COS-及び-OCO-または-SCO-及び-COO-が同時に存在することはなく、aが2のとき、2つのZは異なっていてもよく、bが2のとき、2つのZは異なっていてもよく;
 SpおよびSpは独立して、単結合または炭素数1から10のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-、-CO-、-COO-、-OCO-、または-OCOO-で置き換えられてもよく、少なくとも1つの-(CH-は、-CH=CH-または-C≡C-で置き換えられてもよく、これらの基において、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよく、
複数のSpまたはSpが存在する場合、それぞれが異なっていてもよく;
1およびPは独立して、式(1b)~式(1h)のいずれかで表される基であり、複数のPまたはPが存在する場合、それぞれが異なっていてもよく;

Figure JPOXMLDOC01-appb-I000027

 式(1b)~式(1h)において、      
 M、M、MおよびMは独立して、水素、フッ素、塩素、炭素数1から5のアルキル、または少なくとも1つの水素がフッ素または塩素で置き換えられた炭素数1から5のアルキルであり、XはOまたはSであり;
 Rは水素、フッ素、塩素、または炭素数1から5のアルキルであり、このアルキルにおいて少なくとも1つの水素はフッ素または塩素で置き換えられてもよく、少なくとも1つの-CH-は、-O-で置き換えられてもよく;
 R、R、R、R、およびRは独立して、水素または炭素数1から15のアルキルであり、このアルキルにおいて、少なくとも1つの-CH-は、-O-または-S-で置き換えられてもよく、少なくとも1つの-(CH-は、-CH=CH-または-C≡C-で置き換えられてもよく、これらの基において、少なくとも1つの水素はフッ素または塩素で置き換えられてもよい。
[1] A compound represented by the formula (1).

Figure JPOXMLDOC01-appb-I000026

In equation (1)
a and b are independently 0, 1 or 2, 0 ≦ a + b ≦ 3, and so on.
Ring A 1 , Ring A 2 , Ring A 3 and Ring A 4 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, naphthalene-2,6-diyl, Decahydronaphthrene-2,6-diyl, 1,2,3,4-tetrahydronaphthalene-2,6-diyl, tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyrimidine- 2,5-diyl, pyridine-2,5-diyl, fluorene-2,7-diyl, phenanthrene-2,7-diyl, anthracene-2,6-diyl, perhydrocyclopenta [a] phenanthrene-3,17 -Diyl, or 2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydrocyclopenta [a] phenanthrene-3,17-diyl, In these rings, at least one hydrogen is fluorine, chlorine, alkyl with 1 to 12 carbons, alkenyl with 2 to 12 carbons, alkoxy with 1 to 11 carbons, alkenyloxy with 2 to 11 carbons, -Sp. 1- P 1 , and
May be replaced by 2 -P 2, and in the groups, at least one hydrogen may be replaced by fluorine or chlorine,
When a is 2, two rings A 1 may be different when b is 2, two rings A 4 may be different;
Z 1 , Z 2 , Z 3 , Z 4 and Z 5 are independently single-bonded or alkylenes with 1 to 10 carbon atoms, in which at least one -CH 2- is -O-,-. It may be replaced by S-, -CO-, -COO-, -OCO-, or -OCOO-, and at least one- (CH 2 ) 2 -is -CH = CH- or -C≡C-. It may be replaced, in which at least one hydrogen may be replaced with fluorine or chlorine. However, at least one of Z 2 , Z 3 , or Z 4 is -COS-, -SCO-, -CH = CHCOS-, or -SCOCH = CH-, and Z 2 , Z 3 , or Z. -COS- and -OCO- or -SCO- and -COO- are never simultaneously present in the 4, when a is 2, two Z 1 may be different when b is 2, the two Z 5 may be different;
Sp 1 and Sp 2 are independently single-bonded or alkylene with 1 to 10 carbon atoms, in which at least one -CH 2- is -O-, -CO-, -COO-, -OCO. -Or -OCOO- may be replaced, and at least one- (CH 2 ) 2- may be replaced by -CH = CH- or -C≡C-, at least 1 in these groups. One hydrogen may be replaced with fluorine or chlorine,
If multiple Sp 1 or Sp 2 are present, it may be different from each;
P 1 and P 2 are independent groups represented by any of the formulas (1b) to (1h), and when a plurality of P 1 or P 2 are present, they may be different from each other;

Figure JPOXMLDOC01-appb-I000027

In equations (1b) to (1h),
M 1 , M 2 , M 3 and M 4 are independently hydrogen, fluorine, chlorine, alkyl with 1 to 5 carbon atoms, or alkyl with 1 to 5 carbon atoms in which at least one hydrogen is replaced with fluorine or chlorine. And X 1 is O or S;
R 2 is hydrogen, fluorine, chlorine, or an alkyl having 1 to 5 carbon atoms, in which at least one hydrogen may be replaced by fluorine or chlorine, and at least one -CH 2- is -O-. May be replaced with;
R 3 , R 4 , R 5 , R 6 and R 7 are independently hydrogen or alkyl with 1 to 15 carbon atoms, in which at least one -CH 2- is -O- or-. It may be replaced by S-, at least one- (CH 2 ) 2 -may be replaced by -CH = CH- or -C≡C-, and in these groups, at least one hydrogen is fluorine. Alternatively, it may be replaced with chlorine.
[2]式(1)において、
 aおよびbは独立して、0、1または2であり、0≦a+b≦2であり;
 環A、環A、環Aおよび環Aは独立して、1,4-シクロへキシレン、1,4-シクロヘキセニレン、1,4-フェニレン、ナフタレン-2,6-ジイル、デカヒドロナフタレン-2,6-ジイル、1,2,3,4-テトラヒドロナフタレン-2,6-ジイル、テトラヒドロピラン-2,5-ジイル、1,3-ジオキサン-2,5-ジイル、ピリミジン-2,5-ジイル、ピリジン-2,5-ジイル、フルオレン-2,7-ジイル、フェナントレン-2,7-ジイル、アントラセン-2,6-ジイル、ペルヒドロシクロペンタ[a]フェナントレン-3,17-ジイル、または2,3,4,7,8,9,10,11,12,13,14,15,16,17-テトラデカヒドロシクロペンタ[a]フェナントレン-3,17-ジイルであり、これらの環において、少なくとも1つの水素は、フッ素、塩素、炭素数1から12のアルキル、炭素数2から12のアルケニル、炭素数1から11のアルコキシ、炭素数2から11のアルケニルオキシ、-Sp-P、または-Sp-Pで置き換えられてもよく、これらの基において、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよく、aが2のとき、2つの環Aは異なっていてもよく、bが2のとき、2つの環Aは異なっていてもよく;
 Z、Z、Z、ZおよびZは独立して、単結合、-(CH-、-C≡C-、-C≡C-C≡C-、-COO-、-OCO-、-CFO-、-OCF-、-CHO-、-OCH-、-CF=CF-、-CH=CHCOO-、-OCOCH=CH-、-CH=CH-、-CH=CHCO-、-COCH=CH-、-COS-、-SCO-、-CH=CHCOS-、または-SCOCH=CH-であり、ただし、Z、Z、またはZの中で少なくとも1つは、-COS-、-SCO-、-CH=CHCOS-、または-SCOCH=CH-であり、Z、Z、またはZにおいて-COS-及び-OCO-または-SCO-及び-COO-が同時に存在することはなく;
aが2のとき、2つのZは異なっていてもよく、2つのZは異なっていてもよく;
 SpおよびSpは独立して、単結合または炭素数1から10のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-、-COO-、または-OCO-で置き換えられてもよく、少なくとも1つの-(CH-は、-CH=CH-で置き換えられてもよく、これらの基において、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよく、複数のSpまたはSpが存在する場合はそれぞれが異なっていてもよく;
 PおよびPは独立して、式(1b)~式(1h)のいずれかで表される基であり、複数のPまたはPが存在する場合、それぞれが異なっていてもよく;

Figure JPOXMLDOC01-appb-I000028

 式(1b)~式(1h)において、      
 M、M、MおよびMは独立して、水素、フッ素、塩素、炭素数1から5のアルキル、または少なくとも1つの水素がフッ素または塩素で置き換えられた炭素数1から5のアルキルであり、XはOまたはSであり;
 Rは水素、フッ素、塩素、または炭素数1から5のアルキルであり、このアルキルにおいて少なくとも1つの水素はフッ素または塩素で置き換えられてもよく、少なくとも1つの-CH-は、-O-で置き換えられてもよく;
 R、R、R、R、およびRは独立して、水素または炭素数1から15のアルキルであり、このアルキルにおいて、少なくとも1つの-CH-は、-O-または-S-で置き換えられてもよく、少なくとも1つの-(CH-は、-CH=CH-または-C≡C-で置き換えられてもよく、これらの基において、少なくとも1つの水素はフッ素または塩素で置き換えられてもよい、[1]に記載の化合物。
[2] In equation (1)
a and b are independently 0, 1 or 2, and 0 ≦ a + b ≦ 2.
Ring A 1 , Ring A 2 , Ring A 3 and Ring A 4 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, naphthalene-2,6-diyl, Decahydronaphthrene-2,6-diyl, 1,2,3,4-tetrahydronaphthalene-2,6-diyl, tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyrimidine- 2,5-diyl, pyridine-2,5-diyl, fluorene-2,7-diyl, phenanthrene-2,7-diyl, anthracene-2,6-diyl, perhydrocyclopenta [a] phenanthrene-3,17 -Diyl, or 2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydrocyclopenta [a] phenanthrene-3,17-diyl, In these rings, at least one hydrogen is fluorine, chlorine, alkyl with 1 to 12 carbon atoms, alkenyl with 2 to 12 carbon atoms, alkoxy with 1 to 11 carbon atoms, alkenyloxy with 2 to 11 carbon atoms, -Sp. It may be replaced by 1- P 1 or -Sp 2- P 2 , in these groups at least one hydrogen may be replaced by fluorine or chlorine, and when a is 2, two rings A 1 may be different when b is 2, two rings a 4 may be different;
Z 1 , Z 2 , Z 3 , Z 4 and Z 5 are independently single-bonded,-(CH 2 ) 2- , -C ≡ C-, -C ≡ C-C ≡ C-, -COO-, -OCO-, -CF 2 O-, -OCF 2- , -CH 2 O-, -OCH 2- , -CF = CF-, -CH = CHCOO-, -OCOCH = CH-, -CH = CH-, -CH = CHCO-, -COCH = CH-, -COS-, -SCO-, -CH = CHCOS-, or -SCOCH = CH-, provided that at least in Z 2 , Z 3 , or Z 4. One is -COS-, -SCO-, -CH = CHCOS-, or -SCOCH = CH-, and in Z 2 , Z 3 , or Z 4 , -COS- and -OCO- or -SCO- and- COO-does not exist at the same time;
When a is 2, two Z 1 may be different, the two Z 5 may be different;
Sp 1 and Sp 2 are independently a single bond or alkylene having 1 to 10 carbon atoms, in the alkylene, at least one of -CH 2 -, -O -, - COO-, or substituted with -OCO- At least one of-(CH 2 ) 2 -may be replaced by -CH = CH-, and in these groups, at least one hydrogen may be replaced by fluorine or chlorine. If multiple Sp 1 or Sp 2 there may be different from each;
P 1 and P 2 are independent groups represented by any of the formulas (1b) to (1h), and when a plurality of P 1 or P 2 are present, they may be different from each other;

Figure JPOXMLDOC01-appb-I000028

In equations (1b) to (1h),
M 1 , M 2 , M 3 and M 4 are independently hydrogen, fluorine, chlorine, alkyl with 1 to 5 carbon atoms, or alkyl with 1 to 5 carbon atoms in which at least one hydrogen is replaced with fluorine or chlorine. And X 1 is O or S;
R 2 is hydrogen, fluorine, chlorine, or an alkyl having 1 to 5 carbon atoms, in which at least one hydrogen may be replaced by fluorine or chlorine, and at least one -CH 2- is -O-. May be replaced with;
R 3 , R 4 , R 5 , R 6 and R 7 are independently hydrogen or alkyl with 1 to 15 carbon atoms, in which at least one -CH 2- is -O- or-. It may be replaced by S-, at least one-(CH 2 ) 2 -may be replaced by -CH = CH- or -C≡C-, and in these groups, at least one hydrogen is fluorine. The compound according to [1], which may be replaced with chlorine.
[3]式(1-1)から式(1-3)のいずれか1つで表される、[1]または[2]に記載の化合物。

Figure JPOXMLDOC01-appb-I000029

式(1-1)から式(1-3)において、
 環A、環A、環Aおよび環Aは独立して、1,4-シクロへキシレン、1,4-フェニレン、ナフタレン-2,6-ジイル、ピリミジン-2,5-ジイル、ピリジン-2,5-ジイル、フルオレン-2,7-ジイル、フェナントレン-2,7-ジイル、またはアントラセン-2,6-ジイルであり、これらの環において、少なくとも1つの水素は、フッ素、塩素、炭素数1から12のアルキル、炭素数2から12のアルケニル、炭素数1から11のアルコキシ、炭素数2から11のアルケニルオキシ、-Sp-P、または-Sp-Pで置き換えられてもよく、これらの基において、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよく、aが2のとき、2つの環Aは異なっていてもよく、bが2のとき、2つの環Aは異なっていてもよく;
 Z、ZおよびZは独立して、単結合、-(CH-、-C≡C-、-C≡C-C≡C-、-COO-、-OCO-、-CFO-、-OCF-、-CHO-、-OCH-、-CF=CF-、-CH=CHCOO-、-OCOCH=CH-、-CH=CH-、-CH=CHCO-、-COCH=CH-、-COS-、-SCO-、-CH=CHCOS-、または-SCOCH=CH-であり、ただし、Z、Z、またはZの中で少なくとも1つは、-COS-、-SCO-、-CH=CHCOS-、または-SCOCH=CH-であり、Z、Z、またはZにおいて-COS-及び-OCO-または-SCO-及び-COO-が同時に存在することはなく;
 SpおよびSpは独立して、単結合または炭素数1から10のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-、-COO-、-OCOO-、または-OCO-で置き換えられてもよく、少なくとも1つの-(CH-は、-CH=CH-で置き換えられてもよく、これらの基において、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよく、複数のSpまたはSpが存在する場合、それぞれが異なっていてもよく;
 PおよびPは独立して、式(1b)~式(1h)のいずれかで表される基であり、複数のPまたはPが存在する場合、それぞれが異なっていてもよく;

Figure JPOXMLDOC01-appb-I000030

 式(1b)~式(1h)において、      
 M、M、MおよびMは独立して、水素、フッ素、塩素、炭素数1から5のアルキル、または少なくとも1つの水素がフッ素または塩素で置き換えられた炭素数1から5のアルキルであり、XはOまたはSであり;
 Rは水素、フッ素、塩素、または炭素数1から5のアルキルであり、このアルキルにおいて少なくとも1つの水素はフッ素または塩素で置き換えられてもよく、少なくとも1つの-CH-は、-O-で置き換えられてもよく;
 R、R、R、R、およびRは独立して、水素、または炭素数1から15のアルキルであり、このアルキルにおいて、少なくとも1つの-CH-は、-O-または-S-で置き換えられてもよく、少なくとも1つの-(CH-は、-CH=CH-または-C≡C-で置き換えられてもよく、これらの基において、少なくとも1つの水素はフッ素または塩素で置き換えられてもよい。
[3] The compound according to [1] or [2], which is represented by any one of formulas (1-1) to (1-3).

Figure JPOXMLDOC01-appb-I000029

In equations (1-1) to (1-3),
Ring A 1 , Ring A 2 , Ring A 3 and Ring A 4 are independent, 1,4-cyclohexylene, 1,4-phenylene, naphthalene-2,6-diyl, pyrimidine-2,5-diyl, Pyridine-2,5-diyl, fluorene-2,7-diyl, phenanthrene-2,7-diyl, or anthracene-2,6-diyl, in which at least one hydrogen is fluorine, chlorine, Replaced by alkyl with 1 to 12 carbons, alkenyl with 2 to 12 carbons, alkoxy with 1 to 11 carbons, alkenyloxy with 2 to 11 carbons, -Sp 1- P 1 or -Sp 2- P 2. at best, and in the groups, at least one hydrogen may be replaced by fluorine or chlorine, when a is 2, two rings a 1 may be different when b is 2, 2 One of the rings a 4 may be different;
Z 2 , Z 3 and Z 4 are independently single-bonded,-(CH 2 ) 2- , -C ≡ C-, -C ≡ C-C ≡ C-, -COO-, -OCO-, -CF 2 O -, - OCF 2 - , - CH 2 O -, - OCH 2 -, - CF = CF -, - CH = CHCOO -, - OCOCH = CH -, - CH = CH -, - CH = CHCO-, -COCH = CH -, - COS - , - SCO -, - CH = CHCOS-, or -SCOCH = a CH-, provided that at least one among Z 2, Z 3 or Z 4, are,-COS -, - SCO -, - CH = CHCOS-, or -SCOCH = a CH-, Z 2, Z 3, or in Z 4 -COS- and -OCO- or -SCO- and -COO- simultaneous presence Never;
Sp 1 and Sp 2 are independently single-bonded or alkylene with 1 to 10 carbon atoms, in which at least one -CH 2- is -O-, -COO-, -OCOO-, or-. It may be replaced by OCO-, at least one- (CH 2 ) 2 -may be replaced by -CH = CH-, and in these groups at least one hydrogen is replaced by fluorine or chlorine. at best, when a plurality of Sp 1 or Sp 2 are present, it may be different from each;
P 1 and P 2 are independent groups represented by any of the formulas (1b) to (1h), and when a plurality of P 1 or P 2 are present, they may be different from each other;

Figure JPOXMLDOC01-appb-I000030

In equations (1b) to (1h),
M 1 , M 2 , M 3 and M 4 are independently hydrogen, fluorine, chlorine, alkyl with 1 to 5 carbon atoms, or alkyl with 1 to 5 carbon atoms in which at least one hydrogen is replaced with fluorine or chlorine. And X 1 is O or S;
R 2 is hydrogen, fluorine, chlorine, or an alkyl having 1 to 5 carbon atoms, in which at least one hydrogen may be replaced by fluorine or chlorine, and at least one -CH 2- is -O-. May be replaced with;
R 3 , R 4 , R 5 , R 6 , and R 7 are independently hydrogen, or alkyl with 1 to 15 carbon atoms, in which at least one -CH 2- is -O- or It may be replaced by —S—, at least one − (CH 2 ) 2 − may be replaced by −CH = CH− or −C≡C−, and in these groups, at least one hydrogen It may be replaced with fluorine or chlorine.
[4]式(1-1)から式(1-3)において、
 環A、環A、環Aおよび環Aは独立して、1,4-シクロへキシレン、1,4-フェニレン、ナフタレン-2,6-ジイル、フルオレン-2,7-ジイル、またはフェナントレン-2,7-ジイルであり、これらの環において、少なくとも1つの水素は、フッ素、塩素、炭素数1から12のアルキル、炭素数2から12のアルケニル、炭素数1から11のアルコキシ、炭素数2から11のアルケニルオキシ、-Sp-P、または-Sp-Pで置き換えられてもよく;
 Z、ZおよびZは独立して、単結合、-(CH-、-C≡C-C≡C-、-C≡C-、-COO-、-OCO-、-CH=CHCOO-、-OCOCH=CH-、-CH=CH-、-CH=CHCO-、-COCH=CH-、-COS-、-SCO-、-CH=CHCOS-、または-SCOCH=CH-であり、ただし、Z、Z、またはZの中で少なくとも1つは、-COS-、-SCO-、-CH=CHCOS-、または-SCOCH=CH-であり、Z、Z、またはZにおいて-COS-及び-OCO-または-SCO-及び-COO-が同時に存在することはなく;
 SpおよびSpは独立して、単結合または炭素数1から10のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-、-COO-、-OCOO-、または-OCO-で置き換えられてもよく、少なくとも1つの-(CH-は、-CH=CH-で置き換えられてもよく、複数のSpまたはSpが存在する場合、それぞれが異なっていてもよく;
 PおよびPは独立して、式(1b)、式(1c)、式(1d)、または式(1e)のいずれかで表される基であり、複数のPまたはPが存在する場合、それぞれが異なっていてもよく;

Figure JPOXMLDOC01-appb-I000031

 式(1b)~式(1e)において、
 M、M、MおよびMは独立して、水素、フッ素、塩素、炭素数1から5のアルキル、または少なくとも1つの水素がフッ素または塩素で置き換えられた炭素数1から5のアルキルであり、XはOまたはSであり;
 Rは水素、フッ素、塩素、または炭素数1から5のアルキルであり、このアルキルにおいて少なくとも1つの水素はフッ素または塩素で置き換えられてもよく、少なくとも1つの-CH-は、-O-で置き換えられてもよく;
 R、R、R、およびRは独立して、水素または炭素数1から15のアルキルであり、このアルキルにおいて、少なくとも1つの-CH-は、-O-または-S-で置き換えられてもよく、少なくとも1つの-(CH-は、-CH=CH-または-C≡C-で置き換えられてもよく、これらの基において、少なくとも1つの水素はフッ素または塩素で置き換えられてもよい、[3]に記載の化合物。
[4] In equations (1-1) to (1-3),
Ring A 1 , Ring A 2 , Ring A 3 and Ring A 4 are independently 1,4-cyclohexylene, 1,4-phenylene, naphthalene-2,6-diyl, fluorene-2,7-diyl, Or phenanthrene-2,7-diyl, in these rings at least one hydrogen is fluorine, chlorine, alkyl with 1 to 12 carbons, alkenyl with 2 to 12 carbons, alkoxy with 1 to 11 carbons, It may be replaced by alkenyloxy with 2 to 11 carbon atoms, -Sp 1- P 1 , or -Sp 2- P 2 ;
Z 2 , Z 3 and Z 4 are independently single-bonded,-(CH 2 ) 2- , -C ≡ C-C ≡ C-, -C ≡ C-, -COO-, -OCO-, -CH = CHCOO-, -OCOCH = CH-, -CH = CH-, -CH = CHCO-, -COCH = CH-, -COS-, -SCO-, -CH = CHCOS-, or -SCOCH = CH-. However, at least one of Z 2 , Z 3 , or Z 4 is -COS-, -SCO-, -CH = CHCOS-, or -SCOCH = CH-, and is Z 2 , Z 3 , or. never -COS- and the -OCO- or -SCO- and -COO- are present simultaneously in the Z 4;
Sp 1 and Sp 2 are independently single-bonded or alkylene with 1 to 10 carbon atoms, in which at least one -CH 2- is -O-, -COO-, -OCOO-, or-. It may be replaced by OCO-, and at least one- (CH 2 ) 2 -may be replaced by -CH = CH-, and if multiple Sp 1 or Sp 2 are present, each is different. Well;
P 1 and P 2 are independently represented by any of the formula (1b), the formula (1c), the formula (1d), or the formula (1e), and there are a plurality of P 1 or P 2. If so, each may be different;

Figure JPOXMLDOC01-appb-I000031

In equations (1b) to (1e),
M 1 , M 2 , M 3 and M 4 are independently hydrogen, fluorine, chlorine, alkyl with 1 to 5 carbon atoms, or alkyl with 1 to 5 carbon atoms in which at least one hydrogen is replaced with fluorine or chlorine. And X 1 is O or S;
R 2 is hydrogen, fluorine, chlorine, or an alkyl having 1 to 5 carbon atoms, in which at least one hydrogen may be replaced by fluorine or chlorine, and at least one -CH 2- is -O-. May be replaced with;
R 3 , R 4 , R 5 and R 6 are independently hydrogen or alkyl with 1 to 15 carbon atoms, in which at least one -CH 2- is -O- or -S-. It may be replaced, and at least one of-(CH 2 ) 2- may be replaced by -CH = CH- or -C≡C-, in which at least one hydrogen is fluorine or chlorine. The compound according to [3], which may be replaced.
[5]式(1-1)から式(1-3)において、
 環A、環A、環Aおよび環Aは独立して、1,4-シクロへキシレン、1,4-フェニレン、ナフタレン-2,6-ジイル、フルオレン-2,7-ジイル、またはフェナントレン-2,7-ジイルであり、これらの環において、少なくとも1つの水素は、フッ素、塩素、メチル、またはエチルで置き換えられてもよく;
、ZおよびZは独立して、単結合、-(CH-、-C≡C-C≡C-、-C≡C-、-COO-、-OCO-、-CH=CHCOO-、-OCOCH=CH-、-CH=CH-、-CH=CHCO-、-COCH=CH-、-COS-、-SCO-、-CH=CHCOS-、または-SCOCH=CH-であり、ただし、Z、Z、またはZの中で少なくとも1つは、-COS-、-SCO-、-CH=CHCOS-、または-SCOCH=CH-であり、Z、Z、またはZにおいて-COS-及び-OCO-または-SCO-及び-COO-が同時に存在することはなく;
 SpおよびSpは独立して、単結合または炭素数1から10のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-、-COO-、-OCOO-、または-OCO-で置き換えられてもよく、少なくとも1つの-(CH-は、-CH=CH-で置き換えられてもよく、複数のSpまたはSpが存在する場合、それぞれが異なっていてもよく;
 PおよびPは独立して、式(1b-1)、(1b-2)、(1b-3)、(1b-4)、式(1b-5)、(1c-1)、(1d-1)、(1d-2)または(1e-1)で表される基であり、X、X、X、XおよびXは独立してOまたはSである[3]に記載の化合物。

Figure JPOXMLDOC01-appb-I000032
[5] In equations (1-1) to (1-3),
Ring A 1 , Ring A 2 , Ring A 3 and Ring A 4 are independent, 1,4-cyclohexylene, 1,4-phenylene, naphthalene-2,6-diyl, fluorene-2,7-diyl, Alternatively, it may be phenanthrene-2,7-diyl, in which at least one hydrogen may be replaced with fluorine, chlorine, methyl, or ethyl;
Z 2 , Z 3 and Z 4 are independently single-bonded,-(CH 2 ) 2- , -C ≡ C-C ≡ C-, -C ≡ C-, -COO-, -OCO-, -CH = CHCOO-, -OCOCH = CH-, -CH = CH-, -CH = CHCO-, -COCH = CH-, -COS-, -SCO-, -CH = CHCOS-, or -SCOCH = CH-. However, at least one of Z 2 , Z 3 , or Z 4 is -COS-, -SCO-, -CH = CHCOS-, or -SCOCH = CH-, and is Z 2 , Z 3 , or. never -COS- and the -OCO- or -SCO- and -COO- are present simultaneously in the Z 4;
Sp 1 and Sp 2 are independently single-bonded or alkylene with 1 to 10 carbon atoms, in which at least one -CH 2- is -O-, -COO-, -OCOO-, or-. It may be replaced by OCO-, and at least one- (CH 2 ) 2 -may be replaced by -CH = CH-, and if multiple Sp 1 or Sp 2 are present, each is different. Well;
P 1 and P 2 are each independently formula (1b-1), (1b -2), (1b-3), (1b-4), formula (1b-5), (1c -1), (1d -1), a group represented by (1d-2) or (1e-1), where X 2 , X 3 , X 4 , X 5 and X 6 are independently O or S [3]. The compound described.

Figure JPOXMLDOC01-appb-I000032
[6]式(1-1)から式(1-3)で表される化合物において、Z、Z、またはZのいずれか1つは、-COS-または-SCO-である、[3]に記載の化合物。 [6] In the compounds represented by the formulas (1-1) to (1-3), any one of Z 2 , Z 3 , or Z 4 is -COS- or -SCO-, [ 3] The compound according to.
[7]下記のいずれか一つの式で表される、[1]から[6]のいずれか1項に記載の化合物。

Figure JPOXMLDOC01-appb-I000033

Figure JPOXMLDOC01-appb-I000034

Figure JPOXMLDOC01-appb-I000035

Figure JPOXMLDOC01-appb-I000036

 PおよびPは独立して、式(1b-1)、(1b-2)、(1b-3)、(1b-4)、式(1b-5)、(1c-1)、(1d-1)、(1d-2)または(1e-1)で表される基であり、X、X、X、XおよびXは独立してOまたはSであり;
 SpおよびSpは独立して、単結合または炭素数1から10のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-、-COO-、-OCOO-、または-OCO-で置き換えられてもよく、少なくとも1つの-(CH-は、-CH=CH-で置き換えられてもよく;
 P、P、SpおよびSp以外の部分構造において、少なくとも1つの水素は、フッ素、塩素、メチル、またはエチルで置き換えられてもよい。
[7] The compound according to any one of [1] to [6], which is represented by any one of the following formulas.

Figure JPOXMLDOC01-appb-I000033

Figure JPOXMLDOC01-appb-I000034

Figure JPOXMLDOC01-appb-I000035

Figure JPOXMLDOC01-appb-I000036

P 1 and P 2 are each independently formula (1b-1), (1b -2), (1b-3), (1b-4), formula (1b-5), (1c -1), (1d -1), a group represented by (1d-2) or (1e-1), where X 2 , X 3 , X 4 , X 5 and X 6 are independently O or S;
Sp 1 and Sp 2 are independently single bonds or alkylenes having 1 to 10 carbon atoms, in which at least one -CH 2- is -O-, -COO-, -OCOO-, or-. It may be replaced by OCO-, and at least one- (CH 2 ) 2- may be replaced by -CH = CH-;
In partial structures other than P 1 , P 2 , Sp 1 and Sp 2 , at least one hydrogen may be replaced with fluorine, chlorine, methyl, or ethyl.
[8]式(1-1-1)~(1-1-7)、(1-2-1)~(1-2-14)、(1-3-1)、または(1-3-2)で表される化合物において、SpおよびSpが独立して、炭素数1から10のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-、-COO-、-OCOO-、または-OCO-で置き換えられてもよく、少なくとも1つの-(CH-は、-CH=CH-で置き換えられてもよい[7]に記載の化合物。 [8] Equations (1-1-1) to (1-1-7), (1-2-1) to (1-2-14), (1-3-1), or (1-3-1) In the compound represented by 2), Sp 1 and Sp 2 are independently alkylenes having 1 to 10 carbon atoms, and in this alkylene, at least one -CH 2- is -O-, -COO-,. The compound according to [7], which may be replaced by -OCOO-, or -OCO-, and at least one- (CH 2 ) 2 -may be replaced by -CH = CH-.
[9][1]から[8]のいずれか1項に記載した化合物の少なくとも1つを含有する液晶組成物。 [9] A liquid crystal composition containing at least one of the compounds according to any one of [1] to [8].
[10]式(2)から式(4)で表される化合物の群から選択される少なくとも1つの化合物をさらに含有する、[9]に記載の液晶組成物。

Figure JPOXMLDOC01-appb-I000037

式(2)から式(4)において、
 R11およびR12は独立して、炭素数1から10のアルキルまたは炭素数2から10のアルケニルであり、このアルキルおよびアルケニルにおいて、少なくとも1つの-CH-は-O-で置き換えられてもよく、少なくとも1つの水素はフッ素で置き換えられてもよく;
 環B、環B、環B、および環Bは独立して、1,4-シクロヘキシレン、1,4-フェニレン、2-フルオロ-1,4-フェニレン、2,5-ジフルオロ-1,4-フェニレン、またはピリミジン-2,5-ジイルであり;
 Z11、Z12、およびZ13は独立して、単結合、-(CH-、-CH=CH-、-C≡C-、または-COO-である。
[10] The liquid crystal composition according to [9], further containing at least one compound selected from the group of compounds represented by formulas (2) to (4).

Figure JPOXMLDOC01-appb-I000037

In equations (2) to (4),
R 11 and R 12 are independently alkyl with 1 to 10 carbon atoms or alkenyl with 2 to 10 carbon atoms, even if at least one -CH 2- is replaced with -O- in the alkyl and alkenyl. Well, at least one hydrogen may be replaced by fluorine;
Ring B 1 , Ring B 2 , Ring B 3 , and Ring B 4 are independent, 1,4-cyclohexylene, 1,4-phenylene, 2-fluoro-1,4-phenylene, 2,5-difluoro-. 1,4-phenylene, or pyrimidine-2,5-diyl;
Z 11 , Z 12 , and Z 13 are independently single-bonded,-(CH 2 ) 2- , -CH = CH-, -C≡C-, or -COO-.
[11]式(5)から式(7)で表される化合物の群から選択される少なくとも1つの化合物をさらに含有する、[9]または[10]に記載の液晶組成物。

Figure JPOXMLDOC01-appb-I000038

式(5)から式(7)において、
 R13は炭素数1から10のアルキルまたは炭素数2から10のアルケニルであり、このアルキルおよびアルケニルにおいて、少なくとも1つの-CH-は-O-で置き換えられてもよく、少なくとも1つの水素はフッ素で置き換えられてもよく;
 X11は、フッ素、塩素、-OCF、-OCHF、-CF、-CHF、-CHF、-OCFCHF、または-OCFCHFCFであり;
 環C、環C、および環Cは独立して、1,4-シクロヘキシレン、少なくとも1つの水素がフッ素で置き換えられてもよい1,4-フェニレン、テトラヒドロピラン-2,5-ジイル、1,3-ジオキサン-2,5-ジイル、またはピリミジン-2,5-ジイルであり;
 Z14、Z15、およびZ16は独立して、単結合、-(CH-、-CH=CH-、-C≡C-、-COO-、-CFO-、-OCF-、-CHO-、-CF=CF-、-CH=CF-または-(CH-であり;
 L11およびL12は独立して、水素またはフッ素である。
[11] The liquid crystal composition according to [9] or [10], which further contains at least one compound selected from the group of compounds represented by formulas (5) to (7).

Figure JPOXMLDOC01-appb-I000038

In equations (5) to (7),
R 13 is an alkyl having 1 to 10 carbon atoms or an alkenyl having 2 to 10 carbon atoms, in which at least one -CH 2- may be replaced with -O-, and at least one hydrogen is. May be replaced with fluorine;
X 11 is fluorine, chlorine, -OCF 3 , -OCHF 2 , -CF 3 , -CHF 2 , -CH 2 F, -OCF 2 CHF 2 , or -OCF 2 CHFCF 3 ;
Ring C 1 , Ring C 2 , and Ring C 3 are independently 1,4-cyclohexylene, 1,4-phenylene, where at least one hydrogen may be replaced by fluorine, tetrahydropyran-2,5-diyl. , 1,3-dioxane-2,5-diyl, or pyrimidine-2,5-diyl;
Z 14 , Z 15 and Z 16 are independently single-bonded,-(CH 2 ) 2- , -CH = CH-, -C≡C-, -COO-, -CF 2 O-, -OCF 2 -, - CH 2 O -, - CF = CF -, - CH = CF- or - (CH 2) 4 - a and;
L 11 and L 12 are independently hydrogen or fluorine.
[12]式(8)で表される化合物の群から選択される少なくとも1つの化合物をさらに含有する、[9]から[11]のいずれか1項に記載の液晶組成物。

Figure JPOXMLDOC01-appb-I000039

式(8)において、
 R14は炭素数1から10のアルキルまたは炭素数2から10のアルケニルであり、このアルキルおよびアルケニルにおいて、少なくとも1つの-CH-は-O-で置き換えられてもよく、少なくとも1つの水素はフッ素で置き換えられてもよく;
 X12は-C≡Nまたは-C≡C-C≡Nであり;
 環Dは独立して、1,4-シクロヘキシレン、少なくとも1つの水素がフッ素で置き換えられてもよい1,4-フェニレン、テトラヒドロピラン-2,5-ジイル、1,3-ジオキサン-2,5-ジイル、またはピリミジン-2,5-ジイルであり;
 Z17は独立して、単結合、-(CH-、-C≡C-、-COO-、-CFO-、-OCF-、または-CHO-であり;
 L13およびL14は独立して、水素またはフッ素であり;
 iは、1、2、3、または4である。
[12] The liquid crystal composition according to any one of [9] to [11], which further contains at least one compound selected from the group of compounds represented by the formula (8).

Figure JPOXMLDOC01-appb-I000039

In equation (8)
R 14 is an alkyl having 1 to 10 carbon atoms or an alkenyl having 2 to 10 carbon atoms, in which at least one -CH 2- may be replaced with -O-, and at least one hydrogen is. May be replaced with fluorine;
X 12 is -C≡N or -C≡C-C≡N;
Ring D 1 is independently 1,4-cyclohexylene, 1,4-phenylene in which at least one hydrogen may be replaced by fluorine, tetrahydropyran-2,5-diyl, 1,3-dioxane-2, 5-dioxane, or pyrimidine-2,5-dioxane;
Z 17 is independently a single bond, - (CH 2) 2 - , - C≡C -, - COO -, - CF 2 O -, - OCF 2 -, or -CH 2 O-;
L 13 and L 14 are independently hydrogen or fluorine;
i is 1, 2, 3, or 4.
[13]式(9)から式(15)で表される化合物の群から選択される少なくとも1つの化合物をさらに含有する、[9]から[12]のいずれか1項に記載の液晶組成物。

Figure JPOXMLDOC01-appb-I000040

式(9)から式(15)において、
 R15およびR16は独立して、炭素数1から10のアルキルまたは炭素数2から10のアルケニルであり、このアルキルおよびアルケニルにおいて、少なくとも1つの-CH2-は-O-で置き換えられてもよく、少なくとも1つの水素はフッ素で置き換えられてもよく;
 R17は、水素、フッ素、炭素数1から10のアルキル、または炭素数2から10のアルケニルであり、このアルキルおよびアルケニルにおいて、少なくとも1つの-CH-は-O-で置き換えられてもよく、少なくとも1つの水素はフッ素で置き換えられてもよく;
 環E、環E、環E、および環Eは独立して、1,4-シクロヘキシレン、1,4-シクロヘキセニレン、少なくとも1つの水素がフッ素で置き換えられてもよい1,4-フェニレン、テトラヒドロピラン-2,5-ジイル、またはデカヒドロナフタレン-2,6-ジイルであり;
 環Eおよび環Eは独立して、1,4-シクロヘキシレン、1,4-シクロヘキセニレン、1,4-フェニレン、テトラヒドロピラン-2,5-ジイル、またはデカヒドロナフタレン-2,6-ジイルであり;
 Z18、Z19、Z20、およびZ21は独立して、単結合、-(CH-、-COO-、-CHO-、-OCF-、または-OCFCHCH-であり;
 L15およびL16は独立して、フッ素または塩素であり;
 S11は、水素またはメチルであり;
 Xは、-CHF-または-CF-であり;
 j、k、m、n、p、q、r、およびsは独立して、0または1であり、k、m、n、およびpの和は、1または2であり、q、r、およびsの和は、0、1、2、または3であり、tは、1、2、または3である。
[13] The liquid crystal composition according to any one of [9] to [12], further containing at least one compound selected from the group of compounds represented by the formulas (9) to (15). ..

Figure JPOXMLDOC01-appb-I000040

In equations (9) to (15),
R 15 and R 16 are independently alkyls with 1 to 10 carbon atoms or alkenyl with 2 to 10 carbon atoms, even if at least one -CH 2- is replaced with -O- in the alkyl and alkenyl. Well, at least one hydrogen may be replaced by fluorine;
R 17 is hydrogen, fluorine, an alkyl having 1 to 10 carbon atoms, or an alkenyl having 2 to 10 carbon atoms, in which at least one -CH 2- may be replaced with -O-. , At least one hydrogen may be replaced by fluorine;
Ring E 1 , Ring E 2 , Ring E 3 , and Ring E 4 may independently replace 1,4-cyclohexylene, 1,4-cyclohexenylene, and at least one hydrogen with fluorine 1, 4-Phenylene, tetrahydropyran-2,5-diyl, or decahydronaphthalene-2,6-diyl;
Rings E 5 and E 6 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, tetrahydropyran-2,5-diyl, or decahydronaphthalene-2,6. -Jeil;
Z 18, Z 19, Z 20 , and Z 21 are independently a single bond, - (CH 2) 2 - , - COO -, - CH 2 O -, - OCF 2 -, or -OCF 2 CH 2 CH 2- is;
L 15 and L 16 are independently fluorine or chlorine;
S 11 is hydrogen or methyl;
X is -CHF- or -CF 2- ;
j, k, m, n, p, q, r, and s are independently 0 or 1, and the sum of k, m, n, and p is 1 or 2, q, r, and The sum of s is 0, 1, 2, or 3, and t is 1, 2, or 3.
[14]式(16)で表される化合物の群から選択される少なくとも1つの重合性化合物を含有する、[9]から[13]のいずれか1項に記載の液晶組成物。

Figure JPOXMLDOC01-appb-I000041

式(16)において、
 環Fおよび環Iは独立して、シクロヘキシル、シクロヘキセニル、フェニル、1-ナフチル、2-ナフチル、テトラヒドロピラン-2-イル、1,3-ジオキサン-2-イル、ピリミジン-2-イル、またはピリジン-2-イルであり、これらの環において、少なくとも1つの水素は、フッ素、塩素、炭素数1から12のアルキル、または少なくとも1つの水素がフッ素または塩素で置き換えられた炭素数1から12のアルキルで置き換えられてもよく;
 環Gは、1,4-シクロへキシレン、1,4-シクロヘキセニレン、1,4-フェニレン、ナフタレン-1,2-ジイル、ナフタレン-1,3-ジイル、ナフタレン-1,4-ジイル、ナフタレン-1,5-ジイル、ナフタレン-1,6-ジイル、ナフタレン-1,7-ジイル、ナフタレン-1,8-ジイル、ナフタレン-2,3-ジイル、ナフタレン-2,6-ジイル、ナフタレン-2,7-ジイル、テトラヒドロピラン-2,5-ジイル、1,3-ジオキサン-2,5-ジイル、ピリミジン-2,5-ジイル、またはピリジン-2,5-ジイルであり、これらの環において、少なくとも1つの水素は、フッ素、塩素、炭素数1から12のアルキル、炭素数1から12のアルコキシ、または少なくとも1つの水素がフッ素または塩素で置き換えられた炭素数1から12のアルキルで置き換えられてもよく;
 Z22およびZ23は独立して、単結合または炭素数1から10のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-、-CO-、-COO-、または-OCO-で置き換えられてもよく、少なくとも1つの-(CH-は、-CH=CH-、-C(CH)=CH-、-CH=C(CH)-、または-C(CH)=C(CH)-で置き換えられてもよく、これらの基において、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよく;
 P11、P12、およびP13は独立して、式(P-1)から式(P-5)で表される基の群から選択された重合性基であり;

Figure JPOXMLDOC01-appb-I000042

 M11、M12、およびM13は独立して、水素、フッ素、炭素数1から5のアルキル、または少なくとも1つの水素がフッ素または塩素で置き換えられた炭素数1から5のアルキルであり;
 Sp11、Sp12、およびSp13は独立して、単結合または炭素数1から10のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-、-COO-、-OCO-、または-OCOO-で置き換えられてもよく、少なくとも1つの-(CH-は、-CH=CH-または-C≡C-で置き換えられてもよく、これらの基において、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよく;
 uは、0、1、または2であり;
 f、g、およびhは独立して、0、1、2、3、または4であり、そしてf、g、およびhの和は2以上である。
[14] The liquid crystal composition according to any one of [9] to [13], which contains at least one polymerizable compound selected from the group of compounds represented by the formula (16).

Figure JPOXMLDOC01-appb-I000041

In equation (16)
Rings F and I are independently cyclohexyl, cyclohexenyl, phenyl, 1-naphthyl, 2-naphthyl, tetrahydropyran-2-yl, 1,3-dioxane-2-yl, pyrimidine-2-yl, or pyridine. -2-yl, in these rings at least one hydrogen is fluorine, chlorine, alkyl with 1 to 12 carbon atoms, or at least one hydrogen is alkyl with 1 to 12 carbon atoms with fluorine or chlorine replaced. May be replaced with;
Ring G is 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, naphthalene-1,2-diyl, naphthalene-1,3-diyl, naphthalene-1,4-diyl, Naphthalene-1,5-diyl, naphthalene-1,6-diyl, naphthalene-1,7-diyl, naphthalene-1,8-diyl, naphthalene-2,3-diyl, naphthalene-2,6-diyl, naphthalene- 2,7-Diyl, tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyrimidine-2,5-diyl, or pyridine-2,5-diyl, in these rings. , At least one hydrogen is replaced with fluorine, chlorine, alkyl with 1 to 12 carbon atoms, alkoxy with 1 to 12 carbon atoms, or alkyl with 1 to 12 carbon atoms in which at least one hydrogen is replaced with fluorine or chlorine. May;
Z 22 and Z 23 are independently single bonds or alkylenes with 1 to 10 carbon atoms, in which at least one -CH 2- is -O-, -CO-, -COO-, or-. It may be replaced by OCO-, and at least one- (CH 2 ) 2- is -CH = CH-, -C (CH 3 ) = CH-, -CH = C (CH 3 )-, or -C. It may be replaced by (CH 3 ) = C (CH 3 )-and at least one hydrogen in these groups may be replaced by fluorine or chlorine;
P 11, P 12, and P 13 are independently a polymerizable group selected from the group of radicals represented by the formula (P-1) by the formula (P-5);

Figure JPOXMLDOC01-appb-I000042

M 11 , M 12 , and M 13 are independently hydrogen, fluorine, alkyl having 1 to 5 carbon atoms, or alkyl having 1 to 5 carbon atoms in which at least one hydrogen is replaced with fluorine or chlorine;
Sp 11 , Sp 12 , and Sp 13 are independently single bonds or alkylenes with 1 to 10 carbon atoms, in which at least one -CH 2- is -O-, -COO-, -OCO. -Or -OCOO- may be replaced, and at least one- (CH 2 ) 2- may be replaced with -CH = CH- or -C≡C-, at least 1 in these groups. One hydrogen may be replaced with fluorine or chlorine;
u is 0, 1, or 2;
f, g, and h are independently 0, 1, 2, 3, or 4, and the sum of f, g, and h is greater than or equal to 2.
[15]式(16-1)から式(16-27)で表される化合物の群から選択された少なくとも1つの重合性化合物を含有する、[9]から[14]のいずれか1項に記載の液晶組成物。

Figure JPOXMLDOC01-appb-I000043

Figure JPOXMLDOC01-appb-I000044

Figure JPOXMLDOC01-appb-I000045

式(16-1)から式(16-27)において、
 P11、P12、およびP13は独立して、式(P-1)から式(P-3)で表される基の群から選択された重合性基であり、ここでM11、M12、およびM13は独立して、水素、フッ素、炭素数1から5のアルキル、または少なくとも1つの水素がフッ素または塩素で置き換えられた炭素数1から5のアルキルであり;

Figure JPOXMLDOC01-appb-I000046

 Sp11、Sp12、およびSp13は独立して、単結合または炭素数1から10のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-、-COO-、-OCO-、または-OCOO-で置き換えられてもよく、少なくとも1つの-(CH-は、-CH=CH-または-C≡C-で置き換えられてもよく、これらの基において、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよい。
[15] In any one of [9] to [14], which contains at least one polymerizable compound selected from the group of compounds represented by the formulas (16-1) to (16-27). The liquid crystal composition described.

Figure JPOXMLDOC01-appb-I000043

Figure JPOXMLDOC01-appb-I000044

Figure JPOXMLDOC01-appb-I000045

In equations (16-1) to (16-27),
P 11 , P 12 , and P 13 are independently polymerizable groups selected from the group of groups represented by the formulas (P-1) to (P-3), wherein M 11 , M. 12, and M 13 are independently hydrogen, fluorine, alkyl of C 1 -C 5 alkyl or at least one hydrogen is from 1 carbon atoms is replaced by fluorine or chlorine, 5;

Figure JPOXMLDOC01-appb-I000046

Sp 11 , Sp 12 , and Sp 13 are independently single bonds or alkylenes with 1 to 10 carbon atoms, in which at least one -CH 2- is -O-, -COO-, -OCO. -Or -OCOO- may be replaced, and at least one- (CH 2 ) 2- may be replaced with -CH = CH- or -C≡C-, at least 1 in these groups. One hydrogen may be replaced with fluorine or chlorine.
[16]式(1)および式(16)以外の重合性化合物、重合開始剤、重合禁止剤、光学活性化合物、酸化防止剤、紫外線吸収剤、光安定剤、熱安定剤、および消泡剤の少なくとも1つをさらに含有する、[9]から[15]のいずれか1項に記載の液晶組成物。 [16] Polymerizable compounds other than the formulas (1) and (16), polymerization initiators, polymerization inhibitors, optically active compounds, antioxidants, ultraviolet absorbers, light stabilizers, heat stabilizers, and defoamers. The liquid crystal composition according to any one of [9] to [15], further containing at least one of.
[17][9]から[16]のいずれか1項に記載の液晶組成物を含有する、液晶表示素子。 [17] A liquid crystal display device containing the liquid crystal composition according to any one of [9] to [16].
 本発明は、次の項も含む。(a)重合性化合物、重合開始剤、重合禁止剤、光学活性化合物、酸化防止剤、紫外線吸収剤、光安定剤、熱安定剤、消泡剤のような添加物の少なくとも2つをさらに含有する上記の液晶組成物。(b)上記の液晶組成物に化合物(1)または化合物(16)とは異なる重合性化合物を添加することによって調製した重合性組成物。(c)上記の液晶組成物に化合物(1)と化合物(16)とを添加することによって調製した重合性組成物。(d)重合性組成物を重合させることによって調製した液晶複合体。(e)この液晶複合体を含有する高分子支持配向型の素子。(f)上記の液晶組成物に化合物(1)と化合物(16)と、化合物(1)または化合物(16)とは異なる重合性化合物とを添加することによって調製した重合性組成物を使用することによって作成した高分子支持配向型の素子。
 化合物(1)の態様、化合物(1)の合成、液晶組成物、および液晶表示素子について順に説明する。
The present invention also includes the following sections. (A) Further contains at least two additives such as a polymerizable compound, a polymerization initiator, a polymerization inhibitor, an optically active compound, an antioxidant, an ultraviolet absorber, a light stabilizer, a heat stabilizer, and an antifoaming agent. The above liquid crystal composition. (B) A polymerizable composition prepared by adding a polymerizable compound different from the compound (1) or the compound (16) to the above liquid crystal composition. (C) A polymerizable composition prepared by adding compound (1) and compound (16) to the above liquid crystal composition. (D) A liquid crystal composite prepared by polymerizing a polymerizable composition. (E) A polymer-supported orientation type device containing this liquid crystal composite. (F) A polymerizable composition prepared by adding a compound (1), a compound (16), and a polymerizable compound different from the compound (1) or the compound (16) to the above liquid crystal composition is used. A polymer-supported orientation type element created by this.
Aspects of compound (1), synthesis of compound (1), a liquid crystal composition, and a liquid crystal display element will be described in order.
1.化合物(1)の態様
 本発明の実施形態にかかる化合物(1)は、少なくとも1つのチオエステル(-COS-、-SCO-)またはチオ桂皮酸エステル(-CH=CHCOS-、-SCOCH=CH-)を結合基としてもつ、重合性基を有する極性化合物であることを特徴とする。化合物(1)は、チオエステル(-COS-、-SCO-)またはチオ桂皮酸エステル(-CH=CHCOS-、-SCOCH=CH-)などの構造を分子内に持つことにより、高い光吸収特性および比較的長波長領域の光を吸収する特性を持ち、それらが存在しない化合物と比較し、短時間または低エネルギーの光照射で充分な特性を発現する。
1. 1. Aspects of Compound (1) The compound (1) according to the embodiment of the present invention contains at least one thioester (-COS-, -SCO-) or thiocinnamic acid ester (-CH = CHCOS-, -SCOCH = CH-). It is a polar compound having a polymerizable group having the above as a bonding group. Compound (1) has high light absorption characteristics and high light absorption characteristics by having a structure such as thioester (-COS-, -SCO-) or thiosilicate ester (-CH = CHCOS-, -SCOCH = CH-) in the molecule. It has the property of absorbing light in a relatively long wavelength region, and exhibits sufficient properties with short-time or low-energy light irradiation as compared with compounds in which they do not exist.
 化合物(1)の用途の一つは、液晶表示素子に使われる液晶組成物用の添加物である。化合物(1)は液晶分子の配向を水平に制御する目的で添加される。このような添加物は、素子に密閉された条件下では化学的に安定であり、液晶組成物への高い溶解度を有し、そして液晶表示素子に用いた場合の電圧保持率が大きいことが好ましい。化合物(1)は、このような特性をかなりの程度で充足する。 One of the uses of compound (1) is an additive for a liquid crystal composition used in a liquid crystal display element. Compound (1) is added for the purpose of horizontally controlling the orientation of liquid crystal molecules. Such additives are preferably chemically stable under the condition of being sealed in the device, have high solubility in the liquid crystal composition, and have a high voltage retention when used in the liquid crystal display device. .. Compound (1) satisfies such properties to a large extent.
 化合物(1)の好ましい例について説明をする。化合物(1)におけるR、Z~Z、A~A、Sp、Sp、P、P、aおよびbの好ましい例は、化合物(1)の下位式にも適用される。化合物(1)において、これらの基の種類を適切に組み合わせることによって、特性を任意に調整することが可能である。化合物の特性に大きな差異がないので、化合物(1)は、H(重水素)、13Cなどの同位体を天然存在比の量より多く含んでもよい。

Figure JPOXMLDOC01-appb-I000047
A preferred example of compound (1) will be described. Preferred examples of compounds of (1) R 1, Z 1 ~ Z 5, A 1 ~ A 4, Sp 1, Sp 2, P 1, P 2, a and b are applied to the sub-formulas of compound (1) Will be done. In compound (1), the properties can be arbitrarily adjusted by appropriately combining the types of these groups. Compound (1) may contain more isotopes such as 2 H (deuterium) and 13 C than the natural abundance ratio, as there are no significant differences in the properties of the compounds.

Figure JPOXMLDOC01-appb-I000047
環A、環A、環Aおよび環Aは独立して、1,4-シクロへキシレン、1,4-シクロヘキセニレン、1,4-フェニレン、ナフタレン-2,6-ジイル、デカヒドロナフタレン-2,6-ジイル、1,2,3,4-テトラヒドロナフタレン-2,6-ジイル、テトラヒドロピラン-2,5-ジイル、1,3-ジオキサン-2,5-ジイル、ピリミジン-2,5-ジイル、ピリジン-2,5-ジイル、フルオレン-2,7-ジイル、フェナントレン-2,7-ジイル、アントラセン-2,6-ジイル、ペルヒドロシクロペンタ[a]フェナントレン-3,17-ジイル、2,3,4,7,8,9,10,11,12,13,14,15,16,17-テトラデカヒドロシクロペンタ[a]フェナントレン-3,17-ジイルであり、これらの環において、少なくとも1つの水素は、フッ素、塩素、炭素数1から12のアルキル、炭素数2から12のアルケニル、炭素数1から11のアルコキシ、炭素数2から11のアルケニルオキシ、-Sp-P、または-Sp-Pで置き換えられてもよく、これらの基において、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよく、aが2のとき、2つの環Aは異なっていてもよく、bが2のとき、2つの環Aは異なっていてもよく。 Ring A 1 , Ring A 2 , Ring A 3 and Ring A 4 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, naphthalene-2,6-diyl, Decahydronaphthrene-2,6-diyl, 1,2,3,4-tetrahydronaphthalene-2,6-diyl, tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyrimidine- 2,5-diyl, pyridine-2,5-diyl, fluorene-2,7-diyl, phenanthrene-2,7-diyl, anthracene-2,6-diyl, perhydrocyclopenta [a] phenanthrene-3,17 -Diyl, 2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydrocyclopenta [a] phenanthrene-3,17-diyl, these In the ring of, at least one hydrogen is fluorine, chlorine, alkyl with 1 to 12 carbon atoms, alkenyl with 2 to 12 carbon atoms, alkoxy with 1 to 11 carbon atoms, alkenyloxy with 2 to 11 carbon atoms, -Sp 1 It may be replaced by -P 1 or -Sp 2- P 2 , and in these groups at least one hydrogen may be replaced by fluorine or chlorine, and when a is 2, two rings A 1 It may be different when b is 2, the two rings a 4 may be different.
 好ましい環A、A、AおよびAは独立して、1,4-シクロへキシレン、1,4-シクロヘキセニレン、1,4-フェニレン、ナフタレン-2,6-ジイル、デカヒドロナフタレン-2,6-ジイル、1,2,3,4-テトラヒドロナフタレン-2,6-ジイル、テトラヒドロピラン-2,5-ジイル、1,3-ジオキサン-2,5-ジイル、ピリミジン-2,5-ジイル、ピリジン-2,5-ジイル、ペルヒドロシクロペンタ[a]フェナントレン-3,17-ジイル、2,3,4,7,8,9,10,11,12,13,14,15,16,17-テトラデカヒドロシクロペンタ[a]フェナントレン-3,17-ジイルであり、好ましいcは1または2であり、これらの環において、少なくとも1つの水素は、フッ素、塩素、炭素数1から12のアルキル、炭素数2から12のアルケニル、炭素数1から11のアルコキシ、または炭素数2から11のアルケニルオキシで置き換えられてもよく、これらの基において、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよい。さらに好ましくは、1,4-シクロへキシレン、1,4-フェニレン、ペルヒドロシクロペンタ[a]フェナントレン-3,17-ジイル、または2,3,4,7,8,9,10,11,12,13,14,15,16,17-テトラデカヒドロシクロペンタ[a]フェナントレン-3,17-ジイルであり、これらの環において、少なくとも1つの水素はフッ素、または炭素数1から5のアルキルで置き換えられてもよい。特に好ましくは、1,4-シクロへキシレン、1,4-フェニレン、またはペルヒドロシクロペンタ[a]フェナントレン-3,17-ジイルであり、これらの環において、少なくとも1つの水素はフッ素、メチル、またはエチルで置き換えられてもよい。 Preferred rings A 1 , A 2 , A 3 and A 4 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, naphthalene-2,6-diyl, decahydro. Naphthalene-2,6-diyl, 1,2,3,4-tetrahydronaphthalene-2,6-diyl, tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyrimidine-2, 5-diyl, pyridine-2,5-diyl, perhydrocyclopenta [a] phenanthrene-3,17-diyl, 2,3,4,7,8,9,10,11,12,13,14,15 , 16,17-Tetradecahydrocyclopenta [a] Phenanthrene-3,17-diyl, preferably c is 1 or 2, and in these rings, at least one hydrogen is fluorine, chlorine, 1 carbon. It may be replaced by an alkyl from 12 to an alkenyl having 2 to 12 carbons, an alkoxy having 1 to 11 carbons, or an alkenyloxy having 2 to 11 carbons, and in these groups, at least one hydrogen is fluorine or It may be replaced with chlorine. More preferably, 1,4-cyclohexylene, 1,4-phenylene, perhydrocyclopenta [a] phenanthrene-3,17-diyl, or 2,3,4,7,8,9,10,11, 12,13,14,15,16,17-tetradecahydrocyclopenta [a] phenanthrene-3,17-diyl, in these rings at least one hydrogen is fluorine or alkyl with 1 to 5 carbon atoms. May be replaced with. Particularly preferred are 1,4-cyclohexylene, 1,4-phenylene, or perhydrocyclopenta [a] phenanthrene-3,17-diyl, in which at least one hydrogen is fluorine, methyl, Alternatively, it may be replaced with ethyl.
 Z、Z、Z、ZおよびZは独立して、単結合、-(CH-、-C≡C-、-C≡C-C≡C-、-COO-、-OCO-、-CFO-、-OCF-、-CHO-、-OCH-、-CF=CF-、-CH=CHCOO-、-OCOCH=CH-、-CH=CH-、-CH=CHCO-、-COCH=CH-、-COS-、-SCO-、-CH=CHCOS-、または-SCOCH=CH-であり、ただし、Z、Z、またはZの中で少なくとも1つは、-COS-、-SCO-、-CH=CHCOS-、または-SCOCH=CH-であり、aが2のとき、2つのZは異なっていてもよく、2つのZは異なっていてもよい。
 好ましいZ、Z、Z、ZおよびZは独立して、単結合、-(CH-、-CH=CH-、-C≡C-、-COO-、-OCO-、-CFO-、-OCF-、-CHO-、-OCH-、-CF=CF-、-COS-、-SCO-、-CH=CHCOS-、または-SCOCH=CH-である。さらに好ましくは、単結合、-(CH-、-CH=CH-、-COS-、-SCO-、-CH=CHCOS-、または-SCOCH=CH-である。特に好ましくは、単結合、-COS-、-SCO-、-CH=CHCOS-、または-SCOCH=CH-である。
Z 1 , Z 2 , Z 3 , Z 4 and Z 5 are independently single-bonded,-(CH 2 ) 2- , -C ≡ C-, -C ≡ C-C ≡ C-, -COO-, -OCO-, -CF 2 O-, -OCF 2- , -CH 2 O-, -OCH 2- , -CF = CF-, -CH = CHCOO-, -OCOCH = CH-, -CH = CH-, -CH = CHCO-, -COCH = CH-, -COS-, -SCO-, -CH = CHCOS-, or -SCOCH = CH-, provided that at least in Z 2 , Z 3 , or Z 4. one, -COS -, - SCO -, - CH = CHCOS-, or -SCOCH = a CH-, when a is 2, two Z 1 may be different, two Z 5 are different You may be.
Preferred Z 1 , Z 2 , Z 3 , Z 4 and Z 5 are independently single-bonded,-(CH 2 ) 2- , -CH = CH-, -C≡C-, -COO-, -OCO- , -CF 2 O -, - OCF 2 -, - CH 2 O -, - OCH 2 -, - CF = CF -, - COS -, - SCO -, - CH = CHCOS-, or -SCOCH = CH- in is there. More preferably, a single bond, - (CH 2) 2 - , - CH = CH -, - COS -, - SCO -, - CH = CHCOS-, or -SCOCH = a CH-. Particularly preferred are single bonds, -COS-, -SCO-, -CH = CHCOS-, or -SCOCH = CH-.
 SpおよびSpは独立して、単結合または炭素数1から10のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-、-CO-、-COO-、-OCO-、または-OCOO-で置き換えられてもよく、少なくとも1つの-(CH-は、-CH=CH-または-C≡C-で置き換えられてもよく、これらの基において、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよい。
 好ましいSpおよびSpは独立して、単結合、炭素数1~6のアルキレン、1つの-CH-が-O-で置き換えられた炭素数1~6のアルキレン、または-OCOO-である。さらに好ましくは、炭素数1~6のアルキレン、または-OCOO-である。
Sp 1 and Sp 2 are independently single-bonded or alkylene with 1 to 10 carbon atoms, in which at least one -CH 2- is -O-, -CO-, -COO-, -OCO. -Or -OCOO- may be replaced, and at least one- (CH 2 ) 2- may be replaced with -CH = CH- or -C≡C-, at least 1 in these groups. One hydrogen may be replaced with fluorine or chlorine.
Preferred Sp 1 and Sp 2 are independently single bonds, alkylenes with 1 to 6 carbon atoms, alkylene with 1 to 6 carbon atoms in which one -CH 2- has been replaced with -O-, or -OCOO-. .. More preferably, it is an alkylene having 1 to 6 carbon atoms or -OCOO-.
 PおよびPは独立して、式(1b)~式(1h)のいずれかで表される基である。 P 1 and P 2 are independent groups represented by any of the formulas (1b) to (1h).
 好ましいPおよびPは独立して、(1b)、(1c)、(1d)、および(1e)のいずれかで表される基である。

Figure JPOXMLDOC01-appb-I000048
Preferred P 1 and P 2 are independently represented by any of (1b), (1c), (1d), and (1e).

Figure JPOXMLDOC01-appb-I000048
 好ましいM、M、MおよびMは独立して、水素、フッ素、メチル、エチル、またはトリフルオロメチルである。さらに好ましくは、水素である。 Preferred M 1 , M 2 , M 3 and M 4 are independently hydrogen, fluorine, methyl, ethyl, or trifluoromethyl. More preferably, it is hydrogen.
 Rは水素、フッ素、塩素、または炭素数1から5のアルキルであり、このアルキルにおいて少なくとも1つの水素はフッ素または塩素で置き換えられてもよく、少なくとも1つの-CH-は、-O-で置き換えられてもよい。 R 2 is hydrogen, fluorine, chlorine, or an alkyl having 1 to 5 carbon atoms, in which at least one hydrogen may be replaced by fluorine or chlorine, and at least one -CH 2- is -O-. May be replaced with.
 好ましいRは、水素、フッ素、メチル、エチル、メトキシメチル、またはトリフルオロメチルである。さらに好ましくは、水素である。 Preferred R 2 is hydrogen, fluorine, methyl, ethyl, methoxymethyl, or trifluoromethyl. More preferably, it is hydrogen.
 R、R、R、R、およびRは独立して、水素、または炭素数1から15の直鎖状、分岐状または環状のアルキルであり、このアルキルにおいて、少なくとも1つの-CH-は、-O-または-S-で置き換えられてもよく、少なくとも1つの-(CH-は、-CH=CH-または-C≡C-で置き換えられてもよく、これらの基において、少なくとも1つの水素はフッ素または塩素で置き換えられてもよい。 R 3 , R 4 , R 5 , R 6 and R 7 are independently hydrogen, or linear, branched or cyclic alkyl with 1 to 15 carbon atoms, in which at least one − CH 2- may be replaced by -O- or -S-, and at least one- (CH 2 ) 2- may be replaced by -CH = CH- or -C≡C-, these. At least one hydrogen may be replaced by fluorine or chlorine.
 好ましいR、R、R、R、およびRは独立して、水素、炭素数1~10の直鎖状アルキル、炭素数2~10の直鎖状アルケニル、炭素数1~10の直鎖状アルコキシ、または炭素数3~6の環状アルキルである。さらに好ましくは、水素、炭素数2~6の直鎖状アルキル、炭素数2~6の直鎖状アルケニル、炭素数1~5の直鎖状アルコキシ、または炭素数4~6の環状アルキルである。 Preferred R 3 , R 4 , R 5 , R 6 and R 7 are independently hydrogen, linear alkyl with 1-10 carbon atoms, linear alkoxy with 2-10 carbon atoms, 1-10 carbon atoms. Linear alkoxy, or cyclic alkyl having 3 to 6 carbon atoms. More preferably, it is hydrogen, a linear alkyl having 2 to 6 carbon atoms, a linear alkenyl having 2 to 6 carbon atoms, a linear alkoxy having 1 to 5 carbon atoms, or a cyclic alkyl having 4 to 6 carbon atoms. ..
は、OまたはSである。 X 1 is O or S.
 さらに好ましい基は、式(1b-1)、(1b-2)、(1b-3)、(1b-4)、式(1b-5)、(1c-1)、(1d-1)(1d-2)または(1e-1)で表される基である。

Figure JPOXMLDOC01-appb-I000049

 式(1b)~式(1h)において、MおよびMは独立して、水素、フッ素、塩素、炭素数1から5のアルキル、または少なくとも1つの水素がフッ素または塩素で置き換えられた炭素数1から5のアルキルであり、X、X、X、XおよびXは独立してOまたはSである。
More preferred groups are formulas (1b-1), (1b-2), (1b-3), (1b-4), formulas (1b-5), (1c-1), (1d-1) (1d). -2) or a group represented by (1e-1).

Figure JPOXMLDOC01-appb-I000049

In formulas (1b) to (1h), M 1 and M 2 independently have hydrogen, fluorine, chlorine, an alkyl having 1 to 5 carbon atoms, or at least one hydrogen having a carbon number replaced by fluorine or chlorine. It is an alkyl of 1 to 5, and X 2 , X 3 , X 4 , X 5 and X 6 are independently O or S.
 aおよびbは独立して、0、1または2であり、好ましくは、0≦a+b≦2である。 A and b are independently 0, 1 or 2, preferably 0 ≦ a + b ≦ 2.
 化合物(1)の好ましい例は、式(1-1)~(1-3)である。

Figure JPOXMLDOC01-appb-I000050

 式(1-1)から式(1-3)において、
環A、環A、環Aおよび環Aは独立して、1,4-シクロへキシレン、1,4-フェニレン、ナフタレン-2,6-ジイル、ピリミジン-2,5-ジイル、ピリジン-2,5-ジイル、フルオレン-2,7-ジイル、フェナントレン-2,7-ジイル、アントラセン-2,6-ジイルであり、これらの環において、少なくとも1つの水素は、フッ素、塩素、炭素数1から12のアルキル、炭素数2から12のアルケニル、炭素数1から11のアルコキシ、炭素数2から11のアルケニルオキシ、-Sp-P、または-Sp-Pで置き換えられてもよく、これらの基において、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよく、aが2のとき、2つの環Aは異なっていてもよく、bが2のとき、2つの環Aは異なっていてもよく;
これらの環において、少なくとも1つの水素は、フッ素、塩素、炭素数1から12のアルキル、炭素数2から12のアルケニル、炭素数1から11のアルコキシ、炭素数2から11のアルケニルオキシ、-Sp-P、または-Sp-Pで置き換えられてもよく、これらの基において、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよく;
 Z、ZおよびZは独立して、単結合、-(CH-、-C≡C-、-C≡C-C≡C-、-COO-、-OCO-、-CFO-、-OCF-、-CHO-、-OCH-、-CF=CF-、-CH=CHCOO-、-OCOCH=CH-、-CH=CH-、-CH=CHCO-、-COCH=CH-、-COS-、-SCO-、-CH=CHCOS-、または-SCOCH=CH-であり、ただし、Z、Z、またはZの中で少なくとも1つは、-COS-、-SCO-、-CH=CHCOS-、または-SCOCH=CH-であり;
 SpおよびSpは独立して、単結合または炭素数1から10のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-、-COO-、-OCOO-、または-OCO-で置き換えられてもよく、少なくとも1つの-(CH-は、-CH=CH-で置き換えられてもよく、これらの基において、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよく、構造内に複数のSpまたはSpが存在する場合、それぞれが異なっていてもよく;
 PおよびPは独立して、式(1b)~式(1h)のいずれかで表される基であり、構造内に複数のPまたはPが存在する場合、それぞれが異なっていてもよく;

Figure JPOXMLDOC01-appb-I000051

式(1b)~式(1h)において
 M、M、MおよびMは独立して、水素、フッ素、塩素、炭素数1から5のアルキル、または少なくとも1つの水素がフッ素または塩素で置き換えられた炭素数1から5のアルキルであり、XはOまたはSであり;
 Rは水素、フッ素、塩素、または炭素数1から5のアルキルであり、このアルキルにおいて少なくとも1つの水素はフッ素または塩素で置き換えられてもよく、少なくとも1つの-CH-は、-O-で置き換えられてもよく;
 R、R、R、R、およびRは独立して、水素、または炭素数1から15のアルキルであり、このアルキルにおいて、少なくとも1つの-CH-は、-O-または-S-で置き換えられてもよく、少なくとも1つの-(CH-は、-CH=CH-または-C≡C-で置き換えられてもよく、これらの基において、少なくとも1つの水素はフッ素または塩素で置き換えられてもよい。
Preferred examples of the compound (1) are formulas (1-1) to (1-3).

Figure JPOXMLDOC01-appb-I000050

In equations (1-1) to (1-3),
Ring A 1 , Ring A 2 , Ring A 3 and Ring A 4 are independent, 1,4-cyclohexylene, 1,4-phenylene, naphthalene-2,6-diyl, pyrimidine-2,5-diyl, Pyridine-2,5-diyl, fluorene-2,7-diyl, phenanthrene-2,7-diyl, anthracene-2,6-diyl, and at least one hydrogen in these rings is fluorine, chlorine, carbon. Replaced by alkyl numbers 1 to 12, alkenyl with 2 to 12 carbons, alkoxy with 1 to 11 carbons, alkenyloxy with 2 to 11 carbons, -Sp 1- P 1 or -Sp 2- P 2. in even better, these groups, at least one hydrogen may be replaced by fluorine or chlorine, when a is 2, two rings a 1 may be different when b is 2, the two ring A 4 may be different;
In these rings, at least one hydrogen is fluorine, chlorine, alkyl with 1 to 12 carbons, alkenyl with 2 to 12 carbons, alkoxy with 1 to 11 carbons, alkenyloxy with 2 to 11 carbons, -Sp. It may be replaced with 1- P 1 or -Sp 2- P 2 , and in these groups at least one hydrogen may be replaced with fluorine or chlorine;
Z 2 , Z 3 and Z 4 are independently single-bonded,-(CH 2 ) 2- , -C ≡ C-, -C ≡ C-C ≡ C-, -COO-, -OCO-, -CF 2 O -, - OCF 2 - , - CH 2 O -, - OCH 2 -, - CF = CF -, - CH = CHCOO -, - OCOCH = CH -, - CH = CH -, - CH = CHCO-, -COCH = CH -, - COS - , - SCO -, - CH = CHCOS-, or -SCOCH = a CH-, provided that at least one among Z 2, Z 3 or Z 4, are,-COS -, -SCO-, -CH = CHCOS-, or -SCOCH = CH-;
Sp 1 and Sp 2 are independently single-bonded or alkylene with 1 to 10 carbon atoms, in which at least one -CH 2- is -O-, -COO-, -OCOO-, or-. It may be replaced by OCO-, at least one- (CH 2 ) 2 -may be replaced by -CH = CH-, and in these groups at least one hydrogen is replaced by fluorine or chlorine. at best, if there are a plurality of Sp 1 or Sp 2 in the structure, it may be different from each;
P 1 and P 2 are independent groups represented by any of the formulas (1b) to (1h), and when a plurality of P 1 or P 2 are present in the structure, they are different from each other. Well;

Figure JPOXMLDOC01-appb-I000051

In formulas (1b) to (1h), M 1 , M 2 , M 3 and M 4 are independently hydrogen, fluorine, chlorine, alkyl having 1 to 5 carbon atoms, or at least one hydrogen is fluorine or chlorine. The substituted alkyl with 1 to 5 carbon atoms, where X 1 is O or S;
R 2 is hydrogen, fluorine, chlorine, or an alkyl having 1 to 5 carbon atoms, in which at least one hydrogen may be replaced by fluorine or chlorine, and at least one -CH 2- is -O-. May be replaced with;
R 3 , R 4 , R 5 , R 6 , and R 7 are independently hydrogen, or alkyl with 1 to 15 carbon atoms, in which at least one -CH 2- is -O- or It may be replaced by —S—, at least one − (CH 2 ) 2 − may be replaced by −CH = CH− or −C≡C−, and in these groups, at least one hydrogen It may be replaced with fluorine or chlorine.
 式(1-1)、式(1-2)、または式(1-3)で表される化合物において、Z、Z、またはZのいずれか1つは、-COS-または-SCO-であることが好ましい。
 また、式(1-1)、式(1-2)、または式(1-3)で表される化合物において、Z、Z、またはZのいずれか1つは、-CH=CHCOS-、または-SCOCH=CH-であることが好ましい。
In the compound represented by the formula (1-1), the formula (1-2), or the formula (1-3), any one of Z 2 , Z 3 , or Z 4 is -COS- or -SCO. -Preferably.
Further, in the compound represented by the formula (1-1), the formula (1-2), or the formula (1-3), any one of Z 2 , Z 3 , or Z 4 has -CH = CHCOS. -Or-SCOCH = CH-is preferable.
 化合物(1)は、以下の式で表される化合物であることが好ましい。

Figure JPOXMLDOC01-appb-I000052

Figure JPOXMLDOC01-appb-I000053

Figure JPOXMLDOC01-appb-I000054

Figure JPOXMLDOC01-appb-I000055

 PおよびPは独立して、式(1b-1)、(1b-2)、(1b-3)、(1b-4)、式(1b-5)、(1c-1)、(1d-1)、(1d-2)または(1e-1)で表される基であり、X、X、X、XおよびXは独立してOまたはSであり;
 SpおよびSpは独立して、単結合または炭素数1から10のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-、-COO-、-OCOO-、または-OCO-で置き換えられてもよく、少なくとも1つの-(CH-は、-CH=CH-で置き換えられてもよく;
 P、P、SpおよびSp以外の部分構造において、少なくとも1つの水素は、フッ素、塩素、メチル、またはエチルで置き換えられてもよい。
The compound (1) is preferably a compound represented by the following formula.

Figure JPOXMLDOC01-appb-I000052

Figure JPOXMLDOC01-appb-I000053

Figure JPOXMLDOC01-appb-I000054

Figure JPOXMLDOC01-appb-I000055

P 1 and P 2 are each independently formula (1b-1), (1b -2), (1b-3), (1b-4), formula (1b-5), (1c -1), (1d -1), a group represented by (1d-2) or (1e-1), where X 2 , X 3 , X 4 , X 5 and X 6 are independently O or S;
Sp 1 and Sp 2 are independently single bonds or alkylenes having 1 to 10 carbon atoms, in which at least one -CH 2- is -O-, -COO-, -OCOO-, or-. It may be replaced by OCO-, and at least one- (CH 2 ) 2- may be replaced by -CH = CH-;
In partial structures other than P 1 , P 2 , Sp 1 and Sp 2 , at least one hydrogen may be replaced with fluorine, chlorine, methyl, or ethyl.
また、化合物(1)の具体的な例は、後述の実施例の中で述べる。 Specific examples of compound (1) will be described in Examples described later.
 式(2)から(15)は、液晶組成物の成分化合物を示している。化合物(2)から(4)は小さな誘電率異方性を有する。化合物(5)から(7)は、正に大きな誘電率異方性を有する。化合物(8)はシアノ基を有するので正により大きな誘電率異方性を有する。化合物(9)から(16)は、負に大きな誘電率異方性を有する。これらの化合物の具体的な例は、後で述べる。 Formulas (2) to (15) represent the component compounds of the liquid crystal composition. Compounds (2) to (4) have small dielectric anisotropy. Compounds (5) to (7) have a very large dielectric anisotropy. Since compound (8) has a cyano group, it has a larger positive dielectric anisotropy. Compounds (9) to (16) have a large negative dielectric anisotropy. Specific examples of these compounds will be described later.
 化合物(16)において、P11、P12、およびP13は独立して、重合性基である。 In compound (16), P 11 , P 12 , and P 13 are independently polymerizable groups.
 好ましいP11、P12、およびP13は、式(P-1)から式(P-5)で表される基の群から選択された重合性基である。さらに好ましいP11、P12、およびP13は、基(P-1)、基(P-2)、または基(P-3)である。特に好ましい基(P-1)は、-OCO-CH=CHまたは-OCO-C(CH)=CHである。基(P-1)から基(P-5)の波線は、結合する部位を示す。

Figure JPOXMLDOC01-appb-I000056
Preferred P 11 , P 12 and P 13 are polymerizable groups selected from the group of groups represented by formulas (P-1) to (P-5). More preferred P 11 , P 12 , and P 13 are groups (P-1), groups (P-2), or groups (P-3). A particularly preferred group (P-1) is -OCO-CH = CH 2 or -OCO-C (CH 3 ) = CH 2 . The wavy line from the group (P-1) to the group (P-5) indicates the site to be bonded.

Figure JPOXMLDOC01-appb-I000056
 基(P-1)から基(P-5)において、M11、M12、およびM13は独立して、水素、フッ素、炭素数1から5のアルキル、または少なくとも1つの水素がフッ素または塩素で置き換えられた炭素数1から5のアルキルである。
 好ましいM11、M12、およびM13は、反応性を上げるために水素またはメチルである。さらに好ましいM11はメチルであり、さらに好ましいM12およびM13は水素である。
From group (P-1) to group (P-5), M 11 , M 12 , and M 13 are independently hydrogen, fluorine, alkyl with 1 to 5 carbon atoms, or at least one hydrogen is fluorine or chlorine. It is an alkyl having 1 to 5 carbon atoms replaced with.
Preferred M 11 , M 12 , and M 13 are hydrogen or methyl to increase reactivity. The more preferred M 11 is methyl and the more preferred M 12 and M 13 are hydrogen.
 Sp11、Sp12、およびSp13は独立して、単結合または炭素数1から10のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-、-COO-、-OCO-、または-OCOO-で置き換えられてもよく、少なくとも1つの-(CH-は、-CH=CH-または-C≡C-で置き換えられてもよく、これらの基において、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよい。 Sp 11 , Sp 12 , and Sp 13 are independently single bonds or alkylenes with 1 to 10 carbon atoms, in which at least one -CH 2- is -O-, -COO-, -OCO. -Or -OCOO- may be replaced, and at least one- (CH 2 ) 2- may be replaced with -CH = CH- or -C≡C-, at least 1 in these groups. One hydrogen may be replaced with fluorine or chlorine.
 好ましいSp11、Sp12、およびSp13は、単結合である。 Preferred Sp 11 , Sp 12 , and Sp 13 are single bonds.
 環Fおよび環Iは独立して、シクロヘキシル、シクロヘキセニル、フェニル、1-ナフチル、2-ナフチル、テトラヒドロピラン-2-イル、1,3-ジオキサン-2-イル、ピリミジン-2-イル、またはピリジン-2-イルであり、これらの環において、少なくとも1つの水素は、フッ素、塩素、炭素数1から12のアルキル、炭素数1から12のアルコキシ、または少なくとも1つの水素がフッ素または塩素で置き換えられた炭素数1から12のアルキルで置き換えられてもよい。 Rings F and I are independently cyclohexyl, cyclohexenyl, phenyl, 1-naphthyl, 2-naphthyl, tetrahydropyran-2-yl, 1,3-dioxane-2-yl, pyrimidin-2-yl, or pyridine. -2-yl, in these rings at least one hydrogen is fluorine, chlorine, alkyl with 1 to 12 carbons, alkoxy with 1 to 12 carbons, or at least one hydrogen is replaced with fluorine or chlorine. It may be replaced with an alkyl having 1 to 12 carbon atoms.
 好ましい環Fおよび環Iは、フェニルである。環Gは、1,4-シクロへキシレン、1,4-シクロヘキセニレン、1,4-フェニレン、ナフタレン-1,2-ジイル、ナフタレン-1,3-ジイル、ナフタレン-1,4-ジイル、ナフタレン-1,5-ジイル、ナフタレン-1,6-ジイル、ナフタレン-1,7-ジイル、ナフタレン-1,8-ジイル、ナフタレン-2,3-ジイル、ナフタレン-2,6-ジイル、ナフタレン-2,7-ジイル、テトラヒドロピラン-2,5-ジイル、1,3-ジオキサン-2,5-ジイル、ピリミジン-2,5-ジイル、またはピリジン-2,5-ジイルであり、これらの環において、少なくとも1つの水素は、フッ素、塩素、炭素数1から12のアルキル、炭素数1から12のアルコキシ、または少なくとも1つの水素がフッ素または塩素で置き換えられた炭素数1から12のアルキルで置き換えられてもよい。特に好ましい環Gは、1,4-フェニレンまたは2-フルオロ-1,4-フェニレンである。 Preferred rings F and I are phenyl. Ring G is 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, naphthalene-1,2-diyl, naphthalene-1,3-diyl, naphthalene-1,4-diyl, Naphthalene-1,5-diyl, naphthalene-1,6-diyl, naphthalene-1,7-diyl, naphthalene-1,8-diyl, naphthalene-2,3-diyl, naphthalene-2,6-diyl, naphthalene- 2,7-Diyl, tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyrimidine-2,5-diyl, or pyridine-2,5-diyl, in these rings. , At least one hydrogen is replaced with fluorine, chlorine, alkyl with 1 to 12 carbon atoms, alkoxy with 1 to 12 carbon atoms, or alkyl with 1 to 12 carbon atoms in which at least one hydrogen is replaced with fluorine or chlorine. You may. A particularly preferred ring G is 1,4-phenylene or 2-fluoro-1,4-phenylene.
 Z22およびZ23は独立して、単結合または炭素数1から10のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-、-CO-、-COO-、または-OCO-で置き換えられてもよく、少なくとも1つの-(CH-は、-CH=CH-、-C(CH)=CH-、-CH=C(CH)-、または-C(CH)=C(CH)-で置き換えられてもよく、これらの基において、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよい。 Z 22 and Z 23 are independently single bonds or alkylenes with 1 to 10 carbon atoms, in which at least one -CH 2- is -O-, -CO-, -COO-, or-. It may be replaced by OCO-, and at least one- (CH 2 ) 2- is -CH = CH-, -C (CH 3 ) = CH-, -CH = C (CH 3 )-, or -C. It may be replaced by (CH 3 ) = C (CH 3 )-and at least one hydrogen in these groups may be replaced by fluorine or chlorine.
 好ましいZ22およびZ23は、単結合、-(CH-、-CHO-、-OCH-、-COO-、または-OCO-である。さらに好ましいZ22およびZ23は、単結合である。 Preferred Z 22 and Z 23 are single bonds,-(CH 2 ) 2- , -CH 2 O-, -OCH 2- , -COO-, or -OCO-. More preferred Z 22 and Z 23 are single bonds.
 uは、0、1、または2である。 U is 0, 1, or 2.
 好ましいuは、0または1である。f、g、およびhは独立して、0、1、2、3、または4であり、そして、f、g、およびhの和は、1以上である。好ましいf、g、またはhは、1または2である。 The preferred u is 0 or 1. f, g, and h are independently 0, 1, 2, 3, or 4, and the sum of f, g, and h is greater than or equal to 1. The preferred f, g, or h is 1 or 2.
2.化合物(1)の合成
 化合物(1)の合成法について説明する。化合物(1)は、有機合成化学の方法を適切に組み合わせることにより合成できる。合成法を記載しなかった化合物は、「オーガニック・シンセシス」(Organic Syntheses, John Wiley & Sons, Inc)、「オーガニック・リアクションズ」(Organic Reactions, John Wiley & Sons, Inc)、「コンプリヘンシブ・オーガニック・シンセシス」(Comprehensive Organic Synthesis, Pergamon Press)、「新実験化学講座」(丸善)などの成書に記載された方法によって合成する。
2. Synthesis of Compound (1) A method for synthesizing compound (1) will be described. Compound (1) can be synthesized by appropriately combining synthetic organic chemistry methods. Compounds for which the synthetic method was not described are "Organic Syntheses" (John Wiley & Sons, Inc), "Organic Reactions" (Organic Reactions, John Wiley & Sons, Inc), and "Comprehensive Organic". -Syntheses by the methods described in books such as "Comprehensive Organic Synthesis, Pergamon Press" and "New Experimental Chemistry Course" (Maruzen).
2-1.結合基Z、Z、Z、ZおよびZの生成
 化合物(1)における結合基を生成する方法の例は、下記のスキームのとおりである。このスキームにおいて、MSG(またはMSG)は、少なくとも1つの環を有する一価の有機基である。複数のMSG(またはMSG)が表す一価の有機基は、同一であってもよいし、または異なってもよい。化合物(1A)~(1L)は、化合物(1)または化合物(1)の中間体に相当する。
2-1. Generation of Binding Groups Z 1 , Z 2 , Z 3 , Z 4 and Z 5 Examples of methods for generating binding groups in compound (1) are as follows. In this scheme, MSG 1 (or MSG 2 ) is a monovalent organic group having at least one ring. The monovalent organic groups represented by a plurality of MSG 1 (or MSG 2) may be the same or different. Compounds (1A) to (1L) correspond to compound (1) or an intermediate of compound (1).

Figure JPOXMLDOC01-appb-I000057

Figure JPOXMLDOC01-appb-I000057

Figure JPOXMLDOC01-appb-I000058

Figure JPOXMLDOC01-appb-I000058

Figure JPOXMLDOC01-appb-I000059

Figure JPOXMLDOC01-appb-I000059

Figure JPOXMLDOC01-appb-I000060

Figure JPOXMLDOC01-appb-I000060

Figure JPOXMLDOC01-appb-I000061

Figure JPOXMLDOC01-appb-I000061

Figure JPOXMLDOC01-appb-I000062

Figure JPOXMLDOC01-appb-I000063

Figure JPOXMLDOC01-appb-I000062

Figure JPOXMLDOC01-appb-I000063
(I)単結合の生成
 アリールホウ酸(21)と化合物(22)を、炭酸塩、テトラキス(トリフェニルホスフィン)パラジウム触媒の存在下で反応させ、化合物(1A)を合成する。この化合物(1A)は、化合物(23)にn-ブチルリチウムを、次いで塩化亜鉛を反応させ、ジクロロビス(トリフェニルホスフィン)パラジウム触媒の存在下で化合物(22)を反応させても合成される。
(I) Formation of Single Bond Arylboric acid (21) and compound (22) are reacted in the presence of a carbonate and a tetrakis (triphenylphosphine) palladium catalyst to synthesize compound (1A). This compound (1A) is also synthesized by reacting compound (23) with n-butyllithium and then zinc chloride, and reacting compound (22) in the presence of a dichlorobis (triphenylphosphine) palladium catalyst.
(II)-COO-と-OCO-の生成
 化合物(23)にn-ブチルリチウムを、次いで二酸化炭素を反応させ、カルボン酸(24)を得る。このカルボン酸(24)と、化合物(21)から誘導したフェノール(25)とをDCC(1,3-ジシクロヘキシルカルボジイミド)とDMAP(4-ジメチルアミノピリジン)の存在下で脱水させて-COO-を有する化合物(1B)を合成する。この方法によって-OCO-を有する化合物も合成する。
(II) Production of -COO- and -OCO- The compound (23) is reacted with n-butyllithium and then carbon dioxide to obtain a carboxylic acid (24). The carboxylic acid (24) and the phenol (25) derived from the compound (21) were dehydrated in the presence of DCC (1,3-dicyclohexylcarbodiimide) and DMAP (4-dimethylaminopyridine) to give -COO-. Synthesize the compound (1B) having. Compounds with -OCO- are also synthesized by this method.
(III)-CFO-と-OCF-の生成
 化合物(1B)をローソン試薬で硫黄化し、化合物(26)を得る。化合物(26)をフッ化水素ピリジン錯体とNBS(N-ブロモスクシンイミド)でフッ素化し、-CFO-を有する化合物(1C)を合成する。M. Kuroboshi et al., Chem. Lett., 1992,827.を参照。化合物(1C)は化合物(26)をDAST((ジエチルアミノ)サルファートリフルオリド)でフッ素化しても合成される。W. H. Bunnelle et al., J. Org. Chem. 1990, 55, 768.を参照。この方法によって-OCF-を有する化合物も合成する。
(III) -Production of -CF 2 O- and -OCF 2- Compound (1B) is sulfurized with Lawesson's reagent to obtain compound (26). Compound (26) is fluorinated with a hydrogen fluoride pyridine complex and NBS (N-bromosuccinimide) to synthesize compound (1C) having -CF 2 O-. See M. Kuroboshi et al., Chem. Lett., 1992, 827. Compound (1C) is also synthesized by fluorinating compound (26) with DAST ((diethylamino) sulfatrifluoride). See W. H. Bunnelle et al., J. Org. Chem. 1990, 55, 768. Compounds with -OCF 2- are also synthesized by this method.
(IV)-CH=CH-の生成
 化合物(22)をn-ブチルリチウム、次いでDMF(N,N-ジメチルホルムアミド)と反応させてアルデヒド(27)を得る。ホスホニウム塩(28)とカリウムtert-ブトキシドを反応させて発生させたリンイリドを、アルデヒド(27)と反応させて化合物(1D)を合成する。反応条件によってはシス体が生成するので、必要に応じて公知の方法によりシス体をトランス体に異性化する。
Production of (IV) -CH = CH- Compound (22) is reacted with n-butyllithium and then DMF (N, N-dimethylformamide) to obtain aldehyde (27). Phosphorium salt (28) and potassium tert-butoxide are reacted to generate linylide, which is then reacted with aldehyde (27) to synthesize compound (1D). Since a cis form is produced depending on the reaction conditions, the cis form is isomerized to a trans form by a known method if necessary.
(V)-(CH-の生成
 化合物(1D)をパラジウム炭素触媒の存在下で水素化し、化合物(1E)を合成する。
Production of (V)-(CH 2 ) 2 -The compound (1D) is hydrogenated in the presence of a palladium carbon catalyst to synthesize the compound (1E).
(VI)-C≡C-の生成
 ジクロロパラジウムとヨウ化銅の触媒存在下で、化合物(23)に2-メチル-3-ブチン-2-オールを反応させたのち、塩基性条件下で脱保護して化合物(29)を得る。ジクロロビス(トリフェニルホスフィン)パラジウムとハロゲン化銅との触媒存在下、化合物(29)を化合物(22)と反応させて、化合物(1F)を合成する。
Production of (VI) -C≡C- After reacting compound (23) with 2-methyl-3-butin-2-ol in the presence of a catalyst of dichloropalladium and copper iodide, it is removed under basic conditions. Protect to obtain compound (29). Compound (29) is reacted with compound (22) in the presence of a catalyst of dichlorobis (triphenylphosphine) palladium and copper halide to synthesize compound (1F).
(VII)-CHO-と-OCH-の生成
 化合物(27)を水素化ホウ素ナトリウムで還元して化合物(30)を得る。これを臭化水素酸で臭素化して化合物(31)を得る。炭酸カリウムの存在下、化合物(25)と化合物(31)を反応させて、化合物(1G)を合成する。この方法によって-OCH-を有する化合物も合成する。
Production of (VII) -CH 2 O- and -OCH 2- Compound (27) is reduced with sodium borohydride to obtain compound (30). This is brominated with hydrobromic acid to obtain compound (31). Compound (25) and compound (31) are reacted in the presence of potassium carbonate to synthesize compound (1G). Compounds with -OCH 2- are also synthesized by this method.
(VIII)-CF=CF-の生成
 化合物(23)をn-ブチルリチウムで処理したあと、テトラフルオロエチレンを反応させて化合物(32)を得る。化合物(22)をn-ブチルリチウムで処理したあと化合物(32)と反応させて、化合物(1H)を合成する。
Production of (VIII) -CF = CF- Compound (23) is treated with n-butyllithium and then reacted with tetrafluoroethylene to obtain compound (32). Compound (22) is treated with n-butyllithium and then reacted with compound (32) to synthesize compound (1H).
(IX)-CH=CHCO-と-COCH=CH-の生成
 化合物(40)と化合物(27)をNaOH存在下で、アルドール縮合反応をし化合物(1I)を合成する。
(IX) Production of -CH = CHCO- and -COCH = CH- Compound (40) and compound (27) are subjected to an aldol condensation reaction in the presence of NaOH to synthesize compound (1I).
(X)-CH=CHCOO-と-OCOCH=CH-の生成
ケイ皮酸(41)と、化合物(25)をDCC(1,3-ジシクロヘキシルカルボジイミド)とDMAP(4-ジメチルアミノピリジン)の存在下で脱水させて化合物(1J)を合成する。
Formation of (X) -CH = CHCOO- and -OCOCH = CH-Cinnamic acid (41) and compound (25) in the presence of DCC (1,3-dicyclohexylcarbodiimide) and DMAP (4-dimethylaminopyridine) Dehydrate with to synthesize compound (1J).
(XI)-CH=CHCOS-と-SCOCH=CH-の生成
ケイ皮酸(41)と、化合物(26)をDCC(1,3-ジシクロヘキシルカルボジイミド)とDMAP(4-ジメチルアミノピリジン)の存在下で脱水させて化合物(1K)を合成する。
Formation of (XI) -CH = CHCOS- and -SCOCCH = CH-Cinnamic acid (41) and compound (26) in the presence of DCC (1,3-dicyclohexylcarbodiimide) and DMAP (4-dimethylaminopyridine) Dehydrate with to synthesize compound (1K).
(XII)-COS-と-SCO-の生成
カルボン酸(24)と、化合物(26)をDCC(1,3-ジシクロヘキシルカルボジイミド)とDMAP(4-ジメチルアミノピリジン)の存在下で脱水させて化合物(1L)を合成する。
Production of (XII) -COS- and -SCO- The carboxylic acid (24) and the compound (26) are dehydrated in the presence of DCC (1,3-dicyclohexylcarbodiimide) and DMAP (4-dimethylaminopyridine) to form the compound. (1L) is synthesized.
2-2.環A、A、AおよびAの生成
 1,4-シクロヘキシレン、1,4-シクロヘキセニレン、1,4-フェニレン、2-フルオロ-1,4-フェニレン、2-メチル-1,4-フェニレン、2-エチル-1,4-フェニレン、ナフタレン-2,6-ジイル、デカヒドロナフタレン-2,6-ジイル、1,2,3,4-テトラヒドロナフタレン-2,6-ジイル、テトラヒドロピラン-2,5-ジイル、1,3-ジオキサン-2,5-ジイル、ピリミジン-2,5-ジイル、ピリジン-2,5-ジイル、ペルヒドロシクロペンタ[a]フェナントレン-3,17-ジイル、2,3,4,7,8,9,10,11,12,13,14,15,16,17-テトラデカヒドロシクロペンタ[a]フェナントレン-3,17-ジイルなどの環に関しては出発物が市販されているか、または合成法がよく知られている。
2-2. Formation of rings A 1 , A 2 , A 3 and A 4 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, 2-fluoro-1,4-phenylene, 2-methyl-1 , 4-Phenanthrene, 2-Ethyl-1,4-Phenanthrene, Naphthalene-2,6-Diyl, Decahydronaphthalene-2,6-Diyl, 1,2,3,4-Tetrahydropyranphthalene-2,6-Diyl, Tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyrimidine-2,5-diyl, pyridine-2,5-diyl, perhydrocyclopenta [a] phenanthrene-3,17- For rings such as dioxane, 2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydrocyclopenta [a] phenanthrene-3,17-dioxane The starting material is commercially available or the synthetic method is well known.
2-3.連結基SpまたはSp、および重合性基PまたはPの生成
 重合性基PまたはPの好ましい例は、アクリル酸エステル(1b)、マレイミド(1c)、イタコン酸エステル(1d)、ビニルエステル(1e)、オキシラニル(1g)、またはビニルオキシ(1h)である。

Figure JPOXMLDOC01-appb-I000064
2-3. Production of Linking Group Sp 1 or Sp 2 and Polymerizing Group P 1 or P 2 Preferred examples of the polymerizable group P 1 or P 2 are acrylic ester (1b), maleimide (1c), itaconic acid ester (1d). , Vinyl ester (1e), oxylanyl (1g), or vinyloxy (1h).

Figure JPOXMLDOC01-appb-I000064
 この重合性基が連結基SpまたはSpで環に結合した化合物を合成する方法の例は、下記のとおりである。まず、連結基SpまたはSpが単結合である例を示す。 An example of a method for synthesizing a compound in which this polymerizable group is bonded to a ring with a linking group Sp 1 or Sp 2 is as follows. First, an example in which the linking group Sp 1 or Sp 2 is a single bond will be shown.
(1) 単結合である化合物の合成
 SpまたはSpが単結合である化合物の合成方法は、下記のスキームのとおりである。このスキームにおいて、MSGは、少なくとも1つの環を有する一価の有機基である。化合物(1S)から(1X)は、化合物(1)に相当する。重合性基がアクリレート誘導体の場合は、対応するアクリル酸とHO-MSGとのエステル化によって合成する。ビニルオキシは、HO-MSGと臭化ビニルのエーテル化により合成する。オキシラニルは、末端2重結合の酸化により合成する。マレイミド基は、アミノ基と無水マレイン酸との反応により合成する。イタコン酸エステルは、対応するイタコン酸とHO-MSGとのエステル化によって合成する。ビニルエステルは、酢酸ビニルとHOOC-MSGとのエステル交換反応により合成する。
(1) Synthesis of compound having a single bond The method for synthesizing a compound having Sp 1 or Sp 2 having a single bond is as follows. In this scheme, MSG 1 is a monovalent organic group having at least one ring. Compounds (1S) to (1X) correspond to compound (1). When the polymerizable group is an acrylate derivative, it is synthesized by esterification of the corresponding acrylic acid and HO-MSG 1 . Vinyloxy is synthesized by etherification of HO-MSG 1 and vinyl bromide. Oxylanyl is synthesized by oxidation of the terminal double bond. The maleimide group is synthesized by the reaction of an amino group with maleic anhydride. Itaconic acid esters are synthesized by esterification of the corresponding itaconic acid with HO-MSG 1 . Vinyl ester is synthesized by transesterification reaction of vinyl acetate and HOOC-MSG 1 .

Figure JPOXMLDOC01-appb-I000065

Figure JPOXMLDOC01-appb-I000065

Figure JPOXMLDOC01-appb-I000066

Figure JPOXMLDOC01-appb-I000066

Figure JPOXMLDOC01-appb-I000067

Figure JPOXMLDOC01-appb-I000067
 連結基SpまたはSpが単結合である化合物の合成法を以上に述べた。その他の連結基を生成する方法は、結合基Z、Z、Z、ZおよびZの合成法を参考に合成できる。 The method for synthesizing a compound in which the linking group Sp 1 or Sp 2 is a single bond has been described above. Other methods for producing the linking group can be synthesized with reference to the method for synthesizing the linking groups Z 1 , Z 2 , Z 3 , Z 4 and Z 5 .
2-4.合成例
 化合物(1)を合成する方法の例は、次のとおりである。これらの化合物において、MESは、少なくとも1つの環を有するメソゲン基である。P、M、M、Sp、およびSpの定義は、前記と同一である。
 化合物(51A)、および化合物(51B)は、市販されているか、もしくは適切な環構造を有するメソゲン(MES)を出発物として一般的な有機合成法に従って合成することができる。
 MESとSpがエーテル結合で連結している化合物を合成する場合は、化合物(51A)を出発物として、化合物(52)および水酸化カリウムなどの塩基を用いてエーテル化を行うことにより、化合物(53A)を得ることができる。またMESとSpが単結合で連結している化合物を合成する場合は、化合物(51B)を出発物として、化合物(52)、パラジウムなどの金属触媒、および塩基を使用してクロスカップリング反応を行うことによって、化合物(53B)を得ることができる。化合物(53A)または(53B)は必要に応じてTMS、THPなどの保護基を作用させた化合物(54A)または(54B)に誘導する場合がある。
 その後、化合物(53A)、(53B)、(54A)または化合物(54B)から、化合物(55)および水酸化カリウムなどの塩基の存在下で再度エーテル化を行うことにより、化合物(57A)または(57B)を得ることができる。この際、前段階で保護基を作用させた場合は、脱保護反応によって保護基を取り除く。
2-4. Synthesis example An example of a method for synthesizing compound (1) is as follows. In these compounds, MES is a mesogen group with at least one ring. The definitions of P 1 , M 1 , M 2 , Sp 1 , and Sp 2 are the same as above.
Compound (51A) and compound (51B) can be synthesized according to a general organic synthesis method using commercially available or mesogen (MES) having an appropriate ring structure as a starting material.
When synthesizing a compound in which MES and Sp 1 are linked by an ether bond, the compound (51A) is used as a starting material, and the compound is etherified with a base such as compound (52) and potassium hydroxide. (53A) can be obtained. When synthesizing a compound in which MES and Sp 1 are linked by a single bond, a cross-coupling reaction is carried out using compound (52), a metal catalyst such as palladium, and a base starting from compound (51B). The compound (53B) can be obtained by carrying out the above. Compound (53A) or (53B) may, if necessary, induce compound (54A) or (54B) on which a protecting group such as TMS or THP is acted.
The compound (53A), (53B), (54A) or compound (54B) is then etherified again in the presence of a base such as compound (55) and potassium hydroxide to give compound (57A) or (54B). 57B) can be obtained. At this time, if the protecting group is allowed to act in the previous step, the protecting group is removed by a deprotection reaction.

Figure JPOXMLDOC01-appb-I000068

が式(1b-3)で表される基である化合物(1)は、化合物(57)より以下の方法で合成できる。化合物(57)から、化合物(58)、DCCおよびDMAPの存在下でエステル化反応を行うことにより化合物(1Y)に誘導できる。

Figure JPOXMLDOC01-appb-I000069

Figure JPOXMLDOC01-appb-I000068

Compound (1), of which P 2 is a group represented by the formula (1b-3), can be synthesized from compound (57) by the following method. Compound (57) can be derived to compound (1Y) by performing an esterification reaction in the presence of compound (58), DCC and DMAP.

Figure JPOXMLDOC01-appb-I000069
3.液晶組成物
 本発明の実施形態にかかる液晶組成物は、化合物(1)を成分Aとして含む。化合物(1)は、素子の基板との非共有結合的な相互作用によって、液晶分子の配向の制御に寄与することができる。この組成物は、化合物(1)を成分Aとして含み、以下に示す成分B、C、D、およびEから選択された液晶性化合物をさらに含むことが好ましい。成分Bは、化合物(2)から(4)である。成分Cは化合物(5)から(7)である。成分Dは、化合物(8)である。成分Eは、化合物(9)から(16)である。この組成物は、化合物(2)から(16)とは異なる、その他の液晶性化合物を含んでもよい。この組成物を調製するときには、正または負の誘電率異方性の大きさなどを考慮して成分B、C、D、およびEを選択することが好ましい。成分を適切に選択した組成物は、高い上限温度、低い下限温度、小さな粘度、適切な光学異方性(すなわち、大きな光学異方性または小さな光学異方性)、正または負に大きな誘電率異方性、大きな比抵抗、熱または紫外線に対する安定性、および適切な弾性定数(すなわち、大きな弾性定数または小さな弾性定数)を有する。
3. 3. Liquid crystal composition The liquid crystal composition according to the embodiment of the present invention contains compound (1) as a component A. The compound (1) can contribute to the control of the orientation of the liquid crystal molecules by the non-covalent interaction with the substrate of the device. This composition preferably contains compound (1) as component A and further contains a liquid crystal compound selected from the components B, C, D, and E shown below. Component B is compounds (2) to (4). Component C is compounds (5) to (7). Component D is compound (8). Component E is compounds (9) to (16). This composition may contain other liquid crystal compounds different from the compounds (2) to (16). When preparing this composition, it is preferable to select the components B, C, D, and E in consideration of the magnitude of positive or negative dielectric anisotropy. A composition with properly selected components has a high upper limit temperature, a lower lower limit temperature, a small viscosity, a suitable optical anisotropy (ie, a large optical anisotropy or a small optical anisotropy), and a large positive or negative modulus. It has anisotropy, high specific resistance, stability against heat or ultraviolet rays, and a suitable elastic constant (ie, a large elastic constant or a small elastic constant).
 化合物(1)の好ましい割合は、紫外線に対して高い安定性を維持するために液晶組成物の重量に基づいて、通常、約0.01重量%以上であり、液晶組成物へ溶解させるために、通常、約10重量%以下である。さらに好ましい割合は、液晶組成物の重量に基づいて、約0.1重量%から約5重量%の範囲である。最も好ましい割合は、液晶組成物の重量に基づいて、約0.5重量%から約3重量%の範囲である。 The preferred proportion of compound (1) is typically about 0.01% by weight or more, based on the weight of the liquid crystal composition to maintain high stability to UV light, to dissolve in the liquid crystal composition. Usually, it is about 10% by weight or less. A more preferred proportion is in the range of about 0.1% to about 5% by weight, based on the weight of the liquid crystal composition. The most preferred proportion is in the range of about 0.5% by weight to about 3% by weight, based on the weight of the liquid crystal composition.
 成分Bは、2つの末端基がアルキルなどである化合物である。成分Bの好ましい例として、化合物(2-1)から(2-11)、化合物(3-1)から(3-19)、および化合物(4-1)から(4-7)を挙げることができる。成分Bの化合物において、R11およびR12は独立して、炭素数1から10のアルキルまたは炭素数2から10のアルケニルであり、このアルキルまたはアルケニルにおいて、少なくとも1つの-CH-は-O-で置き換えられてもよく、少なくとも1つの水素はフッ素で置き換えられてもよい。 Component B is a compound having two terminal groups such as alkyl. Preferred examples of the component B include compounds (2-1) to (2-11), compounds (3-1) to (3-19), and compounds (4-1) to (4-7). it can. In the compound of component B, R 11 and R 12 are independently an alkyl having 1 to 10 carbon atoms or an alkenyl having 2 to 10 carbon atoms, and in this alkyl or alkenyl, at least one -CH 2- is -O. It may be replaced with −, and at least one hydrogen may be replaced with fluorine.

Figure JPOXMLDOC01-appb-I000070

Figure JPOXMLDOC01-appb-I000070
 成分Bは、誘電率異方性の絶対値が小さいので、中性に近い化合物である。化合物(2)は、主として粘度の減少または光学異方性の調整に効果がある。化合物(3)および(4)は、上限温度を高くすることによってネマチック相の温度範囲を広げる効果、または光学異方性の調整に効果がある。 Component B is a compound that is close to neutral because the absolute value of dielectric anisotropy is small. Compound (2) is mainly effective in reducing viscosity or adjusting optical anisotropy. The compounds (3) and (4) are effective in widening the temperature range of the nematic phase by increasing the upper limit temperature, or in adjusting the optical anisotropy.
 成分Bの含有量を増加させるにつれて組成物の誘電率異方性が小さくなるが粘度は小さくなる。そこで、素子のしきい値電圧の要求値を満たす限り、含有量は多いほうが好ましい。IPS、VAなどのモード用の組成物を調製する場合には、成分Bの含有量は、液晶組成物の重量に基づいて、好ましくは30重量%以上、さらに好ましくは40重量%以上である。 As the content of component B is increased, the dielectric anisotropy of the composition decreases, but the viscosity decreases. Therefore, as long as the required value of the threshold voltage of the element is satisfied, the content is preferably large. When preparing a composition for a mode such as IPS or VA, the content of component B is preferably 30% by weight or more, more preferably 40% by weight or more, based on the weight of the liquid crystal composition.
 成分Cは、右末端にフッ素、塩素またはフッ素含有基を有する化合物(5)~(7)である。成分Cの好ましい例として、化合物(5-1)から(5-16)、化合物(6-1)から(6-120)、化合物(7-1)から(7-62)を挙げることができる。成分Cの化合物において、R13は炭素数1から10のアルキルまたは炭素数2から10のアルケニルであり、このアルキルおよびアルケニルにおいて、少なくとも1つの-CH-は-O-で置き換えられてもよく、少なくとも1つの水素はフッ素で置き換えられてもよく;X11は、フッ素、塩素、-OCF、-OCHF、-CF、-CHF、-CHF、-OCFCHF、または-OCFCHFCFである。 Component C is a compound (5) to (7) having fluorine, chlorine or a fluorine-containing group at the right end. Preferred examples of the component C include compounds (5-1) to (5-16), compounds (6-1) to (6-120), and compounds (7-1) to (7-62). .. In the compound of component C, R 13 is an alkyl having 1 to 10 carbon atoms or an alkenyl having 2 to 10 carbon atoms, in which at least one -CH 2- may be replaced with -O-. , At least one hydrogen may be replaced with fluorine; X 11 is fluorine, chlorine, -OCF 3 , -OCHF 2 , -CF 3 , -CHF 2 , -CH 2 F, -OCF 2 CHF 2 , or. -OCF 2 CHFCF 3 .

Figure JPOXMLDOC01-appb-I000071

Figure JPOXMLDOC01-appb-I000071

Figure JPOXMLDOC01-appb-I000072

Figure JPOXMLDOC01-appb-I000072

Figure JPOXMLDOC01-appb-I000073

Figure JPOXMLDOC01-appb-I000073

Figure JPOXMLDOC01-appb-I000074

Figure JPOXMLDOC01-appb-I000075

Figure JPOXMLDOC01-appb-I000074

Figure JPOXMLDOC01-appb-I000075

Figure JPOXMLDOC01-appb-I000076

Figure JPOXMLDOC01-appb-I000076

Figure JPOXMLDOC01-appb-I000077

Figure JPOXMLDOC01-appb-I000078

Figure JPOXMLDOC01-appb-I000077

Figure JPOXMLDOC01-appb-I000078
 成分Cは、誘電率異方性が正であり、熱、光などに対する安定性が非常に優れているので、IPS、FFS、OCBなどのモード用の組成物を調製する場合に用いられる。成分Cの含有量は、液晶組成物の重量に基づいて1重量%から99重量%の範囲が適しており、好ましくは10重量%から97重量%の範囲、さらに好ましくは40重量%から95重量%の範囲である。成分Cを誘電率異方性が負である組成物に添加する場合、成分Cの含有量は液晶組成物の重量に基づいて30重量%以下が好ましい。成分Cを添加することにより、組成物の弾性定数を調整し、素子の電圧-透過率曲線を調整することが可能となる。 Component C has a positive dielectric anisotropy and is extremely stable against heat, light, etc., and is therefore used when preparing a composition for modes such as IPS, FFS, and OCB. The content of component C is preferably in the range of 1% by weight to 99% by weight, preferably in the range of 10% by weight to 97% by weight, more preferably 40% by weight to 95% by weight, based on the weight of the liquid crystal composition. It is in the range of%. When the component C is added to a composition having a negative dielectric anisotropy, the content of the component C is preferably 30% by weight or less based on the weight of the liquid crystal composition. By adding the component C, it is possible to adjust the elastic constant of the composition and adjust the voltage-transmittance curve of the device.
 成分Dは、右末端基が-C≡Nまたは-C≡C-C≡Nである化合物(8)である。成分Dの好ましい例として、化合物(8-1)から(8-64)を挙げることができる。成分Dの化合物において、R14は炭素数1から10のアルキルまたは炭素数2から10のアルケニルであり、このアルキルおよびアルケニルにおいて、少なくとも1つの-CH-は-O-で置き換えられてもよく、少なくとも1つの水素はフッ素で置き換えられてもよく;X12は-C≡Nまたは-C≡C-C≡Nである。 Component D is compound (8) whose right terminal group is -C≡N or -C≡C-C≡N. Preferred examples of the component D include compounds (8-1) to (8-64). In the compound of component D, R 14 is an alkyl having 1 to 10 carbon atoms or an alkenyl having 2 to 10 carbon atoms, in which at least one -CH 2- may be replaced with -O-. , At least one hydrogen may be replaced by fluorine; X 12 is -C ≡ N or -C ≡ C-C ≡ N.

Figure JPOXMLDOC01-appb-I000079

Figure JPOXMLDOC01-appb-I000079

Figure JPOXMLDOC01-appb-I000080

Figure JPOXMLDOC01-appb-I000080
 成分Dは、誘電率異方性が正であり、その値が大きいので、TNなどのモード用の組成物を調製する場合に主として用いられる。この成分Dを添加することにより、組成物の誘電率異方性を大きくすることができる。成分Dは、液晶相の温度範囲を広げる、粘度を調整する、または光学異方性を調整する、という効果をもたらす。成分Dは、素子の電圧-透過率曲線の調整にも有用である。 Component D has a positive dielectric anisotropy and a large value, so it is mainly used when preparing a composition for a mode such as TN. By adding this component D, the dielectric anisotropy of the composition can be increased. The component D has the effect of widening the temperature range of the liquid crystal phase, adjusting the viscosity, or adjusting the optical anisotropy. Component D is also useful for adjusting the voltage-transmittance curve of the device.
 TNなどのモード用の組成物を調製する場合には、成分Dの含有量は、液晶組成物の重量に基づいて1重量%から99重量%の範囲が適しており、好ましくは10重量%から97重量%の範囲、さらに好ましくは40重量%から95重量%の範囲である。成分Dを誘電率異方性が負である組成物に添加する場合、成分Dの含有量は液晶組成物の重量に基づいて30重量%以下が好ましい。成分Dを添加することにより、組成物の弾性定数を調整し、素子の電圧-透過率曲線を調整することが可能となる。 When preparing a composition for a mode such as TN, the content of component D is preferably in the range of 1% by weight to 99% by weight, preferably from 10% by weight, based on the weight of the liquid crystal composition. It is in the range of 97% by weight, more preferably 40% by weight to 95% by weight. When the component D is added to a composition having a negative dielectric anisotropy, the content of the component D is preferably 30% by weight or less based on the weight of the liquid crystal composition. By adding the component D, it is possible to adjust the elastic constant of the composition and adjust the voltage-transmittance curve of the device.
 成分Eは、化合物(9)から(16)である。これらの化合物は、2,3-ジフルオロ-1,4-フェニレンのように、ラテラル位が2つのフッ素または塩素で置換されたフェニレンを有する。 Component E is compounds (9) to (16). These compounds have phenylene in which the lateral position is substituted with two fluorines or chlorine, such as 2,3-difluoro-1,4-phenylene.
 成分Eの好ましい例として、化合物(9-1)から(9-8)、化合物(10-1)から(10-17)、化合物(11-1)、化合物(12-1)から(12-3)、化合物(13-1)から(13-11)、化合物(14-1)から(14-3)、化合物(15-1)から(15-3)および化合物(16-1)から(16-3)を挙げることができる。成分Eの化合物において、R15およびR16は独立して、炭素数1から10のアルキルまたは炭素数2から10のアルケニルであり、このアルキルおよびアルケニルにおいて、少なくとも1つの-CH2-は-O-で置き換えられてもよく、少なくとも1つの水素はフッ素で置き換えられてもよく;R17は、水素、フッ素、炭素数1から10のアルキル、または炭素数2から10のアルケニルであり、このアルキルおよびアルケニルにおいて、少なくとも1つの-CH2-は-O-で置き換えられてもよく、少なくとも1つの水素はフッ素で置き換えられてもよい。 Preferred examples of component E are compounds (9-1) to (9-8), compounds (10-1) to (10-17), compounds (11-1), compounds (12-1) to (12-). 3), compound (13-1) to (13-11), compound (14-1) to (14-3), compound (15-1) to (15-3) and compound (16-1) to (16-1). 16-3) can be mentioned. In the compound of component E, R 15 and R 16 are independently alkyl with 1 to 10 carbon atoms or alkenyl with 2 to 10 carbon atoms, in which at least one -CH 2- is -O. - may be replaced by at least one hydrogen may be replaced by fluorine; R 17 is hydrogen, fluorine, alkenyl alkyl of from 10 1 carbon atoms, or from 2 to 10 carbon atoms, the alkyl And in alkenyl, at least one -CH 2- may be replaced with -O- and at least one hydrogen may be replaced with fluorine.

Figure JPOXMLDOC01-appb-I000081

Figure JPOXMLDOC01-appb-I000081

Figure JPOXMLDOC01-appb-I000082

Figure JPOXMLDOC01-appb-I000083

Figure JPOXMLDOC01-appb-I000082

Figure JPOXMLDOC01-appb-I000083
 成分Eは、誘電率異方性が負に大きい。成分Eは、IPS、VA、PSAなどのモード用の組成物を調製する場合に用いられる。成分Eの含有量を増加させるにつれて組成物の誘電率異方性が負に大きくなるが、粘度が大きくなる。そこで、素子のしきい値電圧の要求値を満たす限り、含有量は少ないほうが好ましい。誘電率異方性が-5程度であることを考慮すると、充分な電圧駆動をさせるには、液晶組成物の重量に基づいて、成分Eの含有量が40重量%以上であることが好ましい。 Component E has a large negative dielectric anisotropy. Component E is used when preparing a composition for modes such as IPS, VA, PSA and the like. As the content of the component E is increased, the dielectric anisotropy of the composition becomes negatively large, but the viscosity becomes large. Therefore, as long as the required value of the threshold voltage of the element is satisfied, the content is preferably small. Considering that the dielectric anisotropy is about −5, the content of the component E is preferably 40% by weight or more based on the weight of the liquid crystal composition in order to drive the liquid crystal sufficiently.
 成分Eのうち、化合物(9)は二環化合物であるので、主として、粘度の減少、光学異方性の調整、または誘電率異方性の増加に効果がある。化合物(10)および(11)は三環化合物であるので、上限温度を高くする、光学異方性を大きくする、または誘電率異方性を大きくするという効果がある。化合物(12)から(16)は、誘電率異方性を大きくするという効果がある。 Of the component E, the compound (9) is a bicyclic compound, and is therefore mainly effective in reducing the viscosity, adjusting the optical anisotropy, or increasing the dielectric anisotropy. Since the compounds (10) and (11) are tricyclic compounds, they have the effects of increasing the upper limit temperature, increasing the optical anisotropy, or increasing the dielectric anisotropy. The compounds (12) to (16) have the effect of increasing the dielectric anisotropy.
 IPS、VA、PSAなどのモード用の組成物を調製する場合には、成分Eの含有量は、液晶組成物の重量に基づいて、好ましくは40重量%以上であり、さらに好ましくは50重量%から95重量%の範囲である。成分Eを誘電率異方性が正である組成物に添加する場合は、成分Eの含有量は液晶組成物の重量に基づいて30重量%以下が好ましい。成分Eを添加することにより、組成物の弾性定数を調整し、素子の電圧-透過率曲線を調整することが可能となる。 When preparing a composition for modes such as IPS, VA, PSA, the content of component E is preferably 40% by weight or more, more preferably 50% by weight, based on the weight of the liquid crystal composition. In the range of 95% by weight. When the component E is added to the composition having a positive dielectric anisotropy, the content of the component E is preferably 30% by weight or less based on the weight of the liquid crystal composition. By adding the component E, it is possible to adjust the elastic constant of the composition and adjust the voltage-transmittance curve of the device.
 以上に述べた成分B、C、D、およびEを適切に組み合わせることによって、高い上限温度、低い下限温度、小さな粘度、適切な光学異方性、正または負に大きな誘電率異方性、大きな比抵抗、紫外線に対する高い安定性、熱に対する高い安定性、大きな弾性定数などの特性の少なくとも1つを充足する液晶組成物を調製することができる。必要に応じて、成分B、C、D、およびEとは異なる液晶性化合物を添加してもよい。 By properly combining the components B, C, D, and E described above, a high upper limit temperature, a lower lower limit temperature, a small viscosity, an appropriate optical anisotropy, a large positive or negative dielectric anisotropy, and a large A liquid crystal composition can be prepared that satisfies at least one of the properties such as specific resistance, high stability against ultraviolet rays, high stability against heat, and a large elastic constant. If necessary, liquid crystal compounds different from the components B, C, D, and E may be added.
 液晶組成物は公知の方法によって調製される。例えば、成分化合物を混合し、そして加熱によって互いに溶解させる。用途に応じて、この組成物に添加物を添加してよい。添加物の例は、式(1)および式(16)以外の重合性化合物、重合開始剤、重合禁止剤、光学活性化合物、酸化防止剤、紫外線吸収剤、光安定剤、熱安定剤、消泡剤などである。このような添加物は当業者によく知られており、文献に記載されている。 The liquid crystal composition is prepared by a known method. For example, the constituent compounds are mixed and dissolved by heating. Additives may be added to this composition depending on the application. Examples of additives include polymerizable compounds other than the formulas (1) and (16), polymerization initiators, polymerization inhibitors, optically active compounds, antioxidants, ultraviolet absorbers, light stabilizers, heat stabilizers, and defoamers. For example, foaming agent. Such additives are well known to those of skill in the art and are described in the literature.
 重合性化合物は、液晶組成物中に重合体を生成させる目的で添加される。電極間に電圧を印加した状態で紫外線を照射して、重合性化合物と化合物(1)とを共重合させることによって、液晶組成物の中に重合体を生成させる。この際、化合物(1)は、極性基がガラス(または金属酸化物)の基板表面と非共有結合的に相互作用した状態で固定化される。これにより、液晶分子の配向を制御する能力がさらに向上すると同時に、化合物(1)が液晶組成物中に漏れ出す事が無くなる。また、ガラス(または金属酸化物)の基板表面おいても、適切なプレチルトが得られるので、応答時間が短縮され、かつ電圧保持率の大きな液晶表示素子が得られる。 The polymerizable compound is added for the purpose of forming a polymer in the liquid crystal composition. A polymer is produced in the liquid crystal composition by irradiating ultraviolet rays with a voltage applied between the electrodes to copolymerize the polymerizable compound and the compound (1). At this time, the compound (1) is immobilized in a state in which the polar group interacts with the surface of the glass (or metal oxide) substrate in a non-covalent bond. As a result, the ability to control the orientation of the liquid crystal molecules is further improved, and at the same time, the compound (1) does not leak into the liquid crystal composition. Further, since an appropriate pretilt can be obtained even on the substrate surface of glass (or metal oxide), a liquid crystal display element having a short response time and a large voltage holding ratio can be obtained.
 重合性化合物の好ましい例は、アクリレート、メタクリレート、ビニル化合物、ビニルオキシ化合物、プロペニルエーテル、エポキシ化合物(オキシラン、オキセタン)、およびビニルケトンである。さらに好ましい例は、少なくとも1つのアクリロイルオキシを有する化合物および少なくとも1つのメタクリロイルオキシを有する化合物である。さらに好ましい例には、アクリロイルオキシとメタクリロイルオキシの両方を有する化合物も含まれる。 Preferred examples of the polymerizable compound are acrylate, methacrylate, vinyl compound, vinyloxy compound, propenyl ether, epoxy compound (oxylane, oxetane), and vinyl ketone. More preferred examples are compounds having at least one acryloyloxy and compounds having at least one methacryloyloxy. More preferred examples also include compounds having both acryloyloxy and methacryloyloxy.
 重合性化合物のさらに好ましい例は、化合物(M-1)から(M-17)である。化合物(M-1)から(M-17)において、R25からR31は独立して、水素またはメチルであり;s、v、およびxは独立して、0または1であり;tおよびuは独立して、1から10の整数であり;L21からL26は独立して、水素またはフッ素であり、L27およびL28は独立して、水素、フッ素、またはメチルである。 More preferred examples of the polymerizable compounds are compounds (M-1) to (M-17). In compounds (M-1) to (M-17), R 25 to R 31 are independently hydrogen or methyl; s, v, and x are independently 0 or 1; t and u. Are independently integers from 1 to 10; L 21 to L 26 are independently hydrogen or fluorine, and L 27 and L 28 are independently hydrogen, fluorine, or methyl.

Figure JPOXMLDOC01-appb-I000084

Figure JPOXMLDOC01-appb-I000084
 重合性化合物は、重合開始剤を添加することによって、速やかに重合させることができる。反応温度を最適化することによって、残存する重合性化合物の量を減少させることができる。光ラジカル重合開始剤の例は、BASF社のダロキュアシリーズからTPO、1173、および4265であり、イルガキュアシリーズから184、369、500、651、784、819、907、1300、1700、1800、1850、および2959である。 The polymerizable compound can be rapidly polymerized by adding a polymerization initiator. By optimizing the reaction temperature, the amount of residual polymerizable compound can be reduced. Examples of photoradical polymerization initiators are TPO, 1173, and 4265 from BASF's DaroCure series and 184,369,500,651,784,819,907,1300,1700,1800,1850 from the Irgacure series. , And 2959.
 光ラジカル重合開始剤の追加例は、4-メトキシフェニル-2,4-ビス(トリクロロメチル)トリアジン、2-(4-ブトキシスチリル)-5-トリクロロメチル-1,3,4-オキサジアゾール、9-フェニルアクリジン、9,10-ベンズフェナジン、ベンゾフェノン/ミヒラーズケトン混合物、ヘキサアリールビイミダゾール/メルカプトベンズイミダゾール混合物、1-(4-イソプロピルフェニル)-2-ヒドロキシ-2-メチルプロパン-1-オン、ベンジルジメチルケタール、2-メチル-1-[4-(メチルチオ)フェニル]-2-モルホリノプロパン-1-オン、2,4-ジエチルキサントン/p-ジメチルアミノ安息香酸メチル混合物、ベンゾフェノン/メチルトリエタノールアミン混合物である。 Additional examples of photoradical polymerization initiators include 4-methoxyphenyl-2,4-bis (trichloromethyl) triazine, 2- (4-butoxystyryl) -5-trichloromethyl-1,3,4-oxadiazole, 9-Phenylaclysine, 9,10-benzphenazine, benzophenone / Michler's ketone mixture, hexaarylbiimidazole / mercaptobenzimidazole mixture, 1- (4-isopropylphenyl) -2-hydroxy-2-methylpropan-1-one, benzyl Dimethylketal, 2-methyl-1- [4- (methylthio) phenyl] -2-morpholinopropane-1-one, 2,4-diethylxanthone / p-dimethylaminomethyl benzoate mixture, benzophenone / methyltriethanolamine mixture Is.
 液晶組成物に光ラジカル重合開始剤を添加したあと、電場を印加した状態で紫外線を照射することによって重合を行うことができる。しかし、未反応の重合開始剤または重合開始剤の分解生成物は、素子に画像の焼き付きなどの表示不良を引き起こすかもしれない。これを防ぐために重合開始剤を添加しないまま光重合を行ってもよい。照射する光の好ましい波長は150nmから500nmの範囲である。さらに好ましい波長は250nmから450nmの範囲であり、最も好ましい波長は300nmから400nmの範囲である。 After adding a photoradical polymerization initiator to the liquid crystal composition, polymerization can be carried out by irradiating ultraviolet rays with an electric field applied. However, unreacted polymerization initiators or degradation products of the polymerization initiators may cause display defects such as image burn-in on the device. In order to prevent this, photopolymerization may be carried out without adding a polymerization initiator. The preferred wavelength of the emitted light is in the range of 150 nm to 500 nm. More preferred wavelengths are in the range of 250 nm to 450 nm, and most preferred wavelengths are in the range of 300 nm to 400 nm.
 チオエステル(-COS-、-SCO-)またはチオ桂皮酸エステル(-CH=CHCOS-、-SCOCH=CH-)を結合基として有する化合物(1)を組成物に混合した場合、成分Aである化合物(1)が組成物の特性に及ぼす主要な効果は次のとおりである。この化合物(1)は、偏光によってフリース転位または光二量化を生じるとき、分子レベルで一定方向に配列される。したがって、極性化合物から調製した薄膜は、ポリイミドのような配向膜と同様に、液晶分子を配向させる。 A compound that is a component A when a compound (1) having a thioester (-COS-, -SCO-) or a thiocinnamic acid ester (-CH = CHCOS-, -SCOCH = CH-) as a binding group is mixed with the composition. The main effects of (1) on the properties of the composition are as follows. This compound (1) is arranged in a certain direction at the molecular level when the Fries rearrangement or photodimerization is caused by polarized light. Therefore, the thin film prepared from the polar compound orients the liquid crystal molecules in the same manner as the alignment film such as polyimide.
 芳香族チオエステルを有し、重合性基を有する化合物(1)である場合は、紫外光が照射されることにより芳香族チオエステル部位が光分解することでラジカルが形成されて、光フリース転位を生じる。
 光フリース転位において、芳香族チオエステル部位の光分解は偏光紫外光の偏光方向と芳香族チオエステル部位の長軸方向が同一方向であった場合に生じる。光分解後は再結合し、互変異性化によりチオール基が分子内に生じる。このチオール基により、基板界面の相互作用が生じ、極性化合物が基板界面側に異方性を持って吸着しやすくなると考えられる。また、重合性基を有しているため重合により偏光の向きに沿って反応した化合物(1)がその方向性を失うことなく固定化される。この性質を利用して液晶分子を配向させることが可能な薄膜を調製することができる。この薄膜を調製するために、照射する紫外線は直線偏光が適している。まず、液晶組成物に極性化合物である化合物(1)を0.1重量%から10重量%の範囲で添加し、極性化合物を溶解させるために組成物を加温する。この組成物を、配向膜を有しない素子に注入する。次に、素子を加温しながら直線偏光を照射することによって、極性化合物を光フリース転位させ、重合させる。
光フリース転位した極性化合物は一定方向に配列され、重合後に形成される薄膜は液晶配向膜としての機能を有する。
In the case of the compound (1) having an aromatic thioester and having a polymerizable group, the aromatic thioester site is photodecomposed by irradiation with ultraviolet light to form radicals, which causes photofries rearrangement. ..
In the optical Fries rearrangement, photodecomposition of the aromatic thioester moiety occurs when the polarization direction of the polarized ultraviolet light and the long axis direction of the aromatic thioester moiety are the same direction. After photolysis, it recombines and tautomerization produces thiol groups in the molecule. It is considered that this thiol group causes an interaction between the substrate interfaces and makes it easier for polar compounds to be adsorbed on the substrate interface side with anisotropy. Further, since it has a polymerizable group, the compound (1) that has reacted along the direction of polarized light by polymerization is immobilized without losing its directionality. A thin film capable of orienting liquid crystal molecules can be prepared by utilizing this property. In order to prepare this thin film, linearly polarized light is suitable for the ultraviolet rays to be irradiated. First, the compound (1), which is a polar compound, is added to the liquid crystal composition in the range of 0.1% by weight to 10% by weight, and the composition is heated to dissolve the polar compound. This composition is injected into a device that does not have an alignment film. Next, the polar compound is subjected to photofries rearrangement and polymerized by irradiating the element with linearly polarized light while heating it.
The polar compounds rearranged with optical fries are arranged in a certain direction, and the thin film formed after polymerization has a function as a liquid crystal alignment film.
 重合性化合物を保管するとき、重合を防止するために重合禁止剤を添加してもよい。重合性化合物は、通常は重合禁止剤を除去しないまま組成物に添加される。重合禁止剤の例は、ヒドロキノン、メチルヒドロキノンのようなヒドロキノン誘導体、4-t-ブチルカテコール、4-メトキシフェノ-ル、フェノチアジンなどである。 When storing the polymerizable compound, a polymerization inhibitor may be added to prevent polymerization. The polymerizable compound is usually added to the composition without removing the polymerization inhibitor. Examples of polymerization inhibitors are hydroquinone, hydroquinone derivatives such as methylhydroquinone, 4-t-butylcatechol, 4-methoxyphenol, phenothiazine and the like.
 光学活性化合物は、液晶分子にらせん構造を誘起して必要なねじれ角を与えることによって逆ねじれを防ぐ、という効果をもたらす。光学活性化合物を添加することによって、らせんピッチを調整することができる。らせんピッチの温度依存性を調整する目的で2つ以上の光学活性化合物を添加してもよい。光学活性化合物の好ましい例として、下記の化合物(Op-1)から(Op-18)を挙げることができる。化合物(Op-18)において、環Jは1,4-シクロへキシレンまたは1,4-フェニレンであり、R28は炭素数1から10のアルキルである。 The optically active compound has the effect of preventing reverse twisting by inducing a helical structure in the liquid crystal molecule to give the required twist angle. The spiral pitch can be adjusted by adding an optically active compound. Two or more optically active compounds may be added for the purpose of adjusting the temperature dependence of the spiral pitch. Preferred examples of the optically active compound include the following compounds (Op-1) to (Op-18). In compound (Op-18), ring J is 1,4-cyclohexylene or 1,4-phenylene, and R 28 is an alkyl having 1 to 10 carbon atoms.

Figure JPOXMLDOC01-appb-I000085

Figure JPOXMLDOC01-appb-I000085
 酸化防止剤は、大きな電圧保持率を維持するために有効である。酸化防止剤の好ましい例として、下記の化合物(AO-1)および(AO-2);IRGANOX 415、IRGANOX 565、IRGANOX 1010、IRGANOX 1035、IRGANOX 3114、およびIRGANOX 1098(商品名:BASF社)を挙げることができる。紫外線吸収剤は、上限温度の低下を防ぐために有効である。紫外線吸収剤の好ましい例は、ベンゾフェノン誘導体、ベンゾエート誘導体、トリアゾール誘導体などである。具体例として下記の化合物(AO-3)および(AO-4);TINUVIN 329、TINUVIN P、TINUVIN 326、TINUVIN 234、TINUVIN 213、TINUVIN 400、TINUVIN 328、およびTINUVIN 99-2(商品名:BASF社);および1,4-ジアザビシクロ[2.2.2]オクタン(DABCO)を挙げることができる。 Antioxidants are effective in maintaining a large voltage retention rate. Preferred examples of the antioxidants include the following compounds (AO-1) and (AO-2); IRGANOX 415, IRGANOX 565, IRGANOX 1010, IRGANOX 1035, IRGANOX 3114, and IRGANOX 1098 (trade name: BASF). be able to. The ultraviolet absorber is effective for preventing a decrease in the upper limit temperature. Preferred examples of the UV absorber are benzophenone derivatives, benzoate derivatives, triazole derivatives and the like. Specific examples include the following compounds (AO-3) and (AO-4); TINUVIN 329, TINUVIN P, TINUVIN 326, TINUVIN 234, TINUVIN 213, TINUVIN 400, TINUVIN 328, and TINUVIN 99-2 (trade name: BASF). ); And 1,4-diazabicyclo [2.2.2] octane (DABCO) can be mentioned.
 立体障害のあるアミンのような光安定剤は、大きな電圧保持率を維持するために好ましい。光安定剤の好ましい例として、下記の化合物(AO-5)および(AO-6);TINUVIN 144、TINUVIN 765、およびTINUVIN 770DF(商品名:BASF社)を挙げることができる。熱安定剤も大きな電圧保持率を維持するために有効であり、好ましい例としてIRGAFOS 168(商品名:BASF社)を挙げることができる。消泡剤は、泡立ちを防ぐために有効である。消泡剤の好ましい例は、ジメチルシリコーンオイル、メチルフェニルシリコーンオイルなどである。 A light stabilizer such as amine with steric hindrance is preferable in order to maintain a large voltage holding ratio. Preferred examples of the light stabilizer include the following compounds (AO-5) and (AO-6); TINUVIN 144, TINUVIN 765, and TINUVIN 770DF (trade name: BASF). A heat stabilizer is also effective for maintaining a large voltage holding ratio, and a preferable example thereof is IRGAFOS 168 (trade name: BASF). Defoamers are effective in preventing foaming. Preferred examples of the defoaming agent are dimethyl silicone oil, methyl phenyl silicone oil and the like.

Figure JPOXMLDOC01-appb-I000086

Figure JPOXMLDOC01-appb-I000086
 化合物(AO-1)において、R40は炭素数1から20のアルキル、炭素数1から20のアルコキシ、-COOR41、または-CHCHCOOR41であり、ここでR41は炭素数1から20のアルキルである。化合物(AO-2)および(AO-5)において、R42は炭素数1から20のアルキルである。化合物(AO-5)において、R43は水素、メチル、またはO(酸素ラジカル)であり、環Gは1,4-シクロへキシレンまたは1,4-フェニレンであり、zは1、2、または3である。 In compound (AO-1), R 40 is an alkyl having 1 to 20 carbon atoms, an alkoxy having 1 to 20 carbon atoms, -COOR 41 , or -CH 2 CH 2 COOR 41 , where R 41 has 1 carbon atom. To 20 alkyl. In compounds (AO-2) and (AO-5), R 42 is an alkyl having 1 to 20 carbon atoms. In compound (AO-5), R 43 is hydrogen, methyl, or O · (oxygen radical), ring G is 1,4-cyclohexylene or 1,4-phenylene, z is 1, 2, Or 3.
4.液晶表示素子
 液晶組成物は、PC、TN、STN、OCB、PSAなどの動作モードを有し、アクティブマトリックス方式で駆動する液晶表示素子に使用できる。この組成物は、PC、TN、STN、OCB、VA、IPSなどの動作モードを有し、パッシブマトリクス方式で駆動する液晶表示素子にも使用することができる。これらの素子は、反射型、透過型、半透過型のいずれのタイプにも適用ができる。
4. Liquid crystal display element The liquid crystal composition has an operation mode such as PC, TN, STN, OCB, PSA, and can be used for a liquid crystal display element driven by an active matrix method. This composition has an operation mode such as PC, TN, STN, OCB, VA, and IPS, and can also be used for a liquid crystal display element driven by a passive matrix method. These elements can be applied to any type of reflective type, transmissive type, and semitransparent type.
 この組成物は、ネマチック液晶をマイクロカプセル化して作製したNCAP(nematic curvilinear aligned phase)素子、液晶中に三次元網目状高分子を形成して作製したポリマー分散型液晶表示素子(PDLCD)、そしてポリマーネットワーク液晶表示素子(PNLCD)にも使用できる。重合性化合物の添加量が液晶組成物の重量に基づいて約10重量%以下であるとき、PSAモードの液晶表示素子が作製される。重合性化合物の好ましい割合は、液晶組成物の重量に基づいて、約0.1重量%から約2重量%の範囲である。さらに好ましい割合は、液晶組成物の重量に基づいて、約0.2重量%から約1.0重量%の範囲である。PSAモードの素子は、アクティブマトリックス、パッシブマトリクスのような駆動方式で駆動させることができる。このような素子は、反射型、透過型、半透過型のいずれのタイプにも適用ができる。重合性化合物の添加量を増やすことによって、高分子分散(polymer dispersed)モードの素子も作製することができる。 This composition consists of an NCAP (nematic curvilinear aligned phase) element produced by microencapsulating a nematic liquid crystal, a polymer dispersed liquid crystal display element (PDLCD) produced by forming a three-dimensional network polymer in the liquid crystal, and a polymer. It can also be used for network liquid crystal display elements (PNLCD). When the amount of the polymerizable compound added is about 10% by weight or less based on the weight of the liquid crystal composition, a PSA mode liquid crystal display device is produced. The preferred proportion of the polymerizable compound is in the range of about 0.1% by weight to about 2% by weight, based on the weight of the liquid crystal composition. A more preferred proportion is in the range of about 0.2% by weight to about 1.0% by weight, based on the weight of the liquid crystal composition. The PSA mode element can be driven by a drive system such as an active matrix or a passive matrix. Such an element can be applied to any type of reflective type, transmissive type, and semitransparent type. By increasing the amount of the polymerizable compound added, a device in the polymer dispersed mode can also be manufactured.
 高分子支持配向型の素子では、組成物に含まれる重合体が液晶分子を配向させる。極性化合物である化合物(1)は、液晶分子が配列するのを援助する。すなわち、化合物(1)は、配向膜の代わりに用いることができる。このような素子を製造する方法の一例は、次のとおりである。
 アレイ基板とカラーフィルター基板と呼ばれる2つの基板を有する素子を用意する。この基板は配向膜を有しない。この基板の少なくとも1つは、電極層を有する。液晶性化合物を混合して液晶組成物を調製する。この組成物に重合性化合物および極性化合物である化合物(1)を添加する。必要に応じて添加物をさらに添加してもよい。この組成物を素子に注入する。この素子に光照射する。紫外線が好ましい。光照射によって重合性化合物を重合させる。この重合によって、重合体を含む組成物が生成し、PSAモードを有する素子が作製される。
In a polymer-supported orientation type device, the polymer contained in the composition orients the liquid crystal molecules. Compound (1), which is a polar compound, assists in arranging liquid crystal molecules. That is, compound (1) can be used instead of the alignment film. An example of a method for manufacturing such an element is as follows.
An element having two substrates called an array substrate and a color filter substrate is prepared. This substrate has no alignment film. At least one of the substrates has an electrode layer. Liquid crystal compounds are mixed to prepare a liquid crystal composition. A polymerizable compound and a compound (1) which is a polar compound are added to this composition. Additional additives may be added as needed. This composition is injected into the device. Light is applied to this element. Ultraviolet rays are preferred. The polymerizable compound is polymerized by light irradiation. By this polymerization, a composition containing a polymer is produced, and an element having a PSA mode is produced.
 素子を製造する方法を説明する。第一は、極性化合物である化合物(1)を液晶組成物に添加し、組成物を上限温度より高い温度で加温して溶解させる工程である。第二は、この組成物を液晶表示素子に注入する工程である。第三は、上限温度より高い温度に液晶組成物を加温したまま、偏光紫外線を照射する工程である。極性化合物である化合物(1)は、直線偏光によって光フリース転位または光二量化を起こし、同時に重合も進行する。化合物(1)の重合体は薄膜として基板上に形成され固定化される。この重合体は分子レベルで一定方向に配列されるので、薄膜は液晶配向膜としての機能を有する。この方法によって、ポリイミドのような配向膜を有しない液晶表示素子を製造することができる。 The method of manufacturing the element will be explained. The first is a step of adding the compound (1), which is a polar compound, to the liquid crystal composition, and heating and dissolving the composition at a temperature higher than the upper limit temperature. The second is a step of injecting this composition into the liquid crystal display element. The third is a step of irradiating polarized ultraviolet rays while the liquid crystal composition is heated to a temperature higher than the upper limit temperature. Compound (1), which is a polar compound, undergoes photo-Fries rearrangement or photodimerization by linearly polarized light, and at the same time, polymerization also proceeds. The polymer of compound (1) is formed and immobilized on the substrate as a thin film. Since this polymer is arranged in a certain direction at the molecular level, the thin film has a function as a liquid crystal alignment film. By this method, a liquid crystal display element having no alignment film such as polyimide can be manufactured.
 この手順において、極性化合物である化合物(1)は、極性基が基板表面と相互作用するので、基板上に偏在する。この化合物(1)が、偏光紫外線の照射により液晶分子を配向させ、同時に重合性化合物が紫外線によって重合するので、この配向を維持した重合体が生成する。この重合体の効果によって、液晶分子の配向が追加的に安定化するので、素子の応答時間が短縮される。画像の焼き付きは、液晶分子の動作不良であるから、この重合体の効果によって焼き付きも同時に改善されることになる。特に本発明の実施形態にかかる化合物(1)は重合性の極性化合物である為、液晶分子を配向させると共に、他の重合性化合物と共重合する。これによって極性化合物が液晶組成物中に漏れ出す事が無くなる為、電圧保持率の大きな液晶表示素子が得られる。 In this procedure, the polar compound (1) is unevenly distributed on the substrate because the polar groups interact with the surface of the substrate. The compound (1) orients the liquid crystal molecules by irradiation with polarized ultraviolet rays, and at the same time, the polymerizable compound is polymerized by the ultraviolet rays, so that a polymer maintaining this orientation is produced. The effect of this polymer further stabilizes the orientation of the liquid crystal molecules, thus shortening the response time of the device. Since the burn-in of the image is a malfunction of the liquid crystal molecules, the burn-in is also improved at the same time by the effect of this polymer. In particular, since the compound (1) according to the embodiment of the present invention is a polymerizable polar compound, the liquid crystal molecules are oriented and copolymerized with other polymerizable compounds. As a result, the polar compound does not leak into the liquid crystal composition, so that a liquid crystal display element having a large voltage holding ratio can be obtained.
 実施例(合成例、素子の使用例を含む)により、本発明をさらに詳しく説明する。本発明はこれらの実施例によっては制限されない。本発明は、使用例1の組成物と使用例2の組成物との混合物を含む。本発明は、使用例の組成物の少なくとも2つを混合することによって調製した混合物をも含む。
1.化合物(1)の実施例
The present invention will be described in more detail with reference to Examples (including synthesis examples and device usage examples). The present invention is not limited by these examples. The present invention includes a mixture of the composition of Example 1 and the composition of Example 2. The present invention also includes a mixture prepared by mixing at least two of the compositions of Examples.
1. 1. Example of compound (1)
 化合物(1)は、実施例1などに示す手順により合成した。特に記載のない限り、反応は窒素雰囲気下で行った。合成した化合物は、NMR分析などの方法により同定した。化合物(1)、液晶性化合物、組成物、素子の特性は、下記の方法により測定した。 Compound (1) was synthesized by the procedure shown in Example 1 and the like. Unless otherwise stated, the reaction was carried out in a nitrogen atmosphere. The synthesized compound was identified by a method such as NMR analysis. The characteristics of the compound (1), the liquid crystal compound, the composition, and the device were measured by the following methods.
 NMR分析:測定には、ブルカーバイオスピン社製のDRX-500を用いた。H-NMRの測定では、試料をCDClなどの重水素化溶媒に溶解させ、測定は、室温で、500MHz、積算回数16回の条件で行った。テトラメチルシランを内部標準として用いた。19F-NMRの測定では、CFClを内部標準として用い、積算回数24回で行った。核磁気共鳴スペクトルの説明において、sはシングレット、dはダブレット、tはトリプレット、qはカルテット、quinはクインテット、sexはセクステット、mはマルチプレット、brはブロードであることを意味する。 NMR analysis: A DRX-500 manufactured by Bruker Biospin was used for the measurement. 1 In the 1 H-NMR measurement, the sample was dissolved in a deuterated solvent such as CDCl 3, and the measurement was carried out at room temperature under the conditions of 500 MHz and 16 times of integration. Tetramethylsilane was used as an internal standard. 19 In the F-NMR measurement, CFCl 3 was used as an internal standard, and the number of integrations was 24. In the description of the nuclear magnetic resonance spectrum, s is singlet, d is doublet, t is triplet, q is quartet, quin is quintet, sex is sextet, m is multiplet, and br is broad.
 ガスクロマト分析:測定には、島津製作所製のGC-2010型ガスクロマトグラフを用いた。カラムは、Agilent Technologies Inc.製のキャピラリカラムDB-1(長さ60m、内径0.25mm、膜厚0.25μm)を用いた。キャリアーガスとしてはヘリウム(1ml/分)を用いた。試料気化室の温度を300℃、検出器(FID)部分の温度を300℃に設定した。試料はアセトンに溶解して、1重量%の溶液となるように調製し、得られた溶液1μlを試料気化室に注入した。記録計には島津製作所製のGCSolutionシステムなどを用いた。 Gas chromatograph analysis: A GC-2010 type gas chromatograph manufactured by Shimadzu Corporation was used for the measurement. As the column, a capillary column DB-1 (length 60 m, inner diameter 0.25 mm, film thickness 0.25 μm) manufactured by Agilent Technologies Inc. was used. Helium (1 ml / min) was used as the carrier gas. The temperature of the sample vaporization chamber was set to 300 ° C., and the temperature of the detector (FID) portion was set to 300 ° C. The sample was dissolved in acetone to prepare a 1% by weight solution, and 1 μl of the obtained solution was injected into the sample vaporization chamber. A GC Solution system manufactured by Shimadzu Corporation was used as the recorder.
 HPLC分析:測定には、島津製作所製のProminence(LC-20AD;SPD-20A)を用いた。カラムはワイエムシー製のYMC-Pack ODS-A(長さ150mm、内径4.6mm、粒子径5μm)を用いた。溶出液はアセトニトリルと水を適宜混合して用いた。検出器としてはUV検出器、RI検出器、CORONA検出器などを適宜用いた。UV検出器を用いた場合、検出波長は254nmとした。試料はアセトニトリルに溶解して、0.1重量%の溶液となるように調製し、この溶液1μLを試料室に導入した。記録計としては島津製作所製のC-R7Aplusを用いた。 HPLC analysis: Prominence (LC-20AD; SPD-20A) manufactured by Shimadzu Corporation was used for the measurement. As the column, YMC-Pack ODS-A (length 150 mm, inner diameter 4.6 mm, particle diameter 5 μm) manufactured by YMC was used. The eluate used was an appropriate mixture of acetonitrile and water. As the detector, a UV detector, an RI detector, a CORONA detector and the like were appropriately used. When a UV detector was used, the detection wavelength was 254 nm. The sample was prepared to dissolve in acetonitrile to form a 0.1% by weight solution, and 1 μL of this solution was introduced into the sample chamber. As a recorder, C-R7Aplus manufactured by Shimadzu Corporation was used.
 紫外可視分光分析:測定には、島津製作所製のPharmaSpec UV-1700用いた。検出波長は190nmから700nmとした。試料はアセトニトリルに溶解して、0.01mmol/Lの溶液となるように調製し、石英セル(光路長1cm)に入れて測定した。 Ultraviolet-visible spectroscopic analysis: For the measurement, PharmaSpec UV-1700 manufactured by Shimadzu Corporation was used. The detection wavelength was 190 nm to 700 nm. The sample was prepared by dissolving it in acetonitrile to form a solution of 0.01 mmol / L, and placed in a quartz cell (optical path length 1 cm) for measurement.
 測定試料:相構造および転移温度(透明点、融点、重合開始温度など)を測定するときには、化合物そのものを試料として用いた。 Measurement sample: When measuring the phase structure and transition temperature (transparency point, melting point, polymerization initiation temperature, etc.), the compound itself was used as a sample.
 測定方法:特性の測定は下記の方法で行った。これらの多くは、社団法人電子情報技術産業協会(JEITA;Japan Electronics and Information Technology Industries Association)で審議制定されるJEITA規格(JEITA・ED-2521B)に記載された方法、またはこれを修飾した方法であった。測定に用いたTN素子には、薄膜トランジスター(TFT)を取り付けなかった。 Measurement method: The characteristics were measured by the following method. Most of these are methods described in the JEITA standard (JEITA ED-2521B), which is deliberated and enacted by the Japan Electronics and Information Technology Industries Association (JEITA), or a modified method. there were. A thin film transistor (TFT) was not attached to the TN element used for the measurement.
(1)相構造
 偏光顕微鏡を備えた融点測定装置のホットプレート(メトラー社FP-52型ホットステージ)に試料を置いた。この試料を、3℃/分の速度で加熱しながら相状態とその変化を偏光顕微鏡で観察し、相の種類を特定した。
(1) Phase structure A sample was placed on a hot plate (FP-52 type hot stage manufactured by Mettler) of a melting point measuring device equipped with a polarizing microscope. The phase state and its change were observed with a polarizing microscope while heating this sample at a rate of 3 ° C./min to identify the type of phase.
(2)転移温度(℃)
 測定には、パーキンエルマー社製の走査熱量計、Diamond DSCシステムまたはエスエスアイ・ナノテクノロジー社製の高感度示差走査熱量計、X-DSC7000を用いた。試料は、3℃/分の速度で昇降温し、試料の相変化に伴う吸熱ピークまたは発熱ピークの開始点を外挿により求め、転移温度を決定した。化合物の融点、重合開始温度もこの装置を使って測定した。化合物が固体からスメクチック相、ネマチック相などの液晶相に転移する温度を「液晶相の下限温度」と略すことがある。化合物が液晶相から液体に転移する温度を「透明点」と略すことがある。
(2) Transition temperature (° C)
For the measurement, a scanning calorimeter manufactured by PerkinElmer, a Diamond DSC system, or a high-sensitivity differential scanning calorimeter manufactured by SSI Nanotechnology, X-DSC7000 was used. The temperature of the sample was raised and lowered at a rate of 3 ° C./min, and the start point of the endothermic peak or the exothermic peak accompanying the phase change of the sample was determined by extrapolation to determine the transition temperature. The melting point and polymerization initiation temperature of the compound were also measured using this device. The temperature at which a compound transitions from a solid to a liquid crystal phase such as a smectic phase or a nematic phase may be abbreviated as "lower limit temperature of the liquid crystal phase". The temperature at which a compound transitions from the liquid crystal phase to a liquid may be abbreviated as "transparency point".
 結晶はCと表した。結晶の種類の区別がつく場合は、それぞれをC、Cのように表した。スメクチック相はS、ネマチック相はNと表した。スメクチック相の中で、スメクチックA相、スメクチックB相、スメクチックC相、またはスメクチックF相の区別がつく場合は、それぞれS、S、S、またはSと表した。液体(アイソトロピック)はIと表した。転移温度は、例えば、「C 50.0 N 100.0 I」のように表記した。これは、結晶からネマチック相への転移温度が50.0℃であり、ネマチック相から液体への転移温度が100.0℃であることを示す。 The crystal was represented as C. When the types of crystals can be distinguished, they are represented as C 1 and C 2 , respectively. The smectic phase was represented as S and the nematic phase was represented as N. Among the smectic phase, a smectic A phase, a smectic B phase, if can be distinguished in the smectic C phase, or a smectic F phase, respectively S A, S B, expressed as S C or S F,. The liquid (isotropic) was represented as I. The transition temperature is expressed as, for example, "C 50.0 N 100.0 I". This indicates that the transition temperature from the crystal to the nematic phase is 50.0 ° C. and the transition temperature from the nematic phase to the liquid is 100.0 ° C.
(3)ネマチック相の上限温度(TNIまたはNI;℃)
 偏光顕微鏡を備えた融点測定装置のホットプレートに試料を置き、1℃/分の速度で加熱した。試料の一部がネマチック相から等方性液体に変化したときの温度を測定した。ネマチック相の上限温度を「上限温度」と略すことがある。試料が化合物(1)と母液晶との混合物であるときは、TNIの記号で示した。試料が化合物(1)と成分B、C、Dのような化合物との混合物であるときは、NIの記号で示した。
(3) Upper limit temperature of nematic phase (T NI or NI; ° C)
The sample was placed on a hot plate of a melting point measuring device equipped with a polarizing microscope and heated at a rate of 1 ° C./min. The temperature at which a part of the sample changed from the nematic phase to the isotropic liquid was measured. The upper limit temperature of the nematic phase may be abbreviated as "upper limit temperature". When the sample was a mixture of compound (1) and mother liquid crystal, it was indicated by the TNI symbol. When the sample is a mixture of compound (1) and compounds such as components B, C and D, it is indicated by the symbol NI.
(4)ネマチック相の下限温度(T;℃)
 ネマチック相を有する試料を0℃、-10℃、-20℃、-30℃、および-40℃のフリーザー中に10日間保管したあと、液晶相を観察した。例えば、試料が-20℃ではネマチック相のままであり、-30℃では結晶またはスメクチック相に変化したとき、Tを≦-20℃と記載した。ネマチック相の下限温度を「下限温度」と略すことがある。
(4) Minimum Temperature of a Nematic Phase (T C; ° C.)
A sample having a nematic phase was stored in a freezer at 0 ° C., −10 ° C., −20 ° C., −30 ° C., and −40 ° C. for 10 days, and then the liquid crystal phase was observed. For example, TC was described as ≤-20 ° C when the sample remained in the nematic phase at −20 ° C. and changed to a crystalline or smectic phase at −30 ° C. The lower limit temperature of the nematic phase may be abbreviated as "lower limit temperature".
(5)粘度(バルク粘度;η;20℃で測定;mPa・s)
 測定には、東京計器株式会社製のE型回転粘度計を用いた。
(5) Viscosity (bulk viscosity; η; measured at 20 ° C; mPa · s)
An E-type rotational viscometer manufactured by Tokyo Keiki Co., Ltd. was used for the measurement.
(6)光学異方性(屈折率異方性;25℃で測定;Δn)
 測定は、波長589nmの光を用い、接眼鏡に偏光板を取り付けたアッベ屈折計により行なった。主プリズムの表面を一方向にラビングしたあと、試料を主プリズムに滴下した。屈折率(n∥)は偏光の方向がラビングの方向と平行であるときに測定した。屈折率(n⊥)は偏光の方向がラビングの方向と垂直であるときに測定した。光学異方性(Δn)の値は、Δn=n∥-n⊥、の式から計算した。
(6) Optical anisotropy (refractive index anisotropy; measured at 25 ° C; Δn)
The measurement was performed using light having a wavelength of 589 nm with an Abbe refractometer in which a polarizing plate was attached to the eyepiece. After rubbing the surface of the main prism in one direction, the sample was dropped onto the main prism. The refractive index (n∥) was measured when the direction of polarization was parallel to the direction of rubbing. The refractive index (n⊥) was measured when the direction of polarization was perpendicular to the direction of rubbing. The value of optical anisotropy (Δn) was calculated from the equation Δn = n∥−n⊥.
(7)比抵抗(ρ;25℃で測定;Ωcm)
 電極を備えた容器に試料1.0mLを注入した。この容器に直流電圧(10V)を印加し、10秒後の直流電流を測定した。比抵抗は次の式から算出した。(比抵抗)={(電圧)×(容器の電気容量)}/{(直流電流)×(真空の誘電率)}。
(7) Specific resistance (ρ; measured at 25 ° C; Ωcm)
1.0 mL of sample was injected into a container equipped with electrodes. A DC voltage (10 V) was applied to this container, and the DC current after 10 seconds was measured. The specific resistance was calculated from the following formula. (Specific resistance) = {(voltage) × (electric capacity of container)} / {(DC current) × (dielectric constant of vacuum)}.
 誘電率異方性が正の試料と負の試料とでは、特性の測定法が異なることがある。誘電率異方性が正であるときの測定法は、項(8a)から(12a)に記載した。誘電率異方性が負の場合は、項(8b)から(12b)に記載した。 The method of measuring the characteristics may differ between a sample with a positive dielectric anisotropy and a sample with a negative dielectric anisotropy. The measuring method when the dielectric anisotropy is positive is described in Items (8a) to (12a). When the dielectric anisotropy is negative, it is described in the items (8b) to (12b).
(8a)粘度(回転粘度;γ1;25℃で測定;mPa・s)
 正の誘電率異方性:測定は、M. Imai et al., Molecular Crystals and Liquid Crystals, Vol. 259, 37 (1995) に記載された方法に従った。ツイスト角が0度であり、そして2枚のガラス基板の間隔(セルギャップ)が5μmであるTN素子に試料を入れた。この素子に16Vから19.5Vの範囲で0.5V毎に段階的に印加した。0.2秒の無印加のあと、ただ1つの矩形波(矩形パルス;0.2秒)と無印加(2秒)の条件で印加を繰り返した。この印加によって発生した過渡電流(transient current)のピーク電流(peak current)とピーク時間(peak time)を測定した。これらの測定値とM.Imaiらの論文、40頁の計算式(8)とから回転粘度の値を得た。この計算で必要な誘電率異方性の値は、この回転粘度を測定した素子を用い、下に記載した方法で求めた。
(8a) Viscosity (rotational viscosity; γ1; measured at 25 ° C.; mPa · s)
Positive Permittivity Anisotropy: Measurements were made according to the method described in M. Imai et al., Molecular Crystals and Liquid Crystals, Vol. 259, 37 (1995). The sample was placed in a TN device having a twist angle of 0 degrees and a distance (cell gap) between the two glass substrates of 5 μm. A stepwise application was applied to this device in 0.5 V increments in the range of 16 V to 19.5 V. After no application for 0.2 seconds, application was repeated under the conditions of only one square wave (square pulse; 0.2 seconds) and no application (2 seconds). The peak current and peak time of the transient current generated by this application were measured. These measurements and M.I. The value of rotational viscosity was obtained from the paper by Imai et al., Calculation formula (8) on page 40. The value of the dielectric anisotropy required for this calculation was obtained by the method described below using the device whose rotational viscosity was measured.
(8b)粘度(回転粘度;γ1;25℃で測定;mPa・s)
 負の誘電率異方性:測定は、M. Imai et al., Molecular Crystals and Liquid Crystals, Vol. 259, 37 (1995) に記載された方法に従った。2枚のガラス基板の間隔(セルギャップ)が20μmのVA素子に試料を入れた。この素子に39ボルトから50ボルトの範囲で1ボルト毎に段階的に印加した。0.2秒の無印加のあと、ただ1つの矩形波(矩形パルス;0.2秒)と無印加(2秒)の条件で印加を繰り返した。この印加によって発生した過渡電流(transient current)のピーク電流(peak current)とピーク時間(peak time)を測定した。これらの測定値とM.Imaiらの論文、40頁の計算式(8)とから回転粘度の値を得た。この計算に必要な誘電率異方性は、下記の誘電率異方性の項で測定した値を用いた。
(8b) Viscosity (rotational viscosity; γ1; measured at 25 ° C.; mPa · s)
Negative Permittivity Anisotropy: Measurements were made according to the method described in M. Imai et al., Molecular Crystals and Liquid Crystals, Vol. 259, 37 (1995). The sample was placed in a VA element having a distance (cell gap) of 20 μm between the two glass substrates. A stepwise application was applied to this device in the range of 39 to 50 volts in 1 volt increments. After no application for 0.2 seconds, application was repeated under the conditions of only one square wave (square pulse; 0.2 seconds) and no application (2 seconds). The peak current and peak time of the transient current generated by this application were measured. These measurements and M.I. The value of rotational viscosity was obtained from the paper by Imai et al., Calculation formula (8) on page 40. For the dielectric anisotropy required for this calculation, the value measured in the section of dielectric anisotropy below was used.
(9a)誘電率異方性(Δε;25℃で測定)
 正の誘電率異方性:2枚のガラス基板の間隔(セルギャップ)が9μmであり、そしてツイスト角が80度であるTN素子に試料を入れた。この素子にサイン波(10V、1kHz)を印加し、2秒後に液晶分子の長軸方向における誘電率(ε∥)を測定した。この素子にサイン波(0.5V、1kHz)を印加し、2秒後に液晶分子の短軸方向における誘電率(ε⊥)を測定した。誘電率異方性の値は、Δε=ε∥-ε⊥、の式から計算した。
(9a) Dielectric constant anisotropy (Δε; measured at 25 ° C)
Positive permittivity anisotropy: The sample was placed in a TN device with a spacing (cell gap) between the two glass substrates of 9 μm and a twist angle of 80 degrees. A sine wave (10 V, 1 kHz) was applied to this device, and after 2 seconds, the dielectric constant (ε∥) of the liquid crystal molecule in the long axis direction was measured. A sine wave (0.5 V, 1 kHz) was applied to this device, and after 2 seconds, the permittivity (ε⊥) of the liquid crystal molecule in the minor axis direction was measured. The value of permittivity anisotropy was calculated from the equation Δε = ε∥-ε⊥.
(9b)誘電率異方性(Δε;25℃で測定)
 負の誘電率異方性:誘電率異方性の値は、Δε=ε∥-ε⊥、の式から計算した。誘電率(ε∥およびε⊥)は次のように測定した。
1)誘電率(ε∥)の測定:よく洗浄したガラス基板にオクタデシルトリエトキシシラン(0.16mL)のエタノール(20mL)溶液を塗布した。ガラス基板をスピンナーで回転させたあと、150℃で1時間加熱した。2枚のガラス基板の間隔(セルギャップ)が4μmであるVA素子に試料を入れ、この素子を紫外線で硬化する接着剤で密閉した。この素子にサイン波(0.5V、1kHz)を印加し、2秒後に液晶分子の長軸方向における誘電率(ε∥)を測定した。
2)誘電率(ε⊥)の測定:よく洗浄したガラス基板にポリイミド溶液を塗布した。このガラス基板を焼成した後、得られた配向膜にラビング処理をした。2枚のガラス基板の間隔(セルギャップ)が9μmであり、ツイスト角が80度であるTN素子に試料を入れた。この素子にサイン波(0.5V、1kHz)を印加し、2秒後に液晶分子の短軸方向における誘電率(ε⊥)を測定した。
(9b) Dielectric constant anisotropy (Δε; measured at 25 ° C)
Negative permittivity anisotropy: The value of permittivity anisotropy was calculated from the equation Δε = ε∥-ε⊥. The permittivity (ε∥ and ε⊥) was measured as follows.
1) Measurement of permittivity (ε∥): A solution of octadecyltriethoxysilane (0.16 mL) in ethanol (20 mL) was applied to a well-washed glass substrate. After rotating the glass substrate with a spinner, it was heated at 150 ° C. for 1 hour. A sample was placed in a VA element in which the distance (cell gap) between the two glass substrates was 4 μm, and this element was sealed with an adhesive that cures with ultraviolet rays. A sine wave (0.5 V, 1 kHz) was applied to this device, and after 2 seconds, the permittivity (ε∥) of the liquid crystal molecule in the long axis direction was measured.
2) Measurement of permittivity (ε⊥): A polyimide solution was applied to a well-cleaned glass substrate. After firing this glass substrate, the obtained alignment film was subjected to a rubbing treatment. The sample was placed in a TN element in which the distance (cell gap) between the two glass substrates was 9 μm and the twist angle was 80 degrees. A sine wave (0.5 V, 1 kHz) was applied to this device, and after 2 seconds, the permittivity (ε⊥) of the liquid crystal molecule in the minor axis direction was measured.
(10a)弾性定数(K;25℃で測定;pN)
 正の誘電率異方性:測定には横河・ヒューレットパッカード株式会社製のHP4284A型LCRメータを用いた。2枚のガラス基板の間隔(セルギャップ)が20μmである水平配向素子に試料を入れた。この素子に0ボルトから20ボルト電荷を印加し、静電容量および印加電圧を測定した。測定した静電容量(C)と印加電圧(V)の値を「液晶デバイスハンドブック」(日刊工業新聞社)、75頁にある式(2.98)、式(2.101)を用いてフィッティングし、式(2.99)からK11およびK33の値を得た。次に171頁にある式(3.18)に、先ほど求めたK11およびK33の値を用いてK22を算出した。弾性定数Kは、このようにして求めたK11、K22およびK33の平均値で表した。
(10a) Elastic constant (K; measured at 25 ° C; pN)
Positive permittivity anisotropy: An HP4284A LCR meter manufactured by Yokogawa Hewlett-Packard Co., Ltd. was used for the measurement. The sample was placed in a horizontally oriented element in which the distance (cell gap) between the two glass substrates was 20 μm. A charge of 0 to 20 volts was applied to this device, and the capacitance and applied voltage were measured. Fit the measured capacitance (C) and applied voltage (V) values using the "Liquid Crystal Device Handbook" (Nikkan Kogyo Shimbun), formulas (2.98) and formula (2.11) on page 75. Then, the values of K 11 and K 33 were obtained from the equation (2.99). Next, K 22 was calculated using the values of K 11 and K 33 obtained earlier in the formula (3.18) on page 171. The elastic constant K is represented by the average value of K 11 , K 22, and K 33 thus obtained.
(10b)弾性定数(K11およびK33;25℃で測定;pN)
 負の誘電率異方性:測定には株式会社東陽テクニカ製のEC-1型弾性定数測定器を用いた。2枚のガラス基板の間隔(セルギャップ)が20μmである垂直配向素子に試料を入れた。この素子に20ボルトから0ボルト電荷を印加し、静電容量および印加電圧を測定した。静電容量(C)と印加電圧(V)の値を、「液晶デバイスハンドブック」(日刊工業新聞社)、75頁にある式(2.98)、式(2.101)を用いてフィッティングし、式(2.100)から弾性定数の値を得た。
(10b) Elastic constants (K 11 and K 33 ; measured at 25 ° C; pN)
Negative permittivity anisotropy: An EC-1 type elastic constant measuring instrument manufactured by Toyo Corporation was used for the measurement. The sample was placed in a vertically oriented element in which the distance (cell gap) between the two glass substrates was 20 μm. A charge of 20 to 0 volts was applied to this device, and the capacitance and applied voltage were measured. The values of capacitance (C) and applied voltage (V) are fitted using the formulas (2.98) and (2.11) on page 75 of the "Liquid Crystal Device Handbook" (Nikkan Kogyo Shimbun). , The value of the elastic constant was obtained from the equation (2.10).
(11a)しきい値電圧(Vth;25℃で測定;V)
 正の誘電率異方性:測定には大塚電子株式会社製のLCD5100型輝度計を用いた。光源はハロゲンランプであった。2枚のガラス基板の間隔(セルギャップ)が0.45/Δn(μm)であり、ツイスト角が80度であるノーマリーホワイトモード(normally white mode)のTN素子に試料を入れた。この素子に印加する電圧(32Hz、矩形波)は0Vから10Vまで0.02Vずつ段階的に増加させた。この際に、素子に垂直方向から光を照射し、素子を透過した光量を測定した。この光量が最大になったときが透過率100%であり、この光量が最小であったときが透過率0%である電圧-透過率曲線を作成した。しきい値電圧は透過率が90%になったときの電圧で表した。
(11a) Threshold voltage (Vth; measured at 25 ° C; V)
Positive permittivity anisotropy: An LCD5100 type luminance meter manufactured by Otsuka Electronics Co., Ltd. was used for the measurement. The light source was a halogen lamp. The sample was placed in a normally white mode TN element in which the distance (cell gap) between the two glass substrates was 0.45 / Δn (μm) and the twist angle was 80 degrees. The voltage (32 Hz, square wave) applied to this device was gradually increased by 0.02 V from 0 V to 10 V. At this time, the element was irradiated with light from the vertical direction, and the amount of light transmitted through the element was measured. A voltage-transmittance curve was created in which the transmittance was 100% when the amount of light was maximum and the transmittance was 0% when the amount of light was minimum. The threshold voltage is expressed as the voltage when the transmittance reaches 90%.
(11b)しきい値電圧(Vth;25℃で測定;V)
 負の誘電率異方性:測定には大塚電子株式会社製のLCD5100型輝度計を用いた。光源はハロゲンランプであった。2枚のガラス基板の間隔(セルギャップ)が4μmであり、ラビング方向がアンチパラレルであるノーマリーブラックモード(normally black mode)のVA素子に試料を入れ、この素子を紫外線で硬化する接着剤を用いて密閉した。この素子に印加する電圧(60Hz、矩形波)は0Vから20Vまで0.02Vずつ段階的に増加させた。この際に、素子に垂直方向から光を照射し、素子を透過した光量を測定した。この光量が最大になったときが透過率100%であり、この光量が最小であったときが透過率0%である電圧-透過率曲線を作成した。しきい値電圧は透過率が10%になったときの電圧で表した。
(11b) Threshold voltage (Vth; measured at 25 ° C; V)
Negative permittivity anisotropy: An LCD5100 type luminance meter manufactured by Otsuka Electronics Co., Ltd. was used for the measurement. The light source was a halogen lamp. A sample is placed in a VA element in normally black mode in which the distance (cell gap) between two glass substrates is 4 μm and the rubbing direction is anti-parallel, and an adhesive that cures this element with ultraviolet rays is applied. Sealed using. The voltage (60 Hz, square wave) applied to this device was gradually increased by 0.02 V from 0 V to 20 V. At this time, the element was irradiated with light from the vertical direction, and the amount of light transmitted through the element was measured. A voltage-transmittance curve was created in which the transmittance was 100% when the amount of light was maximum and the transmittance was 0% when the amount of light was minimum. The threshold voltage is expressed as the voltage when the transmittance reaches 10%.
(12a)応答時間(τ;25℃で測定;ms)
 正の誘電率異方性:測定には大塚電子株式会社製のLCD5100型輝度計を用いた。光源はハロゲンランプであった。ローパス・フィルター(Low-pass filter)は5kHzに設定した。2枚のガラス基板の間隔(セルギャップ)が5.0μmであり、ツイスト角が80度であるノーマリーホワイトモード(normally white mode)のTN素子に試料を入れた。この素子に矩形波(60Hz、5V、0.5秒)を印加した。この際に、素子に垂直方向から光を照射し、素子を透過した光量を測定した。この光量が最大になったときが透過率100%であり、この光量が最小であったときが透過率0%であるとみなした。立ち上がり時間(τr:rise time;ミリ秒)は、透過率が90%から10%に変化するのに要した時間である。立ち下がり時間(τf:fall time;ミリ秒)は透過率10%から90%に変化するのに要した時間である。応答時間は、このようにして求めた立ち上がり時間と立ち下がり時間との和で表した。
(12a) Response time (τ; measured at 25 ° C; ms)
Positive permittivity anisotropy: An LCD5100 type luminance meter manufactured by Otsuka Electronics Co., Ltd. was used for the measurement. The light source was a halogen lamp. The low-pass filter was set to 5 kHz. The sample was placed in a normally white mode TN element in which the distance (cell gap) between the two glass substrates was 5.0 μm and the twist angle was 80 degrees. A square wave (60 Hz, 5 V, 0.5 seconds) was applied to this device. At this time, the element was irradiated with light from the vertical direction, and the amount of light transmitted through the element was measured. It was considered that the transmittance was 100% when the amount of light was maximum, and the transmittance was 0% when the amount of light was minimum. The rise time (τr: rise time; millisecond) is the time required for the transmittance to change from 90% to 10%. The fall time (τf: fall time; millisecond) is the time required for the transmittance to change from 10% to 90%. The response time was expressed as the sum of the rise time and the fall time obtained in this way.
(12b)応答時間(τ;25℃で測定;ms)
 負の誘電率異方性:測定には大塚電子株式会社製のLCD5100型輝度計を用いた。光源はハロゲンランプであった。ローパス・フィルター(Low-pass filter)は5kHzに設定した。2枚のガラス基板の間隔(セルギャップ)が3.2μmであり、ラビング方向がアンチパラレルであるノーマリーブラックモード(normally black mode)のPVA素子に試料を入れた。この素子を紫外線で硬化する接着剤を用いて密閉した。この素子にしきい値電圧を若干超える程度の電圧を1分間印加し、次に5.6Vの電圧を印加しながら23.5mW/cmの紫外線を8分間照射した。この素子に矩形波(60Hz、10V、0.5秒)を印加した。この際に、素子に垂直方向から光を照射し、素子を透過した光量を測定した。この光量が最大になったときが透過率100%であり、この光量が最小であったときが透過率0%であるとみなした。応答時間は透過率90%から10%に変化するのに要した時間(立ち下がり時間;fall time;ミリ秒)で表した。
(12b) Response time (τ; measured at 25 ° C; ms)
Negative permittivity anisotropy: An LCD5100 type luminance meter manufactured by Otsuka Electronics Co., Ltd. was used for the measurement. The light source was a halogen lamp. The low-pass filter was set to 5 kHz. The sample was placed in a normally black mode PVA element in which the distance between the two glass substrates (cell gap) was 3.2 μm and the rubbing direction was antiparallel. This element was sealed with an UV curable adhesive. A voltage slightly exceeding the threshold voltage was applied to this device for 1 minute, and then 23.5 mW / cm 2 ultraviolet rays were irradiated for 8 minutes while applying a voltage of 5.6 V. A square wave (60 Hz, 10 V, 0.5 seconds) was applied to this device. At this time, the element was irradiated with light from the vertical direction, and the amount of light transmitted through the element was measured. It was considered that the transmittance was 100% when the amount of light was maximum, and the transmittance was 0% when the amount of light was minimum. The response time was expressed as the time required for the transmittance to change from 90% to 10% (fall time; fall time; millisecond).
原料
 ソルミックス(登録商標)A-11は、エタノール(85.5%)、メタノール(13.4%)とイソプロパノール(1.1%)の混合物であり、日本アルコール販売(株)から入手した。
Raw material Solmix (registered trademark) A-11 is a mixture of ethanol (85.5%), methanol (13.4%) and isopropanol (1.1%), and was obtained from Japan Alcohol Trading Co., Ltd.
[合成例1]
化合物(No.1)の合成

Figure JPOXMLDOC01-appb-I000087
[Synthesis Example 1]
Synthesis of compound (No. 1)

Figure JPOXMLDOC01-appb-I000087
第1工程
 化合物(T-1)(10.00g)、化合物(T-2)(17.01g)、DMAP(1.30g)、およびジクロロメタン(150ml)を反応器に入れ、0℃に冷却した。そこへDCC(12.00g)を添加し、室温に戻しつつ12時間攪拌した。不溶物を濾別した後、反応混合物を水に注ぎ込み、水層をジクロロメタンで抽出した。有機層を水で洗浄し、無水硫酸マグネシウムで乾燥した。この溶液を減圧下で濃縮し、残渣をシリカゲルクロマトグラフィー(容積比、酢酸エチル:トルエン=1:19)で精製し、化合物(T-3)(9.98g;41%)を得た。尚、化合物(T-2)は、市販品(4-([6-(acryloyloxy)hexyl]oxy)benzoic acid)を、例えばSigma-Aldrichから入手することが出来る。
First step Compound (T-1) (10.00 g), compound (T-2) (17.01 g), DMAP (1.30 g), and dichloromethane (150 ml) were placed in a reactor and cooled to 0 ° C. .. DCC (12.00 g) was added thereto, and the mixture was stirred for 12 hours while returning to room temperature. After filtering the insoluble material, the reaction mixture was poured into water and the aqueous layer was extracted with dichloromethane. The organic layer was washed with water and dried over anhydrous magnesium sulfate. This solution was concentrated under reduced pressure, and the residue was purified by silica gel chromatography (volume ratio, ethyl acetate: toluene = 1:19) to obtain compound (T-3) (9.98 g; 41%). As the compound (T-2), a commercially available product (4-([6- (acrylolyloxy) oxy) benzoic acid) can be obtained from, for example, Sigma-Aldrich.
第2工程
 化合物(T-3)(5.00g)、化合物(T-4)(2.68g)、ヨウ化銅(0.21g)、Pd(PPh(0.4g)、THF(50ml)及びトリエチルアミン(50ml)を容器に採り、窒素雰囲気下で一晩攪拌した。反応混合物を水に注ぎトルエンにて抽出し、水にて洗浄した後、無水硫酸マグネシウムで乾燥し、減圧濃縮して淡茶色固体を得た。この固体を溶液にして、シリカゲルカラムクロマトグラフィー(容積比、酢酸エチル:トルエン=1:4)、で精製し、ヘプタンで再沈殿することにより化合物(No.1)(3.00g;45%)を得た。
Second step Compound (T-3) (5.00 g), Compound (T-4) (2.68 g), Copper iodide (0.21 g), Pd (PPh 3 ) 4 (0.4 g), THF ( 50 ml) and triethylamine (50 ml) were taken in a container and stirred overnight in a nitrogen atmosphere. The reaction mixture was poured into water, extracted with toluene, washed with water, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure to give a light brown solid. This solid is used as a solution, purified by silica gel column chromatography (volume ratio, ethyl acetate: toluene = 1: 4), and reprecipitated with heptane to compound (No. 1) (3.00 g; 45%). Got
 得られた化合物(No.1)のNMR分析値は、以下の通りである。
H-NMR:化学シフトδ(ppm;CDCl):8.02(d,2H)、7.59(d,2H)、7.51(d,2H)、7.50(d,2H)、6.97(d,2H)、6.92(d,2H)、6.46(dd,1H)、6.45(dd,1H)、6.19(dd,1H)、6.14(dd,1H)、5.88(dd,1H)、5.87(dd,1H)、4.56(t,2H)、4.27(t,2H)、4.20(t,2H)、4.07(t,2H)、1.86(quint,2H)、1.75(quint,2H)、1.55(quint,2H)、1.49(quint,2H).
The NMR analysis values of the obtained compound (No. 1) are as follows.
1 H-NMR: Chemical shift δ (ppm; CDCl 3 ): 8.02 (d, 2H), 7.59 (d, 2H), 7.51 (d, 2H), 7.50 (d, 2H) , 6.97 (d, 2H), 6.92 (d, 2H), 6.46 (dd, 1H), 6.45 (dd, 1H), 6.19 (dd, 1H), 6.14 ( dd, 1H), 5.88 (dd, 1H), 5.87 (dd, 1H), 4.56 (t, 2H), 4.27 (t, 2H), 4.20 (t, 2H), 4.07 (t, 2H), 1.86 (quint, 2H), 1.75 (quint, 2H), 1.55 (quint, 2H), 1.49 (quint, 2H).
化合物(No.1)の物性は、次のとおりであった。
 転移温度(℃):C 83.1 I 重合温度(℃):212.8
The physical properties of compound (No. 1) were as follows.
Transition temperature (° C): C 83.1 I Polymerization temperature (° C): 212.8
[合成例2]
化合物(No.2)の合成

Figure JPOXMLDOC01-appb-I000088
[Synthesis Example 2]
Synthesis of compound (No. 2)

Figure JPOXMLDOC01-appb-I000088
第1工程
 化合物(T-5)(0.50g)、化合物(T-2)(1.47g)、DMAP(0.06g)、およびジクロロメタン(100ml)を反応器に入れ、0℃に冷却した。そこへDCC(1.04g)を添加し、室温に戻しつつ12時間攪拌した。不溶物を濾別した後、反応混合物を水に注ぎ込み、水層をジクロロメタンで抽出した。有機層を水で洗浄し、無水硫酸マグネシウムで乾燥した。この溶液を減圧下で濃縮し、残渣をシリカゲルクロマトグラフィー(容積比、酢酸エチル:トルエン=1:4)で精製し、ヘプタンで再沈殿することにより化合物(No.2)(0.92g;52%)を得た。
First step Compound (T-5) (0.50 g), compound (T-2) (1.47 g), DMAP (0.06 g), and dichloromethane (100 ml) were placed in a reactor and cooled to 0 ° C. .. DCC (1.04 g) was added thereto, and the mixture was stirred for 12 hours while returning to room temperature. After filtering the insoluble material, the reaction mixture was poured into water and the aqueous layer was extracted with dichloromethane. The organic layer was washed with water and dried over anhydrous magnesium sulfate. The solution was concentrated under reduced pressure, the residue was purified by silica gel chromatography (volume ratio, ethyl acetate: toluene = 1: 4), and reprecipitated with heptane to compound (No. 2) (0.92 g; 52). %) Was obtained.
 得られた化合物(No.2)のNMR分析値は、以下の通りである。
H-NMR:化学シフトδ(ppm;CDCl):8.04(d,4H)、7.71(d,4H)、7.62(d,4H)、6.98(d,4H)、6.43(dd,2H)、6.17(dd,2H)、5.85(dd,2H)、4.21(t,2H)、4.07(t,2H)、1.86(quint,4H)、1.75(quint,4H)、1.55(quint,4H)、1.49(quint,4H).
The NMR analysis values of the obtained compound (No. 2) are as follows.
1 1 H-NMR: Chemical shift δ (ppm; CDCl 3 ): 8.04 (d, 4H), 7.71 (d, 4H), 7.62 (d, 4H), 6.98 (d, 4H) , 6.43 (dd, 2H), 6.17 (dd, 2H), 5.85 (dd, 2H), 4.21 (t, 2H), 4.07 (t, 2H), 1.86 ( Quant, 4H), 1.75 (quint, 4H), 1.55 (quint, 4H), 1.49 (quint, 4H).
化合物(No.2)の物性は、次のとおりであった。
 転移温度(℃):C 124.8 I 重合温度(℃):127.7
The physical properties of compound (No. 2) were as follows.
Transition temperature (° C): C 124.8 I Polymerization temperature (° C): 127.7
[合成例3]
化合物(No.617)の合成

Figure JPOXMLDOC01-appb-I000089
[Synthesis Example 3]
Synthesis of compound (No. 617)

Figure JPOXMLDOC01-appb-I000089
第1工程
 化合物(T-6)(25.0g)およびTHF(200ml)を反応器に入れ、-60℃以下に冷却した。そこへsec-BuLi(1M hexane solution)(75ml)を-60℃以下を保ちながら滴下し、その後1時間攪拌した。そこに硫黄(2.5g)を添加し、30分攪拌後室温に戻し、更に1時間攪拌した。そこに化合物(T-7)をゆっくり添加し、1時間攪拌した。反応混合物を水に注ぎ込み、水層をトルエンで抽出した。有機層を水で洗浄し、無水硫酸マグネシウムで乾燥した。この溶液を減圧下で濃縮し、残渣をシリカゲルクロマトグラフィー(容積比、酢酸エチル:トルエン=3:10)で精製し、化合物(T-8)(14.9g;38%)を得た。尚、化合物(T-6)および化合物(T-7)は、既知物質であり、当業者であれば容易に合成法を得ることが出来る。
First step Compound (T-6) (25.0 g) and THF (200 ml) were placed in a reactor and cooled to −60 ° C. or lower. Se-BuLi (1M hexane solution) (75 ml) was added dropwise thereto while maintaining a temperature of −60 ° C. or lower, and the mixture was then stirred for 1 hour. Sulfur (2.5 g) was added thereto, and the mixture was stirred for 30 minutes, returned to room temperature, and further stirred for 1 hour. Compound (T-7) was slowly added thereto, and the mixture was stirred for 1 hour. The reaction mixture was poured into water and the aqueous layer was extracted with toluene. The organic layer was washed with water and dried over anhydrous magnesium sulfate. The solution was concentrated under reduced pressure and the residue was purified by silica gel chromatography (volume ratio, ethyl acetate: toluene = 3:10) to give compound (T-8) (14.9 g; 38%). The compound (T-6) and the compound (T-7) are known substances, and those skilled in the art can easily obtain a synthetic method.
第2工程
 化合物(T-8)(16.4g)、PPTS(ピリジニウムパラトルエンスルホン酸)(4.1g)、THF(150ml)及びMeOH(150ml)を容器に採り、窒素雰囲気下、40℃で4時間攪拌した。反応混合物を水に注ぎ酢酸エチルにて抽出し、無水硫酸マグネシウムで乾燥し、減圧濃縮して淡茶色固体を得た。この固体を溶液にして、シリカゲルカラムクロマトグラフィー(容積比、酢酸エチル:トルエン=1:3)、で精製し、化合物(T-9)(13.1g;89%)を得た。
Second step Compound (T-8) (16.4 g), PPTS (pyridinium pyridinium paratoluene sulfonic acid) (4.1 g), THF (150 ml) and MeOH (150 ml) were taken in a container and placed at 40 ° C. The mixture was stirred for 4 hours. The reaction mixture was poured into water, extracted with ethyl acetate, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure to give a light brown solid. This solid was used as a solution and purified by silica gel column chromatography (volume ratio, ethyl acetate: toluene = 1: 3) to obtain compound (T-9) (13.1 g; 89%).
第3工程
 化合物(T-9)(12.6g)、メタクリル酸(3.0g)、DMAP(0.99g)、およびジクロロメタン(250ml)を反応器に入れ、0℃に冷却した。そこへDCC(7.19g)を添加し、室温に戻しつつ12時間攪拌した。不溶物を濾別した後、反応混合物を水に注ぎ込み、水層をジクロロメタンで抽出した。有機層を水で洗浄し、無水硫酸マグネシウムで乾燥した。この溶液を減圧下で濃縮し、残渣をシリカゲルクロマトグラフィー(トルエン)で精製し、化合物(T-10)(10.64g;71%)を得た。
Step 3 Compound (T-9) (12.6 g), methacrylic acid (3.0 g), DMAP (0.99 g), and dichloromethane (250 ml) were placed in a reactor and cooled to 0 ° C. DCC (7.19 g) was added thereto, and the mixture was stirred for 12 hours while returning to room temperature. After filtering the insoluble material, the reaction mixture was poured into water and the aqueous layer was extracted with dichloromethane. The organic layer was washed with water and dried over anhydrous magnesium sulfate. The solution was concentrated under reduced pressure and the residue was purified by silica gel chromatography (toluene) to give compound (T-10) (10.64 g; 71%).
第4工程
 化合物(T-10)(10.1g)、化合物(T-11)(3.2g)、ヨウ化銅(0.35g)、Pd(PPh(1.08g)、THF(100ml)及びトリエチルアミン(50ml)を容器に採り、窒素雰囲気下で一晩攪拌した。反応混合物を水に注ぎトルエンにて抽出し、水にて洗浄した後、無水硫酸マグネシウムで乾燥し、減圧濃縮して淡茶色固体を得た。この固体を溶液にして、シリカゲルカラムクロマトグラフィー(容積比、酢酸エチル:ヘプタン=1:1)、で精製し、ヘプタンで再沈殿することにより化合物(T-12)(6.72g;63%)を得た。
Step 4 Compound (T-10) (10.1 g), Compound (T-11) (3.2 g), Copper iodide (0.35 g), Pd (PPh 3 ) 4 (1.08 g), THF ( 100 ml) and triethylamine (50 ml) were taken in a container and stirred overnight in a nitrogen atmosphere. The reaction mixture was poured into water, extracted with toluene, washed with water, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure to give a light brown solid. This solid is made into a solution, purified by silica gel column chromatography (volume ratio, ethyl acetate: heptane = 1: 1), and reprecipitated with heptane to compound (T-12) (6.72 g; 63%). Got
第5工程
 化合物(T-12)(6.72g)、化合物(T-13)(1.37g)、DMAP(0.29g)、およびジクロロメタン(134ml)を反応器に入れ、0℃に冷却した。そこへDCC(3.15g)を添加し、室温に戻しつつ12時間攪拌した。不溶物を濾別した後、反応混合物を水に注ぎ込み、水層をジクロロメタンで抽出した。有機層を水で洗浄し、無水硫酸マグネシウムで乾燥した。この溶液を減圧下で濃縮し、残渣をシリカゲルクロマトグラフィー(容積比、酢酸エチル:トルエン=19:1)で精製し、化合物(No.617)(6.93g;85%)を得た。
Step 5 Compound (T-12) (6.72 g), compound (T-13) (1.37 g), DMAP (0.29 g), and dichloromethane (134 ml) were placed in a reactor and cooled to 0 ° C. .. DCC (3.15 g) was added thereto, and the mixture was stirred for 12 hours while returning to room temperature. After filtering the insoluble material, the reaction mixture was poured into water and the aqueous layer was extracted with dichloromethane. The organic layer was washed with water and dried over anhydrous magnesium sulfate. This solution was concentrated under reduced pressure, and the residue was purified by silica gel chromatography (volume ratio, ethyl acetate: toluene = 19: 1) to obtain compound (No. 617) (6.93 g; 85%).
 得られた化合物(No.617)のNMR分析値は、以下の通りである。
H-NMR:化学シフトδ(ppm;CDCl3):7.87(s,1H)、7.82(d,1H)、7.55(d,1H)、7.50(d,2H)、7.39(d,2H)、6.97(d,2H)、6.92(d,2H)、6.10(s,1H)、5.78(dd,1H)、5.55(t,1H)、5.38(dd,1H)、4.61(t,2H)、4.28(t,2H)、4.16(t,2H)、4.00(t,2H)、2.57(s,3H)、1.95(s,3H)、1.82(quint,2H)、1.72(quint,2H)、1.55(quint,2H)、1.47(quint,2H).
The NMR analysis values of the obtained compound (No. 617) are as follows.
1 H-NMR: Chemical shift δ (ppm; CDCl 3 ): 7.87 (s, 1H), 7.82 (d, 1H), 7.55 (d, 1H), 7.50 (d, 2H) , 7.39 (d, 2H), 6.97 (d, 2H), 6.92 (d, 2H), 6.10 (s, 1H), 5.78 (dd, 1H), 5.55 ( t, 1H), 5.38 (dd, 1H), 4.61 (t, 2H), 4.28 (t, 2H), 4.16 (t, 2H), 4.00 (t, 2H), 2.57 (s, 3H), 1.95 (s, 3H), 1.82 (quint, 2H), 1.72 (quint, 2H), 1.55 (quint, 2H), 1.47 (quint) , 2H).
化合物(No.617)の物性は、次のとおりであった。
 転移温度(℃):C 72.25 I 重合温度(℃):118.8
The physical properties of compound (No. 617) were as follows.
Transition temperature (° C): C 72.25 I Polymerization temperature (° C): 118.8
[合成例4]
化合物(No.618)の合成
合成例3において、化合物(T-6)の代わりに化合物(T-14)、化合物(T-7)の代わりに化合物(T-15)を用いることで、化合物(No.618)を得た。尚、化合物(T-14)は化合物(T-6)の合成法を参考にすれば容易に合成できる。また、化合物(T-15)は既知物質である。

Figure JPOXMLDOC01-appb-I000090
[Synthesis Example 4]
Synthesis of compound (No. 618) In Synthesis Example 3, compound (T-14) is used instead of compound (T-6), and compound (T-15) is used instead of compound (T-7). (No. 618) was obtained. The compound (T-14) can be easily synthesized by referring to the method for synthesizing the compound (T-6). In addition, compound (T-15) is a known substance.

Figure JPOXMLDOC01-appb-I000090
 得られた化合物(No.618)のNMR分析値は、以下の通りである。
H-NMR:化学シフトδ(ppm;CDCl3):8.15(d,2H)、7.62(d,2H)、7.51(d,2H)、7.31(d,1H)、7.05(s,1H)、7.03(d,1H)、6.92(d,2H)、6.10(s,1H)、5.67(dd,1H)、5.55(t,1H)、5.38(dd,1H)、4.61(t,2H)、4.28(t,2H)、4.15(t,2H)、2.90(t,2H)、2.40(s,3H)、1.95(s,3H)、1.67(quint,2H)、1.66(quint,2H)、1.50(quint,2H)、1.43(quint,2H).
The NMR analysis values of the obtained compound (No. 618) are as follows.
1 H-NMR: Chemical shift δ (ppm; CDCl 3 ): 8.15 (d, 2H), 7.62 (d, 2H), 7.51 (d, 2H), 7.31 (d, 1H) , 7.05 (s, 1H), 7.03 (d, 1H), 6.92 (d, 2H), 6.10 (s, 1H), 5.67 (dd, 1H), 5.55 ( t, 1H), 5.38 (dd, 1H), 4.61 (t, 2H), 4.28 (t, 2H), 4.15 (t, 2H), 2.90 (t, 2H), 2.40 (s, 3H), 1.95 (s, 3H), 1.67 (quint, 2H), 1.66 (quint, 2H), 1.50 (quint, 2H), 1.43 (quint) , 2H).
化合物(No.618)の物性は、次のとおりであった。
 転移温度(℃):C 59.74 I 重合温度(℃):154.6
The physical properties of compound (No. 618) were as follows.
Transition temperature (° C): C 59.74 I Polymerization temperature (° C): 154.6
 合成例に記載した合成法に準じて、化合物(1)の具体例として、合成例に示した化合物に加えて、以下の化合物を合成できる。 As a specific example of compound (1), the following compound can be synthesized in addition to the compound shown in the synthesis example according to the synthesis method described in the synthesis example.

Figure JPOXMLDOC01-appb-I000091

Figure JPOXMLDOC01-appb-I000091

Figure JPOXMLDOC01-appb-I000092

Figure JPOXMLDOC01-appb-I000092

Figure JPOXMLDOC01-appb-I000093

Figure JPOXMLDOC01-appb-I000093

Figure JPOXMLDOC01-appb-I000094

Figure JPOXMLDOC01-appb-I000094

Figure JPOXMLDOC01-appb-I000095

Figure JPOXMLDOC01-appb-I000095

Figure JPOXMLDOC01-appb-I000096

Figure JPOXMLDOC01-appb-I000096

Figure JPOXMLDOC01-appb-I000097

Figure JPOXMLDOC01-appb-I000097

Figure JPOXMLDOC01-appb-I000098

Figure JPOXMLDOC01-appb-I000098

Figure JPOXMLDOC01-appb-I000099

Figure JPOXMLDOC01-appb-I000099

Figure JPOXMLDOC01-appb-I000100

Figure JPOXMLDOC01-appb-I000100

Figure JPOXMLDOC01-appb-I000101

Figure JPOXMLDOC01-appb-I000101

Figure JPOXMLDOC01-appb-I000102

Figure JPOXMLDOC01-appb-I000102

Figure JPOXMLDOC01-appb-I000103

Figure JPOXMLDOC01-appb-I000103

Figure JPOXMLDOC01-appb-I000104

Figure JPOXMLDOC01-appb-I000104

Figure JPOXMLDOC01-appb-I000105

Figure JPOXMLDOC01-appb-I000105

Figure JPOXMLDOC01-appb-I000106

Figure JPOXMLDOC01-appb-I000106

Figure JPOXMLDOC01-appb-I000107

Figure JPOXMLDOC01-appb-I000107

Figure JPOXMLDOC01-appb-I000108

Figure JPOXMLDOC01-appb-I000108

Figure JPOXMLDOC01-appb-I000109

Figure JPOXMLDOC01-appb-I000109

Figure JPOXMLDOC01-appb-I000110

Figure JPOXMLDOC01-appb-I000110

Figure JPOXMLDOC01-appb-I000111

Figure JPOXMLDOC01-appb-I000111

Figure JPOXMLDOC01-appb-I000112

Figure JPOXMLDOC01-appb-I000112

Figure JPOXMLDOC01-appb-I000113

Figure JPOXMLDOC01-appb-I000113

Figure JPOXMLDOC01-appb-I000114

Figure JPOXMLDOC01-appb-I000114

Figure JPOXMLDOC01-appb-I000115

Figure JPOXMLDOC01-appb-I000115

Figure JPOXMLDOC01-appb-I000116

Figure JPOXMLDOC01-appb-I000116

Figure JPOXMLDOC01-appb-I000117

Figure JPOXMLDOC01-appb-I000117

Figure JPOXMLDOC01-appb-I000118

Figure JPOXMLDOC01-appb-I000118

Figure JPOXMLDOC01-appb-I000119

Figure JPOXMLDOC01-appb-I000119

Figure JPOXMLDOC01-appb-I000120

Figure JPOXMLDOC01-appb-I000120

Figure JPOXMLDOC01-appb-I000121

Figure JPOXMLDOC01-appb-I000121

Figure JPOXMLDOC01-appb-I000122

Figure JPOXMLDOC01-appb-I000122

Figure JPOXMLDOC01-appb-I000123

Figure JPOXMLDOC01-appb-I000123

Figure JPOXMLDOC01-appb-I000124

Figure JPOXMLDOC01-appb-I000124

Figure JPOXMLDOC01-appb-I000125

Figure JPOXMLDOC01-appb-I000125

Figure JPOXMLDOC01-appb-I000126

Figure JPOXMLDOC01-appb-I000126

Figure JPOXMLDOC01-appb-I000127

Figure JPOXMLDOC01-appb-I000127

Figure JPOXMLDOC01-appb-I000128

Figure JPOXMLDOC01-appb-I000128

Figure JPOXMLDOC01-appb-I000129

Figure JPOXMLDOC01-appb-I000129

Figure JPOXMLDOC01-appb-I000130

Figure JPOXMLDOC01-appb-I000130

Figure JPOXMLDOC01-appb-I000131

Figure JPOXMLDOC01-appb-I000131

Figure JPOXMLDOC01-appb-I000132

Figure JPOXMLDOC01-appb-I000132

Figure JPOXMLDOC01-appb-I000133

Figure JPOXMLDOC01-appb-I000133

Figure JPOXMLDOC01-appb-I000134

Figure JPOXMLDOC01-appb-I000134

Figure JPOXMLDOC01-appb-I000135

Figure JPOXMLDOC01-appb-I000135

Figure JPOXMLDOC01-appb-I000136

Figure JPOXMLDOC01-appb-I000136

Figure JPOXMLDOC01-appb-I000137

Figure JPOXMLDOC01-appb-I000137

Figure JPOXMLDOC01-appb-I000138

Figure JPOXMLDOC01-appb-I000138

Figure JPOXMLDOC01-appb-I000139

Figure JPOXMLDOC01-appb-I000139

Figure JPOXMLDOC01-appb-I000140

Figure JPOXMLDOC01-appb-I000140

Figure JPOXMLDOC01-appb-I000141

Figure JPOXMLDOC01-appb-I000141

Figure JPOXMLDOC01-appb-I000142

Figure JPOXMLDOC01-appb-I000142

Figure JPOXMLDOC01-appb-I000143

Figure JPOXMLDOC01-appb-I000143

Figure JPOXMLDOC01-appb-I000144

Figure JPOXMLDOC01-appb-I000144

Figure JPOXMLDOC01-appb-I000145

Figure JPOXMLDOC01-appb-I000145

Figure JPOXMLDOC01-appb-I000146

Figure JPOXMLDOC01-appb-I000146

Figure JPOXMLDOC01-appb-I000147

Figure JPOXMLDOC01-appb-I000147

Figure JPOXMLDOC01-appb-I000148

Figure JPOXMLDOC01-appb-I000148

Figure JPOXMLDOC01-appb-I000149

Figure JPOXMLDOC01-appb-I000149

Figure JPOXMLDOC01-appb-I000150

Figure JPOXMLDOC01-appb-I000150

Figure JPOXMLDOC01-appb-I000151

Figure JPOXMLDOC01-appb-I000151

Figure JPOXMLDOC01-appb-I000152

Figure JPOXMLDOC01-appb-I000152

Figure JPOXMLDOC01-appb-I000153

Figure JPOXMLDOC01-appb-I000153

Figure JPOXMLDOC01-appb-I000154

Figure JPOXMLDOC01-appb-I000154

Figure JPOXMLDOC01-appb-I000155

Figure JPOXMLDOC01-appb-I000155

Figure JPOXMLDOC01-appb-I000156

Figure JPOXMLDOC01-appb-I000156

Figure JPOXMLDOC01-appb-I000157

Figure JPOXMLDOC01-appb-I000157
2.素子の使用例
 使用例における化合物は、下記の表2の定義に基づいて記号により表した。表2において、1,4-シクロヘキシレンに関する立体配置はトランスである。記号の後にあるかっこ内の番号は化合物の番号に対応する。(-)の記号はその他の液晶性化合物を意味する。液晶性化合物の割合(百分率)は、液晶組成物の重量に基づいた重量百分率(重量%)である。最後に、組成物の特性値をまとめた。

Figure JPOXMLDOC01-appb-I000158

Figure JPOXMLDOC01-appb-I000159
2. Example of device use The compounds in the example of use are represented by symbols based on the definitions in Table 2 below. In Table 2, the configuration for 1,4-cyclohexylene is trans. The number in parentheses after the symbol corresponds to the compound number. The symbol (-) means other liquid crystal compounds. The proportion (percentage) of the liquid crystal compound is a weight percentage (% by weight) based on the weight of the liquid crystal composition. Finally, the characteristic values of the composition are summarized.

Figure JPOXMLDOC01-appb-I000158

Figure JPOXMLDOC01-appb-I000159
1.原料
 配向膜を有しない素子に、極性化合物を添加した組成物を注入した。直線偏光を照射したあと、この素子における液晶分子の配向を確認した。最初に原料を説明する。原料は、組成物(M1)から組成物(M41)のような組成物、化合物(No.1)から化合物(No.618)のような化合物(1)の中から適宜選択した。組成物は以下のとおりである。
1. 1. The composition to which the polar compound was added was injected into the device having no raw material alignment film. After irradiating with linearly polarized light, the orientation of the liquid crystal molecules in this device was confirmed. First, the raw materials will be described. The raw material was appropriately selected from the composition (M1) to the composition (M41) and the compound (No. 1) to the compound (No. 618) such as the compound (1). The composition is as follows.
[組成物(M1)]
3-HB(2F,3F)-O2        (9-1)    10%
5-HB(2F,3F)-O2        (9-1)     7%
2-BB(2F,3F)-O2        (9-3)     7%
3-BB(2F,3F)-O2        (9-3)     7%
3-B(2F,3F)B(2F,3F)-O2 (9-7)     3%
2-HHB(2F,3F)-O2       (10-1)    5%
3-HHB(2F,3F)-O2       (10-1)   10%
2-HBB(2F,3F)-O2       (10-7)    8%
3-HBB(2F,3F)-O2       (10-7)   10%
2-HH-3                (2-1)    14%
3-HB-O1               (2-5)     5%
3-HHB-1               (3-1)     3%
3-HHB-O1              (3-1)     3%
3-HHB-3               (3-1)     4%
2-BB(F)B-3            (3-6)     4%
 NI=73.2℃;Tc<-20℃;Δn=0.113;Δε=-4.0;Vth=2.18V;η=22.6mPa・s.
[Composition (M1)]
3-HB (2F, 3F) -O2 (9-1) 10%
5-HB (2F, 3F) -O2 (9-1) 7%
2-BB (2F, 3F) -O2 (9-3) 7%
3-BB (2F, 3F) -O2 (9-3) 7%
3-B (2F, 3F) B (2F, 3F) -O2 (9-7) 3%
2-HHB (2F, 3F) -O2 (10-1) 5%
3-HHB (2F, 3F) -O2 (10-1) 10%
2-HBB (2F, 3F) -O2 (10-7) 8%
3-HBB (2F, 3F) -O2 (10-7) 10%
2-HH-3 (2-1) 14%
3-HB-O1 (2-5) 5%
3-HHB-1 (3-1) 3%
3-HHB-O1 (3-1) 3%
3-HHB-3 (3-1) 4%
2-BB (F) B-3 (3-6) 4%
NI = 73.2 ° C; Tc <-20 ° C; Δn = 0.113; Δε = -4.0; Vth = 2.18V; η = 22.6mPa · s.
[組成物(M2)]
3-HB(2F,3F)-O4        (9-1)     6%
3-H2B(2F,3F)-O2       (9-4)     8%
3-H1OB(2F,3F)-O2      (9-5)     4%
3-BB(2F,3F)-O2        (9-3)     7%
2-HHB(2F,3F)-O2       (10-1)    7%
3-HHB(2F,3F)-O2       (10-1)    7%
3-HH2B(2F,3F)-O2      (10-4)    7%
5-HH2B(2F,3F)-O2      (10-4)    4%
2-HBB(2F,3F)-O2       (10-7)    5%
3-HBB(2F,3F)-O2       (10-7)    5%
4-HBB(2F,3F)-O2       (10-7)    6%
2-HH-3                (2-1)    12%
1-BB-5                (2-8)    12%
3-HHB-1               (3-1)     4%
3-HHB-O1              (3-1)     3%
3-HBB-2               (3-4)     3%
 NI=82.8℃;Tc<-30℃;Δn=0.118;Δε=-4.4;Vth=2.13V;η=22.5mPa・s.
[Composition (M2)]
3-HB (2F, 3F) -O4 (9-1) 6%
3-H2B (2F, 3F) -O2 (9-4) 8%
3-H1OB (2F, 3F) -O2 (9-5) 4%
3-BB (2F, 3F) -O2 (9-3) 7%
2-HHB (2F, 3F) -O2 (10-1) 7%
3-HHB (2F, 3F) -O2 (10-1) 7%
3-HH2B (2F, 3F) -O2 (10-4) 7%
5-HH2B (2F, 3F) -O2 (10-4) 4%
2-HBB (2F, 3F) -O2 (10-7) 5%
3-HBB (2F, 3F) -O2 (10-7) 5%
4-HBB (2F, 3F) -O2 (10-7) 6%
2-HH-3 (2-1) 12%
1-BB-5 (2-8) 12%
3-HHB-1 (3-1) 4%
3-HHB-O1 (3-1) 3%
3-HBB-2 (3-4) 3%
NI = 82.8 ° C; Tc <-30 ° C; Δn = 0.118; Δε = -4.4; Vth = 2.13V; η = 22.5mPa · s.
[組成物(M3)]
3-HB(2F,3F)-O2        (9-1)     7%
5-HB(2F,3F)-O2        (9-1)     7%
3-BB(2F,3F)-O2        (9-3)     8%
3-HHB(2F,3F)-O2       (10-1)    5%
5-HHB(2F,3F)-O2       (10-1)    4%
3-HH1OB(2F,3F)-O2     (10-5)    4%
2-BB(2F,3F)B-3        (11-1)    5%
2-HBB(2F,3F)-O2       (10-7)    3%
3-HBB(2F,3F)-O2       (10-7)    8%
4-HBB(2F,3F)-O2       (10-7)    5%
5-HBB(2F,3F)-O2       (10-7)    8%
3-HH-V                (2-1)    27%
3-HH-V1               (2-1)     6%
V-HHB-1               (3-1)     3%
 NI=78.1℃;Tc<-30℃;Δn=0.107;Δε=-3.2;Vth=2.02V;η=15.9mPa・s.
[Composition (M3)]
3-HB (2F, 3F) -O2 (9-1) 7%
5-HB (2F, 3F) -O2 (9-1) 7%
3-BB (2F, 3F) -O2 (9-3) 8%
3-HHB (2F, 3F) -O2 (10-1) 5%
5-HHB (2F, 3F) -O2 (10-1) 4%
3-HH1OB (2F, 3F) -O2 (10-5) 4%
2-BB (2F, 3F) B-3 (11-1) 5%
2-HBB (2F, 3F) -O2 (10-7) 3%
3-HBB (2F, 3F) -O2 (10-7) 8%
4-HBB (2F, 3F) -O2 (10-7) 5%
5-HBB (2F, 3F) -O2 (10-7) 8%
3-HH-V (2-1) 27%
3-HH-V1 (2-1) 6%
V-HHB-1 (3-1) 3%
NI = 78.1 ° C; Tc <-30 ° C; Δn = 0.107; Δε = -3.2; Vth = 2.02V; η = 15.9 mPa · s.
[組成物(M4)]
3-HB(2F,3F)-O2        (9-1)    10%
5-HB(2F,3F)-O2        (9-1)    10%
3-H2B(2F,3F)-O2       (9-4)     8%
5-H2B(2F,3F)-O2       (9-4)     8%
2-HBB(2F,3F)-O2       (10-7)    6%
3-HBB(2F,3F)-O2       (10-7)    8%
4-HBB(2F,3F)-O2       (10-7)    7%
5-HBB(2F,3F)-O2       (10-7)    7%
3-HDhB(2F,3F)-O2      (10-3)    5%
3-HH-4                (2-1)    14%
V-HHB-1               (3-1)    10%
3-HBB-2               (3-4)     7%
 NI=88.5℃;Tc<-30℃;Δn=0.108;Δε=-3.8;Vth=2.25V;η=24.6mPa・s;VHR-1=99.1%;VHR-2=98.2%;VHR-3=97.8%.
[Composition (M4)]
3-HB (2F, 3F) -O2 (9-1) 10%
5-HB (2F, 3F) -O2 (9-1) 10%
3-H2B (2F, 3F) -O2 (9-4) 8%
5-H2B (2F, 3F) -O2 (9-4) 8%
2-HBB (2F, 3F) -O2 (10-7) 6%
3-HBB (2F, 3F) -O2 (10-7) 8%
4-HBB (2F, 3F) -O2 (10-7) 7%
5-HBB (2F, 3F) -O2 (10-7) 7%
3-HDhB (2F, 3F) -O2 (10-3) 5%
3-HH-4 (2-1) 14%
V-HHB-1 (3-1) 10%
3-HBB-2 (3-4) 7%
NI = 88.5 ° C; Tc <-30 ° C; Δn = 0.108; Δε = -3.8; Vth = 2.25V; η = 24.6mPa · s; VHR-1 = 99.1%; VHR -2 = 98.2%; VHR-3 = 97.8%.
[組成物(M5)]
3-HB(2F,3F)-O2        (9-1)     7%
3-HB(2F,3F)-O4        (9-1)     8%
3-H2B(2F,3F)-O2       (9-4)     8%
3-BB(2F,3F)-O2        (9-3)    10%
2-HHB(2F,3F)-O2       (10-1)    4%
3-HHB(2F,3F)-O2       (10-1)    7%
3-HHB(2F,3F)-1        (10-1)    6%
2-HBB(2F,3F)-O2       (10-7)    6%
3-HBB(2F,3F)-O2       (10-7)    6%
4-HBB(2F,3F)-O2       (10-7)    5%
5-HBB(2F,3F)-O2       (10-7)    4%
3-HEB(2F,3F)B(2F,3F)-O2 (16-1)  3%
3-H1OCro(7F,8F)-5     (13-2)    3%
3-HDhB(2F,3F)-O2      (10-3)    5%
3-HH-O1               (2-1)     5%
1-BB-5                (2-8)     4%
V-HHB-1               (3-1)     4%
5-HB(F)BH-3           (4-2)     5%
 NI=81.1℃;Tc<-30℃;Δn=0.119;Δε=-4.5;Vth=1.69V;η=31.4mPa・s.
[Composition (M5)]
3-HB (2F, 3F) -O2 (9-1) 7%
3-HB (2F, 3F) -O4 (9-1) 8%
3-H2B (2F, 3F) -O2 (9-4) 8%
3-BB (2F, 3F) -O2 (9-3) 10%
2-HHB (2F, 3F) -O2 (10-1) 4%
3-HHB (2F, 3F) -O2 (10-1) 7%
3-HHB (2F, 3F) -1 (10-1) 6%
2-HBB (2F, 3F) -O2 (10-7) 6%
3-HBB (2F, 3F) -O2 (10-7) 6%
4-HBB (2F, 3F) -O2 (10-7) 5%
5-HBB (2F, 3F) -O2 (10-7) 4%
3-HEB (2F, 3F) B (2F, 3F) -O2 (16-1) 3%
3-H1OCro (7F, 8F) -5 (13-2) 3%
3-HDhB (2F, 3F) -O2 (10-3) 5%
3-HH-O1 (2-1) 5%
1-BB-5 (2-8) 4%
V-HHB-1 (3-1) 4%
5-HB (F) BH-3 (4-2) 5%
NI = 81.1 ° C; Tc <-30 ° C; Δn = 0.119; Δε = -4.5; Vth = 1.69V; η = 31.4mPa · s.
[組成物(M6)]
3-HB(2F,3F)-O4        (9-1)    15%
3-HBB(2F,3F)-O2       (10-7)    8%
4-HBB(2F,3F)-O2       (10-7)    5%
5-HBB(2F,3F)-O2       (10-7)    7%
3-dhBB(2F,3F)-O2      (10-9)    5%
3-chB(2F,3F)-O2       (16-2)    7%
2-HchB(2F,3F)-O2      (16-3)    8%
5-HH-V                (2-1)    18%
7-HB-1                (2-5)     5%
V-HHB-1               (3-1)     7%
V2-HHB-1              (3-1)     7%
3-HBB(F)B-3           (4-5)     8%
 NI=98.8℃;Tc<-30℃;Δn=0.111;Δε=-3.2;Vth=2.47V;η=23.9mPa・s.
[Composition (M6)]
3-HB (2F, 3F) -O4 (9-1) 15%
3-HBB (2F, 3F) -O2 (10-7) 8%
4-HBB (2F, 3F) -O2 (10-7) 5%
5-HBB (2F, 3F) -O2 (10-7) 7%
3-dhBB (2F, 3F) -O2 (10-9) 5%
3-chB (2F, 3F) -O2 (16-2) 7%
2-HchB (2F, 3F) -O2 (16-3) 8%
5-HH-V (2-1) 18%
7-HB-1 (2-5) 5%
V-HHB-1 (3-1) 7%
V2-HHB-1 (3-1) 7%
3-HBB (F) B-3 (4-5) 8%
NI = 98.8 ° C; Tc <-30 ° C; Δn = 0.111; Δε = -3.2; Vth = 2.47V; η = 23.9mPa · s.
[組成物(M7)]
3-H2B(2F,3F)-O2       (9-4)    18%
5-H2B(2F,3F)-O2       (9-4)    17%
3-HHB(2F,3Cl)-O2      (10-12)   5%
3-HBB(2F,3Cl)-O2      (10-13)   8%
5-HBB(2F,3Cl)-O2      (10-13)   7%
3-HDhB(2F,3F)-O2      (10-3)    5%
3-HH-V                (2-1)    11%
3-HH-VFF              (2-1)     7%
F3-HH-V               (2-1)    10%
3-HHEH-3              (3-13)    4%
3-HB(F)HH-2           (4-7)     4%
3-HHEBH-3             (4-6)     4%
 NI=77.5℃;Tc<-30℃;Δn=0.084;Δε=-2.6;Vth=2.43V;η=22.8mPa・s.
[Composition (M7)]
3-H2B (2F, 3F) -O2 (9-4) 18%
5-H2B (2F, 3F) -O2 (9-4) 17%
3-HHB (2F, 3Cl) -O2 (10-12) 5%
3-HBB (2F, 3Cl) -O2 (10-13) 8%
5-HBB (2F, 3Cl) -O2 (10-13) 7%
3-HDhB (2F, 3F) -O2 (10-3) 5%
3-HH-V (2-1) 11%
3-HH-VFF (2-1) 7%
F3-HH-V (2-1) 10%
3-HHEH-3 (3-13) 4%
3-HB (F) HH-2 (4-7) 4%
3-HHEBH-3 (4-6) 4%
NI = 77.5 ° C; Tc <-30 ° C; Δn = 0.084; Δε = -2.6; Vth = 2.43V; η = 22.8mPa · s.
[組成物(M8)]
3-HB(2F,3F)-O2        (9-1)     8%
3-H2B(2F,3F)-O2       (9-4)    10%
3-BB(2F,3F)-O2        (9-3)    10%
2O-BB(2F,3F)-O2       (9-3)     3%
2-HHB(2F,3F)-O2       (10-1)    4%
3-HHB(2F,3F)-O2       (10-1)    7%
2-HHB(2F,3F)-1        (10-1)    5%
2-BB(2F,3F)B-3        (11-1)    6%
2-BB(2F,3F)B-4        (11-1)    6%
2-HBB(2F,3F)-O2       (10-7)    4%
3-HBB(2F,3F)-O2       (10-7)    7%
3-HH1OCro(7F,8F)-5    (13-6)    4%
3-HDhB(2F,3F)-O2      (10-3)    6%
3-dhBB(2F,3F)-O2      (10-9)    4%
3-HH-V                (2-1)    11%
1-BB-5                (2-8)     5%
 NI=70.6℃;Tc<-20℃;Δn=0.129;Δε=-4.3;Vth=1.69V;η=27.0mPa・s.
[Composition (M8)]
3-HB (2F, 3F) -O2 (9-1) 8%
3-H2B (2F, 3F) -O2 (9-4) 10%
3-BB (2F, 3F) -O2 (9-3) 10%
2O-BB (2F, 3F) -O2 (9-3) 3%
2-HHB (2F, 3F) -O2 (10-1) 4%
3-HHB (2F, 3F) -O2 (10-1) 7%
2-HHB (2F, 3F) -1 (10-1) 5%
2-BB (2F, 3F) B-3 (11-1) 6%
2-BB (2F, 3F) B-4 (11-1) 6%
2-HBB (2F, 3F) -O2 (10-7) 4%
3-HBB (2F, 3F) -O2 (10-7) 7%
3-HH1OCro (7F, 8F) -5 (13-6) 4%
3-HDhB (2F, 3F) -O2 (10-3) 6%
3-dhBB (2F, 3F) -O2 (10-9) 4%
3-HH-V (2-1) 11%
1-BB-5 (2-8) 5%
NI = 70.6 ° C; Tc <-20 ° C; Δn = 0.129; Δε = -4.3; Vth = 1.69V; η = 27.0 mPa · s.
[組成物(M9)]
3-HB(2F,3F)-O4        (9-1)    14%
3-H1OB(2F,3F)-O2      (9-5)     3%
3-BB(2F,3F)-O2        (9-3)    10%
2-HHB(2F,3F)-O2       (10-1)    7%
3-HHB(2F,3F)-O2       (10-1)    7%
3-HH1OB(2F,3F)-O2     (10-5)    6%
2-HBB(2F,3F)-O2       (10-7)    4%
3-HBB(2F,3F)-O2       (10-7)    6%
4-HBB(2F,3F)-O2       (10-7)    4%
3-HH-V                (2-1)    14%
1-BB-3                (2-8)     3%
3-HHB-1               (3-1)     4%
3-HHB-O1              (3-1)     4%
V-HBB-2               (3-4)     4%
1-BB(F)B-2V           (3-6)     6%
5-HBBH-1O1            (4-1)     4%
 NI=93.0℃;Tc<-30℃;Δn=0.123;Δε=-4.0;Vth=2.27V;η=29.6mPa・s.
[Composition (M9)]
3-HB (2F, 3F) -O4 (9-1) 14%
3-H1OB (2F, 3F) -O2 (9-5) 3%
3-BB (2F, 3F) -O2 (9-3) 10%
2-HHB (2F, 3F) -O2 (10-1) 7%
3-HHB (2F, 3F) -O2 (10-1) 7%
3-HH1OB (2F, 3F) -O2 (10-5) 6%
2-HBB (2F, 3F) -O2 (10-7) 4%
3-HBB (2F, 3F) -O2 (10-7) 6%
4-HBB (2F, 3F) -O2 (10-7) 4%
3-HH-V (2-1) 14%
1-BB-3 (2-8) 3%
3-HHB-1 (3-1) 4%
3-HHB-O1 (3-1) 4%
V-HBB-2 (3-4) 4%
1-BB (F) B-2V (3-6) 6%
5-HBBH-1O1 (4-1) 4%
NI = 93.0 ° C; Tc <-30 ° C; Δn = 0.123; Δε = -4.0; Vth = 2.27V; η = 29.6 mPa · s.
[組成物(M10)]
3-HB(2F,3F)-O4        (9-1)     6%
3-H2B(2F,3F)-O2       (9-4)     8%
3-H1OB(2F,3F)-O2      (9-5)     5%
3-BB(2F,3F)-O2        (9-3)    10%
2-HHB(2F,3F)-O2       (10-1)    7%
3-HHB(2F,3F)-O2       (10-1)    7%
5-HHB(2F,3F)-O2       (10-1)    7%
2-HBB(2F,3F)-O2       (10-7)    4%
3-HBB(2F,3F)-O2       (10-7)    7%
5-HBB(2F,3F)-O2       (10-7)    6%
3-HH-V                (2-1)    11%
1-BB-3                (2-8)     6%
3-HHB-1               (3-1)     4%
3-HHB-O1              (3-1)     4%
3-HBB-2               (3-4)     4%
3-B(F)BB-2            (3-8)     4%
 NI=87.6℃;Tc<-30℃;Δn=0.126;Δε=-4.5;Vth=2.21V;η=25.3mPa・s.
[Composition (M10)]
3-HB (2F, 3F) -O4 (9-1) 6%
3-H2B (2F, 3F) -O2 (9-4) 8%
3-H1OB (2F, 3F) -O2 (9-5) 5%
3-BB (2F, 3F) -O2 (9-3) 10%
2-HHB (2F, 3F) -O2 (10-1) 7%
3-HHB (2F, 3F) -O2 (10-1) 7%
5-HHB (2F, 3F) -O2 (10-1) 7%
2-HBB (2F, 3F) -O2 (10-7) 4%
3-HBB (2F, 3F) -O2 (10-7) 7%
5-HBB (2F, 3F) -O2 (10-7) 6%
3-HH-V (2-1) 11%
1-BB-3 (2-8) 6%
3-HHB-1 (3-1) 4%
3-HHB-O1 (3-1) 4%
3-HBB-2 (3-4) 4%
3-B (F) BB-2 (3-8) 4%
NI = 87.6 ° C; Tc <-30 ° C; Δn = 0.126; Δε = -4.5; Vth = 2.21V; η = 25.3 mPa · s.
[組成物(M11)]
3-HB(2F,3F)-O4        (9-1)     6%
3-H2B(2F,3F)-O2       (9-4)     8%
3-H1OB(2F,3F)-O2      (9-5)     4%
3-BB(2F,3F)-O2        (9-3)     7%
2-HHB(2F,3F)-O2       (10-1)    6%
3-HHB(2F,3F)-O2       (10-1)   10%
5-HHB(2F,3F)-O2       (10-1)    8%
2-HBB(2F,3F)-O2       (10-7)    5%
3-HBB(2F,3F)-O2       (10-7)    7%
5-HBB(2F,3F)-O2       (10-7)    5%
2-HH-3                (2-1)    12%
1-BB-3                (2-8)     6%
3-HHB-1               (3-1)     3%
3-HHB-O1              (3-1)     4%
3-HBB-2               (3-4)     6%
3-B(F)BB-2            (3-8)     3%
 NI=93.0℃;Tc<-20℃;Δn=0.124;Δε=-4.5;Vth=2.22V;η=25.0mPa・s.
[Composition (M11)]
3-HB (2F, 3F) -O4 (9-1) 6%
3-H2B (2F, 3F) -O2 (9-4) 8%
3-H1OB (2F, 3F) -O2 (9-5) 4%
3-BB (2F, 3F) -O2 (9-3) 7%
2-HHB (2F, 3F) -O2 (10-1) 6%
3-HHB (2F, 3F) -O2 (10-1) 10%
5-HHB (2F, 3F) -O2 (10-1) 8%
2-HBB (2F, 3F) -O2 (10-7) 5%
3-HBB (2F, 3F) -O2 (10-7) 7%
5-HBB (2F, 3F) -O2 (10-7) 5%
2-HH-3 (2-1) 12%
1-BB-3 (2-8) 6%
3-HHB-1 (3-1) 3%
3-HHB-O1 (3-1) 4%
3-HBB-2 (3-4) 6%
3-B (F) BB-2 (3-8) 3%
NI = 93.0 ° C; Tc <-20 ° C; Δn = 0.124; Δε = −4.5; Vth = 2.22V; η = 25.0 mPa · s.
[組成物(M12)]
3-HB(2F,3F)-O2        (9-1)     7%
5-HB(2F,3F)-O2        (9-1)     7%
3-BB(2F,3F)-O2        (9-3)     8%
3-HHB(2F,3F)-O2       (10-1)    4%
5-HHB(2F,3F)-O2       (10-1)    5%
3-HH1OB(2F,3F)-O2     (10-5)    5%
2-BB(2F,3F)B-3        (11-1)    4%
2-HBB(2F,3F)-O2       (10-7)    3%
3-HBB(2F,3F)-O2       (10-7)    8%
4-HBB(2F,3F)-O2       (10-7)    5%
5-HBB(2F,3F)-O2       (10-7)    8%
3-HH-V                (2-1)    33%
V-HHB-1               (3-1)     3%
 NI=76.4℃;Tc<-30℃;Δn=0.104;Δε=-3.2;Vth=2.06V;η=15.6mPa・s.
[Composition (M12)]
3-HB (2F, 3F) -O2 (9-1) 7%
5-HB (2F, 3F) -O2 (9-1) 7%
3-BB (2F, 3F) -O2 (9-3) 8%
3-HHB (2F, 3F) -O2 (10-1) 4%
5-HHB (2F, 3F) -O2 (10-1) 5%
3-HH1OB (2F, 3F) -O2 (10-5) 5%
2-BB (2F, 3F) B-3 (11-1) 4%
2-HBB (2F, 3F) -O2 (10-7) 3%
3-HBB (2F, 3F) -O2 (10-7) 8%
4-HBB (2F, 3F) -O2 (10-7) 5%
5-HBB (2F, 3F) -O2 (10-7) 8%
3-HH-V (2-1) 33%
V-HHB-1 (3-1) 3%
NI = 76.4 ° C; Tc <-30 ° C; Δn = 0.104; Δε = -3.2; Vth = 2.06V; η = 15.6 mPa · s.
[組成物(M13)]
2-H1OB(2F,3F)-O2      (9-5)     6%
3-H1OB(2F,3F)-O2      (9-5)     4%
3-BB(2F,3F)-O2        (9-3)     3%
2-HH1OB(2F,3F)-O2     (10-5)   14%
2-HBB(2F,3F)-O2       (10-7)    7%
3-HBB(2F,3F)-O2       (10-7)   11%
5-HBB(2F,3F)-O2       (10-7)    9%
2-HH-3                (2-1)     5%
3-HH-VFF              (2-1)    30%
1-BB-3                (2-8)     5%
3-HHB-1               (3-1)     3%
3-HBB-2               (3-4)     3%
 NI=78.3℃;Tc<-20℃;Δn=0.103;Δε=-3.2;Vth=2.17V;η=17.7mPa・s.
[Composition (M13)]
2-H1OB (2F, 3F) -O2 (9-5) 6%
3-H1OB (2F, 3F) -O2 (9-5) 4%
3-BB (2F, 3F) -O2 (9-3) 3%
2-HH1OB (2F, 3F) -O2 (10-5) 14%
2-HBB (2F, 3F) -O2 (10-7) 7%
3-HBB (2F, 3F) -O2 (10-7) 11%
5-HBB (2F, 3F) -O2 (10-7) 9%
2-HH-3 (2-1) 5%
3-HH-VFF (2-1) 30%
1-BB-3 (2-8) 5%
3-HHB-1 (3-1) 3%
3-HBB-2 (3-4) 3%
NI = 78.3 ° C; Tc <-20 ° C; Δn = 0.103; Δε = -3.2; Vth = 2.17V; η = 17.7mPa · s.
[組成物(M14)]
3-HB(2F,3F)-O2        (9-1)     5%
5-HB(2F,3F)-O2        (9-1)     7%
3-BB(2F,3F)-O2        (9-3)     8%
3-HHB(2F,3F)-O2       (10-1)    5%
5-HHB(2F,3F)-O2       (10-1)    4%
3-HH1OB(2F,3F)-O2     (10-5)    5%
2-BB(2F,3F)B-3        (11-1)    4%
2-HBB(2F,3F)-O2       (10-7)    3%
3-HBB(2F,3F)-O2       (10-7)    9%
4-HBB(2F,3F)-O2       (10-7)    4%
5-HBB(2F,3F)-O2       (10-7)    8%
3-HH-V                (2-1)    27%
3-HH-V1               (2-1)     6%
V-HHB-1               (3-1)     5%
 NI=81.2℃;Tc<-20℃;Δn=0.107;Δε=-3.2;Vth=2.11V;η=15.5mPa・s.
[Composition (M14)]
3-HB (2F, 3F) -O2 (9-1) 5%
5-HB (2F, 3F) -O2 (9-1) 7%
3-BB (2F, 3F) -O2 (9-3) 8%
3-HHB (2F, 3F) -O2 (10-1) 5%
5-HHB (2F, 3F) -O2 (10-1) 4%
3-HH1OB (2F, 3F) -O2 (10-5) 5%
2-BB (2F, 3F) B-3 (11-1) 4%
2-HBB (2F, 3F) -O2 (10-7) 3%
3-HBB (2F, 3F) -O2 (10-7) 9%
4-HBB (2F, 3F) -O2 (10-7) 4%
5-HBB (2F, 3F) -O2 (10-7) 8%
3-HH-V (2-1) 27%
3-HH-V1 (2-1) 6%
V-HHB-1 (3-1) 5%
NI = 81.2 ° C; Tc <-20 ° C; Δn = 0.107; Δε = -3.2; Vth = 2.11V; η = 15.5 mPa · s.
[組成物(M15)]
3-H2B(2F,3F)-O2       (9-4)     7%
3-HHB(2F,3F)-O2       (10-1)    8%
3-HH1OB(2F,3F)-O2     (10-5)    5%
2-BB(2F,3F)B-3        (11-1)    7%
2-BB(2F,3F)B-4        (11-1)    7%
3-HDhB(2F,3F)-O2      (10-3)    3%
5-HDhB(2F,3F)-O2      (10-3)    4%
2-HchB(2F,3F)-O2      (16-3)    8%
4-HH-V                (2-1)    15%
3-HH-V1               (2-1)     6%
1-HH-2V1              (2-1)     6%
3-HH-2V1              (2-1)     4%
V2-BB-1               (2-8)     5%
1V2-BB-1              (2-8)     5%
3-HHB-1               (3-1)     6%
3-HB(F)BH-3           (4-2)     4%
 NI=88.7℃;Tc<-30℃;Δn=0.115;Δε=-1.9;Vth=2.82V;η=17.3mPa・s.
[Composition (M15)]
3-H2B (2F, 3F) -O2 (9-4) 7%
3-HHB (2F, 3F) -O2 (10-1) 8%
3-HH1OB (2F, 3F) -O2 (10-5) 5%
2-BB (2F, 3F) B-3 (11-1) 7%
2-BB (2F, 3F) B-4 (11-1) 7%
3-HDhB (2F, 3F) -O2 (10-3) 3%
5-HDhB (2F, 3F) -O2 (10-3) 4%
2-HchB (2F, 3F) -O2 (16-3) 8%
4-HH-V (2-1) 15%
3-HH-V1 (2-1) 6%
1-HH-2V1 (2-1) 6%
3-HH-2V1 (2-1) 4%
V2-BB-1 (2-8) 5%
1V2-BB-1 (2-8) 5%
3-HHB-1 (3-1) 6%
3-HB (F) BH-3 (4-2) 4%
NI = 88.7 ° C; Tc <-30 ° C; Δn = 0.115; Δε = -1.9; Vth = 2.82V; η = 17.3mPa · s.
[組成物(M16)]
V2-H2B(2F,3F)-O2      (9-4)     8%
V2-H1OB(2F,3F)-O4     (9-5)     4%
3-BB(2F,3F)-O2        (9-3)     7%
2-HHB(2F,3F)-O2       (10-1)    7%
3-HHB(2F,3F)-O2       (10-1)    7%
3-HH2B(2F,3F)-O2      (10-4)    7%
5-HH2B(2F,3F)-O2      (10-4)    4%
V-HH2B(2F,3F)-O2      (10-4)    6%
V2-HBB(2F,3F)-O2      (10-7)    5%
V-HBB(2F,3F)-O2       (10-7)    5%
V-HBB(2F,3F)-O4       (10-7)    6%
2-HH-3                (2-1)    12%
1-BB-5                (2-8)    12%
3-HHB-1               (3-1)     4%
3-HHB-O1              (3-1)     3%
3-HBB-2               (3-4)     3%
 NI=89.9℃;Tc<-20℃;Δn=0.122;Δε=-4.2;Vth=2.16V;η=23.4mPa・s.
[Composition (M16)]
V2-H2B (2F, 3F) -O2 (9-4) 8%
V2-H1OB (2F, 3F) -O4 (9-5) 4%
3-BB (2F, 3F) -O2 (9-3) 7%
2-HHB (2F, 3F) -O2 (10-1) 7%
3-HHB (2F, 3F) -O2 (10-1) 7%
3-HH2B (2F, 3F) -O2 (10-4) 7%
5-HH2B (2F, 3F) -O2 (10-4) 4%
V-HH2B (2F, 3F) -O2 (10-4) 6%
V2-HBB (2F, 3F) -O2 (10-7) 5%
V-HBB (2F, 3F) -O2 (10-7) 5%
V-HBB (2F, 3F) -O4 (10-7) 6%
2-HH-3 (2-1) 12%
1-BB-5 (2-8) 12%
3-HHB-1 (3-1) 4%
3-HHB-O1 (3-1) 3%
3-HBB-2 (3-4) 3%
NI = 89.9 ° C; Tc <-20 ° C; Δn = 0.122; Δε = -4.2; Vth = 2.16V; η = 23.4 mPa · s.
[組成物(M17)]
3-HB(2F,3F)-O2        (9-1)     3%
V-HB(2F,3F)-O2        (9-1)     3%
V2-HB(2F,3F)-O2       (9-1)     5%
5-H2B(2F,3F)-O2       (9-4)     5%
V2-BB(2F,3F)-O2       (9-3)     3%
1V2-BB(2F,3F)-O2      (9-3)     3%
3-HHB(2F,3F)-O2       (10-1)    6%
V-HHB(2F,3F)-O2       (10-1)    6%
V-HHB(2F,3F)-O4       (10-1)    5%
V2-HHB(2F,3F)-O2      (10-1)    4%
V2-BB(2F,3F)B-1       (11-1)    4%
V2-HBB(2F,3F)-O2      (10-7)    5%
V-HBB(2F,3F)-O2       (10-7)    4%
V-HBB(2F,3F)-O4       (10-7)    5%
V-HHB(2F,3Cl)-O2      (10-12)   3%
3-HH-V                (2-1)    27%
3-HH-V1               (2-1)     6%
V-HHB-1               (3-1)     3%
 NI=77.1℃;Tc<-20℃;Δn=0.101;Δε=-3.0;Vth=2.04V;η=13.9mPa・s.
[Composition (M17)]
3-HB (2F, 3F) -O2 (9-1) 3%
V-HB (2F, 3F) -O2 (9-1) 3%
V2-HB (2F, 3F) -O2 (9-1) 5%
5-H2B (2F, 3F) -O2 (9-4) 5%
V2-BB (2F, 3F) -O2 (9-3) 3%
1V2-BB (2F, 3F) -O2 (9-3) 3%
3-HHB (2F, 3F) -O2 (10-1) 6%
V-HHB (2F, 3F) -O2 (10-1) 6%
V-HHB (2F, 3F) -O4 (10-1) 5%
V2-HHB (2F, 3F) -O2 (10-1) 4%
V2-BB (2F, 3F) B-1 (11-1) 4%
V2-HBB (2F, 3F) -O2 (10-7) 5%
V-HBB (2F, 3F) -O2 (10-7) 4%
V-HBB (2F, 3F) -O4 (10-7) 5%
V-HHB (2F, 3Cl) -O2 (10-12) 3%
3-HH-V (2-1) 27%
3-HH-V1 (2-1) 6%
V-HHB-1 (3-1) 3%
NI = 77.1 ° C; Tc <-20 ° C; Δn = 0.101; Δε = −3.0; Vth = 2.04V; η = 13.9 mPa · s.
[組成物(M18)]
V-HB(2F,3F)-O2        (9-1)    10%
V2-HB(2F,3F)-O2       (9-1)    10%
2-H1OB(2F,3F)-O2      (9-5)     3%
3-H1OB(2F,3F)-O2      (9-5)     3%
2O-BB(2F,3F)-O2       (9-3)     3%
V2-BB(2F,3F)-O2       (9-3)     8%
V2-HHB(2F,3F)-O2      (10-1)    5%
2-HBB(2F,3F)-O2       (10-7)    3%
3-HBB(2F,3F)-O2       (10-7)    3%
V-HBB(2F,3F)-O2       (10-7)    6%
V-HBB(2F,3F)-O4       (10-7)    8%
V-HHB(2F,3Cl)-O2      (10-12)   7%
3-HH-4                (2-1)    14%
V-HHB-1               (3-1)    10%
3-HBB-2               (3-4)     7%
 NI=75.9℃;Tc<-20℃;Δn=0.114;Δε=-3.9;Vth=2.20V;η=24.7mPa・s.
[Composition (M18)]
V-HB (2F, 3F) -O2 (9-1) 10%
V2-HB (2F, 3F) -O2 (9-1) 10%
2-H1OB (2F, 3F) -O2 (9-5) 3%
3-H1OB (2F, 3F) -O2 (9-5) 3%
2O-BB (2F, 3F) -O2 (9-3) 3%
V2-BB (2F, 3F) -O2 (9-3) 8%
V2-HHB (2F, 3F) -O2 (10-1) 5%
2-HBB (2F, 3F) -O2 (10-7) 3%
3-HBB (2F, 3F) -O2 (10-7) 3%
V-HBB (2F, 3F) -O2 (10-7) 6%
V-HBB (2F, 3F) -O4 (10-7) 8%
V-HHB (2F, 3Cl) -O2 (10-12) 7%
3-HH-4 (2-1) 14%
V-HHB-1 (3-1) 10%
3-HBB-2 (3-4) 7%
NI = 75.9 ° C; Tc <-20 ° C; Δn = 0.114; Δε = -3.9; Vth = 2.20V; η = 24.7mPa · s.
[組成物(M19)]
2-H1OB(2F,3F)-O2      (9-5)     7%
3-H1OB(2F,3F)-O2      (9-5)    11%
3-HH1OB(2F,3F)-O2     (10-5)    8%
2-HBB(2F,3F)-O2       (10-7)    3%
3-HBB(2F,3F)-O2       (10-7)    9%
5-HBB(2F,3F)-O2       (10-7)    7%
V-HBB(2F,3F)-O2       (10-7)    8%
3-HDhB(2F,3F)-O2      (10-3)  3.5%
2-HH-3                (2-1)    21%
3-HH-4                (2-1)     5%
3-HB-O2               (2-5)   2.5%
1-BB-3                (2-8)     4%
3-HHB-1               (3-1)   1.5%
3-HBB-2               (3-4)   9.5%
 NI=80.8℃;Tc<-20℃;Δn=0.108;Δε=-3.8;Vth=2.02V;η=19.8mPa・s.
[Composition (M19)]
2-H1OB (2F, 3F) -O2 (9-5) 7%
3-H1OB (2F, 3F) -O2 (9-5) 11%
3-HH1OB (2F, 3F) -O2 (10-5) 8%
2-HBB (2F, 3F) -O2 (10-7) 3%
3-HBB (2F, 3F) -O2 (10-7) 9%
5-HBB (2F, 3F) -O2 (10-7) 7%
V-HBB (2F, 3F) -O2 (10-7) 8%
3-HDhB (2F, 3F) -O2 (10-3) 3.5%
2-HH-3 (2-1) 21%
3-HH-4 (2-1) 5%
3-HB-O2 (2-5) 2.5%
1-BB-3 (2-8) 4%
3-HHB-1 (3-1) 1.5%
3-HBB-2 (3-4) 9.5%
NI = 80.8 ° C; Tc <-20 ° C; Δn = 0.108; Δε = -3.8; Vth = 2.02V; η = 19.8 mPa · s.
[組成物(M20)]
2-H1OB(2F,3F)-O2      (9-5)   5.5%
2-BB(2F,3F)-O2        (9-3)    11%
2-HH1OB(2F,3F)-O2     (10-5)   13%
3-HH1OB(2F,3F)-O2     (10-5) 15.5%
3-HBB(2F,3F)-O2       (10-7)    9%
2-HH-3                (2-1)    25%
3-HH-4                (2-1)     3%
3-HBB-2               (3-4)    14%
5-B(F)BB-2            (3-8)     4%
 NI=85.3℃;Tc<-20℃;Δn=0.109;Δε=-3.6;Vth=2.06V;η=20.9mPa・s.
[Composition (M20)]
2-H1OB (2F, 3F) -O2 (9-5) 5.5%
2-BB (2F, 3F) -O2 (9-3) 11%
2-HH1OB (2F, 3F) -O2 (10-5) 13%
3-HH1OB (2F, 3F) -O2 (10-5) 15.5%
3-HBB (2F, 3F) -O2 (10-7) 9%
2-HH-3 (2-1) 25%
3-HH-4 (2-1) 3%
3-HBB-2 (3-4) 14%
5-B (F) BB-2 (3-8) 4%
NI = 85.3 ° C; Tc <-20 ° C; Δn = 0.109; Δε = -3.6; Vth = 2.06V; η = 20.9mPa · s.
[組成物(M21)]
V-HB(2F,3F)-O2        (9-1)     7%
V-2BB(2F,3F)-O2       (9-3)    10%
V-HHB(2F,3F)-O1       (10-1)    7%
V-HHB(2F,3F)-O2       (10-1)    9%
V-2HHB(2F,3F)-O2      (10-1)    8%
3-HH2B(2F,3F)-O2      (10-4)    9%
V-HBB(2F,3F)-O2       (10-7)    7%
V-HBB(2F,3F)-O4       (10-7)    7%
2-HH-3                (2-1)     9%
3-HH-4                (2-1)     3%
3-HH-V                (2-1)    15%
3-HH-V1               (2-1)     6%
1V2-HH-3              (2-1)     3%
 NI=87.5℃;Tc<-20℃;Δn=0.100;Δε=-3.4;Vth=2.25V;η=16.6mPa・s.
[Composition (M21)]
V-HB (2F, 3F) -O2 (9-1) 7%
V-2BB (2F, 3F) -O2 (9-3) 10%
V-HHB (2F, 3F) -O1 (10-1) 7%
V-HHB (2F, 3F) -O2 (10-1) 9%
V-2HHB (2F, 3F) -O2 (10-1) 8%
3-HH2B (2F, 3F) -O2 (10-4) 9%
V-HBB (2F, 3F) -O2 (10-7) 7%
V-HBB (2F, 3F) -O4 (10-7) 7%
2-HH-3 (2-1) 9%
3-HH-4 (2-1) 3%
3-HH-V (2-1) 15%
3-HH-V1 (2-1) 6%
1V2-HH-3 (2-1) 3%
NI = 87.5 ° C; Tc <-20 ° C; Δn = 0.100; Δε = -3.4; Vth = 2.25V; η = 16.6 mPa · s.
[組成物(M22)]
3-HHXB(F,F)-F         (6-100)   6%
3-BB(F,F)XB(F,F)-F    (6-97)   13%
3-HHBB(F,F)-F         (7-6)     4%
4-HHBB(F,F)-F         (7-6)     5%
3-HBBXB(F,F)-F        (7-32)    3%
3-BB(F)B(F,F)XB(F)-F  (7-46)    2%
4-BB(F)B(F,F)XB(F,F)-F (7-47)   8%
5-BB(F)B(F,F)XB(F,F)-F (7-47)   7%
3-HH-V                (2-1)    44%
V-HHB-1               (3-1)     6%
2-BB(F)B-3             (3-6)    2%
NI=79.8℃;Tc<-30℃;Δn=0.106;Δε=8.5;Vth=1.45V;η=11.6mPa・s;γ1=60.0mPa・s.
[Composition (M22)]
3-HHXB (F, F) -F (6-100) 6%
3-BB (F, F) XB (F, F) -F (6-97) 13%
3-HHBB (F, F) -F (7-6) 4%
4-HHBB (F, F) -F (7-6) 5%
3-HBBXB (F, F) -F (7-32) 3%
3-BB (F) B (F, F) XB (F) -F (7-46) 2%
4-BB (F) B (F, F) XB (F, F) -F (7-47) 8%
5-BB (F) B (F, F) XB (F, F) -F (7-47) 7%
3-HH-V (2-1) 44%
V-HHB-1 (3-1) 6%
2-BB (F) B-3 (3-6) 2%
NI = 79.8 ° C; Tc <-30 ° C; Δn = 0.106; Δε = 8.5; Vth = 1.45V; η = 11.6 mPa · s; γ1 = 60.0 mPa · s.
[組成物(M23)]
5-HXB(F,F)-F          (5-13)    3%
3-HHXB(F,F)-F         (6-100)   3%
3-HHXB(F,F)-CF3       (6-100)   3%
3-HGB(F,F)-F          (6-103)   3%
3-HB(F)B(F,F)-F       (6-50)    5%
3-BB(F,F)XB(F,F)-F    (6-97)    6%
3-HHBB(F,F)-F         (7-6)     6%
5-BB(F)B(F,F)XB(F)B(F,F)-F (-)
                                2%
3-BB(2F,3F)XB(F,F)-F  (6-114)   4%
3-B(2F,3F)BXB(F,F)-F  (6-115)   5%
3-HHB(F,F)XB(F,F)-F   (7-29)    4%
3-HB-CL               (5-2)     3%
3-HHB-OCF3            (6-1)     3%
3-HH-V                (2-1)    22%
3-HH-V1               (2-1)    10%
5-HB-O2               (2-5)     5%
3-HHEH-3              (3-13)    3%
3-HBB-2               (3-4)     7%
5-B(F)BB-3            (3-8)     3%
NI=71.2℃;Tc<-20℃;Δn=0.099;Δε=6.1;Vth=1.74V;η=13.2mPa・s;γ1=59.3mPa・s.
[Composition (M23)]
5-HXB (F, F) -F (5-13) 3%
3-HHXB (F, F) -F (6-100) 3%
3-HHXB (F, F) -CF3 (6-100) 3%
3-HGB (F, F) -F (6-103) 3%
3-HB (F) B (F, F) -F (6-50) 5%
3-BB (F, F) XB (F, F) -F (6-97) 6%
3-HHBB (F, F) -F (7-6) 6%
5-BB (F) B (F, F) XB (F) B (F, F) -F (-)
2%
3-BB (2F, 3F) XB (F, F) -F (6-114) 4%
3-B (2F, 3F) BXB (F, F) -F (6-115) 5%
3-HHB (F, F) XB (F, F) -F (7-29) 4%
3-HB-CL (5-2) 3%
3-HHB-OCF3 (6-1) 3%
3-HH-V (2-1) 22%
3-HH-V1 (2-1) 10%
5-HB-O2 (2-5) 5%
3-HHEH-3 (3-13) 3%
3-HBB-2 (3-4) 7%
5-B (F) BB-3 (3-8) 3%
NI = 71.2 ° C; Tc <-20 ° C; Δn = 0.099; Δε = 6.1; Vth = 1.74V; η = 13.2 mPa · s; γ1 = 59.3 mPa · s.
[組成物(M24)]
5-HXB(F,F)-F          (5-13)    6%
3-HHXB(F,F)-F         (6-100)   6%
V-HB(F)B(F,F)-F       (6-50)    5%
3-HHB(F)B(F,F)-F      (7-9)     7%
2-BB(F)B(F,F)XB(F)-F  (7-47)    3%
3-BB(F)B(F,F)XB(F)-F  (7-47)    3%
4-BB(F)B(F,F)XB(F)-F  (7-47)    4%
5-HB-CL               (5-2)     5%
2-HH-5                (2-1)     8%
3-HH-V                (2-1)    10%
3-HH-V1               (2-1)     7%
4-HH-V                (2-1)    10%
4-HH-V1               (2-1)     8%
5-HB-O2               (2-5)     7%
4-HHEH-3              (3-13)    3%
1-BB(F)B-2V           (3-6)     3%
1O1-HBBH-3            (4-1)     5%
NI=78.5℃;Tc<-20℃;Δn=0.095;Δε=3.4;Vth=1.50V;η=8.4mPa・s;γ1=54.2mPa・s.
[Composition (M24)]
5-HXB (F, F) -F (5-13) 6%
3-HHXB (F, F) -F (6-100) 6%
V-HB (F) B (F, F) -F (6-50) 5%
3-HHB (F) B (F, F) -F (7-9) 7%
2-BB (F) B (F, F) XB (F) -F (7-47) 3%
3-BB (F) B (F, F) XB (F) -F (7-47) 3%
4-BB (F) B (F, F) XB (F) -F (7-47) 4%
5-HB-CL (5-2) 5%
2-HH-5 (2-1) 8%
3-HH-V (2-1) 10%
3-HH-V1 (2-1) 7%
4-HH-V (2-1) 10%
4-HH-V1 (2-1) 8%
5-HB-O2 (2-5) 7%
4-HHEH-3 (3-13) 3%
1-BB (F) B-2V (3-6) 3%
1O1-HBBH-3 (4-1) 5%
NI = 78.5 ° C; Tc <-20 ° C; Δn = 0.095; Δε = 3.4; Vth = 1.50V; η = 8.4mPa · s; γ1 = 54.2mPa · s.
[組成物(M25)]
3-HHEB(F,F)-F         (6-12)    5%
3-HHXB(F,F)-F         (6-100)   7%
5-HBEB(F,F)-F         (6-39)    5%
3-BB(F,F)XB(F,F)-F    (6-97)   10%
2-HHB(F)B(F,F)-F      (7-9)     3%
3-HB(2F,3F)BXB(F,F)-F (7-58)    3%
3-BB(2F,3F)BXB(F,F)-F (7-59)    2%
5-HHB(F,F)XB(F,F)-F   (7-29)    6%
2-HH-3                (2-1)     8%
3-HH-V                (2-1)    20%
3-HH-V1               (2-1)     7%
4-HH-V                (2-1)     6%
5-HB-O2               (2-5)     5%
V2-B2BB-1             (3)       3%
3-HHEBH-3             (4-6)     5%
3-HHEBH-5             (4-6)     5%
NI=90.3℃;Tc<-20℃;Δn=0.089;Δε=5.5;Vth=1.65V;η=13.6mPa・s;γ1=60.1mPa・s.
[Composition (M25)]
3-HHEB (F, F) -F (6-12) 5%
3-HHXB (F, F) -F (6-100) 7%
5-HBEB (F, F) -F (6-39) 5%
3-BB (F, F) XB (F, F) -F (6-97) 10%
2-HHB (F) B (F, F) -F (7-9) 3%
3-HB (2F, 3F) BXB (F, F) -F (7-58) 3%
3-BB (2F, 3F) BXB (F, F) -F (7-59) 2%
5-HHB (F, F) XB (F, F) -F (7-29) 6%
2-HH-3 (2-1) 8%
3-HH-V (2-1) 20%
3-HH-V1 (2-1) 7%
4-HH-V (2-1) 6%
5-HB-O2 (2-5) 5%
V2-B2BB-1 (3) 3%
3-HHEBH-3 (4-6) 5%
3-HHEBH-5 (4-6) 5%
NI = 90.3 ° C; Tc <-20 ° C; Δn = 0.089; Δε = 5.5; Vth = 1.65V; η = 13.6 mPa · s; γ1 = 60.1 mPa · s.
[組成物(M26)]
3-BB(F,F)XB(F,F)-F    (6-97)   12%
3-HHBB(F,F)-F         (7-6)     5%
4-HHBB(F,F)-F         (7-6)     4%
3-HBBXB(F,F)-F        (7-32)    3%
3-BB(F)B(F,F)XB(F)-F  (7-46)    3%
3-BB(F)B(F,F)XB(F,F)-F (7-47)   3%
4-BB(F)B(F,F)XB(F,F)-F (7-47)   5%
5-BB(F)B(F,F)XB(F,F)-F (7-47)   4%
2-HH-3                (2-1)     6%
3-HH-5                (2-1)     6%
3-HH-V                (2-1)    25%
3-HH-VFF              (2-1)     6%
5-HB-O2               (2-5)     7%
V-HHB-1               (3-1)     6%
V-HBB-2               (3-4)     5%
NI=78.3℃;Tc<-20℃;Δn=0.107;Δε=7.0;Vth=1.55V;η=11.6mPa・s;γ1=55.6mPa・s.
[Composition (M26)]
3-BB (F, F) XB (F, F) -F (6-97) 12%
3-HHBB (F, F) -F (7-6) 5%
4-HHBB (F, F) -F (7-6) 4%
3-HBBXB (F, F) -F (7-32) 3%
3-BB (F) B (F, F) XB (F) -F (7-46) 3%
3-BB (F) B (F, F) XB (F, F) -F (7-47) 3%
4-BB (F) B (F, F) XB (F, F) -F (7-47) 5%
5-BB (F) B (F, F) XB (F, F) -F (7-47) 4%
2-HH-3 (2-1) 6%
3-HH-5 (2-1) 6%
3-HH-V (2-1) 25%
3-HH-VFF (2-1) 6%
5-HB-O2 (2-5) 7%
V-HHB-1 (3-1) 6%
V-HBB-2 (3-4) 5%
NI = 78.3 ° C; Tc <-20 ° C; Δn = 0.107; Δε = 7.0; Vth = 1.55V; η = 11.6mPa · s; γ1 = 55.6mPa · s.
[組成物(M27)]
3-HHXB(F,F)-F         (6-100)   3%
3-BBXB(F,F)-F         (6-91)    3%
3-BB(F,F)XB(F,F)-F    (6-97)    8%
3-HHBB(F,F)-F         (7-6)     5%
4-HHBB(F,F)-F         (7-6)     4%
3-BB(F)B(F,F)XB(F,F)-F (7-47)   3%
4-BB(F)B(F,F)XB(F,F)-F (7-47)   6%
5-BB(F)B(F,F)XB(F,F)-F (7-47)   5%
3-HH-V                (2-1)    30%
3-HH-V1               (2-1)     5%
3-HHB-O1              (3-1)     2%
V-HHB-1               (3-1)     5%
2-BB(F)B-3            (3-6)     6%
F3-HH-V               (2-1)    15%
NI=80.4℃;Tc<-20℃;Δn=0.106;Δε=5.8;Vth=1.40V;η=11.6mPa・s;γ1=61.0mPa・s.
[Composition (M27)]
3-HHXB (F, F) -F (6-100) 3%
3-BBXB (F, F) -F (6-91) 3%
3-BB (F, F) XB (F, F) -F (6-97) 8%
3-HHBB (F, F) -F (7-6) 5%
4-HHBB (F, F) -F (7-6) 4%
3-BB (F) B (F, F) XB (F, F) -F (7-47) 3%
4-BB (F) B (F, F) XB (F, F) -F (7-47) 6%
5-BB (F) B (F, F) XB (F, F) -F (7-47) 5%
3-HH-V (2-1) 30%
3-HH-V1 (2-1) 5%
3-HHB-O1 (3-1) 2%
V-HHB-1 (3-1) 5%
2-BB (F) B-3 (3-6) 6%
F3-HH-V (2-1) 15%
NI = 80.4 ° C; Tc <-20 ° C; Δn = 0.106; Δε = 5.8; Vth = 1.40V; η = 11.6mPa · s; γ1 = 61.0mPa · s.
[組成物(M28)]
3-HGB(F,F)-F          (6-103)   3%
5-GHB(F,F)-F          (6-109)   4%
3-GB(F,F)XB(F,F)-F    (6-113)   5%
3-BB(F)B(F,F)-CF3     (6-69)    2%
3-HHBB(F,F)-F         (7-6)     4%
3-GBB(F)B(F,F)-F      (7-55)    2%
2-dhBB(F,F)XB(F,F)-F  (7-50)    4%
3-GB(F)B(F,F)XB(F,F)-F (7-57)   3%
3-HGB(F,F)XB(F,F)-F   (―)       5%
7-HB(F,F)-F           (5-4)     3%
2-HH-3                (2-1)    14%
2-HH-5                (2-1)     4%
3-HH-V                (2-1)    26%
1V2-HH-3              (2-1)     5%
1V2-BB-1              (2-8)     3%
2-BB(F)B-3            (3-6)     3%
3-HB(F)HH-2           (4-7)     4%
5-HBB(F)B-2           (4-5)     6%
NI=78.4℃;Tc<-20℃;Δn=0.094;Δε=5.6;Vth=1.45V;η=11.5mPa・s;γ1=61.7mPa・s.
[Composition (M28)]
3-HGB (F, F) -F (6-103) 3%
5-GHB (F, F) -F (6-109) 4%
3-GB (F, F) XB (F, F) -F (6-113) 5%
3-BB (F) B (F, F) -CF3 (6-69) 2%
3-HHBB (F, F) -F (7-6) 4%
3-GBB (F) B (F, F) -F (7-55) 2%
2-dhBB (F, F) XB (F, F) -F (7-50) 4%
3-GB (F) B (F, F) XB (F, F) -F (7-57) 3%
3-HGB (F, F) XB (F, F) -F (-) 5%
7-HB (F, F) -F (5-4) 3%
2-HH-3 (2-1) 14%
2-HH-5 (2-1) 4%
3-HH-V (2-1) 26%
1V2-HH-3 (2-1) 5%
1V2-BB-1 (2-8) 3%
2-BB (F) B-3 (3-6) 3%
3-HB (F) HH-2 (4-7) 4%
5-HBB (F) B-2 (4-5) 6%
NI = 78.4 ° C; Tc <-20 ° C; Δn = 0.094; Δε = 5.6; Vth = 1.45V; η = 11.5mPa · s; γ1 = 61.7mPa · s.
[組成物(M29)]
3-HBB(F,F)-F          (6-24)    5%
5-HBB(F,F)-F          (6-24)    4%
3-BB(F)B(F,F)-F       (6-69)    3%
3-BB(F)B(F,F)XB(F,F)-F (7-47)   3%
4-BB(F)B(F,F)XB(F,F)-F (7-47)   5%
3-BB(F,F)XB(F)B(F,F)-F (7-60)   3%
5-BB(F)B(F,F)XB(F)B(F,F)-F (-)
                                4%
3-HH2BB(F,F)-F        (7-15)    3%
4-HH2BB(F,F)-F        (7-15)    3%
2-HH-5                (2-1)     8%
3-HH-V                (2-1)    25%
3-HH-V1               (2-1)     7%
4-HH-V1               (2-1)     6%
5-HB-O2               (2-5)     5%
7-HB-1                (2-5)     5%
VFF-HHB-O1            (3-1)     8%
VFF-HHB-1             (3-1)     3%
NI=80.0℃;Tc<-20℃;Δn=0.101;Δε=4.6;Vth=1.71V;η=11.0mPa・s;γ1=47.2mPa・s.
[Composition (M29)]
3-HBB (F, F) -F (6-24) 5%
5-HBB (F, F) -F (6-24) 4%
3-BB (F) B (F, F) -F (6-69) 3%
3-BB (F) B (F, F) XB (F, F) -F (7-47) 3%
4-BB (F) B (F, F) XB (F, F) -F (7-47) 5%
3-BB (F, F) XB (F) B (F, F) -F (7-60) 3%
5-BB (F) B (F, F) XB (F) B (F, F) -F (-)
4%
3-HH2BB (F, F) -F (7-15) 3%
4-HH2BB (F, F) -F (7-15) 3%
2-HH-5 (2-1) 8%
3-HH-V (2-1) 25%
3-HH-V1 (2-1) 7%
4-HH-V1 (2-1) 6%
5-HB-O2 (2-5) 5%
7-HB-1 (2-5) 5%
VFF-HHB-O1 (3-1) 8%
VFF-HHB-1 (3-1) 3%
NI = 80.0 ° C; Tc <-20 ° C; Δn = 0.101; Δε = 4.6; Vth = 1.71V; η = 11.0 mPa · s; γ1 = 47.2 mPa · s.
[組成物(M30)]
3-HHB(F,F)-F          (6-3)     8%
3-GB(F)B(F)-F         (6-116)   2%
3-GB(F)B(F,F)-F       (6-117)   3%
3-BB(F,F)XB(F,F)-F    (6-97)    8%
3-GB(F)B(F,F)XB(F,F)-F (7-57)   6%
5-GB(F)B(F,F)XB(F,F)-F (7-57)   5%
3-HH-V                (2-1)    30%
3-HH-V1               (2-1)    10%
1V2-HH-3              (2-1)     8%
3-HH-VFF              (2-1)     8%
V2-BB-1               (2-8)     2%
5-HB(F)BH-3           (4-2)     5%
5-HBBH-3              (4-1)     5%
NI=78.6℃;Tc<-20℃;Δn=0.088;Δε=5.6;Vth=1.85V;η=13.9mPa・s;γ1=66.9mPa・s.
[Composition (M30)]
3-HHB (F, F) -F (6-3) 8%
3-GB (F) B (F) -F (6-116) 2%
3-GB (F) B (F, F) -F (6-117) 3%
3-BB (F, F) XB (F, F) -F (6-97) 8%
3-GB (F) B (F, F) XB (F, F) -F (7-57) 6%
5-GB (F) B (F, F) XB (F, F) -F (7-57) 5%
3-HH-V (2-1) 30%
3-HH-V1 (2-1) 10%
1V2-HH-3 (2-1) 8%
3-HH-VFF (2-1) 8%
V2-BB-1 (2-8) 2%
5-HB (F) BH-3 (4-2) 5%
5-HBBH-3 (4-1) 5%
NI = 78.6 ° C; Tc <-20 ° C; Δn = 0.088; Δε = 5.6; Vth = 1.85V; η = 13.9mPa · s; γ1 = 66.9mPa · s.
[組成物(M31)]
3-HHEB(F,F)-F         (6-12)    4%
5-HHEB(F,F)-F         (6-12)    3%
3-HBEB(F,F)-F         (6-39)    3%
5-HBEB(F,F)-F         (6-39)    3%
3-BB(F)B(F,F)-F       (6-69)    3%
3-GB(F)B(F,F)XB(F,F)-F (7-57)   5%
4-GB(F)B(F,F)XB(F,F)-F (7-57)   5%
5-HB-CL               (2-5)     5%
3-HHB-OCF3            (3-1)     4%
3-HHB(F,F)XB(F,F)-F   (7-29)    5%
5-HHB(F,F)XB(F,F)-F   (7-29)    3%
3-HGB(F,F)XB(F,F)-F   (-)       5%
2-HH-5                (2-1)     3%
3-HH-5                (2-1)     5%
3-HH-V                (2-1)    24%
4-HH-V                (2-1)     5%
1V2-HH-3              (2-1)     5%
3-HHEH-3              (3-13)    5%
5-B(F)BB-2            (3-8)     3%
5-B(F)BB-3            (3-8)     2%
NI=82.9℃;Tc<-20℃;Δn=0.093;Δε=6.9;Vth=1.50V;η=16.3mPa・s;γ1=65.2mPa・s.
[Composition (M31)]
3-HHEB (F, F) -F (6-12) 4%
5-HHEB (F, F) -F (6-12) 3%
3-HBEB (F, F) -F (6-39) 3%
5-HBEB (F, F) -F (6-39) 3%
3-BB (F) B (F, F) -F (6-69) 3%
3-GB (F) B (F, F) XB (F, F) -F (7-57) 5%
4-GB (F) B (F, F) XB (F, F) -F (7-57) 5%
5-HB-CL (2-5) 5%
3-HHB-OCF3 (3-1) 4%
3-HHB (F, F) XB (F, F) -F (7-29) 5%
5-HHB (F, F) XB (F, F) -F (7-29) 3%
3-HGB (F, F) XB (F, F) -F (-) 5%
2-HH-5 (2-1) 3%
3-HH-5 (2-1) 5%
3-HH-V (2-1) 24%
4-HH-V (2-1) 5%
1V2-HH-3 (2-1) 5%
3-HHEH-3 (3-13) 5%
5-B (F) BB-2 (3-8) 3%
5-B (F) BB-3 (3-8) 2%
NI = 82.9 ° C; Tc <-20 ° C; Δn = 0.093; Δε = 6.9; Vth = 1.50V; η = 16.3 mPa · s; γ1 = 65.2 mPa · s.
[組成物(M32)]
3-HHXB(F,F)-F         (6-100)   9%
3-HBB(F,F)-F          (6-24)    3%
3-BB(F)B(F,F)-F       (6-69)    4%
3-BB(F)B(F,F)-CF3     (6-69)    4%
3-BB(F,F)XB(F,F)-F    (6-97)    5%
3-GBB(F)B(F,F)-F      (7-55)    3%
4-GBB(F)B(F,F)-F      (7-55)    4%
3-HH-V                (2-1)    25%
3-HH-V1               (2-1)    10%
5-HB-O2               (2-5)    10%
7-HB-1                (2-5)     5%
V2-BB-1               (2-8)     3%
3-HHB-1               (3-1)     4%
1V-HBB-2              (3-4)     5%
5-HBB(F)B-2           (4-5)     6%
NI=79.6℃;Tc<-20℃;Δn=0.111;Δε=4.7;Vth=1.86V;η=9.7mPa・s;γ1=49.9mPa・s.
[Composition (M32)]
3-HHXB (F, F) -F (6-100) 9%
3-HBB (F, F) -F (6-24) 3%
3-BB (F) B (F, F) -F (6-69) 4%
3-BB (F) B (F, F) -CF3 (6-69) 4%
3-BB (F, F) XB (F, F) -F (6-97) 5%
3-GBB (F) B (F, F) -F (7-55) 3%
4-GBB (F) B (F, F) -F (7-55) 4%
3-HH-V (2-1) 25%
3-HH-V1 (2-1) 10%
5-HB-O2 (2-5) 10%
7-HB-1 (2-5) 5%
V2-BB-1 (2-8) 3%
3-HHB-1 (3-1) 4%
1V-HBB-2 (3-4) 5%
5-HBB (F) B-2 (4-5) 6%
NI = 79.6 ° C; Tc <-20 ° C; Δn = 0.111; Δε = 4.7; Vth = 1.86V; η = 9.7mPa · s; γ1 = 49.9mPa · s.
[組成物(M33)]
3-BB(F,F)XB(F,F)-F    (6-97)   14%
5-BB(F)B(F,F)XB(F,F)-F (7-47)   7%
7-HB(F,F)-F           (5-4)     6%
2-HH-5                (2-1)     5%
3-HH-V                (2-1)    30%
3-HH-V1               (2-1)     3%
3-HH-VFF              (2-1)    10%
3-HHB-1               (3-1)     4%
3-HHB-3               (3-1)     5%
3-HHB-O1              (3-1)     3%
1-BB(F)B-2V           (3-6)     3%
3-HHEBH-3             (4-6)     3%
3-HHEBH-4             (4-6)     4%
3-HHEBH-5             (4-6)     3%
NI=83.0℃;Tc<-20℃;Δn=0.086;Δε=3.8;Vth=1.94V;η=7.5mPa・s;γ1=51.5mPa・s.
[Composition (M33)]
3-BB (F, F) XB (F, F) -F (6-97) 14%
5-BB (F) B (F, F) XB (F, F) -F (7-47) 7%
7-HB (F, F) -F (5-4) 6%
2-HH-5 (2-1) 5%
3-HH-V (2-1) 30%
3-HH-V1 (2-1) 3%
3-HH-VFF (2-1) 10%
3-HHB-1 (3-1) 4%
3-HHB-3 (3-1) 5%
3-HHB-O1 (3-1) 3%
1-BB (F) B-2V (3-6) 3%
3-HHEBH-3 (4-6) 3%
3-HHEBH-4 (4-6) 4%
3-HHEBH-5 (4-6) 3%
NI = 83.0 ° C; Tc <-20 ° C; Δn = 0.086; Δε = 3.8; Vth = 1.94V; η = 7.5 mPa · s; γ1 = 51.5 mPa · s.
[組成物(M34)]
3-HBB(F,F)-F           (6-24)   5%
5-HBB(F,F)-F          (6-24)    4%
3-BB(F)B(F,F)-F       (6-69)    3%
3-BB(F)B(F,F)XB(F,F)-F (7-47)   3%
4-BB(F)B(F,F)XB(F,F)-F (7-47)   5%
3-BB(F,F)XB(F)B(F,F)-F (7-60)   3%
5-BB(F)B(F,F)XB(F)B(F,F)-F (-)
                                4%
3-HH2BB(F,F)-F        (7-15)    3%
4-HH2BB(F,F)-F        (7-15)    3%
2-HH-5                (2-1)     8%
3-HH-V                (2-1)    28%
4-HH-V1               (2-1)     7%
5-HB-O2               (2-5)     2%
7-HB-1                (2-5)     5%
VFF-HHB-O1            (3-1)     8%
VFF-HHB-1             (3-1)     3%
2-BB(2F,3F)B-3        (11-1)    4%
3-HBB(2F,3F)-O2       (10-7)    2%
NI=81.9℃;Tc<-20℃;Δn=0.109;Δε=4.8;Vth=1.75V;η=13.3mPa・s;γ1=57.4mPa・s.
[Composition (M34)]
3-HBB (F, F) -F (6-24) 5%
5-HBB (F, F) -F (6-24) 4%
3-BB (F) B (F, F) -F (6-69) 3%
3-BB (F) B (F, F) XB (F, F) -F (7-47) 3%
4-BB (F) B (F, F) XB (F, F) -F (7-47) 5%
3-BB (F, F) XB (F) B (F, F) -F (7-60) 3%
5-BB (F) B (F, F) XB (F) B (F, F) -F (-)
4%
3-HH2BB (F, F) -F (7-15) 3%
4-HH2BB (F, F) -F (7-15) 3%
2-HH-5 (2-1) 8%
3-HH-V (2-1) 28%
4-HH-V1 (2-1) 7%
5-HB-O2 (2-5) 2%
7-HB-1 (2-5) 5%
VFF-HHB-O1 (3-1) 8%
VFF-HHB-1 (3-1) 3%
2-BB (2F, 3F) B-3 (11-1) 4%
3-HBB (2F, 3F) -O2 (10-7) 2%
NI = 81.9 ° C; Tc <-20 ° C; Δn = 0.109; Δε = 4.8; Vth = 1.75V; η = 13.3 mPa · s; γ1 = 57.4 mPa · s.
[組成物(M35)]
3-HHEB(F,F)-F         (6-12)    4%
3-HBEB(F,F)-F         (6-39)    3%
5-HBEB(F,F)-F         (6-39)    3%
3-BB(F)B(F,F)-F       (6-69)    3%
3-HBBXB(F,F)-F        (7-32)    6%
4-GBB(F,F)XB(F,F)-F   (7-61)    2%
5-GBB(F,F)XB(F,F)-F   (7-61)    2%
3-GB(F)B(F,F)XB(F,F)-F (7-57)   5%
4-GB(F)B(F,F)XB(F,F)-F (7-57)   5%
5-HHB(F,F)XB(F,F)-F   (7-29)    3%
5-HEB(F,F)-F          (5-10)    3%
5-HB-CL               (5-2)     2%
3-HHB-OCF3            (6-1)     4%
3-HH-5                (2-1)     4%
3-HH-V                (2-1)    21%
3-HH-V1               (2-1)     3%
4-HH-V                (2-1)     4%
1V2-HH-3              (2-1)     6%
5-B(F)BB-2            (3-8)     3%
5-B(F)BB-3            (3-8)     2%
3-HB(2F,3F)-O2        (9-1)     3%
3-BB(2F,3F)-O2        (9-3)     2%
3-HHB(2F,3F)-O2       (10-1)    4%
F3-HH-V               (2-1)     3%
NI=78.2℃;Tc<-20℃;Δn=0.101;Δε=6.7;Vth=1.45V;η=17.8mPa・s;γ1=67.8mPa・s.
[Composition (M35)]
3-HHEB (F, F) -F (6-12) 4%
3-HBEB (F, F) -F (6-39) 3%
5-HBEB (F, F) -F (6-39) 3%
3-BB (F) B (F, F) -F (6-69) 3%
3-HBBXB (F, F) -F (7-32) 6%
4-GBB (F, F) XB (F, F) -F (7-61) 2%
5-GBB (F, F) XB (F, F) -F (7-61) 2%
3-GB (F) B (F, F) XB (F, F) -F (7-57) 5%
4-GB (F) B (F, F) XB (F, F) -F (7-57) 5%
5-HHB (F, F) XB (F, F) -F (7-29) 3%
5-HEB (F, F) -F (5-10) 3%
5-HB-CL (5-2) 2%
3-HHB-OCF3 (6-1) 4%
3-HH-5 (2-1) 4%
3-HH-V (2-1) 21%
3-HH-V1 (2-1) 3%
4-HH-V (2-1) 4%
1V2-HH-3 (2-1) 6%
5-B (F) BB-2 (3-8) 3%
5-B (F) BB-3 (3-8) 2%
3-HB (2F, 3F) -O2 (9-1) 3%
3-BB (2F, 3F) -O2 (9-3) 2%
3-HHB (2F, 3F) -O2 (10-1) 4%
F3-HH-V (2-1) 3%
NI = 78.2 ° C; Tc <-20 ° C; Δn = 0.101; Δε = 6.7; Vth = 1.45V; η = 17.8 mPa · s; γ1 = 67.8 mPa · s.
[組成物(M36)]
3-HHB(F,F)-F          (6-3)    10%
3-HHXB(F,F)-F         (6-100)   2%
3-GHB(F,F)-F          (6-109)   5%
3-BB(F)B(F,F)-F       (6-69)    6%
3-BB(F,F)XB(F,F)-F    (6-97)   14%
4-BB(F)B(F,F)XB(F,F)-F (7-47)  10%
5-BB(F)B(F,F)XB(F,F)-F (7-47)   6%
2-HH-3                (2-1)     5%
3-HH-4                (2-1)    11%
3-HH-O1               (2-1)     5%
5-HB-O2               (2-5)     8%
3-HHB-1               (3-1)     6%
3-HHB-3               (3-1)     6%
3-HHB-O1              (3-1)     6%
NI=77.6℃;Tc<-20℃;Δn=0.109;Δε=10.6;Vth=1.34V;η=22.6mPa・s;γ1=92.4mPa・s.
[Composition (M36)]
3-HHB (F, F) -F (6-3) 10%
3-HHXB (F, F) -F (6-100) 2%
3-GHB (F, F) -F (6-109) 5%
3-BB (F) B (F, F) -F (6-69) 6%
3-BB (F, F) XB (F, F) -F (6-97) 14%
4-BB (F) B (F, F) XB (F, F) -F (7-47) 10%
5-BB (F) B (F, F) XB (F, F) -F (7-47) 6%
2-HH-3 (2-1) 5%
3-HH-4 (2-1) 11%
3-HH-O1 (2-1) 5%
5-HB-O2 (2-5) 8%
3-HHB-1 (3-1) 6%
3-HHB-3 (3-1) 6%
3-HHB-O1 (3-1) 6%
NI = 77.6 ° C; Tc <-20 ° C; Δn = 0.109; Δε = 10.6; Vth = 1.34V; η = 22.6 mPa · s; γ1 = 92.4 mPa · s.
[組成物(M37)]
3-HBB-F               (6-22)    3%
3-BB(F,F)XB(F)-OCF3   (6-96)    3%
3-HHB(F)-F            (6-2)     3%
3-HGB(F,F)-F          (6-103)   3%
5-GHB(F,F)-F          (6-109)   3%
3-HBB(F,F)-F          (6-24)    4%
3-BB(F,F)XB(F,F)-F    (6-97)    5%
3-HHBB(F,F)-F         (7-6)     5%
3-HBBXB(F,F)-F        (7-32)    5%
3-BBVFFXB(F,F)-F      (6-119)   8%
3-HH-V                (2-1)    39%
1-HH-V1               (2-1)     3%
1-HH-2V1              (2-1)     4%
3-HHEH-5              (3-13)    3%
1-BB(F)B-2V           (3-6)     3%
3-HHEBH-3             (4-6)     3%
5-HBB(F)B-2           (4-5)     3%
NI=85.2℃;Tc<-20℃;Δn=0.102;Δε=4.1;γ1=43.0mPa・s.
[Composition (M37)]
3-HBB-F (6-22) 3%
3-BB (F, F) XB (F) -OCF3 (6-96) 3%
3-HHB (F) -F (6-2) 3%
3-HGB (F, F) -F (6-103) 3%
5-GHB (F, F) -F (6-109) 3%
3-HBB (F, F) -F (6-24) 4%
3-BB (F, F) XB (F, F) -F (6-97) 5%
3-HHBB (F, F) -F (7-6) 5%
3-HBBXB (F, F) -F (7-32) 5%
3-BBVFFXB (F, F) -F (6-119) 8%
3-HH-V (2-1) 39%
1-HH-V1 (2-1) 3%
1-HH-2V1 (2-1) 4%
3-HHEH-5 (3-13) 3%
1-BB (F) B-2V (3-6) 3%
3-HHEBH-3 (4-6) 3%
5-HBB (F) B-2 (4-5) 3%
NI = 85.2 ° C; Tc <-20 ° C; Δn = 0.102; Δε = 4.1; γ1 = 43.0 mPa · s.
[組成物(M38)]
3-HHBB(F)-F            (7-5)    3%
2-HHEB(F,F)-F          (6-12)   3%
5-BB(F)B(F,F)-F        (6-69)   7%
3-HHB(F)B(F,F)-F       (7-9)    3%
3-GB(F)B(F,F)XB(F,F)-F (7-57)   3%
3-BB(F,F)XB(F)B(F,F)-F (7-60)   3%
3-HHVFFXB(F,F)-F       (6-120)  5%
3-BBVFFXB(F,F)-F       (6-119)  5%
3-HBBVFFXB(F,F)-F      (7-62)   3%
2-HH-5                 (2-1)    5%
3-HH-V                 (2-1)   20%
5-HH-V                 (2-1)   12%
3-HH-V1                (2-1)    4%
4-HH-V1                (2-1)    5%
2-HH-2V1               (2-1)    3%
1-BB-3                 (2-8)    3%
V2-BB(F)B-1            (3-6)    5%
V2-B(F)BB-1            (3-8)    5%
3-HB(F)HH-5            (4-7)    3%
NI=85.8℃;Tc<-20℃;Δn=0.115;Δε=4.2;γ1=41.4mPa・s.
[Composition (M38)]
3-HHBB (F) -F (7-5) 3%
2-HHEB (F, F) -F (6-12) 3%
5-BB (F) B (F, F) -F (6-69) 7%
3-HHB (F) B (F, F) -F (7-9) 3%
3-GB (F) B (F, F) XB (F, F) -F (7-57) 3%
3-BB (F, F) XB (F) B (F, F) -F (7-60) 3%
3-HHVFFXB (F, F) -F (6-120) 5%
3-BBVFFXB (F, F) -F (6-119) 5%
3-HBBVFFXB (F, F) -F (7-62) 3%
2-HH-5 (2-1) 5%
3-HH-V (2-1) 20%
5-HH-V (2-1) 12%
3-HH-V1 (2-1) 4%
4-HH-V1 (2-1) 5%
2-HH-2V1 (2-1) 3%
1-BB-3 (2-8) 3%
V2-BB (F) B-1 (3-6) 5%
V2-B (F) BB-1 (3-8) 5%
3-HB (F) HH-5 (4-7) 3%
NI = 85.8 ° C; Tc <-20 ° C; Δn = 0.115; Δε = 4.2; γ1 = 41.4 mPa · s.
[組成物(M39)]
3-BB(F)XB(F)B(F,F)-F  (7-60)    5%
3-HGB(F,F)-F          (6-103)   3%
5-GHB(F,F)-F          (6-109)   4%
3-GB(F,F)XB(F,F)-F    (6-113)   5%
3-HHBB(F,F)-F         (7-6)     4%
2-dhBB(F,F)XB(F,F)-F  (7-50)    4%
3-GB(F)B(F,F)XB(F,F)-F (7-57)   3%
3-HGB(F,F)XB(F,F)-F   (7)       5%
7-HB(F,F)-F           (5-4)     3%
2-HH-3                (2-1)    14%
2-HH-5                (2-1)     4%
3-HH-V                (2-1)    26%
1V2-HH-3              (2-1)     5%
1V2-BB-1              (2-8)     3%
2-BB(F)B-3            (3-6)     3%
3-HB(F)HH-2           (4-7)     4%
5-HBB(F)B-2           (4-5)     5%
NI=78.4℃;Tc<-20℃;Δn=0.094;Δε=5.6;Vth=1.45V;η=11.5mPa・s;γ1=61.7mPa・s.
[Composition (M39)]
3-BB (F) XB (F) B (F, F) -F (7-60) 5%
3-HGB (F, F) -F (6-103) 3%
5-GHB (F, F) -F (6-109) 4%
3-GB (F, F) XB (F, F) -F (6-113) 5%
3-HHBB (F, F) -F (7-6) 4%
2-dhBB (F, F) XB (F, F) -F (7-50) 4%
3-GB (F) B (F, F) XB (F, F) -F (7-57) 3%
3-HGB (F, F) XB (F, F) -F (7) 5%
7-HB (F, F) -F (5-4) 3%
2-HH-3 (2-1) 14%
2-HH-5 (2-1) 4%
3-HH-V (2-1) 26%
1V2-HH-3 (2-1) 5%
1V2-BB-1 (2-8) 3%
2-BB (F) B-3 (3-6) 3%
3-HB (F) HH-2 (4-7) 4%
5-HBB (F) B-2 (4-5) 5%
NI = 78.4 ° C; Tc <-20 ° C; Δn = 0.094; Δε = 5.6; Vth = 1.45V; η = 11.5mPa · s; γ1 = 61.7mPa · s.
[組成物(M40)]
3-HBB(F,F)-F          (6-24)    5%
5-HBB(F,F)-F          (6-24)    4%
3-BB(F)B(F,F)XB(F,F)-F (7-47)   3%
4-BB(F)B(F,F)XB(F,F)-F (7-47)   5%
3-BB(F,F)XB(F)B(F,F)-F (7-60)  10%
3-HH2BB(F,F)-F        (7-15)    3%
4-HH2BB(F,F)-F        (7-15)    3%
2-HH-5                (2-1)     4%
3-HH-V                (2-1)    25%
3-HH-V1               (2-1)    10%
4-HH-V1               (2-1)     7%
5-HB-O2               (2-5)     5%
7-HB-1                (2-5)     5%
VFF-HHB-O1            (3-1)     8%
VFF-HHB-1             (3-1)     3%
NI=79.3℃;Tc<-20℃;Δn=0.099;Δε=5.0;Vth=1.64V;η=10.4mPa・s;γ1=44.7mPa・s.
[Composition (M40)]
3-HBB (F, F) -F (6-24) 5%
5-HBB (F, F) -F (6-24) 4%
3-BB (F) B (F, F) XB (F, F) -F (7-47) 3%
4-BB (F) B (F, F) XB (F, F) -F (7-47) 5%
3-BB (F, F) XB (F) B (F, F) -F (7-60) 10%
3-HH2BB (F, F) -F (7-15) 3%
4-HH2BB (F, F) -F (7-15) 3%
2-HH-5 (2-1) 4%
3-HH-V (2-1) 25%
3-HH-V1 (2-1) 10%
4-HH-V1 (2-1) 7%
5-HB-O2 (2-5) 5%
7-HB-1 (2-5) 5%
VFF-HHB-O1 (3-1) 8%
VFF-HHB-1 (3-1) 3%
NI = 79.3 ° C; Tc <-20 ° C; Δn = 0.099; Δε = 5.0; Vth = 1.64V; η = 10.4 mPa · s; γ1 = 44.7 mPa · s.
[組成物(M41)]
3-GBXB(F)B(F,F)-F     (7)       5%
3-HHB(F,F)-F          (6-3)     7%
3-GB(F)B(F)-F         (6-116)   2%
3-GB(F)B(F,F)-F       (6-117)   3%
3-BB(F,F)XB(F,F)-F    (6-97)    7%
3-GB(F)B(F,F)XB(F,F)-F (7-57)   4%
5-GB(F)B(F,F)XB(F,F)-F (7-57)   5%
3-HH-V                (2-1)    30%
3-HH-V1               (2-1)    10%
1V2-HH-3              (2-1)     8%
3-HH-VFF              (2-1)     8%
V2-BB-1               (2-8)     2%
5-HB(F)BH-3           (4-2)     4%
5-HBBH-3              (4-1)     5%
NI=79.7℃;Tc<-20℃;Δn=0.091;Δε=5.7;Vth=1.83V;η=14.9mPa・s;γ1=69.3mPa・s.
[Composition (M41)]
3-GBXB (F) B (F, F) -F (7) 5%
3-HHB (F, F) -F (6-3) 7%
3-GB (F) B (F) -F (6-116) 2%
3-GB (F) B (F, F) -F (6-117) 3%
3-BB (F, F) XB (F, F) -F (6-97) 7%
3-GB (F) B (F, F) XB (F, F) -F (7-57) 4%
5-GB (F) B (F, F) XB (F, F) -F (7-57) 5%
3-HH-V (2-1) 30%
3-HH-V1 (2-1) 10%
1V2-HH-3 (2-1) 8%
3-HH-VFF (2-1) 8%
V2-BB-1 (2-8) 2%
5-HB (F) BH-3 (4-2) 4%
5-HBBH-3 (4-1) 5%
NI = 79.7 ° C; Tc <-20 ° C; Δn = 0.091; Δε = 5.7; Vth = 1.83V; η = 14.9 mPa · s; γ1 = 69.3 mPa · s.
2.液晶分子の配向
 使用例1~使用例7
(試料の調製)
 組成物(M1)に化合物(1)として化合物(No.1)を0.1重量%、0.3重量%、0.5重量%、1.0重量%、3.0重量%、5.0重量%、10.0重量%の割合で、酸化防止剤として、R40がn-ヘプチルである化合物(AO-1)を150ppmの割合で添加した。100℃で加熱攪拌し、その後室温に戻し一週間放置したところ、これらの混合物は結晶等の析出は無く完全に溶解していた。
(素子の作製)
 これらの混合物を、配向膜を有しないIPS素子に90℃で注入した。これらの混合物は90℃では等方相を示したので、これらの混合物をネマチック相の上限温度以上で注入したことになる。IPS素子を90℃で加熱しながら、波長313nm、波長335nmおよび波長365nmにピークを有する偏光紫外線を素子に対して法線方向から一定の時間照射することにより配向処理を行い、配向が良好になるまで、照射を続けた。
(偏光紫外線の照射条件)
・波長313nmにおける照度は3mW/cm。ウシオ電機社製UIT-150およびUVD-S313を用いて測定した。
・紫外線の照射ランプは、ウシオ電機株式会社製のUSH-250BYを用いた。
・露光機ユニットはウシオ電機株式会社製ML-251A/Bを用いた。
・偏光紫外線は、ワイヤーグリッド偏光子((株)ポラテクノ製のProFlux UVT260A)を用いて形成した。
(配向の確認方法)
 直線偏光の偏光軸に対して、素子が平行になるようにして、偏光子と検光子が直交して配置された偏光顕微鏡にセットし、この素子に下から光を照射し、光漏れの有無を観察した。光が素子を通過しない場合は、配向が「良好」であると判断した。素子を通過した光が観察された場合は、配向が「不良」で、照射不十分と判断した。
(配向のしやすさの評価)
 照射時間を1分から60分まで変化させて、それぞれの照射時間での配向を確認した。それぞれ、配向が良好になった時点で、照射をやめた。配向が良好になるまでの照射時間を下記表3にまとめた。
2. Orientation of liquid crystal molecules Usage Examples 1 to 7
(Sample preparation)
2. Compound (No. 1) as compound (1) in the composition (M1) is 0.1% by weight, 0.3% by weight, 0.5% by weight, 1.0% by weight, 3.0% by weight, 5. 0 wt%, in a proportion of 10.0 wt%, as an antioxidant, was added compound R 40 is n- heptyl and (AO-1) in a proportion of 150 ppm. When the mixture was heated and stirred at 100 ° C., then returned to room temperature and left for one week, these mixtures were completely dissolved without precipitation of crystals or the like.
(Manufacturing of element)
These mixtures were injected at 90 ° C. into an IPS device without an alignment film. Since these mixtures showed an isotropic phase at 90 ° C., it means that these mixtures were injected above the upper limit temperature of the nematic phase. While heating the IPS element at 90 ° C., the element is aligned by irradiating the element with polarized ultraviolet rays having peaks at wavelengths of 313 nm, 335 nm and 365 nm for a certain period of time from the normal direction, and the orientation is improved. Irradiation was continued until.
(Irradiation conditions for polarized ultraviolet rays)
-The illuminance at a wavelength of 313 nm is 3 mW / cm 2 . The measurement was performed using UIT-150 and UVD-S313 manufactured by Ushio, Inc.
-A USH-250BY manufactured by Ushio, Inc. was used as the ultraviolet irradiation lamp.
-The exposure machine unit used was ML-251A / B manufactured by Ushio, Inc.
-Polarized ultraviolet rays were formed using a wire grid polarizer (ProFlux UVT260A manufactured by Polatechno Co., Ltd.).
(Method of confirming orientation)
Set the element in a polarizing microscope in which the polarizer and the analyzer are arranged orthogonally to the polarization axis of linearly polarized light, and irradiate this element with light from below to check for light leakage. Was observed. If the light did not pass through the element, it was determined that the orientation was "good". When the light passing through the element was observed, it was judged that the orientation was "poor" and the irradiation was insufficient.
(Evaluation of ease of orientation)
The irradiation time was changed from 1 minute to 60 minutes, and the orientation at each irradiation time was confirmed. Irradiation was stopped when the orientation was good. The irradiation time until the orientation becomes good is summarized in Table 3 below.
 使用例8~使用例28
 組成物(M1)を用い、酸化防止剤として、R40がn-ヘプチルである化合物(AO-1)を150ppmの割合で添加し、化合物(1)を下記表3に示す割合で混合した。その他は使用例1と同様に操作した。使用例1と同様な方法で照射時間を測定した。結果を下記表3にまとめた。使用例8から28の混合物も90℃では等方相を示した。
Usage example 8 to usage example 28
Using a composition (M1), as an antioxidant, it was added compound R 40 is n- heptyl and (AO-1) in a proportion of 150 ppm, was mixed in the ratio shown compound (1) in Table 3 below. Others were operated in the same manner as in Usage Example 1. The irradiation time was measured by the same method as in Example 1. The results are summarized in Table 3 below. The mixture of Examples 8 to 28 also showed an isotropic phase at 90 ° C.
表3

Figure JPOXMLDOC01-appb-I000160

Table 3

Figure JPOXMLDOC01-appb-I000160

 使用例1~28において、用いる組成物をM2~M41に変更してそれぞれ同様の操作をしたところ、いずれにおいても、照射時間の大きな変化は無かった。 In Use Examples 1 to 28, when the compositions used were changed to M2 to M41 and the same operations were performed for each, there was no significant change in the irradiation time.
 組成物(M1)から組成物(M41)までの組成物、化合物(No.1)から化合物(No.618)までの化合物(1)の中から適宜選択し、同様の操作を行ったところ、いずれにおいても、照射時間は10分以内であった。 The composition (M1) to the composition (M41) and the compound (No. 1) to the compound (No. 618) were appropriately selected from the composition (1), and the same operation was performed. In each case, the irradiation time was within 10 minutes.
 比較例1~21
 化合物(A-1-1-1)、特許文献3に記載の化合物(S-1)および特許文献2に記載の化合物(S-2)を化合物(1)として、下記表4に示す割合で組成物(M1)に混合し、使用例と同様の操作により、照射時間を評価した。比較例1から21の混合物も90℃では等方相を示した。
その結果、本発明の実施形態にかかる化合物と比較し、いずれの化合物においても、使用例における最長の照射時間である10分では、良好な配向は得られず、良好な配向が確認される照射時間は30分以上であった。また、組成物(M2)から(M41)を用いて同様の評価を行ったところ、いずれも組成物(M1)を用いた場合と同様な傾向であった。

Figure JPOXMLDOC01-appb-I000161
Comparative Examples 1 to 21
Compound (A-1-1-1), compound (S-1) described in Patent Document 3 and compound (S-2) described in Patent Document 2 are designated as compound (1) at the ratios shown in Table 4 below. It was mixed with the composition (M1), and the irradiation time was evaluated by the same operation as in the example of use. The mixture of Comparative Examples 1 to 21 also showed an isotropic phase at 90 ° C.
As a result, as compared with the compound according to the embodiment of the present invention, in any of the compounds, good orientation was not obtained at the longest irradiation time of 10 minutes in the use example, and good orientation was confirmed. The time was more than 30 minutes. Moreover, when the same evaluation was performed using the compositions (M2) to (M41), the tendency was the same as that when the composition (M1) was used.

Figure JPOXMLDOC01-appb-I000161
表4

Figure JPOXMLDOC01-appb-I000162

Table 4

Figure JPOXMLDOC01-appb-I000162

 使用例において、組成物や極性化合物である化合物(1)の種類、量、を変えたが、溶け残りや析出はなく、10分以内の照射で素子の光漏れは観察されなかった。この結果は、素子にポリイミドのような配向膜がなくても配向は良好であり、総ての液晶分子が一定方向に配列していることを示している。一方、比較例においては、30分以内での照射では素子の光漏れが観察され、配向が良好ではなかった。したがって、本発明の実施形態にかかる化合物(1)を用いれば、短い時間または低エネルギーでの光照射での使用が可能であり、それによりタクトタイムの短縮および母液晶の光照射によるダメージを低減することができる。また本発明の実施形態にかかる液晶組成物を用いれば、素子を使用できる広い温度範囲、短い応答時間、高い電圧保持率、低いしきい値電圧、大きなコントラスト比、長い寿命の少なくとも一つの特性を有する液晶表示素子が得られる。さらに、ネマチック相の高い上限温度、ネマチック相の低い下限温度、小さな粘度、適切な光学異方性、負に大きな誘電率異方性、大きな比抵抗、紫外線に対する高い安定性、熱に対する高い安定性のような特性において、少なくとも1つを充足する液晶組成物を有する液晶表示素子が得られる。 In the example of use, the composition and the type and amount of the compound (1), which is a polar compound, were changed, but there was no undissolved residue or precipitation, and no light leakage of the device was observed within 10 minutes of irradiation. This result indicates that the orientation is good even if the device does not have an alignment film such as polyimide, and all the liquid crystal molecules are arranged in a certain direction. On the other hand, in the comparative example, light leakage of the element was observed in the irradiation within 30 minutes, and the orientation was not good. Therefore, by using the compound (1) according to the embodiment of the present invention, it can be used in light irradiation for a short time or with low energy, thereby shortening the tact time and reducing the damage caused by the light irradiation of the mother liquid crystal. can do. Further, by using the liquid crystal composition according to the embodiment of the present invention, at least one characteristic of a wide temperature range in which the device can be used, a short response time, a high voltage retention rate, a low threshold voltage, a large contrast ratio, and a long life can be obtained. The liquid crystal display element to have is obtained. In addition, the high upper temperature of the nematic phase, the lower lower temperature of the nematic phase, small viscosity, proper optical anisotropy, negatively large permittivity anisotropy, large specific resistance, high stability to ultraviolet rays, high stability to heat A liquid crystal display element having a liquid crystal composition satisfying at least one of the above characteristics can be obtained.
 本発明の実施形態にかかる液晶組成物は、液晶モニター、液晶テレビなどに用いることができる。 The liquid crystal composition according to the embodiment of the present invention can be used for a liquid crystal monitor, a liquid crystal television, or the like.

Claims (17)

  1.  式(1)で表される化合物。

    Figure JPOXMLDOC01-appb-I000001

     式(1)において、
     aおよびbは独立して、0、1または2であり、0≦a+b≦3であり、
     環A、環A、環Aおよび環Aは独立して、1,4-シクロへキシレン、1,4-シクロヘキセニレン、1,4-フェニレン、ナフタレン-2,6-ジイル、デカヒドロナフタレン-2,6-ジイル、1,2,3,4-テトラヒドロナフタレン-2,6-ジイル、テトラヒドロピラン-2,5-ジイル、1,3-ジオキサン-2,5-ジイル、ピリミジン-2,5-ジイル、ピリジン-2,5-ジイル、フルオレン-2,7-ジイル、フェナントレン-2,7-ジイル、アントラセン-2,6-ジイル、ペルヒドロシクロペンタ[a]フェナントレン-3,17-ジイル、または2,3,4,7,8,9,10,11,12,13,14,15,16,17-テトラデカヒドロシクロペンタ[a]フェナントレン-3,17-ジイルであり、これらの環において、少なくとも1つの水素は、フッ素、塩素、炭素数1から12のアルキル、炭素数2から12のアルケニル、炭素数1から11のアルコキシ、炭素数2から11のアルケニルオキシ、-Sp-P、または-Sp-Pで置き換えられてもよく、これらの基において、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよく、
    aが2のとき、2つの環Aは異なっていてもよく、bが2のとき、2つの環Aは異なっていてもよく;
     Z、Z、Z、ZおよびZは独立して、単結合または炭素数1から10のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-、-S-、-CO-、-COO-、-OCO-、または-OCOO-で置き換えられてもよく、少なくとも1つの-(CH-は、-CH=CH-または-C≡C-で置き換えられてもよく、これらの基において、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよい。ただし、Z、Z、またはZの中で少なくとも1つは、-COS-、-SCO-、-CH=CHCOS-、または-SCOCH=CH-であり、Z、Z、またはZにおいて-COS-及び-OCO-または-SCO-及び-COO-が同時に存在することはなく、aが2のとき、2つのZは異なっていてもよく、bが2のとき、2つのZは異なっていてもよく;
     SpおよびSpは独立して、単結合または炭素数1から10のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-、-CO-、-COO-、-OCO-、または-OCOO-で置き換えられてもよく、少なくとも1つの-(CH-は、-CH=CH-または-C≡C-で置き換えられてもよく、これらの基において、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよく、
    複数のSpまたはSpが存在する場合、それぞれが異なっていてもよく;
    1およびPは独立して、式(1b)~式(1h)のいずれかで表される基であり、複数のPまたはPが存在する場合、それぞれが異なっていてもよく;

    Figure JPOXMLDOC01-appb-I000002

     式(1b)~式(1h)において、      
     M、M、MおよびMは独立して、水素、フッ素、塩素、炭素数1から5のアルキル、または少なくとも1つの水素がフッ素または塩素で置き換えられた炭素数1から5のアルキルであり、XはOまたはSであり;
     Rは水素、フッ素、塩素、または炭素数1から5のアルキルであり、このアルキルにおいて少なくとも1つの水素はフッ素または塩素で置き換えられてもよく、少なくとも1つの-CH-は、-O-で置き換えられてもよく;
     R、R、R、R、およびRは独立して、水素または炭素数1から15のアルキルであり、このアルキルにおいて、少なくとも1つの-CH-は、-O-または-S-で置き換えられてもよく、少なくとも1つの-(CH-は、-CH=CH-または-C≡C-で置き換えられてもよく、これらの基において、少なくとも1つの水素はフッ素または塩素で置き換えられてもよい。
    A compound represented by the formula (1).

    Figure JPOXMLDOC01-appb-I000001

    In equation (1)
    a and b are independently 0, 1 or 2, 0 ≦ a + b ≦ 3, and so on.
    Ring A 1 , Ring A 2 , Ring A 3 and Ring A 4 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, naphthalene-2,6-diyl, Decahydronaphthrene-2,6-diyl, 1,2,3,4-tetrahydronaphthalene-2,6-diyl, tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyrimidine- 2,5-diyl, pyridine-2,5-diyl, fluorene-2,7-diyl, phenanthrene-2,7-diyl, anthracene-2,6-diyl, perhydrocyclopenta [a] phenanthrene-3,17 -Diyl, or 2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydrocyclopenta [a] phenanthrene-3,17-diyl, In these rings, at least one hydrogen is fluorine, chlorine, alkyl with 1 to 12 carbon atoms, alkenyl with 2 to 12 carbon atoms, alkoxy with 1 to 11 carbon atoms, alkenyloxy with 2 to 11 carbon atoms, -Sp. It may be replaced by 1- P 1 or -Sp 2- P 2 , and in these groups at least one hydrogen may be replaced by fluorine or chlorine.
    When a is 2, two rings A 1 may be different when b is 2, two rings A 4 may be different;
    Z 1 , Z 2 , Z 3 , Z 4 and Z 5 are independently single-bonded or alkylenes with 1 to 10 carbon atoms, in which at least one -CH 2- is -O-,-. It may be replaced by S-, -CO-, -COO-, -OCO-, or -OCOO-, and at least one- (CH 2 ) 2 -is -CH = CH- or -C≡C-. It may be replaced, in which at least one hydrogen may be replaced with fluorine or chlorine. However, at least one of Z 2 , Z 3 , or Z 4 is -COS-, -SCO-, -CH = CHCOS-, or -SCOCH = CH-, and Z 2 , Z 3 , or Z. -COS- and -OCO- or -SCO- and -COO- are never simultaneously present in the 4, when a is 2, two Z 1 may be different when b is 2, the two Z 5 may be different;
    Sp 1 and Sp 2 are independently single-bonded or alkylene with 1 to 10 carbon atoms, in which at least one -CH 2- is -O-, -CO-, -COO-, -OCO. -Or -OCOO- may be replaced, and at least one- (CH 2 ) 2- may be replaced by -CH = CH- or -C≡C-, at least 1 in these groups. One hydrogen may be replaced with fluorine or chlorine,
    If multiple Sp 1 or Sp 2 are present, it may be different from each;
    P 1 and P 2 are independent groups represented by any of the formulas (1b) to (1h), and when a plurality of P 1 or P 2 are present, they may be different from each other;

    Figure JPOXMLDOC01-appb-I000002

    In equations (1b) to (1h),
    M 1 , M 2 , M 3 and M 4 are independently hydrogen, fluorine, chlorine, alkyl with 1 to 5 carbon atoms, or alkyl with 1 to 5 carbon atoms in which at least one hydrogen is replaced with fluorine or chlorine. And X 1 is O or S;
    R 2 is hydrogen, fluorine, chlorine, or an alkyl having 1 to 5 carbon atoms, in which at least one hydrogen may be replaced by fluorine or chlorine, and at least one -CH 2- is -O-. May be replaced with;
    R 3 , R 4 , R 5 , R 6 and R 7 are independently hydrogen or alkyl with 1 to 15 carbon atoms, in which at least one -CH 2- is -O- or-. It may be replaced by S-, at least one- (CH 2 ) 2 -may be replaced by -CH = CH- or -C≡C-, and in these groups, at least one hydrogen is fluorine. Alternatively, it may be replaced with chlorine.
  2.  式(1)において、
     aおよびbは独立して、0、1または2であり、0≦a+b≦2であり;
     環A、環A、環Aおよび環Aは独立して、1,4-シクロへキシレン、1,4-シクロヘキセニレン、1,4-フェニレン、ナフタレン-2,6-ジイル、デカヒドロナフタレン-2,6-ジイル、1,2,3,4-テトラヒドロナフタレン-2,6-ジイル、テトラヒドロピラン-2,5-ジイル、1,3-ジオキサン-2,5-ジイル、ピリミジン-2,5-ジイル、ピリジン-2,5-ジイル、フルオレン-2,7-ジイル、フェナントレン-2,7-ジイル、アントラセン-2,6-ジイル、ペルヒドロシクロペンタ[a]フェナントレン-3,17-ジイル、または2,3,4,7,8,9,10,11,12,13,14,15,16,17-テトラデカヒドロシクロペンタ[a]フェナントレン-3,17-ジイルであり、これらの環において、少なくとも1つの水素は、フッ素、塩素、炭素数1から12のアルキル、炭素数2から12のアルケニル、炭素数1から11のアルコキシ、炭素数2から11のアルケニルオキシ、-Sp-P、または-Sp-Pで置き換えられてもよく、これらの基において、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよく、aが2のとき、2つの環Aは異なっていてもよく、bが2のとき、2つの環Aは異なっていてもよく;
     Z、Z、Z、ZおよびZは独立して、単結合、-(CH-、-C≡C-、-C≡C-C≡C-、-COO-、-OCO-、-CFO-、-OCF-、-CHO-、-OCH-、-CF=CF-、-CH=CHCOO-、-OCOCH=CH-、-CH=CH-、-CH=CHCO-、-COCH=CH-、-COS-、-SCO-、-CH=CHCOS-、または-SCOCH=CH-であり、ただし、Z、Z、またはZの中で少なくとも1つは、-COS-、-SCO-、-CH=CHCOS-、または-SCOCH=CH-であり、Z、Z、またはZにおいて-COS-及び-OCO-または-SCO-及び-COO-が同時に存在することはなく;
    aが2のとき、2つのZは異なっていてもよく、2つのZは異なっていてもよく;
     SpおよびSpは独立して、単結合または炭素数1から10のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-、-COO-、または-OCO-で置き換えられてもよく、少なくとも1つの-(CH-は、-CH=CH-で置き換えられてもよく、これらの基において、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよく、複数のSpまたはSpが存在する場合はそれぞれが異なっていてもよく;
     PおよびPは独立して、式(1b)~式(1h)のいずれかで表される基であり、複数のPまたはPが存在する場合、それぞれが異なっていてもよく;

    Figure JPOXMLDOC01-appb-I000003

     式(1b)~式(1h)において、      
     M、M、MおよびMは独立して、水素、フッ素、塩素、炭素数1から5のアルキル、または少なくとも1つの水素がフッ素または塩素で置き換えられた炭素数1から5のアルキルであり、XはOまたはSであり;
     Rは水素、フッ素、塩素、または炭素数1から5のアルキルであり、このアルキルにおいて少なくとも1つの水素はフッ素または塩素で置き換えられてもよく、少なくとも1つの-CH-は、-O-で置き換えられてもよく;
     R、R、R、R、およびRは独立して、水素または炭素数1から15のアルキルであり、このアルキルにおいて、少なくとも1つの-CH-は、-O-または-S-で置き換えられてもよく、少なくとも1つの-(CH-は、-CH=CH-または-C≡C-で置き換えられてもよく、これらの基において、少なくとも1つの水素はフッ素または塩素で置き換えられてもよい、請求項1に記載の化合物。
    In equation (1)
    a and b are independently 0, 1 or 2, and 0 ≦ a + b ≦ 2.
    Ring A 1 , Ring A 2 , Ring A 3 and Ring A 4 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, naphthalene-2,6-diyl, Decahydronaphthrene-2,6-diyl, 1,2,3,4-tetrahydronaphthalene-2,6-diyl, tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyrimidine- 2,5-diyl, pyridine-2,5-diyl, fluorene-2,7-diyl, phenanthrene-2,7-diyl, anthracene-2,6-diyl, perhydrocyclopenta [a] phenanthrene-3,17 -Diyl, or 2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydrocyclopenta [a] phenanthrene-3,17-diyl, In these rings, at least one hydrogen is fluorine, chlorine, alkyl with 1 to 12 carbon atoms, alkenyl with 2 to 12 carbon atoms, alkoxy with 1 to 11 carbon atoms, alkenyloxy with 2 to 11 carbon atoms, -Sp. It may be replaced by 1- P 1 or -Sp 2- P 2 , in these groups at least one hydrogen may be replaced by fluorine or chlorine, and when a is 2, two rings A 1 may be different when b is 2, two rings a 4 may be different;
    Z 1 , Z 2 , Z 3 , Z 4 and Z 5 are independently single-bonded,-(CH 2 ) 2- , -C ≡ C-, -C ≡ C-C ≡ C-, -COO-, -OCO-, -CF 2 O-, -OCF 2- , -CH 2 O-, -OCH 2- , -CF = CF-, -CH = CHCOO-, -OCOCH = CH-, -CH = CH-, -CH = CHCO-, -COCH = CH-, -COS-, -SCO-, -CH = CHCOS-, or -SCOCH = CH-, provided that at least in Z 2 , Z 3 , or Z 4. One is -COS-, -SCO-, -CH = CHCOS-, or -SCOCH = CH-, and in Z 2 , Z 3 , or Z 4 , -COS- and -OCO- or -SCO- and- COO-does not exist at the same time;
    When a is 2, two Z 1 may be different, the two Z 5 may be different;
    Sp 1 and Sp 2 are independently a single bond or alkylene having 1 to 10 carbon atoms, in the alkylene, at least one of -CH 2 -, -O -, - COO-, or substituted with -OCO- At least one of-(CH 2 ) 2 -may be replaced by -CH = CH-, and in these groups, at least one hydrogen may be replaced by fluorine or chlorine. If multiple Sp 1 or Sp 2 there may be different from each;
    P 1 and P 2 are independent groups represented by any of the formulas (1b) to (1h), and when a plurality of P 1 or P 2 are present, they may be different from each other;

    Figure JPOXMLDOC01-appb-I000003

    In equations (1b) to (1h),
    M 1 , M 2 , M 3 and M 4 are independently hydrogen, fluorine, chlorine, alkyl with 1 to 5 carbon atoms, or alkyl with 1 to 5 carbon atoms in which at least one hydrogen is replaced with fluorine or chlorine. And X 1 is O or S;
    R 2 is hydrogen, fluorine, chlorine, or an alkyl having 1 to 5 carbon atoms, in which at least one hydrogen may be replaced by fluorine or chlorine, and at least one -CH 2- is -O-. May be replaced with;
    R 3 , R 4 , R 5 , R 6 and R 7 are independently hydrogen or alkyl with 1 to 15 carbon atoms, in which at least one -CH 2- is -O- or-. It may be replaced by S-, at least one- (CH 2 ) 2 -may be replaced by -CH = CH- or -C≡C-, and in these groups, at least one hydrogen is fluorine. The compound according to claim 1, which may be replaced with chlorine.
  3.  式(1-1)から式(1-3)のいずれか1つで表される、請求項1または2に記載の化合物。

    Figure JPOXMLDOC01-appb-I000004

    式(1-1)から式(1-3)において、
     環A、環A、環Aおよび環Aは独立して、1,4-シクロへキシレン、1,4-フェニレン、ナフタレン-2,6-ジイル、ピリミジン-2,5-ジイル、ピリジン-2,5-ジイル、フルオレン-2,7-ジイル、フェナントレン-2,7-ジイル、またはアントラセン-2,6-ジイルであり、これらの環において、少なくとも1つの水素は、フッ素、塩素、炭素数1から12のアルキル、炭素数2から12のアルケニル、炭素数1から11のアルコキシ、炭素数2から11のアルケニルオキシ、-Sp-P、または-Sp-Pで置き換えられてもよく、これらの基において、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよく、aが2のとき、2つの環Aは異なっていてもよく、bが2のとき、2つの環Aは異なっていてもよく;
     Z、ZおよびZは独立して、単結合、-(CH-、-C≡C-、-C≡C-C≡C-、-COO-、-OCO-、-CFO-、-OCF-、-CHO-、-OCH-、-CF=CF-、-CH=CHCOO-、-OCOCH=CH-、-CH=CH-、-CH=CHCO-、-COCH=CH-、-COS-、-SCO-、-CH=CHCOS-、または-SCOCH=CH-であり、ただし、Z、Z、またはZの中で少なくとも1つは、-COS-、-SCO-、-CH=CHCOS-、または-SCOCH=CH-であり、Z、Z、またはZにおいて-COS-及び-OCO-または-SCO-及び-COO-が同時に存在することはなく;
     SpおよびSpは独立して、単結合または炭素数1から10のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-、-COO-、-OCOO-、または-OCO-で置き換えられてもよく、少なくとも1つの-(CH-は、-CH=CH-で置き換えられてもよく、これらの基において、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよく、複数のSpまたはSpが存在する場合、それぞれが異なっていてもよく;
     PおよびPは独立して、式(1b)~式(1h)のいずれかで表される基であり、複数のPまたはPが存在する場合、それぞれが異なっていてもよく;

    Figure JPOXMLDOC01-appb-I000005

     式(1b)~式(1h)において、      
     M、M、MおよびMは独立して、水素、フッ素、塩素、炭素数1から5のアルキル、または少なくとも1つの水素がフッ素または塩素で置き換えられた炭素数1から5のアルキルであり、XはOまたはSであり;
     Rは水素、フッ素、塩素、または炭素数1から5のアルキルであり、このアルキルにおいて少なくとも1つの水素はフッ素または塩素で置き換えられてもよく、少なくとも1つの-CH-は、-O-で置き換えられてもよく;
     R、R、R、R、およびRは独立して、水素、または炭素数1から15のアルキルであり、このアルキルにおいて、少なくとも1つの-CH-は、-O-または-S-で置き換えられてもよく、少なくとも1つの-(CH-は、-CH=CH-または-C≡C-で置き換えられてもよく、これらの基において、少なくとも1つの水素はフッ素または塩素で置き換えられてもよい。
    The compound according to claim 1 or 2, which is represented by any one of formulas (1-1) to (1-3).

    Figure JPOXMLDOC01-appb-I000004

    In equations (1-1) to (1-3),
    Ring A 1 , Ring A 2 , Ring A 3 and Ring A 4 are independent, 1,4-cyclohexylene, 1,4-phenylene, naphthalene-2,6-diyl, pyrimidine-2,5-diyl, Pyridine-2,5-diyl, fluorene-2,7-diyl, phenanthrene-2,7-diyl, or anthracene-2,6-diyl, in which at least one hydrogen is fluorine, chlorine, Replaced by alkyl with 1 to 12 carbons, alkenyl with 2 to 12 carbons, alkoxy with 1 to 11 carbons, alkenyloxy with 2 to 11 carbons, -Sp 1- P 1 or -Sp 2- P 2. at best, and in the groups, at least one hydrogen may be replaced by fluorine or chlorine, when a is 2, two rings a 1 may be different when b is 2, 2 One of the rings a 4 may be different;
    Z 2 , Z 3 and Z 4 are independently single-bonded,-(CH 2 ) 2- , -C ≡ C-, -C ≡ C-C ≡ C-, -COO-, -OCO-, -CF 2 O -, - OCF 2 - , - CH 2 O -, - OCH 2 -, - CF = CF -, - CH = CHCOO -, - OCOCH = CH -, - CH = CH -, - CH = CHCO-, -COCH = CH -, - COS - , - SCO -, - CH = CHCOS-, or -SCOCH = a CH-, provided that at least one among Z 2, Z 3 or Z 4, are,-COS -, - SCO -, - CH = CHCOS-, or -SCOCH = a CH-, Z 2, Z 3, or in Z 4 -COS- and -OCO- or -SCO- and -COO- simultaneous presence Never;
    Sp 1 and Sp 2 are independently single-bonded or alkylene with 1 to 10 carbon atoms, in which at least one -CH 2- is -O-, -COO-, -OCOO-, or-. It may be replaced by OCO-, at least one- (CH 2 ) 2 -may be replaced by -CH = CH-, and in these groups at least one hydrogen is replaced by fluorine or chlorine. at best, when a plurality of Sp 1 or Sp 2 are present, it may be different from each;
    P 1 and P 2 are independent groups represented by any of the formulas (1b) to (1h), and when a plurality of P 1 or P 2 are present, they may be different from each other;

    Figure JPOXMLDOC01-appb-I000005

    In equations (1b) to (1h),
    M 1 , M 2 , M 3 and M 4 are independently hydrogen, fluorine, chlorine, alkyl with 1 to 5 carbon atoms, or alkyl with 1 to 5 carbon atoms in which at least one hydrogen is replaced with fluorine or chlorine. And X 1 is O or S;
    R 2 is hydrogen, fluorine, chlorine, or an alkyl having 1 to 5 carbon atoms, in which at least one hydrogen may be replaced by fluorine or chlorine, and at least one -CH 2- is -O-. May be replaced with;
    R 3 , R 4 , R 5 , R 6 , and R 7 are independently hydrogen, or alkyl with 1 to 15 carbon atoms, in which at least one -CH 2- is -O- or It may be replaced by —S—, at least one − (CH 2 ) 2 − may be replaced by −CH = CH− or −C≡C−, and in these groups, at least one hydrogen It may be replaced with fluorine or chlorine.
  4.  式(1-1)から式(1-3)において、
     環A、環A、環Aおよび環Aは独立して、1,4-シクロへキシレン、1,4-フェニレン、ナフタレン-2,6-ジイル、フルオレン-2,7-ジイル、またはフェナントレン-2,7-ジイルであり、これらの環において、少なくとも1つの水素は、フッ素、塩素、炭素数1から12のアルキル、炭素数2から12のアルケニル、炭素数1から11のアルコキシ、炭素数2から11のアルケニルオキシ、-Sp-P、または-Sp-Pで置き換えられてもよく;
     Z、ZおよびZは独立して、単結合、-(CH-、-C≡C-C≡C-、-C≡C-、-COO-、-OCO-、-CH=CHCOO-、-OCOCH=CH-、-CH=CH-、-CH=CHCO-、-COCH=CH-、-COS-、-SCO-、-CH=CHCOS-、または-SCOCH=CH-であり、ただし、Z、Z、またはZの中で少なくとも1つは、-COS-、-SCO-、-CH=CHCOS-、または-SCOCH=CH-であり、Z、Z、またはZにおいて-COS-及び-OCO-または-SCO-及び-COO-が同時に存在することはなく;
     SpおよびSpは独立して、単結合または炭素数1から10のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-、-COO-、-OCOO-、または-OCO-で置き換えられてもよく、少なくとも1つの-(CH-は、-CH=CH-で置き換えられてもよく、複数のSpまたはSpが存在する場合、それぞれが異なっていてもよく;
     PおよびPは独立して、式(1b)、式(1c)、式(1d)、または式(1e)のいずれかで表される基であり、複数のPまたはPが存在する場合、それぞれが異なっていてもよく;

    Figure JPOXMLDOC01-appb-I000006

     式(1b)~式(1e)において、
     M、M、MおよびMは独立して、水素、フッ素、塩素、炭素数1から5のアルキル、または少なくとも1つの水素がフッ素または塩素で置き換えられた炭素数1から5のアルキルであり、XはOまたはSであり;
     Rは水素、フッ素、塩素、または炭素数1から5のアルキルであり、このアルキルにおいて少なくとも1つの水素はフッ素または塩素で置き換えられてもよく、少なくとも1つの-CH-は、-O-で置き換えられてもよく;
     R、R、R、およびRは独立して、水素または炭素数1から15のアルキルであり、このアルキルにおいて、少なくとも1つの-CH-は、-O-または-S-で置き換えられてもよく、少なくとも1つの-(CH-は、-CH=CH-または-C≡C-で置き換えられてもよく、これらの基において、少なくとも1つの水素はフッ素または塩素で置き換えられてもよい、請求項3に記載の化合物。
    In equations (1-1) to (1-3),
    Ring A 1 , Ring A 2 , Ring A 3 and Ring A 4 are independently 1,4-cyclohexylene, 1,4-phenylene, naphthalene-2,6-diyl, fluorene-2,7-diyl, Or phenanthrene-2,7-diyl, in these rings at least one hydrogen is fluorine, chlorine, alkyl with 1 to 12 carbons, alkenyl with 2 to 12 carbons, alkoxy with 1 to 11 carbons, It may be replaced by alkenyloxy with 2 to 11 carbon atoms, -Sp 1- P 1 , or -Sp 2- P 2 ;
    Z 2 , Z 3 and Z 4 are independently single-bonded,-(CH 2 ) 2- , -C ≡ C-C ≡ C-, -C ≡ C-, -COO-, -OCO-, -CH = CHCOO-, -OCOCH = CH-, -CH = CH-, -CH = CHCO-, -COCH = CH-, -COS-, -SCO-, -CH = CHCOS-, or -SCOCH = CH-. However, at least one of Z 2 , Z 3 , or Z 4 is -COS-, -SCO-, -CH = CHCOS-, or -SCOCH = CH-, and is Z 2 , Z 3 , or. never -COS- and the -OCO- or -SCO- and -COO- are present simultaneously in the Z 4;
    Sp 1 and Sp 2 are independently single-bonded or alkylene with 1 to 10 carbon atoms, in which at least one -CH 2- is -O-, -COO-, -OCOO-, or-. It may be replaced by OCO-, and at least one- (CH 2 ) 2 -may be replaced by -CH = CH-, and if multiple Sp 1 or Sp 2 are present, each is different. Well;
    P 1 and P 2 are independently represented by any of the formula (1b), the formula (1c), the formula (1d), or the formula (1e), and there are a plurality of P 1 or P 2. If so, each may be different;

    Figure JPOXMLDOC01-appb-I000006

    In equations (1b) to (1e),
    M 1 , M 2 , M 3 and M 4 are independently hydrogen, fluorine, chlorine, alkyl with 1 to 5 carbon atoms, or alkyl with 1 to 5 carbon atoms in which at least one hydrogen is replaced with fluorine or chlorine. And X 1 is O or S;
    R 2 is hydrogen, fluorine, chlorine, or an alkyl having 1 to 5 carbon atoms, in which at least one hydrogen may be replaced by fluorine or chlorine, and at least one -CH 2- is -O-. May be replaced with;
    R 3 , R 4 , R 5 and R 6 are independently hydrogen or alkyl with 1 to 15 carbon atoms, in which at least one -CH 2- is -O- or -S-. It may be replaced, and at least one- (CH 2 ) 2 -may be replaced by -CH = CH- or -C≡C-, in which at least one hydrogen is fluorine or chlorine. The compound according to claim 3, which may be replaced.
  5.  式(1-1)から式(1-3)において、
     環A、環A、環Aおよび環Aは独立して、1,4-シクロへキシレン、1,4-フェニレン、ナフタレン-2,6-ジイル、フルオレン-2,7-ジイル、またはフェナントレン-2,7-ジイルであり、これらの環において、少なくとも1つの水素は、フッ素、塩素、メチル、またはエチルで置き換えられてもよく;
    、ZおよびZは独立して、単結合、-(CH-、-C≡C-C≡C-、-C≡C-、-COO-、-OCO-、-CH=CHCOO-、-OCOCH=CH-、-CH=CH-、-CH=CHCO-、-COCH=CH-、-COS-、-SCO-、-CH=CHCOS-、または-SCOCH=CH-であり、ただし、Z、Z、またはZの中で少なくとも1つは、-COS-、-SCO-、-CH=CHCOS-、または-SCOCH=CH-であり、Z、Z、またはZにおいて-COS-及び-OCO-または-SCO-及び-COO-が同時に存在することはなく;
     SpおよびSpは独立して、単結合または炭素数1から10のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-、-COO-、-OCOO-、または-OCO-で置き換えられてもよく、少なくとも1つの-(CH-は、-CH=CH-で置き換えられてもよく、複数のSpまたはSpが存在する場合、それぞれが異なっていてもよく;
     PおよびPは独立して、式(1b-1)、(1b-2)、(1b-3)、(1b-4)、式(1b-5)、(1c-1)、(1d-1)、(1d-2)または(1e-1)で表される基であり、X、X、X、XおよびXは独立してOまたはSである請求項3に記載の化合物。

    Figure JPOXMLDOC01-appb-I000007
    In equations (1-1) to (1-3),
    Ring A 1 , Ring A 2 , Ring A 3 and Ring A 4 are independent, 1,4-cyclohexylene, 1,4-phenylene, naphthalene-2,6-diyl, fluorene-2,7-diyl, Alternatively, it may be phenanthrene-2,7-diyl, in which at least one hydrogen may be replaced with fluorine, chlorine, methyl, or ethyl;
    Z 2 , Z 3 and Z 4 are independently single-bonded,-(CH 2 ) 2- , -C ≡ C-C ≡ C-, -C ≡ C-, -COO-, -OCO-, -CH = CHCOO-, -OCOCH = CH-, -CH = CH-, -CH = CHCO-, -COCH = CH-, -COS-, -SCO-, -CH = CHCOS-, or -SCOCH = CH-. However, at least one of Z 2 , Z 3 , or Z 4 is -COS-, -SCO-, -CH = CHCOS-, or -SCOCH = CH-, and is Z 2 , Z 3 , or. never -COS- and the -OCO- or -SCO- and -COO- are present simultaneously in the Z 4;
    Sp 1 and Sp 2 are independently single-bonded or alkylene with 1 to 10 carbon atoms, in which at least one -CH 2- is -O-, -COO-, -OCOO-, or-. It may be replaced by OCO-, and at least one- (CH 2 ) 2 -may be replaced by -CH = CH-, and if multiple Sp 1 or Sp 2 are present, each is different. Well;
    P 1 and P 2 are each independently formula (1b-1), (1b -2), (1b-3), (1b-4), formula (1b-5), (1c -1), (1d -1), (1d-2) or (1e-1) in a group represented by the X 2, X 3, X 4 , X 5 and X 6 claim 3 is O or S independently The compound described.

    Figure JPOXMLDOC01-appb-I000007
  6. 式(1-1)から式(1-3)で表される化合物において、Z、Z、またはZのいずれか1つは、-COS-または-SCO-である、請求項3に記載の化合物。 In claim 3 , in the compound represented by the formulas (1-1) to (1-3), any one of Z 2 , Z 3 , or Z 4 is -COS- or -SCO-. The compound described.
  7.  下記のいずれか一つの式で表される、請求項1から6のいずれか1項に記載の化合物。

    Figure JPOXMLDOC01-appb-I000008

    Figure JPOXMLDOC01-appb-I000009

    Figure JPOXMLDOC01-appb-I000010

    Figure JPOXMLDOC01-appb-I000011

     PおよびPは独立して、式(1b-1)、(1b-2)、(1b-3)、(1b-4)、式(1b-5)、(1c-1)、(1d-1)、(1d-2)または(1e-1)で表される基であり、X、X、X、XおよびXは独立してOまたはSであり;
     SpおよびSpは独立して、単結合または炭素数1から10のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-、-COO-、-OCOO-、または-OCO-で置き換えられてもよく、少なくとも1つの-(CH-は、-CH=CH-で置き換えられてもよく;
     P、P、SpおよびSp以外の部分構造において、少なくとも1つの水素は、フッ素、塩素、メチル、またはエチルで置き換えられてもよい。
    The compound according to any one of claims 1 to 6, which is represented by any one of the following formulas.

    Figure JPOXMLDOC01-appb-I000008

    Figure JPOXMLDOC01-appb-I000009

    Figure JPOXMLDOC01-appb-I000010

    Figure JPOXMLDOC01-appb-I000011

    P 1 and P 2 are each independently formula (1b-1), (1b -2), (1b-3), (1b-4), formula (1b-5), (1c -1), (1d -1), a group represented by (1d-2) or (1e-1), where X 2 , X 3 , X 4 , X 5 and X 6 are independently O or S;
    Sp 1 and Sp 2 are independently single bonds or alkylenes having 1 to 10 carbon atoms, in which at least one -CH 2- is -O-, -COO-, -OCOO-, or-. It may be replaced by OCO-, and at least one- (CH 2 ) 2- may be replaced by -CH = CH-;
    In partial structures other than P 1 , P 2 , Sp 1 and Sp 2 , at least one hydrogen may be replaced with fluorine, chlorine, methyl, or ethyl.
  8.  式(1-1-1)~(1-1-7)、(1-2-1)~(1-2-14)、(1-3-1)、または(1-3-2)で表される化合物において、SpおよびSpが独立して、炭素数1から10のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-、-COO-、-OCOO-、または-OCO-で置き換えられてもよく、少なくとも1つの-(CH-は、-CH=CH-で置き換えられてもよい請求項7に記載の化合物。 In the formulas (1-1-1) to (1-1-7), (1-2-1) to (1-2-14), (1-3-1), or (1-3-2) In the compounds represented, Sp 1 and Sp 2 are independently alkylenes having 1 to 10 carbon atoms, in which at least one -CH 2- is -O-, -COO-, -OCOO-. , Or the compound according to claim 7, wherein the −OCO— may be replaced, and at least one − (CH 2 ) 2 − may be substituted with −CH = CH−.
  9.  請求項1から8のいずれか1項に記載した化合物の少なくとも1つを含有する液晶組成物。 A liquid crystal composition containing at least one of the compounds according to any one of claims 1 to 8.
  10.  式(2)から式(4)で表される化合物の群から選択される少なくとも1つの化合物をさらに含有する、請求項9に記載の液晶組成物。

    Figure JPOXMLDOC01-appb-I000012

    式(2)から式(4)において、
     R11およびR12は独立して、炭素数1から10のアルキルまたは炭素数2から10のアルケニルであり、このアルキルおよびアルケニルにおいて、少なくとも1つの-CH-は-O-で置き換えられてもよく、少なくとも1つの水素はフッ素で置き換えられてもよく;
     環B、環B、環B、および環Bは独立して、1,4-シクロヘキシレン、1,4-フェニレン、2-フルオロ-1,4-フェニレン、2,5-ジフルオロ-1,4-フェニレン、またはピリミジン-2,5-ジイルであり;
     Z11、Z12、およびZ13は独立して、単結合、-(CH-、-CH=CH-、-C≡C-、または-COO-である。
    The liquid crystal composition according to claim 9, further comprising at least one compound selected from the group of compounds represented by formulas (2) to (4).

    Figure JPOXMLDOC01-appb-I000012

    In equations (2) to (4),
    R 11 and R 12 are independently alkyl with 1 to 10 carbon atoms or alkenyl with 2 to 10 carbon atoms, even if at least one -CH 2- is replaced with -O- in the alkyl and alkenyl. Well, at least one hydrogen may be replaced by fluorine;
    Ring B 1 , Ring B 2 , Ring B 3 , and Ring B 4 are independent, 1,4-cyclohexylene, 1,4-phenylene, 2-fluoro-1,4-phenylene, 2,5-difluoro-. 1,4-phenylene, or pyrimidine-2,5-diyl;
    Z 11 , Z 12 , and Z 13 are independently single-bonded,-(CH 2 ) 2- , -CH = CH-, -C≡C-, or -COO-.
  11.  式(5)から式(7)で表される化合物の群から選択される少なくとも1つの化合物をさらに含有する、請求項9または10に記載の液晶組成物。

    Figure JPOXMLDOC01-appb-I000013

    式(5)から式(7)において、
     R13は炭素数1から10のアルキルまたは炭素数2から10のアルケニルであり、このアルキルおよびアルケニルにおいて、少なくとも1つの-CH-は-O-で置き換えられてもよく、少なくとも1つの水素はフッ素で置き換えられてもよく;
     X11は、フッ素、塩素、-OCF、-OCHF、-CF、-CHF、-CHF、-OCFCHF、または-OCFCHFCFであり;
     環C、環C、および環Cは独立して、1,4-シクロヘキシレン、少なくとも1つの水素がフッ素で置き換えられてもよい1,4-フェニレン、テトラヒドロピラン-2,5-ジイル、1,3-ジオキサン-2,5-ジイル、またはピリミジン-2,5-ジイルであり;
     Z14、Z15、およびZ16は独立して、単結合、-(CH-、-CH=CH-、-C≡C-、-COO-、-CFO-、-OCF-、-CHO-、-CF=CF-、-CH=CF-または-(CH-であり;
     L11およびL12は独立して、水素またはフッ素である。
    The liquid crystal composition according to claim 9 or 10, further comprising at least one compound selected from the group of compounds represented by formulas (5) to (7).

    Figure JPOXMLDOC01-appb-I000013

    In equations (5) to (7),
    R 13 is an alkyl having 1 to 10 carbon atoms or an alkenyl having 2 to 10 carbon atoms, in which at least one -CH 2- may be replaced with -O-, and at least one hydrogen is. May be replaced with fluorine;
    X 11 is fluorine, chlorine, -OCF 3 , -OCHF 2 , -CF 3 , -CHF 2 , -CH 2 F, -OCF 2 CHF 2 , or -OCF 2 CHFCF 3 ;
    Ring C 1 , Ring C 2 , and Ring C 3 are independently 1,4-cyclohexylene, 1,4-phenylene, where at least one hydrogen may be replaced by fluorine, tetrahydropyran-2,5-diyl. , 1,3-dioxane-2,5-diyl, or pyrimidine-2,5-diyl;
    Z 14 , Z 15 and Z 16 are independently single-bonded,-(CH 2 ) 2- , -CH = CH-, -C≡C-, -COO-, -CF 2 O-, -OCF 2 -, - CH 2 O -, - CF = CF -, - CH = CF- or - (CH 2) 4 - a and;
    L 11 and L 12 are independently hydrogen or fluorine.
  12.  式(8)で表される化合物の群から選択される少なくとも1つの化合物をさらに含有する、請求項9から11のいずれか1項に記載の液晶組成物。

    Figure JPOXMLDOC01-appb-I000014

    式(8)において、
     R14は炭素数1から10のアルキルまたは炭素数2から10のアルケニルであり、このアルキルおよびアルケニルにおいて、少なくとも1つの-CH2-は-O-で置き換えられてもよく、少なくとも1つの水素はフッ素で置き換えられてもよく;
     X12は-C≡Nまたは-C≡C-C≡Nであり;
     環Dは独立して、1,4-シクロヘキシレン、少なくとも1つの水素がフッ素で置き換えられてもよい1,4-フェニレン、テトラヒドロピラン-2,5-ジイル、1,3-ジオキサン-2,5-ジイル、またはピリミジン-2,5-ジイルであり;
     Z17は独立して、単結合、-(CH-、-C≡C-、-COO-、-CFO-、-OCF-、または-CHO-であり;
     L13およびL14は独立して、水素またはフッ素であり;
     iは、1、2、3、または4である。
    The liquid crystal composition according to any one of claims 9 to 11, further containing at least one compound selected from the group of compounds represented by the formula (8).

    Figure JPOXMLDOC01-appb-I000014

    In equation (8)
    R 14 is an alkyl having 1 to 10 carbon atoms or an alkenyl having 2 to 10 carbon atoms, in which at least one -CH 2- may be replaced with -O-, and at least one hydrogen is. May be replaced with fluorine;
    X 12 is -C≡N or -C≡C-C≡N;
    Ring D 1 is independently 1,4-cyclohexylene, 1,4-phenylene in which at least one hydrogen may be replaced by fluorine, tetrahydropyran-2,5-diyl, 1,3-dioxane-2, 5-dioxane, or pyrimidine-2,5-dioxane;
    Z 17 is independently a single bond, - (CH 2) 2 - , - C≡C -, - COO -, - CF 2 O -, - OCF 2 -, or -CH 2 O-;
    L 13 and L 14 are independently hydrogen or fluorine;
    i is 1, 2, 3, or 4.
  13.  式(9)から式(15)で表される化合物の群から選択される少なくとも1つの化合物をさらに含有する、請求項9から12のいずれか1項に記載の液晶組成物。

    Figure JPOXMLDOC01-appb-I000015

    式(9)から式(15)において、
     R15およびR16は独立して、炭素数1から10のアルキルまたは炭素数2から10のアルケニルであり、このアルキルおよびアルケニルにおいて、少なくとも1つの-CH-は-O-で置き換えられてもよく、少なくとも1つの水素はフッ素で置き換えられてもよく;
     R17は、水素、フッ素、炭素数1から10のアルキル、または炭素数2から10のアルケニルであり、このアルキルおよびアルケニルにおいて、少なくとも1つの-CH-は-O-で置き換えられてもよく、少なくとも1つの水素はフッ素で置き換えられてもよく;
     環E、環E、環E、および環Eは独立して、1,4-シクロヘキシレン、1,4-シクロヘキセニレン、少なくとも1つの水素がフッ素で置き換えられてもよい1,4-フェニレン、テトラヒドロピラン-2,5-ジイル、またはデカヒドロナフタレン-2,6-ジイルであり;
     環Eおよび環Eは独立して、1,4-シクロヘキシレン、1,4-シクロヘキセニレン、1,4-フェニレン、テトラヒドロピラン-2,5-ジイル、またはデカヒドロナフタレン-2,6-ジイルであり;
     Z18、Z19、Z20、およびZ21は独立して、単結合、-(CH-、-COO-、-CHO-、-OCF-、または-OCFCHCH-であり;
     L15およびL16は独立して、フッ素または塩素であり;
     S11は、水素またはメチルであり;
     Xは、-CHF-または-CF-であり;
     j、k、m、n、p、q、r、およびsは独立して、0または1であり、k、m、n、およびpの和は、1または2であり、q、r、およびsの和は、0、1、2、または3であり、tは、1、2、または3である。
    The liquid crystal composition according to any one of claims 9 to 12, further comprising at least one compound selected from the group of compounds represented by the formulas (9) to (15).

    Figure JPOXMLDOC01-appb-I000015

    In equations (9) to (15),
    R 15 and R 16 are independently alkyls with 1 to 10 carbon atoms or alkenyl with 2 to 10 carbon atoms, even if at least one -CH 2- is replaced with -O- in the alkyl and alkenyl. Well, at least one hydrogen may be replaced by fluorine;
    R 17 is hydrogen, fluorine, an alkyl having 1 to 10 carbon atoms, or an alkenyl having 2 to 10 carbon atoms, in which at least one -CH 2- may be replaced with -O-. , At least one hydrogen may be replaced by fluorine;
    Ring E 1 , Ring E 2 , Ring E 3 , and Ring E 4 may independently replace 1,4-cyclohexylene, 1,4-cyclohexenylene, and at least one hydrogen with fluorine 1, 4-Phenylene, tetrahydropyran-2,5-diyl, or decahydronaphthalene-2,6-diyl;
    Rings E 5 and E 6 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, tetrahydropyran-2,5-diyl, or decahydronaphthalene-2,6. -Jeil;
    Z 18, Z 19, Z 20 , and Z 21 are independently a single bond, - (CH 2) 2 - , - COO -, - CH 2 O -, - OCF 2 -, or -OCF 2 CH 2 CH 2- is;
    L 15 and L 16 are independently fluorine or chlorine;
    S 11 is hydrogen or methyl;
    X is -CHF- or -CF 2- ;
    j, k, m, n, p, q, r, and s are independently 0 or 1, and the sum of k, m, n, and p is 1 or 2, q, r, and The sum of s is 0, 1, 2, or 3, and t is 1, 2, or 3.
  14.  式(16)で表される化合物の群から選択される少なくとも1つの重合性化合物を含有する、請求項9から13のいずれか1項に記載の液晶組成物。

    Figure JPOXMLDOC01-appb-I000016

    式(16)において、
     環Fおよび環Iは独立して、シクロヘキシル、シクロヘキセニル、フェニル、1-ナフチル、2-ナフチル、テトラヒドロピラン-2-イル、1,3-ジオキサン-2-イル、ピリミジン-2-イル、またはピリジン-2-イルであり、これらの環において、少なくとも1つの水素は、フッ素、塩素、炭素数1から12のアルキル、または少なくとも1つの水素がフッ素または塩素で置き換えられた炭素数1から12のアルキルで置き換えられてもよく;
     環Gは、1,4-シクロへキシレン、1,4-シクロヘキセニレン、1,4-フェニレン、ナフタレン-1,2-ジイル、ナフタレン-1,3-ジイル、ナフタレン-1,4-ジイル、ナフタレン-1,5-ジイル、ナフタレン-1,6-ジイル、ナフタレン-1,7-ジイル、ナフタレン-1,8-ジイル、ナフタレン-2,3-ジイル、ナフタレン-2,6-ジイル、ナフタレン-2,7-ジイル、テトラヒドロピラン-2,5-ジイル、1,3-ジオキサン-2,5-ジイル、ピリミジン-2,5-ジイル、またはピリジン-2,5-ジイルであり、これらの環において、少なくとも1つの水素は、フッ素、塩素、炭素数1から12のアルキル、炭素数1から12のアルコキシ、または少なくとも1つの水素がフッ素または塩素で置き換えられた炭素数1から12のアルキルで置き換えられてもよく;
     Z22およびZ23は独立して、単結合または炭素数1から10のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-、-CO-、-COO-、または-OCO-で置き換えられてもよく、少なくとも1つの-(CH-は、-CH=CH-、-C(CH)=CH-、-CH=C(CH)-、または-C(CH)=C(CH)-で置き換えられてもよく、これらの基において、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよく;
     P11、P12、およびP13は独立して、式(P-1)から式(P-5)で表される基の群から選択された重合性基であり;

    Figure JPOXMLDOC01-appb-I000017

     M11、M12、およびM13は独立して、水素、フッ素、炭素数1から5のアルキル、または少なくとも1つの水素がフッ素または塩素で置き換えられた炭素数1から5のアルキルであり;
     Sp11、Sp12、およびSp13は独立して、単結合または炭素数1から10のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-、-COO-、-OCO-、または-OCOO-で置き換えられてもよく、少なくとも1つの-(CH-は、-CH=CH-または-C≡C-で置き換えられてもよく、これらの基において、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよく;
     uは、0、1、または2であり;
     f、g、およびhは独立して、0、1、2、3、または4であり、そしてf、g、およびhの和は2以上である。
    The liquid crystal composition according to any one of claims 9 to 13, which contains at least one polymerizable compound selected from the group of compounds represented by the formula (16).

    Figure JPOXMLDOC01-appb-I000016

    In equation (16)
    Rings F and I are independently cyclohexyl, cyclohexenyl, phenyl, 1-naphthyl, 2-naphthyl, tetrahydropyran-2-yl, 1,3-dioxane-2-yl, pyrimidine-2-yl, or pyridine. -2-yl, in these rings at least one hydrogen is fluorine, chlorine, alkyl with 1 to 12 carbon atoms, or at least one hydrogen is alkyl with 1 to 12 carbon atoms with fluorine or chlorine replaced. May be replaced with;
    Ring G is 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, naphthalene-1,2-diyl, naphthalene-1,3-diyl, naphthalene-1,4-diyl, Naphthalene-1,5-diyl, naphthalene-1,6-diyl, naphthalene-1,7-diyl, naphthalene-1,8-diyl, naphthalene-2,3-diyl, naphthalene-2,6-diyl, naphthalene- 2,7-Diyl, tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyrimidine-2,5-diyl, or pyridine-2,5-diyl, in these rings. , At least one hydrogen is replaced with fluorine, chlorine, alkyl with 1 to 12 carbon atoms, alkoxy with 1 to 12 carbon atoms, or alkyl with 1 to 12 carbon atoms in which at least one hydrogen is replaced with fluorine or chlorine. May;
    Z 22 and Z 23 are independently single bonds or alkylenes with 1 to 10 carbon atoms, in which at least one -CH 2- is -O-, -CO-, -COO-, or-. It may be replaced by OCO-, and at least one- (CH 2 ) 2- is -CH = CH-, -C (CH 3 ) = CH-, -CH = C (CH 3 )-, or -C. It may be replaced by (CH 3 ) = C (CH 3 )-and at least one hydrogen in these groups may be replaced by fluorine or chlorine;
    P 11, P 12, and P 13 are independently a polymerizable group selected from the group of radicals represented by the formula (P-1) by the formula (P-5);

    Figure JPOXMLDOC01-appb-I000017

    M 11 , M 12 , and M 13 are independently hydrogen, fluorine, alkyl having 1 to 5 carbon atoms, or alkyl having 1 to 5 carbon atoms in which at least one hydrogen is replaced with fluorine or chlorine;
    Sp 11 , Sp 12 , and Sp 13 are independently single bonds or alkylenes with 1 to 10 carbon atoms, in which at least one -CH 2- is -O-, -COO-, -OCO. -Or -OCOO- may be replaced, and at least one- (CH 2 ) 2- may be replaced with -CH = CH- or -C≡C-, at least 1 in these groups. One hydrogen may be replaced with fluorine or chlorine;
    u is 0, 1, or 2;
    f, g, and h are independently 0, 1, 2, 3, or 4, and the sum of f, g, and h is greater than or equal to 2.
  15.  式(16-1)から式(16-27)で表される化合物の群から選択された少なくとも1つの重合性化合物を含有する、請求項9から14のいずれか1項に記載の液晶組成物。

    Figure JPOXMLDOC01-appb-I000018

    Figure JPOXMLDOC01-appb-I000019

    Figure JPOXMLDOC01-appb-I000020

    式(16-1)から式(16-27)において、
     P11、P12、およびP13は独立して、式(P-1)から式(P-3)で表される基の群から選択された重合性基であり、ここでM11、M12、およびM13は独立して、水素、フッ素、炭素数1から5のアルキル、または少なくとも1つの水素がフッ素または塩素で置き換えられた炭素数1から5のアルキルであり;

    Figure JPOXMLDOC01-appb-I000021

     Sp11、Sp12、およびSp13は独立して、単結合または炭素数1から10のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-、-COO-、-OCO-、または-OCOO-で置き換えられてもよく、少なくとも1つの-(CH-は、-CH=CH-または-C≡C-で置き換えられてもよく、これらの基において、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよい。
    The liquid crystal composition according to any one of claims 9 to 14, which contains at least one polymerizable compound selected from the group of compounds represented by formulas (16-1) to (16-27). ..

    Figure JPOXMLDOC01-appb-I000018

    Figure JPOXMLDOC01-appb-I000019

    Figure JPOXMLDOC01-appb-I000020

    In equations (16-1) to (16-27),
    P 11 , P 12 , and P 13 are independently polymerizable groups selected from the group of groups represented by the formulas (P-1) to (P-3), wherein M 11 , M. 12, and M 13 are independently hydrogen, fluorine, alkyl of C 1 -C 5 alkyl or at least one hydrogen is from 1 carbon atoms is replaced by fluorine or chlorine, 5;

    Figure JPOXMLDOC01-appb-I000021

    Sp 11 , Sp 12 , and Sp 13 are independently single bonds or alkylenes with 1 to 10 carbon atoms, in which at least one -CH 2- is -O-, -COO-, -OCO. -Or -OCOO- may be replaced, and at least one- (CH 2 ) 2- may be replaced with -CH = CH- or -C≡C-, at least 1 in these groups. One hydrogen may be replaced with fluorine or chlorine.
  16.  式(1)および式(16)以外の重合性化合物、重合開始剤、重合禁止剤、光学活性化合物、酸化防止剤、紫外線吸収剤、光安定剤、熱安定剤、および消泡剤の少なくとも1つをさらに含有する、請求項9から15のいずれか1項に記載の液晶組成物。 At least one of a polymerizable compound other than the formulas (1) and (16), a polymerization initiator, a polymerization inhibitor, an optically active compound, an antioxidant, an ultraviolet absorber, a light stabilizer, a heat stabilizer, and an antifoaming agent. The liquid crystal composition according to any one of claims 9 to 15, further comprising one.
  17.  請求項9から16のいずれか1項に記載の液晶組成物を含有する、液晶表示素子。 A liquid crystal display device containing the liquid crystal composition according to any one of claims 9 to 16.
PCT/JP2020/008675 2019-04-25 2020-03-02 Compound, liquid crystal composition, and liquid crystal display element WO2020217710A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2021515844A JPWO2020217710A1 (en) 2019-04-25 2020-03-02
CN202080029849.5A CN113710652A (en) 2019-04-25 2020-03-02 Compound, liquid crystal composition and liquid crystal display element

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019084409 2019-04-25
JP2019-084409 2019-04-25

Publications (1)

Publication Number Publication Date
WO2020217710A1 true WO2020217710A1 (en) 2020-10-29

Family

ID=72942404

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2020/008675 WO2020217710A1 (en) 2019-04-25 2020-03-02 Compound, liquid crystal composition, and liquid crystal display element

Country Status (3)

Country Link
JP (1) JPWO2020217710A1 (en)
CN (1) CN113710652A (en)
WO (1) WO2020217710A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022233908A1 (en) * 2021-05-07 2022-11-10 Merck Patent Gmbh Reactive mesogens

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004091646A (en) * 2002-08-30 2004-03-25 Fuji Photo Film Co Ltd New compound, polymer, optical element containing it, and method for manufacturing polymer
JP2011207942A (en) * 2010-03-29 2011-10-20 Fujifilm Corp Compound, polymerizable composition, polymer, and film
WO2018199096A1 (en) * 2017-04-25 2018-11-01 富士フイルム株式会社 Liquid crystal composition, light-absorbing anisotropic film, laminate, and image display device

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6425041B2 (en) * 2013-07-10 2018-11-21 Jnc株式会社 Polymerizable compound, polymerizable composition and liquid crystal display device
KR20160029755A (en) * 2013-07-11 2016-03-15 제이엔씨 주식회사 Liquid crystal composition and liquid crystal display element
JP6379735B2 (en) * 2014-06-27 2018-08-29 Jnc株式会社 Polymerizable compound having triple bond, liquid crystal composition, and liquid crystal display device
JP6870609B2 (en) * 2015-03-24 2021-05-12 Jnc株式会社 Liquid crystal composition and liquid crystal display element
JP6511975B2 (en) * 2015-06-09 2019-05-15 Jnc株式会社 Liquid crystal composition and liquid crystal display device containing dihydropyran compound
TWI694140B (en) * 2015-07-17 2020-05-21 日商捷恩智股份有限公司 Polymerizable polar compound, liquid crystal composition and liquid crystal display element

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004091646A (en) * 2002-08-30 2004-03-25 Fuji Photo Film Co Ltd New compound, polymer, optical element containing it, and method for manufacturing polymer
JP2011207942A (en) * 2010-03-29 2011-10-20 Fujifilm Corp Compound, polymerizable composition, polymer, and film
WO2018199096A1 (en) * 2017-04-25 2018-11-01 富士フイルム株式会社 Liquid crystal composition, light-absorbing anisotropic film, laminate, and image display device

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
P SAEZ , M RODRIGUEZ-BAEZA , C AGUILERA: "Synthesis and formation of anisotropic network from monomers diacrylates derivatives of 4-hydroxybenzenethiol", EUROPEAN POLYMER JOURNAL, vol. 41, no. 5, 2005, pages 1053 - 1060, XP027696166, ISSN: 0014-3057, DOI: 10.1016/j.eurpolymj.2004.11.039 *
P. SÁEZ, C.AGUILERA: "Anisotropic network formation by the photopolymerization of new monomers derived from 4-hydroxybenzenethiol", JOURNAL OF APPLIED POLYMER SCIENCE, vol. 97, no. 5, 5 September 2005 (2005-09-05), pages 1812 - 1817, XP055758439, ISSN: 0021-8995, DOI: 10.1002/app.21936 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022233908A1 (en) * 2021-05-07 2022-11-10 Merck Patent Gmbh Reactive mesogens

Also Published As

Publication number Publication date
JPWO2020217710A1 (en) 2020-10-29
CN113710652A (en) 2021-11-26
TW202039802A (en) 2020-11-01

Similar Documents

Publication Publication Date Title
JP6623567B2 (en) Dihydropyran compound, liquid crystal composition and liquid crystal display device
JP2016011346A (en) Polymerizable compound, polymerizable composition, and liquid crystal display element
WO2015076077A1 (en) Piperidine derivative, liquid crystal composition, and liquid crystal display element
JP6879207B2 (en) Polymerizable polar compounds, liquid crystal compositions and liquid crystal display devices
JP6766502B2 (en) Liquid crystal compounds having a polyfluoro-2-butenoxy group, liquid crystal compositions, and liquid crystal display devices
JP6756365B2 (en) A low-molecular-weight polar compound that homogenically orients a liquid crystal medium, and a liquid crystal medium containing the same.
WO2020184142A1 (en) Compounds, liquid crystal composition, and liquid crystal display element
JP6638814B2 (en) Polymerizable polar compound, liquid crystal composition and liquid crystal display device
JP7226340B2 (en) Compound, liquid crystal composition and liquid crystal display element
TWI804688B (en) Compound, liquid crystal composition and liquid crystal display element
JP2017025007A (en) Polar compound, liquid crystal composition and liquid crystal display element
US11299675B2 (en) Polymerizable polar compound, liquid crystal composition and liquid crystal display device
WO2019026533A1 (en) Polymerizable polar compound, liquid crystal composition, and liquid crystal display element
JP6919394B2 (en) Liquid crystal compounds having fluorene and CF2O, liquid crystal compositions and liquid crystal display devices
WO2020217710A1 (en) Compound, liquid crystal composition, and liquid crystal display element
JPWO2020008826A1 (en) Compounds, liquid crystal compositions and liquid crystal display devices
TWI787521B (en) O-bonded liquid crystal compound, liquid crystal composition and liquid crystal display element
JP6766556B2 (en) Liquid crystal compounds, liquid crystal compositions and liquid crystal display devices
JPWO2020116380A1 (en) Compounds, liquid crystal compositions, and liquid crystal display devices
JPWO2019111845A1 (en) Polymerizable polar compounds, liquid crystal compositions, and liquid crystal display devices
JPWO2020003599A1 (en) Polymerizable polar compounds, liquid crystal compositions, and liquid crystal display devices
JP2021095386A (en) Compound, liquid crystal composition, and liquid crystal display element
JP7052597B2 (en) Polymerizable polar compounds, liquid crystal compositions, and liquid crystal display devices
JP2021195365A (en) Compound, liquid crystal composition, and liquid crystal display element
WO2020209035A1 (en) Compound, liquid-crystal composition, and liquid-crystal display element

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20795768

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2021515844

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20795768

Country of ref document: EP

Kind code of ref document: A1